Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" ADAMTS3 "ADAMTS-4, KIAA0366" ENSG00000156140 "ADAM metallopeptidase with thrombospondin type 1 motif 3" O15072 4 72280969-72569386 "Cancer-related genes, Predicted secreted proteins" "Heparin-binding, Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 12.3;AN3-CA: 7.1;HEL: 12.7;K-562: 10.8;SH-SY5Y: 6.5;U-2 OS: 7.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA021368, HPA021369" Uncertain Approved "Intermediate filaments" "Secreted to extracellular matrix" "Intermediate filaments" "HPA021368: , HPA021369: " "unprognostic (1.93e-1)" "unprognostic (3.47e-3)" "unprognostic (1.41e-1)" "unprognostic (1.05e-3)" "unprognostic (6.11e-2)" "unprognostic (2.60e-1)" "unprognostic (3.26e-3)" "unprognostic (1.60e-3)" "unprognostic (5.92e-4)" "unprognostic (3.11e-2)" "unprognostic (1.93e-1)" "unprognostic (2.60e-1)" "unprognostic (8.63e-3)" "unprognostic (1.65e-3)" "unprognostic (1.17e-1)" "unprognostic (2.72e-1)" "unprognostic (1.50e-4)" 5.3 2.6 3.3 4.4 5.6 2.1 7.8 0.3 4.6 4.4 2.3 1.1 1.9 0.5 9.6 14.4 1.0 7.5 1.9 2.8 1.3 0.9 4.7 2.7 3.1 2.0 0.7 2.2 7.5 1.0 12.4 1.1 8.2 2.2 2.6 1.1 3.9 1.4 3.4 0.8 1.5 0.9 4.6 1.8 1.9 1.6 5.6 1.3 0.6 4.4 0.8 1.0 2.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 7.1 0.1 0.3 0.1 0.6 2.0 1.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 1.7 0.0 1.6 12.7 0.9 0.0 0.2 0.0 0.0 1.6 0.1 0.6 0.1 0.0 10.8 0.0 0.0 0.0 1.1 0.0 2.0 3.7 0.0 2.5 0.0 4.2 0.0 0.5 6.5 0.0 0.5 0.1 0.1 0.1 0.1 5.3 7.9 0.0 0.6 0.0 0.0 0.0 1.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 5.6 0.3 4.6 1.3 0.9 0.7 2.2 2.2 1.3 ADCY5 AC5 ENSG00000173175 "Adenylate cyclase 5" O95622 3 123282296-123449758 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 69.9" "Cell line enhanced" "Detected in some" "MCF7: 17.6;RPMI-8226: 3.1;RPTEC TERT1: 6.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "basal ganglia: 347.3" "Region enriched" "Detected in all" 6 "basal ganglia: 205.1" "HPA017730, HPA077682" Uncertain Enhanced "Intermediate filaments" "Intermediate filaments" "HPA017730: AB_1844595, HPA077682: " "unprognostic (3.55e-2)" "unprognostic (1.01e-3)" "unprognostic (7.61e-3)" "unprognostic (2.05e-2)" "unprognostic (1.25e-1)" "unprognostic (1.26e-2)" "unprognostic (1.48e-1)" "unprognostic (7.61e-2)" "unprognostic (2.49e-2)" "unprognostic (2.34e-1)" "unprognostic (7.27e-3)" "unprognostic (2.64e-2)" "prognostic favourable (7.46e-6)" "unprognostic (1.81e-2)" "unprognostic (5.65e-2)" "unprognostic (3.19e-2)" "unprognostic (5.97e-4)" 13.3 3.0 12.5 3.7 32.0 0.6 9.3 2.6 14.4 4.5 11.7 10.4 3.1 4.2 6.2 4.4 13.8 5.3 7.3 69.9 10.4 8.3 5.3 2.4 2.6 2.0 15.0 8.6 10.1 5.7 1.1 7.7 4.8 9.7 13.8 4.6 4.6 3.1 16.3 2.2 1.1 4.8 13.5 8.8 4.7 9.6 5.9 16.0 0.0 1.0 0.2 2.6 9.5 8.5 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.6 1.5 0.1 0.1 0.1 0.4 0.0 0.0 0.4 0.1 0.1 0.1 0.0 0.3 0.2 0.5 0.8 0.0 0.0 0.1 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 17.6 0.0 0.0 1.0 0.1 0.0 0.4 3.1 6.3 0.6 2.2 2.0 0.0 0.6 0.1 0.0 0.1 0.0 0.1 1.5 0.1 0.3 0.2 0.7 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 12.5 32.0 2.6 14.4 10.4 8.3 15.0 8.6 9.7 16.0 ALS2 ALS2CR6 ENSG00000003393 "ALS2, alsin Rho guanine nucleotide exchange factor" Q96Q42 2 201700554-201781189 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Amyotrophic lateral sclerosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.8" "Cell line enhanced" "Detected in many" "HMC-1: 52.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 66.8" "Group enriched" "Detected in many" 6 "basophil: 19.0;eosinophil: 5.5" "Lineage enriched" "Detected in all" 10 "granulocytes: 19.0" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 158.8" HPA046588 Enhanced Approved "Intermediate filaments,Cytosol" "Intermediate filaments, Cytosol" "HPA046588: " "unprognostic (3.43e-2)" "unprognostic (2.11e-1)" "unprognostic (1.33e-1)" "unprognostic (2.07e-3)" "unprognostic (2.72e-1)" "unprognostic (7.47e-2)" "unprognostic (1.04e-3)" "unprognostic (9.17e-2)" "unprognostic (4.16e-2)" "unprognostic (1.52e-1)" "unprognostic (2.99e-1)" "unprognostic (2.83e-2)" "unprognostic (1.09e-2)" "unprognostic (1.88e-1)" "unprognostic (1.61e-1)" "unprognostic (2.10e-1)" "unprognostic (1.84e-1)" 6.9 5.3 8.2 4.2 14.7 7.8 8.1 66.8 15.6 5.9 5.6 10.1 5.5 7.4 10.3 10.7 4.7 6.7 6.4 19.9 8.3 7.3 10.4 18.3 7.9 4.1 6.8 11.0 6.8 5.6 8.8 16.8 7.2 13.6 6.6 6.0 8.5 5.2 5.5 12.2 6.9 8.4 7.4 8.3 5.3 6.7 6.1 9.0 3.5 7.5 5.9 4.5 5.5 5.3 1.2 1.0 19.0 1.2 1.7 1.8 0.7 5.1 3.6 8.8 8.2 6.0 6.5 6.5 9.1 12.4 12.2 14.1 8.4 5.1 0.6 4.0 9.5 5.3 5.0 9.2 15.4 1.7 5.0 12.1 3.5 4.8 7.4 9.6 52.8 5.6 5.2 10.2 8.8 12.2 5.7 3.6 9.2 4.1 3.4 12.6 7.3 5.5 2.8 4.9 1.8 7.7 7.0 4.1 5.4 5.3 5.8 8.2 3.7 4.0 7.3 10.7 5.1 3.7 4.6 4.1 5.6 2.1 7.8 1.9 6.8 19.0 0.7 5.5 1.7 1.2 1.8 1.2 1.2 1.2 1.0 1.2 1.3 1.5 0.6 1.7 0.8 0.5 1.8 0.7 8.2 14.7 66.8 15.6 8.3 7.3 6.8 11.0 13.6 9.0 ANAPC4 APC4 ENSG00000053900 "Anaphase promoting complex subunit 4" Q9UJX5 4 25377213-25418498 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032519, HPA038395, HPA038396" Approved Approved "Intermediate filaments" "Intermediate filaments" "CAB032519: AB_2274023, HPA038395: AB_10794632, HPA038396: AB_10795356" "unprognostic (1.36e-1)" "unprognostic (9.15e-2)" "unprognostic (6.06e-3)" "prognostic favourable (5.73e-7)" "unprognostic (1.14e-1)" "prognostic favourable (1.95e-4)" "unprognostic (1.18e-3)" "unprognostic (5.44e-3)" "unprognostic (1.07e-1)" "unprognostic (6.11e-3)" "unprognostic (1.28e-1)" "unprognostic (8.86e-2)" "prognostic unfavourable (1.17e-5)" "unprognostic (1.93e-1)" "unprognostic (1.15e-1)" "unprognostic (8.95e-2)" "prognostic favourable (1.12e-6)" 12.2 15.4 14.5 15.7 14.9 14.7 14.5 16.4 16.4 22.7 13.0 14.8 25.4 10.5 29.2 21.4 13.0 32.3 11.0 10.7 12.6 10.6 12.6 13.0 13.0 16.6 15.8 10.4 18.8 15.3 15.3 22.4 13.7 13.5 15.4 15.5 14.7 13.3 36.5 12.3 13.0 14.4 23.4 16.2 18.2 13.0 9.6 14.2 19.6 13.4 7.3 15.9 18.3 13.4 8.5 6.4 13.8 11.3 9.4 13.8 6.0 12.3 7.2 12.8 13.3 13.5 15.1 18.4 14.7 11.0 14.0 13.6 11.6 19.8 20.2 7.9 12.5 10.0 13.6 12.4 16.2 7.2 10.4 19.6 12.9 10.8 9.1 15.2 16.1 11.6 9.4 12.3 7.5 12.1 28.2 6.1 17.7 9.6 19.6 24.9 17.7 9.1 14.1 21.5 15.0 11.7 13.5 14.4 8.6 11.0 6.6 9.1 9.8 16.4 12.3 12.0 7.6 9.2 16.9 8.1 14.2 19.4 13.0 21.8 11.3 1.8 7.4 13.8 10.1 8.7 13.8 8.5 9.1 11.8 6.4 7.0 8.3 10.3 3.0 9.4 11.3 4.1 11.0 6.0 14.5 14.9 16.4 16.4 12.6 10.6 15.8 10.4 13.5 14.2 APOBEC3C "APOBEC1L, ARDC2, ARDC4, ARP5, bK150C2.3, PBI" ENSG00000244509 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3C" Q9NRW3 22 39014083-39020352 "Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 114.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB033048, HPA071523" Approved Approved "Intermediate filaments" "Intermediate filaments" "CAB033048: AB_2057401, HPA071523: " "unprognostic (1.79e-3)" "prognostic favourable (1.08e-5)" "unprognostic (4.32e-3)" "unprognostic (3.20e-3)" "unprognostic (4.68e-2)" "unprognostic (2.13e-1)" "unprognostic (5.18e-2)" "unprognostic (2.55e-1)" "unprognostic (1.10e-1)" "unprognostic (1.08e-3)" "unprognostic (7.40e-2)" "unprognostic (4.10e-2)" "prognostic unfavourable (8.91e-10)" "unprognostic (5.92e-2)" "unprognostic (1.11e-1)" "unprognostic (4.10e-1)" "unprognostic (3.52e-3)" 13.3 28.0 2.3 15.6 3.4 9.2 8.0 1.1 2.0 21.4 13.1 4.2 27.5 4.5 18.2 23.5 19.6 20.9 13.8 13.0 2.2 2.0 6.3 4.5 11.7 20.9 3.3 2.0 26.4 5.3 0.7 3.3 7.7 3.2 20.7 12.0 12.9 12.3 114.8 3.4 6.9 11.8 17.2 4.2 32.2 8.1 45.6 2.4 16.2 8.7 17.0 45.5 21.8 12.7 48.1 19.7 49.3 42.6 35.2 61.3 26.2 10.6 10.5 1.8 20.6 11.6 24.1 9.0 7.8 15.3 11.6 15.5 10.0 12.1 31.6 5.2 15.4 10.9 1.8 33.1 11.3 11.9 9.0 30.4 0.5 8.2 12.6 19.7 30.6 26.1 19.2 15.1 3.8 6.4 18.5 40.3 23.1 0.1 7.9 10.7 2.7 23.1 13.8 4.8 26.3 7.6 14.1 0.5 1.4 11.3 0.0 5.7 0.1 7.3 3.3 6.2 10.7 3.3 3.3 10.9 11.2 2.6 19.2 12.8 16.2 13.6 20.3 49.3 61.3 40.2 42.2 44.6 33.6 54.6 19.7 48.1 11.5 41.1 2.7 35.2 42.6 16.7 30.5 26.2 2.3 3.4 1.1 2.0 2.2 2.0 3.3 2.0 3.2 2.4 BCAS4 "CNOL, FLJ20495" ENSG00000124243 "Breast carcinoma amplified sequence 4" Q8TDM0 20 50794894-50882676 "Disease related genes, Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.9;lymphoid tissue: 31.6" "Cell line enhanced" "Detected in many" "Daudi: 38.1;U-698: 33.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 28.9;naive B-cell: 28.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA038812 Uncertain Approved "Intermediate filaments,Cytosol" "Intermediate filaments, Cytosol" "HPA038812: AB_10795141" "unprognostic (3.48e-1)" "unprognostic (1.60e-2)" "unprognostic (4.54e-2)" "prognostic unfavourable (4.87e-4)" "unprognostic (8.35e-2)" "unprognostic (2.98e-1)" "unprognostic (2.47e-3)" "unprognostic (1.04e-3)" "unprognostic (2.83e-1)" "unprognostic (1.57e-2)" "unprognostic (1.23e-2)" "unprognostic (2.33e-1)" "unprognostic (2.35e-2)" "unprognostic (1.57e-2)" "unprognostic (1.31e-1)" "unprognostic (2.26e-2)" "unprognostic (4.30e-2)" 1.8 2.3 7.3 29.1 12.9 3.9 4.5 6.2 12.8 4.8 4.2 2.3 4.2 2.4 5.4 7.2 4.7 3.6 3.8 3.1 13.8 7.5 7.0 1.4 3.8 28.5 7.1 9.2 3.0 3.6 9.2 5.4 5.0 5.2 7.7 1.9 8.8 4.9 7.1 2.1 2.1 8.6 6.0 2.0 12.2 4.5 5.1 2.2 9.2 5.9 0.0 31.6 7.6 5.3 28.9 7.0 0.6 0.1 6.9 12.9 5.3 4.8 8.7 0.7 3.8 1.4 3.6 1.5 6.3 5.7 4.6 3.2 4.1 2.9 38.1 2.4 2.6 7.2 4.3 9.1 2.6 2.4 3.8 0.2 3.4 3.4 1.9 0.0 0.2 1.2 5.3 3.5 1.7 0.2 0.1 0.2 1.6 17.0 1.4 0.1 3.1 7.1 11.9 1.1 0.3 2.1 4.4 3.9 4.1 9.8 9.4 0.2 18.6 0.4 0.2 4.9 7.2 4.9 1.5 0.6 2.8 33.9 2.0 0.3 0.4 0.6 0.1 0.1 6.2 0.1 3.5 28.9 3.8 7.5 0.1 28.7 12.9 10.3 0.6 6.9 0.1 7.0 3.1 5.3 7.3 12.9 6.2 12.8 13.8 7.5 7.1 9.2 5.2 2.2 BICDL2 CCDC64B ENSG00000162069 "BICD family like cargo adaptor 2" A1A5D9 16 3027682-3036926 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 31.1;pancreas: 54.1" "Cell line enhanced" "Detected in some" "A-431: 6.3;BEWO: 11.3;CAPAN-2: 10.4;HaCaT: 16.2;MCF7: 15.7;RT4: 7.4;SK-BR-3: 8.1;T-47d: 10.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "eosinophil: 2.6;neutrophil: 3.5" "Lineage enriched" "Detected in single" 15 "granulocytes: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA043251 Approved Approved "Intermediate filaments,Actin filaments,Cytosol" "Intermediate filaments, Actin filaments, Cytosol" "HPA043251: AB_10794925" "unprognostic (2.00e-1)" "unprognostic (5.37e-2)" "unprognostic (1.71e-1)" "unprognostic (6.06e-3)" "unprognostic (9.65e-5)" "unprognostic (5.79e-3)" "unprognostic (6.47e-2)" "unprognostic (1.75e-2)" "unprognostic (2.45e-1)" "unprognostic (1.66e-2)" "unprognostic (2.05e-2)" "unprognostic (4.71e-2)" "unprognostic (8.56e-2)" "unprognostic (2.55e-2)" "unprognostic (2.38e-1)" "unprognostic (4.32e-2)" "prognostic favourable (9.04e-4)" 0.4 0.0 0.4 2.5 0.4 0.0 2.9 0.4 0.4 6.2 7.9 0.4 8.3 5.7 1.0 2.0 31.1 2.2 11.0 0.4 0.4 0.0 1.2 0.4 5.3 0.4 0.4 0.4 0.9 54.1 3.6 0.9 0.5 0.4 5.1 3.5 0.4 13.9 8.3 1.1 13.7 6.9 1.0 0.4 0.4 10.2 0.5 0.4 0.4 2.3 8.6 12.4 6.1 12.0 0.1 0.1 3.5 0.0 0.2 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 1.8 10.4 0.0 0.0 0.0 16.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 7.4 0.1 0.0 0.0 8.1 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.5 0.2 0.0 0.1 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 C11orf95 MGC3032 ENSG00000188070 "Chromosome 11 open reading frame 95" C9JLR9 11 63759892-63768775 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045002 Approved "Intermediate filaments" "Intermediate filaments" "HPA045002: " "unprognostic (4.23e-3)" "unprognostic (7.24e-3)" "unprognostic (6.47e-2)" "unprognostic (9.01e-3)" "unprognostic (7.54e-2)" "unprognostic (3.89e-1)" "unprognostic (8.94e-2)" "unprognostic (3.67e-1)" "unprognostic (1.03e-1)" "unprognostic (6.00e-2)" "unprognostic (8.01e-3)" "unprognostic (2.89e-1)" "unprognostic (1.52e-3)" "unprognostic (1.85e-2)" "unprognostic (6.60e-2)" "unprognostic (5.68e-2)" "unprognostic (1.31e-3)" 7.3 4.7 6.0 3.0 6.3 0.6 9.3 3.4 7.9 11.1 4.3 1.9 7.2 2.1 10.5 4.6 4.2 6.8 7.0 5.2 4.3 6.3 3.8 3.5 3.4 0.1 3.7 14.2 5.3 4.7 1.6 7.3 2.5 5.9 2.0 3.3 5.6 7.4 4.4 1.2 1.9 8.8 1.5 3.5 1.9 3.8 1.0 4.9 6.6 3.4 3.2 5.0 15.1 0.6 0.7 1.0 1.5 2.3 0.9 0.3 2.1 2.9 22.1 7.3 11.6 13.4 3.5 8.1 5.9 3.9 2.7 7.0 1.4 6.9 12.0 7.8 4.9 9.6 3.3 4.4 6.7 6.4 4.6 4.8 3.2 4.0 2.2 3.8 9.9 1.1 6.3 2.1 8.5 5.8 3.1 6.1 2.8 8.1 11.3 10.3 8.5 19.5 4.2 2.1 5.6 2.7 9.3 19.7 3.9 4.2 10.8 5.9 5.4 13.3 7.9 7.4 10.0 4.6 2.8 3.7 8.4 2.1 5.6 3.9 0.0 0.1 0.0 0.8 1.5 0.4 0.0 0.2 0.9 0.0 0.6 0.4 0.6 1.0 2.3 0.3 0.7 0.0 0.3 C12orf54 MGC35033 ENSG00000177627 "Chromosome 12 open reading frame 54" Q6X4T0 12 48482503-48496512 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 38 "testis: 34.8" "Group enriched" "Detected in some" 4 "HaCaT: 2.8;HBEC3-KT: 9.2;hTCEpi: 2.6;hTERT-HME1: 5.5" "Group enriched" "Detected in some" 9 "cervical cancer: 2.9;head and neck cancer: 2.1;lung cancer: 1.6;urothelial cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA073090 Approved "Intermediate filaments" "Intermediate filaments" "HPA073090: " "unprognostic (2.59e-3)" "unprognostic (5.49e-2)" "unprognostic (7.94e-3)" "unprognostic (2.60e-2)" "unprognostic (2.48e-2)" "unprognostic (8.99e-2)" "unprognostic (5.96e-2)" "unprognostic (1.62e-1)" "unprognostic (8.01e-2)" "unprognostic (1.36e-4)" "unprognostic (2.37e-1)" "unprognostic (5.06e-3)" "unprognostic (7.53e-2)" "unprognostic (1.34e-1)" "unprognostic (1.97e-1)" "unprognostic (1.92e-1)" 0.1 0.3 0.2 0.1 0.1 0.0 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.0 0.3 0.1 0.6 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.0 34.8 0.1 0.1 0.1 0.1 0.9 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 9.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 2.6 0.0 5.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.2 0.1 0.3 0.1 0.1 0.1 C17orf98 LOC388381 ENSG00000275489 "Chromosome 17 open reading frame 98" A8MV24 17 38835088-38841455 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 10.7" "Cell line enriched" "Detected in some" 6 "hTCEpi: 7.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051696 Uncertain Approved "Nucleoli,Intermediate filaments" "Intermediate filaments" Nucleoli "HPA051696: " "unprognostic (2.30e-1)" "unprognostic (3.25e-4)" "unprognostic (1.46e-1)" "unprognostic (3.01e-1)" "unprognostic (2.82e-3)" "unprognostic (1.14e-2)" "unprognostic (8.69e-3)" "unprognostic (2.56e-1)" "unprognostic (7.58e-2)" "unprognostic (9.02e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 1.3 0.5 0.4 0.4 0.2 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.2 0.0 0.2 0.2 0.3 0.0 0.0 7.7 0.1 0.0 0.1 0.1 0.0 0.0 0.5 0.0 1.2 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 1.1 0.0 1.0 0.5 0.0 1.3 0.3 0.5 0.0 0.2 0.2 0.5 0.7 0.0 C19orf25 FLJ36666 ENSG00000119559 "Chromosome 19 open reading frame 25" Q9UFG5 19 1461143-1479556 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050270, HPA067491" Approved Approved "Intermediate filaments" "Intermediate filaments" "HPA050270: , HPA067491: " "unprognostic (5.82e-2)" "unprognostic (3.87e-2)" "unprognostic (6.51e-2)" "prognostic favourable (1.08e-4)" "unprognostic (1.74e-1)" "unprognostic (2.14e-3)" "prognostic unfavourable (3.81e-4)" "unprognostic (1.10e-2)" "unprognostic (1.36e-1)" "unprognostic (2.49e-2)" "prognostic favourable (1.21e-4)" "unprognostic (5.35e-2)" "prognostic favourable (9.20e-8)" "unprognostic (3.50e-3)" "unprognostic (8.01e-2)" "unprognostic (1.82e-1)" "unprognostic (1.91e-3)" 12.1 17.9 25.8 14.2 22.1 10.4 11.2 26.4 22.6 12.7 15.7 19.0 17.7 23.2 17.2 12.5 12.1 17.6 12.5 17.2 24.5 21.8 17.9 16.8 13.0 19.9 23.4 15.6 16.4 27.0 10.4 18.2 15.4 15.3 15.3 8.2 16.5 27.0 13.9 11.7 13.7 22.2 14.0 23.0 16.5 16.8 17.6 17.2 17.3 24.1 7.4 14.9 12.6 18.0 28.2 28.6 34.1 20.2 17.1 31.2 23.0 13.1 10.2 6.4 10.1 6.2 5.7 12.7 13.0 9.1 14.1 13.1 14.7 6.8 7.6 10.3 7.0 16.2 9.7 8.3 3.3 23.5 14.6 9.2 6.0 17.1 13.5 14.4 18.2 5.3 18.8 5.9 9.5 7.3 23.8 18.0 8.8 7.4 13.5 12.1 20.3 16.6 22.4 8.9 19.3 9.8 8.9 10.8 14.7 9.6 12.5 15.3 18.3 17.0 8.9 10.9 12.3 22.0 12.4 25.6 13.8 12.5 11.3 14.8 19.4 26.5 20.2 34.1 27.4 19.7 22.2 22.1 25.2 23.4 14.4 28.2 26.1 20.9 32.1 17.1 15.7 28.6 31.2 23.0 25.8 22.1 26.4 22.6 24.5 21.8 23.4 15.6 15.3 17.2 C1orf141 ENSG00000203963 "Chromosome 1 open reading frame 141" Q5JVX7 1 67092165-67231853 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 14.9;fallopian tube: 12.8;testis: 18.7" "Cell line enriched" "Detected in single" 37 "HEL: 17.7" "Not detected" "Not detected" "Region enriched" "Detected in many" 6 "pons and medulla: 14.9" "Group enriched" "Detected in some" 5 "basophil: 2.5;neutrophil: 1.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.5" "Low region specificity" "Detected in all" HPA035316 Uncertain "Intermediate filaments" "Intermediate filaments" "HPA035316: AB_10600886" "unprognostic (1.48e-1)" "unprognostic (8.09e-2)" "unprognostic (2.71e-1)" "unprognostic (2.79e-3)" "unprognostic (1.01e-1)" "unprognostic (2.20e-2)" 0.0 0.0 1.1 0.0 2.6 0.0 0.0 0.1 1.3 0.3 0.1 1.9 0.0 0.0 0.1 1.1 0.0 12.8 0.2 0.0 2.6 1.8 0.1 0.1 2.0 0.1 0.3 0.7 1.8 0.0 0.0 1.0 0.0 14.9 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.5 0.0 0.2 18.7 0.9 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 2.5 0.1 0.4 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 17.7 0.4 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.4 0.0 0.1 0.0 0.5 1.1 2.6 0.1 1.3 2.6 1.8 0.3 0.7 14.9 0.9 C6orf52 ENSG00000137434 "Chromosome 6 open reading frame 52" Q5T4I8 6 10671418-10694797 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 17.7" "Cell line enhanced" "Detected in many" "MCF7: 8.5;NB-4: 7.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 6.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051142 Uncertain Approved "Nuclear speckles,Intermediate filaments" "Nuclear speckles" "Intermediate filaments" "HPA051142: " "unprognostic (1.14e-2)" "unprognostic (2.21e-2)" "unprognostic (1.63e-1)" "prognostic favourable (6.50e-5)" "unprognostic (9.12e-2)" "unprognostic (2.96e-1)" "unprognostic (1.11e-3)" "unprognostic (1.67e-1)" "unprognostic (1.03e-1)" "unprognostic (2.23e-2)" "unprognostic (2.02e-1)" "unprognostic (1.17e-1)" "unprognostic (1.46e-2)" "unprognostic (2.17e-2)" "unprognostic (3.92e-2)" "unprognostic (9.31e-3)" "unprognostic (7.65e-2)" 1.6 2.4 5.6 1.4 4.8 0.9 3.0 2.7 4.3 1.2 1.5 4.4 5.5 7.7 1.4 9.0 0.9 8.0 1.2 0.7 4.9 5.3 3.8 1.4 1.7 1.1 4.5 3.2 1.9 7.7 1.5 2.9 1.5 4.4 3.1 1.0 0.7 1.8 1.7 1.2 2.5 2.1 0.9 4.0 1.0 1.6 17.7 2.6 1.6 2.1 1.0 1.6 1.0 2.0 0.7 1.0 4.7 1.0 1.4 6.2 0.6 1.1 2.7 2.5 2.1 0.9 0.0 4.3 0.2 0.1 0.3 0.6 2.9 2.3 0.1 3.9 0.0 0.2 2.4 0.0 1.0 1.3 4.1 0.6 0.5 0.4 0.0 0.8 0.4 0.5 3.8 1.0 1.5 0.0 4.6 0.3 1.0 8.5 1.8 7.5 2.3 3.0 1.5 0.2 1.0 1.2 0.6 4.9 3.0 0.9 0.6 4.8 0.2 1.5 0.4 2.0 0.6 1.5 1.7 3.5 7.4 1.5 3.4 1.0 1.9 0.0 0.5 4.7 1.2 1.0 0.4 0.5 1.5 1.3 1.0 0.7 0.7 0.6 0.6 1.4 0.7 0.8 6.2 0.6 5.6 4.8 2.7 4.3 4.9 5.3 4.5 3.2 4.4 2.6 C7orf26 MGC2718 ENSG00000146576 "Chromosome 7 open reading frame 26" Q96N11 7 6590017-6608726 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042899, HPA052175" Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol" Nucleoplasm "Nucleoli, Intermediate filaments, Cytosol" "HPA042899: , HPA052175: " "unprognostic (4.85e-2)" "unprognostic (6.87e-2)" "unprognostic (4.51e-2)" "unprognostic (2.50e-2)" "unprognostic (2.18e-2)" "unprognostic (5.22e-2)" "unprognostic (4.28e-3)" "unprognostic (1.49e-1)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "prognostic favourable (6.95e-5)" "unprognostic (4.72e-2)" "unprognostic (2.26e-3)" "unprognostic (4.41e-1)" "unprognostic (1.03e-2)" "unprognostic (3.40e-3)" "unprognostic (1.55e-1)" 19.8 17.1 13.4 21.7 17.7 29.2 20.0 20.6 26.9 19.0 17.9 21.1 21.5 19.4 23.0 15.4 14.7 19.9 15.6 12.8 14.4 14.1 15.4 18.4 19.3 24.1 18.8 20.2 20.6 23.9 17.2 16.6 14.0 15.4 21.1 11.5 16.4 21.2 16.6 18.7 21.9 16.4 19.6 13.1 27.3 18.6 16.8 16.1 31.7 18.3 18.5 20.6 17.6 19.6 4.2 6.4 4.6 3.4 3.3 6.1 1.9 11.1 9.3 6.5 15.4 10.7 6.0 8.6 6.7 5.9 9.7 6.0 8.7 4.7 13.2 8.8 4.9 12.4 8.7 6.1 4.4 5.1 12.5 4.9 5.8 9.1 12.6 11.7 15.9 6.9 9.3 5.8 6.1 10.5 12.9 10.1 5.7 18.7 10.2 24.3 13.0 12.5 20.9 5.2 11.2 6.3 9.8 8.6 15.9 6.5 21.6 9.0 9.8 17.7 7.5 8.1 26.5 8.8 14.6 12.3 12.0 12.2 5.4 13.1 23.8 1.1 3.4 4.6 4.7 3.3 6.1 4.1 5.7 6.0 2.6 4.2 5.9 4.9 3.4 3.3 3.3 6.4 5.4 1.9 13.4 17.7 20.6 26.9 14.4 14.1 18.8 20.2 15.4 16.1 CARD10 "BIMP1, CARMA3" ENSG00000100065 "Caspase recruitment domain family member 10" Q9BWT7 22 37490362-37519542 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 33.6" "Cell line enhanced" "Detected in many" "HBEC3-KT: 23.6;U-2197: 35.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA029359, HPA055612" Approved Approved "Vesicles,Intermediate filaments,Cytosol" "Vesicles, Intermediate filaments" Cytosol "HPA029359: AB_10601354, HPA055612: " "unprognostic (9.12e-3)" "unprognostic (2.28e-1)" "unprognostic (7.51e-2)" "prognostic favourable (3.47e-4)" "unprognostic (4.54e-1)" "unprognostic (2.70e-2)" "prognostic unfavourable (7.73e-6)" "unprognostic (3.66e-2)" "unprognostic (7.70e-2)" "unprognostic (1.93e-1)" "unprognostic (2.16e-1)" "unprognostic (3.68e-2)" "unprognostic (2.78e-2)" "unprognostic (2.87e-2)" "unprognostic (4.34e-1)" "unprognostic (4.31e-2)" "unprognostic (9.69e-2)" 8.1 6.8 3.5 4.5 2.3 0.0 10.2 1.5 2.7 5.7 16.4 2.4 4.1 23.7 9.8 6.4 6.8 5.9 14.1 7.6 1.7 1.1 14.0 10.5 7.0 2.4 1.6 1.3 6.8 8.9 1.6 1.7 4.9 3.8 5.6 6.2 5.6 12.6 3.2 8.0 7.3 33.6 4.1 1.3 3.3 7.0 11.1 1.3 0.7 5.6 13.5 3.9 4.9 9.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 12.8 9.4 1.7 1.3 0.0 3.8 8.5 1.2 2.8 5.5 4.3 5.8 9.2 0.0 4.6 2.2 18.2 2.1 23.6 1.7 0.0 5.1 0.3 5.9 9.0 2.3 0.2 0.8 1.3 4.9 10.5 13.5 11.0 1.3 0.0 4.1 4.4 0.0 0.8 3.1 5.7 0.0 16.9 1.3 8.2 2.2 0.6 1.0 9.0 4.0 0.9 4.3 0.7 14.6 4.1 12.1 35.4 6.7 0.0 0.0 0.0 13.1 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 3.5 2.3 1.5 2.7 1.7 1.1 1.6 1.3 3.8 1.3 CCDC125 KENAE ENSG00000183323 "Coiled-coil domain containing 125" Q86Z20 5 69280175-69332809 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 19.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 5.8;eosinophil: 13.0;neutrophil: 10.9" "Lineage enriched" "Detected in many" 6 "granulocytes: 13.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA041878 Approved Uncertain "Nucleoplasm,Nuclear membrane,Intermediate filaments" "Nuclear membrane, Intermediate filaments" Nucleoplasm "HPA041878: AB_10796787" "prognostic unfavourable (8.06e-4)" "unprognostic (1.01e-1)" "unprognostic (2.35e-2)" "prognostic favourable (4.40e-4)" "unprognostic (1.05e-1)" "unprognostic (1.91e-2)" "unprognostic (8.21e-2)" "unprognostic (3.08e-2)" "unprognostic (4.06e-2)" "unprognostic (5.07e-2)" "unprognostic (2.52e-2)" "unprognostic (1.91e-2)" "unprognostic (2.05e-2)" "unprognostic (5.40e-2)" "unprognostic (4.68e-2)" "unprognostic (2.52e-2)" "prognostic favourable (2.51e-4)" 4.3 6.1 4.9 6.1 5.6 13.6 10.0 4.9 4.7 4.1 7.9 5.8 7.8 6.7 5.9 4.0 6.6 5.5 10.0 3.0 4.8 4.9 5.0 17.6 5.8 6.2 6.4 4.9 4.8 14.9 4.2 10.4 5.5 6.7 10.1 7.9 3.6 15.9 12.3 2.8 5.3 10.6 4.5 4.7 5.2 8.3 3.4 4.1 3.1 5.5 4.7 5.5 7.3 5.6 0.9 1.5 13.0 2.3 1.1 1.1 0.8 2.1 3.5 0.7 10.0 1.2 0.7 12.8 1.3 1.9 0.8 0.5 3.1 10.7 3.9 7.4 1.4 2.7 7.3 3.7 0.8 13.4 5.8 2.4 5.7 6.0 3.1 2.6 1.4 4.1 1.9 4.1 1.3 1.4 7.1 1.7 0.7 8.6 3.4 4.2 0.1 2.3 4.9 0.0 5.2 4.9 2.4 4.1 2.6 2.6 5.9 1.9 19.1 2.7 1.6 0.8 1.4 2.5 2.0 7.8 11.9 1.4 2.5 14.3 0.4 5.8 1.1 13.0 1.1 0.9 0.9 0.9 1.0 0.8 1.5 0.9 0.9 0.5 10.9 1.1 2.3 1.2 0.7 0.8 4.9 5.6 4.9 4.7 4.8 4.9 6.4 4.9 6.7 4.1 CCDC58 FLJ33273 ENSG00000160124 "Coiled-coil domain containing 58" Q4VC31 3 122359591-122383231 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047777, HPA051965" Approved Approved "Nucleoli,Intermediate filaments,Mitochondria" Mitochondria "Nucleoli, Intermediate filaments" "HPA047777: AB_2680152, HPA051965: AB_2681676" "unprognostic (1.51e-1)" "unprognostic (1.23e-1)" "unprognostic (1.24e-1)" "prognostic unfavourable (1.53e-4)" "unprognostic (5.64e-2)" "unprognostic (6.98e-3)" "prognostic unfavourable (2.94e-5)" "unprognostic (2.72e-2)" "unprognostic (1.03e-2)" "unprognostic (4.98e-3)" "unprognostic (5.26e-3)" "unprognostic (1.84e-2)" "unprognostic (7.11e-3)" "unprognostic (1.03e-3)" "unprognostic (2.58e-1)" "unprognostic (1.86e-1)" "prognostic favourable (7.29e-4)" 9.5 13.3 8.7 6.8 8.1 7.1 9.2 6.9 12.6 8.2 13.3 7.1 12.4 10.6 7.3 12.4 14.0 5.8 7.7 12.4 7.2 7.0 21.9 23.3 5.4 10.0 8.6 5.3 8.8 9.3 3.1 7.7 6.7 8.5 8.2 14.4 6.5 7.2 6.9 35.2 6.9 10.2 6.3 7.2 8.6 9.1 8.7 9.3 5.5 8.8 24.5 9.6 8.7 7.1 13.9 18.3 1.7 10.2 11.4 16.1 4.6 34.5 11.0 21.0 13.4 7.8 11.0 27.0 13.3 14.4 32.2 31.8 30.9 17.6 25.4 23.0 10.1 24.2 34.0 22.7 38.7 8.7 12.0 29.9 7.8 37.4 13.1 44.4 10.7 9.0 11.8 19.7 21.7 14.8 33.8 11.1 16.9 17.2 28.3 31.8 40.2 20.8 18.8 24.9 31.2 22.2 18.4 21.2 10.4 15.4 16.4 36.9 16.3 29.3 8.5 18.1 23.2 7.6 26.4 8.8 11.7 54.8 20.6 21.6 15.9 0.4 5.0 1.7 10.2 10.2 12.0 13.9 13.6 13.4 10.3 13.5 16.1 14.9 0.9 11.4 8.5 18.3 10.5 4.6 8.7 8.1 6.9 12.6 7.2 7.0 8.6 5.3 8.5 9.3 CCT8 "C21orf112, Cctq, PRED71" ENSG00000156261 "Chaperonin containing TCP1 subunit 8" P50990 21 29055805-29073797 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018520, HPA021051, HPA029426" Enhanced Approved "Nucleoplasm,Intermediate filaments,Cytosol" 2700000 "Intermediate filaments" "Nucleoplasm, Cytosol" "HPA018520: AB_1846204, HPA021051: AB_1846205, HPA029426: AB_10601796" "unprognostic (3.41e-3)" "unprognostic (2.75e-2)" "unprognostic (2.40e-3)" "unprognostic (1.62e-1)" "unprognostic (1.25e-1)" "unprognostic (4.25e-3)" "prognostic unfavourable (1.56e-5)" "unprognostic (8.78e-2)" "unprognostic (1.37e-1)" "unprognostic (3.09e-1)" "unprognostic (1.02e-2)" "unprognostic (2.91e-1)" "unprognostic (3.01e-2)" "unprognostic (8.26e-2)" "unprognostic (3.50e-2)" "unprognostic (1.25e-1)" "unprognostic (1.57e-1)" 33.5 62.5 28.9 36.1 43.8 28.2 39.7 47.9 46.4 34.5 33.7 15.7 41.9 29.6 37.4 36.4 47.6 33.6 23.6 43.9 33.0 36.0 43.6 42.1 33.2 48.8 28.8 39.2 39.3 47.2 35.4 42.6 41.0 39.6 30.9 38.3 17.0 34.7 38.6 68.4 35.5 30.1 38.3 29.5 39.8 35.2 30.2 30.2 66.6 36.1 52.0 57.6 38.5 47.8 25.6 41.7 17.5 38.1 22.8 27.2 33.9 49.0 27.9 35.7 25.7 26.4 36.4 39.8 39.4 25.1 44.7 37.4 59.1 30.4 97.1 26.5 27.2 19.9 73.6 45.5 50.9 41.0 38.3 134.3 33.6 26.4 27.4 66.3 37.6 27.7 28.1 52.6 43.8 42.7 103.5 56.8 45.6 25.5 49.9 26.0 64.3 34.8 44.9 70.3 60.3 45.7 25.8 35.8 25.8 38.6 40.8 33.8 36.5 58.1 30.8 25.4 71.9 23.9 49.0 36.9 71.3 76.5 29.8 75.5 38.8 17.5 33.7 16.7 18.5 36.9 25.5 25.6 24.0 24.3 41.7 19.2 27.2 24.5 3.7 22.8 38.1 24.6 26.6 33.9 28.9 43.8 47.9 46.4 33.0 36.0 28.8 39.2 39.6 30.2 CDC42BPA "FLJ23347, KIAA0451, MRCK, MRCKA, PK428" ENSG00000143776 "CDC42 binding protein kinase alpha" Q5VT25 1 226989865-227318474 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 2.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB070414, HPA071252" Approved Approved "Intermediate filaments" "Intermediate filaments" "CAB070414: AB_11156796, HPA071252: " "unprognostic (3.67e-3)" "unprognostic (1.45e-1)" "unprognostic (1.10e-1)" "unprognostic (2.78e-2)" "unprognostic (3.04e-1)" "unprognostic (5.90e-2)" "unprognostic (7.89e-2)" "unprognostic (2.27e-1)" "unprognostic (1.46e-1)" "unprognostic (3.93e-1)" "unprognostic (4.88e-2)" "unprognostic (2.87e-2)" "unprognostic (7.73e-3)" "unprognostic (1.35e-1)" "unprognostic (1.70e-1)" "unprognostic (9.79e-2)" "unprognostic (1.21e-2)" 17.2 15.2 19.1 8.6 21.1 3.9 14.0 29.2 20.4 21.1 19.3 16.4 13.1 16.9 15.8 9.9 12.3 12.9 16.6 14.1 21.7 17.7 20.8 17.0 11.7 3.5 20.0 16.3 17.4 15.1 29.3 29.6 14.8 19.3 21.1 12.4 11.0 8.4 18.5 11.9 7.6 17.2 27.6 16.6 8.8 25.2 26.7 19.9 0.7 9.8 7.3 2.5 23.4 23.1 0.1 0.7 2.0 0.1 0.0 0.1 0.0 9.3 8.9 9.5 4.4 9.5 11.8 3.3 10.7 15.2 7.4 7.8 7.2 21.3 0.0 11.6 17.8 4.3 6.9 6.0 9.1 0.0 5.6 7.2 10.5 2.8 10.8 5.8 3.2 8.2 7.7 12.0 12.1 24.8 18.4 0.0 12.1 2.5 0.1 1.0 7.7 8.5 0.0 16.0 0.0 12.0 18.1 6.8 10.0 18.2 7.6 10.7 9.9 0.3 24.9 13.7 7.1 15.5 14.2 0.0 0.0 0.0 18.1 0.0 18.2 2.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 19.1 21.1 29.2 20.4 21.7 17.7 20.0 16.3 19.3 19.9 CHID1 "FLJ42707, MGC3234" ENSG00000177830 "Chitinase domain containing 1" Q9BWS9 11 867860-915058 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039374 Uncertain Uncertain "Nucleoplasm,Intermediate filaments" "Intracellular and membrane" 1700000 "Nucleoplasm, Intermediate filaments" "HPA039374: AB_10673609" "unprognostic (1.85e-1)" "unprognostic (2.19e-1)" "unprognostic (8.96e-2)" "prognostic favourable (6.76e-4)" "unprognostic (4.82e-2)" "unprognostic (3.22e-1)" "unprognostic (1.97e-2)" "unprognostic (3.62e-2)" "unprognostic (7.88e-2)" "unprognostic (2.29e-1)" "unprognostic (1.12e-2)" "unprognostic (5.21e-2)" "unprognostic (1.74e-3)" "unprognostic (1.15e-1)" "unprognostic (7.53e-2)" "unprognostic (3.29e-2)" "unprognostic (2.89e-2)" 18.2 26.6 19.3 17.8 22.2 16.5 19.7 13.4 25.2 20.4 18.3 14.1 23.3 12.9 18.1 40.1 18.5 27.8 25.9 22.0 16.0 19.3 21.0 47.5 14.2 19.6 17.1 17.8 26.1 63.0 20.1 26.8 27.8 13.7 19.5 12.8 21.0 36.8 23.0 14.5 12.8 14.3 22.4 16.5 29.7 16.8 36.4 12.9 10.9 20.3 21.9 13.8 15.6 15.7 20.5 33.6 8.3 23.1 18.4 17.9 18.8 19.3 19.0 14.4 35.2 55.9 29.7 24.4 21.8 25.9 21.4 20.9 20.7 57.3 15.9 20.4 31.9 38.4 14.3 25.4 15.7 13.9 35.3 11.4 7.0 19.0 25.8 26.4 10.2 28.7 16.1 14.5 21.2 18.0 20.7 41.0 14.8 13.7 14.8 34.7 12.8 28.9 12.8 13.9 28.7 15.7 5.6 27.7 22.8 23.7 33.4 20.2 13.5 40.7 17.5 24.5 10.7 6.8 17.5 24.2 20.4 9.6 27.4 23.2 19.1 7.6 23.1 8.3 16.9 20.4 17.9 20.5 16.4 17.6 33.6 15.1 17.4 17.4 3.0 18.4 19.2 31.4 14.1 18.8 19.3 22.2 13.4 25.2 16.0 19.3 17.1 17.8 13.7 12.9 CLK3 clk3 ENSG00000179335 "CDC like kinase 3" P49761 15 74598500-74645414 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046817 Approved Supported "Nucleoplasm,Intermediate filaments" "Nucleoplasm, Intermediate filaments" "HPA046817: AB_10964124" "unprognostic (4.10e-2)" "unprognostic (8.43e-2)" "prognostic unfavourable (2.05e-6)" "unprognostic (1.91e-3)" "unprognostic (7.91e-2)" "unprognostic (5.76e-2)" "unprognostic (1.46e-1)" "unprognostic (1.30e-2)" "unprognostic (1.95e-1)" "unprognostic (2.54e-1)" "unprognostic (8.14e-3)" "prognostic unfavourable (5.92e-4)" "unprognostic (1.35e-2)" "unprognostic (2.24e-1)" "unprognostic (9.73e-2)" "unprognostic (2.48e-1)" "unprognostic (2.25e-2)" 20.9 17.2 15.7 24.7 22.5 62.7 31.1 23.4 18.8 24.9 24.6 23.1 16.4 18.6 24.1 17.7 25.3 17.3 21.2 16.4 17.8 13.5 17.2 16.0 19.6 21.9 29.3 14.5 23.7 21.8 19.0 19.9 27.9 16.7 20.6 14.4 19.9 24.8 20.9 28.4 24.1 20.7 19.8 19.2 23.8 19.6 31.5 23.3 28.8 21.0 12.0 23.7 23.2 19.8 38.9 36.0 60.7 46.0 43.6 43.4 39.7 22.3 14.2 18.8 10.5 24.2 18.5 14.8 15.3 24.2 21.9 26.9 19.2 14.8 20.4 11.3 13.6 15.8 35.0 14.7 14.3 28.9 19.1 25.0 21.1 13.3 38.5 6.7 19.4 23.2 29.3 28.7 24.0 23.9 12.1 14.9 12.7 15.8 19.8 22.7 12.0 10.0 16.1 9.0 13.3 17.0 16.2 10.6 12.4 12.2 13.6 13.5 12.9 13.5 11.0 13.0 10.0 8.1 20.0 24.4 19.6 16.7 11.4 33.0 16.3 32.9 34.4 45.0 38.5 37.4 37.4 37.7 41.1 39.7 31.9 38.9 42.1 40.1 60.7 43.6 46.0 36.0 43.4 39.7 15.7 22.5 23.4 18.8 17.8 13.5 29.3 14.5 16.7 23.3 COL9A3 "DJ885L7.4.1, EDM3, FLJ90759, IDD, MED" ENSG00000092758 "Collagen type IX alpha 3 chain" Q14050 20 62816244-62841159 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 26.4;retina: 37.2;salivary gland: 38.9;thyroid gland: 18.1" "Group enriched" "Detected in some" 6 "BEWO: 52.5;Hep G2: 20.7;SK-MEL-30: 17.2;WM-115: 20.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA040125, HPA058323" Supported Approved "Nucleoplasm,Intermediate filaments" "Secreted to extracellular matrix" Nucleoplasm "Intermediate filaments" "HPA040125: AB_10805604, HPA058323: " "unprognostic (1.14e-3)" "unprognostic (2.14e-2)" "unprognostic (3.93e-1)" "unprognostic (1.21e-3)" "unprognostic (4.25e-2)" "unprognostic (2.39e-2)" "unprognostic (2.33e-1)" "unprognostic (1.24e-2)" "unprognostic (1.27e-1)" "unprognostic (1.25e-1)" "unprognostic (2.39e-1)" "unprognostic (2.13e-1)" "unprognostic (1.64e-2)" "unprognostic (2.94e-1)" "unprognostic (1.51e-1)" "unprognostic (4.79e-2)" "unprognostic (2.67e-1)" 2.2 2.0 11.2 2.3 16.3 1.2 1.5 1.5 8.9 1.7 3.4 26.4 1.6 2.3 1.8 1.5 1.6 1.2 1.4 2.1 14.9 9.8 1.4 1.3 1.3 1.4 18.4 8.1 1.6 5.4 1.1 5.3 1.9 12.4 1.7 1.3 37.2 38.9 3.4 1.5 1.8 2.5 1.4 25.0 1.2 1.8 6.4 15.2 0.0 18.1 1.4 1.2 1.3 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.3 52.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 4.8 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 2.4 20.7 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 2.3 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 17.2 0.0 1.9 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 20.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 16.3 1.5 8.0 14.9 9.8 18.4 8.1 12.4 15.2 CPEB3 KIAA0940 ENSG00000107864 "Cytoplasmic polyadenylation element binding protein 3" Q8NE35 10 92046692-92291087 "Predicted intracellular proteins" "Translation regulation" "Activator, Repressor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.4;liver: 39.5" "Cell line enhanced" "Detected in many" "Karpas-707: 15.8;U-266/70: 8.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 6.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059056 Approved "Nucleoplasm,Nuclear bodies,Intermediate filaments" Nucleoplasm "Nuclear bodies, Intermediate filaments" "HPA059056: " "unprognostic (4.90e-2)" "unprognostic (2.12e-2)" "unprognostic (3.00e-1)" "unprognostic (5.66e-2)" "unprognostic (1.92e-1)" "unprognostic (2.95e-5)" "prognostic favourable (5.06e-5)" "unprognostic (4.09e-4)" "unprognostic (2.73e-1)" "unprognostic (2.40e-1)" "unprognostic (1.47e-2)" "unprognostic (2.42e-2)" "prognostic favourable (3.84e-9)" "unprognostic (3.33e-2)" "unprognostic (7.42e-2)" "unprognostic (1.36e-2)" "unprognostic (1.40e-1)" 3.1 6.1 11.9 3.0 10.9 2.9 5.0 33.4 24.6 4.0 3.8 4.4 5.5 4.8 3.3 6.8 6.0 3.3 3.4 7.0 10.7 11.5 7.0 39.5 3.6 3.0 10.3 15.1 5.8 5.4 6.6 8.6 2.8 16.4 6.5 4.2 3.0 10.2 8.0 23.4 5.3 4.6 3.4 4.6 4.1 4.5 20.5 7.0 0.3 9.3 5.4 3.4 3.3 4.5 1.8 0.9 6.5 1.5 0.5 0.7 0.5 1.1 0.3 0.4 2.6 0.7 0.7 1.1 1.1 0.8 1.6 1.3 0.8 2.6 1.4 1.3 0.5 3.3 1.1 0.9 0.9 1.6 1.4 1.8 1.8 0.9 2.0 0.9 1.9 0.6 2.0 1.0 3.1 1.5 1.3 15.8 0.6 0.9 1.2 1.0 0.2 1.2 1.5 2.3 2.7 1.6 0.5 2.0 0.6 1.0 3.0 1.9 3.8 2.0 1.2 0.8 0.8 0.6 1.0 8.8 2.3 1.5 0.4 3.0 0.2 6.5 1.1 2.2 0.7 1.4 0.5 1.8 0.4 0.7 0.9 0.5 0.4 0.4 1.3 0.5 1.5 0.6 0.3 0.5 11.9 10.9 33.4 24.6 10.7 11.5 10.3 15.1 16.4 7.0 CRP PTX1 ENSG00000132693 "C-reactive protein" P02741 1 159712289-159714589 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 66 "liver: 1139.7" "Cell line enhanced" "Detected in some" "EFO-21: 8.0;HDLM-2: 7.6;U-2 OS: 5.4;U-266/84: 12.8" "Cancer enriched" "Detected in some" 13 "liver cancer: 1010.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB005036, HPA027367, HPA027396" Supported Approved "Nucleoplasm,Vesicles,Intermediate filaments" "Secreted to blood" 1832500000 5400000000 "Nucleoplasm, Vesicles" "Intermediate filaments" "CAB005036: AB_562362, HPA027367: AB_1847216, HPA027396: AB_1847217" "unprognostic (3.74e-1)" "unprognostic (5.31e-2)" "unprognostic (2.97e-2)" "unprognostic (1.27e-1)" "unprognostic (3.57e-2)" "unprognostic (1.33e-2)" "unprognostic (3.13e-1)" "prognostic unfavourable (4.17e-10)" "unprognostic (3.39e-2)" "unprognostic (3.48e-1)" "unprognostic (5.60e-2)" "unprognostic (6.61e-2)" 0.4 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.0 17.2 0.1 0.1 0.0 0.1 1139.7 0.1 0.1 0.1 0.1 0.1 7.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.3 0.0 0.0 0.0 7.6 0.0 0.3 0.0 0.0 0.0 0.3 0.1 1.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 5.4 0.1 0.9 0.0 12.8 2.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CRTAP "CASP, LEPREL3, P3H5" ENSG00000170275 "Cartilage associated protein" O75718 3 33113979-33147773 "Disease related genes, Predicted secreted proteins" "Disease mutation, Dwarfism, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 121.2;ASC TERT1: 79.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "classical monocyte: 67.8" "Group enriched" "Detected in all" 5 "dendritic cells: 55.8;monocytes: 67.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043598, HPA044150" Approved Approved "Intermediate filaments,Actin filaments,Cytosol" "Secreted to blood" "Intermediate filaments, Actin filaments, Cytosol" "HPA043598: AB_10960991, HPA044150: AB_10959594" "unprognostic (5.29e-2)" "unprognostic (2.64e-1)" "unprognostic (2.13e-1)" "unprognostic (1.85e-3)" "unprognostic (7.36e-2)" "unprognostic (4.73e-3)" "unprognostic (4.28e-2)" "unprognostic (1.87e-1)" "unprognostic (9.97e-2)" "unprognostic (4.62e-2)" "unprognostic (3.70e-1)" "unprognostic (1.40e-1)" "unprognostic (2.10e-1)" "unprognostic (1.41e-1)" "unprognostic (1.79e-1)" "unprognostic (9.93e-2)" "unprognostic (1.28e-3)" 59.2 33.4 16.3 13.4 22.2 13.6 63.2 5.4 14.1 57.5 39.4 23.3 32.7 12.8 54.2 41.1 42.8 35.1 43.5 37.0 16.8 13.1 25.7 16.8 35.9 37.8 24.2 13.0 48.5 13.3 14.6 7.6 25.4 13.8 54.5 19.7 35.4 16.4 42.2 23.9 24.6 18.8 66.1 22.8 17.6 25.2 26.1 19.0 5.1 34.1 25.8 18.3 62.4 59.7 7.6 55.8 5.5 67.8 6.9 12.9 30.8 9.0 17.9 5.6 17.6 121.2 79.4 32.6 19.8 43.2 24.0 22.9 6.0 5.1 6.3 22.1 37.5 11.7 9.9 15.1 17.4 15.6 15.6 9.9 14.0 6.2 36.3 6.4 8.1 63.3 31.0 21.6 27.6 25.2 8.4 12.1 24.2 7.7 2.3 6.5 6.7 24.4 8.4 16.5 12.1 18.8 6.1 1.1 9.1 13.4 11.8 28.5 12.6 15.7 16.4 31.5 13.5 17.1 20.9 8.8 29.7 0.9 24.7 12.9 17.2 2.1 67.8 4.9 6.9 26.3 10.0 7.6 10.1 7.7 55.8 6.8 5.8 5.4 5.5 6.9 7.8 15.0 12.9 30.8 16.3 22.2 5.4 14.1 16.8 13.1 24.2 13.0 13.8 19.0 CRYGD CRYG4 ENSG00000118231 "Crystallin gamma D" P07320 2 208121607-208124501 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "ovary: 17.7" "Cell line enriched" "Detected in single" 19 "HEL: 15.0" "Cancer enhanced" "Detected in some" "testis cancer: 3.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041269, HPA043386" Supported Approved "Plasma membrane,Intermediate filaments,Cytokinetic bridge" "Plasma membrane, Intermediate filaments" "Cytokinetic bridge" "HPA041269: , HPA043386: " "unprognostic (4.49e-2)" "unprognostic (2.64e-1)" "unprognostic (3.62e-1)" 0.2 0.2 4.2 0.2 2.0 2.3 0.2 0.0 2.5 0.2 0.2 0.3 0.0 0.4 0.2 0.2 0.3 0.3 0.2 0.6 2.1 4.3 0.2 0.2 0.2 0.2 4.0 1.6 17.7 0.2 0.2 0.4 0.5 1.9 2.0 0.2 2.1 0.2 0.2 0.2 0.2 0.4 0.2 0.4 0.2 0.5 1.4 0.5 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 4.2 2.0 0.0 2.5 2.1 4.3 4.0 1.6 1.9 0.5 CTNS "CTNS-LSB, PQLC4" ENSG00000040531 "Cystinosin, lysosomal cystine transporter" O60931 17 3636468-3661542 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Melanin biosynthesis, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 46.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046947 Supported "Vesicles,Intermediate filaments" "Vesicles, Intermediate filaments" "HPA046947: " "unprognostic (1.64e-1)" "unprognostic (1.70e-1)" "unprognostic (1.21e-1)" "unprognostic (8.25e-2)" "unprognostic (8.39e-2)" "prognostic favourable (7.33e-4)" "unprognostic (1.28e-2)" "unprognostic (8.02e-2)" "unprognostic (1.94e-1)" "unprognostic (6.62e-3)" "prognostic favourable (6.39e-5)" "unprognostic (8.40e-2)" "unprognostic (2.25e-1)" "unprognostic (1.80e-1)" "unprognostic (5.64e-2)" "unprognostic (1.96e-1)" "unprognostic (1.52e-1)" 9.6 19.0 8.5 8.2 11.9 8.3 12.1 5.0 9.9 18.8 8.2 16.1 34.8 10.8 10.3 7.2 7.3 8.3 10.6 9.3 7.7 5.9 23.9 16.4 11.4 9.1 12.1 5.6 12.6 32.7 11.3 14.5 13.2 8.5 10.2 6.4 11.4 10.5 46.2 22.6 18.0 9.2 7.9 10.2 12.2 12.9 27.0 13.0 11.7 9.0 6.5 9.0 10.1 9.1 3.5 19.6 13.7 5.6 2.5 3.3 3.7 6.1 13.8 8.1 6.9 13.2 6.7 5.1 6.0 10.1 6.9 8.7 7.7 6.1 3.7 6.4 4.0 15.8 7.1 4.1 5.3 46.0 12.5 4.2 10.4 6.2 17.8 2.8 28.8 8.3 5.2 7.3 5.9 7.6 4.3 5.8 6.5 5.6 2.8 2.7 3.6 6.1 6.2 3.3 8.7 6.2 6.3 1.6 5.9 7.0 9.4 7.0 6.6 2.8 8.9 6.8 4.3 15.4 4.9 4.7 6.0 1.7 10.5 3.0 4.6 13.7 5.6 12.1 1.9 3.7 2.7 3.5 2.3 3.3 5.4 3.1 2.9 3.1 2.0 2.5 3.8 19.6 2.6 3.7 8.5 11.9 5.0 9.9 7.7 5.9 12.1 5.6 8.5 13.0 CXorf57 "FLJ10178, FLJ14191" ENSG00000147231 "Chromosome X open reading frame 57" Q6NSI4 X 106611930-106679442 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.8;pituitary gland: 32.3" "Cell line enhanced" "Detected in many" "HEK 293: 22.2;Karpas-707: 11.4;RT4: 23.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 10 "gdT-cell: 3.5;MAIT T-cell: 2.6;memory B-cell: 3.9;memory CD4 T-cell: 3.0;memory CD8 T-cell: 2.4;naive B-cell: 2.9;naive CD4 T-cell: 3.7;naive CD8 T-cell: 3.0;NK-cell: 2.1;T-reg: 1.1" "Group enriched" "Detected in many" 11 "B-cells: 3.9;NK-cells: 2.1;T-cells: 3.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA000896, HPA001374" Uncertain Approved "Intermediate filaments" "Intermediate filaments" "HPA000896: AB_1078880, HPA001374: " "unprognostic (3.30e-2)" "unprognostic (5.59e-3)" "unprognostic (2.67e-2)" "unprognostic (1.46e-3)" "unprognostic (4.85e-2)" "unprognostic (8.26e-2)" "unprognostic (1.24e-2)" "unprognostic (1.89e-1)" "unprognostic (3.02e-1)" "unprognostic (5.49e-2)" "unprognostic (3.81e-3)" "unprognostic (1.17e-1)" "unprognostic (4.20e-3)" "unprognostic (1.63e-1)" "unprognostic (2.70e-1)" "unprognostic (2.21e-2)" "unprognostic (1.23e-3)" 1.4 12.0 5.2 2.1 23.0 0.8 2.3 0.9 8.5 2.9 1.3 6.8 1.0 1.8 5.1 3.7 1.3 6.3 1.0 1.5 5.9 25.8 4.2 2.2 3.8 4.8 4.7 5.3 11.3 2.5 0.1 32.3 5.7 6.3 2.3 1.3 2.6 1.1 2.2 2.2 4.0 2.0 1.5 4.5 2.9 4.2 6.0 5.4 1.9 5.2 0.4 3.3 5.9 2.0 3.9 0.2 0.2 0.0 2.1 3.7 1.2 4.1 0.0 4.3 6.0 2.5 2.1 6.5 0.1 0.8 0.0 0.0 0.9 0.8 8.7 0.0 0.5 1.1 11.0 1.8 0.0 0.0 22.2 2.8 0.0 0.2 0.1 0.0 1.9 1.2 1.3 0.3 0.8 0.0 0.1 11.4 0.9 0.0 7.9 0.0 3.9 0.7 0.0 4.0 0.0 1.8 23.3 7.1 0.0 0.4 0.1 2.5 1.0 0.1 0.0 1.9 1.6 0.0 2.6 4.1 1.7 10.7 3.3 0.0 3.1 0.0 0.0 0.0 3.5 0.0 2.6 3.9 3.0 2.4 0.0 2.9 3.7 3.0 0.2 2.1 0.0 0.2 1.1 1.2 5.2 23.0 0.9 6.8 5.9 25.8 4.7 5.3 6.3 5.4 DDX60 FLJ20035 ENSG00000137628 "DExD/H-box helicase 60" Q8IY21 4 168216293-168318807 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 22.5;BJ hTERT+ SV40 Large T+ RasG12V: 21.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA046952 Approved Supported "Intermediate filaments,Cytosol" Cytosol "Intermediate filaments" "HPA046952: AB_10963572" "unprognostic (4.05e-2)" "unprognostic (2.87e-1)" "unprognostic (7.22e-3)" "unprognostic (7.71e-2)" "unprognostic (2.30e-1)" "unprognostic (2.65e-2)" "unprognostic (1.50e-2)" "unprognostic (3.15e-2)" "unprognostic (3.06e-1)" "unprognostic (8.69e-3)" "prognostic unfavourable (3.35e-4)" "unprognostic (1.65e-1)" "unprognostic (4.03e-2)" "unprognostic (2.48e-1)" "unprognostic (3.02e-1)" "unprognostic (3.20e-2)" "unprognostic (2.44e-1)" 18.0 8.3 4.1 18.5 5.0 4.4 9.0 1.3 3.8 11.4 14.8 4.3 5.1 8.8 10.8 15.2 10.7 8.1 11.5 8.5 3.7 3.5 10.0 8.8 21.6 18.7 4.2 3.2 20.3 5.5 8.8 6.7 25.5 5.6 11.6 14.3 9.0 15.6 6.2 5.6 7.9 16.7 11.2 6.1 18.9 29.2 5.7 3.9 23.2 14.5 6.0 9.3 8.2 7.2 4.1 2.5 3.2 6.3 7.6 10.0 3.5 5.5 1.2 2.8 1.1 2.1 7.7 3.1 1.8 13.5 22.5 21.8 0.0 12.2 0.0 1.1 3.0 4.6 0.3 4.5 6.5 4.3 0.5 8.7 4.8 0.0 10.1 3.2 2.2 6.9 1.9 5.7 1.3 8.4 0.0 1.6 2.8 0.3 4.9 2.4 0.5 1.6 3.3 1.4 0.1 6.6 3.4 0.6 0.6 3.5 0.9 13.6 0.9 4.1 5.6 1.4 1.4 0.5 1.4 1.0 0.2 0.0 4.3 3.8 3.9 3.2 2.8 2.6 8.5 5.1 10.0 4.1 6.7 8.0 2.5 3.3 6.8 8.5 2.8 7.6 6.3 0.2 5.5 3.5 4.1 5.0 1.3 3.8 3.7 3.5 4.2 3.2 5.6 3.9 DES "CMD1I, CSM1, CSM2" ENSG00000175084 Desmin P17661 2 219418377-219426739 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Muscle protein" "Cancer-related genes, Cardiomyopathy, Desmin-related myopathy, Disease mutation, Limb-girdle muscular dystrophy, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 531.0;skeletal muscle: 600.8;smooth muscle: 439.9" "Cell line enhanced" "Detected in some" "HSkMC: 17.6;LHCN-M2: 35.2;RH-30: 81.8" "Cancer enhanced" "Detected in all" "prostate cancer: 562.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "classical monocyte: 2.7;intermediate monocyte: 1.9;non-classical monocyte: 1.4" "Lineage enriched" "Detected in single" 6 "monocytes: 2.7" "Not detected" "Not detected" "Region enhanced" "Detected in many" "midbrain: 45.7" "CAB000034, HPA018803" Enhanced Supported "Intermediate filaments" 1300000 "Intermediate filaments" "CAB000034: , HPA018803: AB_1847616" "unprognostic (1.75e-1)" "unprognostic (1.95e-3)" "unprognostic (3.43e-2)" "unprognostic (8.76e-2)" "unprognostic (7.75e-3)" "unprognostic (6.61e-3)" "unprognostic (1.55e-1)" "unprognostic (2.72e-2)" "unprognostic (4.67e-1)" "unprognostic (3.84e-2)" "unprognostic (2.57e-1)" "unprognostic (7.43e-2)" "prognostic unfavourable (5.08e-4)" "unprognostic (3.49e-2)" "unprognostic (1.34e-1)" "unprognostic (1.22e-1)" "unprognostic (9.25e-3)" 9.1 2.5 0.1 35.1 0.2 0.1 1.9 0.1 0.3 41.3 238.3 0.4 69.1 12.6 95.6 80.2 209.7 33.0 149.8 531.0 0.1 0.1 2.1 0.3 4.8 3.0 0.3 0.8 20.3 0.7 0.0 0.1 2.4 0.8 101.0 11.2 3.8 11.9 104.2 600.8 4.2 43.2 439.9 0.3 0.6 72.6 10.9 0.0 0.0 9.4 161.2 12.5 343.7 34.4 0.0 0.2 0.4 2.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.3 17.6 0.0 0.0 0.0 0.0 0.6 0.0 35.2 0.0 0.0 9.2 0.1 0.0 0.0 81.8 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.0 0.7 0.1 0.2 0.1 0.3 0.1 0.1 0.3 0.8 0.8 0.0 DHX34 "DDX34, KIAA0134" ENSG00000134815 "DExH-box helicase 34" Q14147 19 47349281-47382704 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 13.5" "Lineage enriched" "Detected in many" 6 "granulocytes: 13.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042159, HPA043558" Uncertain Uncertain "Nucleoplasm,Intermediate filaments" "Nucleoplasm, Intermediate filaments" "HPA042159: AB_10963066, HPA043558: AB_10961262" "unprognostic (1.26e-1)" "unprognostic (5.17e-2)" "unprognostic (1.05e-1)" "unprognostic (1.64e-1)" "unprognostic (1.08e-1)" "unprognostic (3.06e-3)" "prognostic unfavourable (8.63e-6)" "unprognostic (9.14e-2)" "unprognostic (4.74e-2)" "unprognostic (5.11e-2)" "unprognostic (4.76e-3)" "unprognostic (2.02e-2)" "prognostic unfavourable (3.16e-6)" "unprognostic (7.38e-2)" "unprognostic (1.59e-1)" "unprognostic (2.72e-1)" "unprognostic (7.21e-3)" 6.8 6.9 12.6 11.0 11.5 20.3 6.6 18.7 13.3 8.2 5.9 9.1 8.9 7.7 10.4 5.3 8.3 9.0 5.7 6.0 11.2 6.4 7.2 10.9 8.9 7.9 12.3 8.4 13.3 12.9 7.8 14.2 7.8 11.4 8.9 4.6 8.5 9.9 8.3 7.8 11.8 7.0 6.6 10.5 13.5 6.7 21.8 12.5 5.6 9.6 4.6 9.6 7.3 11.2 1.5 1.9 13.5 2.2 0.8 1.8 1.1 7.1 18.8 4.6 9.1 4.1 2.8 8.8 5.7 1.9 5.9 5.3 12.0 7.0 11.0 5.8 3.2 10.5 6.4 7.5 3.0 9.1 17.4 11.5 10.2 9.1 4.5 8.9 4.9 3.5 6.1 10.0 5.6 3.9 19.1 4.8 3.9 8.4 8.8 22.2 9.6 11.3 9.7 3.7 6.6 3.2 9.7 8.3 5.1 7.0 7.0 4.6 6.3 5.7 4.4 6.9 9.0 4.3 10.0 7.3 10.0 10.3 5.6 6.5 8.1 1.0 2.0 0.8 1.3 2.2 1.2 1.2 1.0 1.8 1.9 1.5 1.6 0.7 13.5 0.8 1.7 1.5 0.6 1.1 12.6 11.5 18.7 13.3 11.2 6.4 12.3 8.4 11.4 12.5 DHX57 DDX57 ENSG00000163214 "DExH-box helicase 57" Q6P158 2 38797729-38875934 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036160 Uncertain Approved "Nucleoli,Intermediate filaments,Microtubules,Cytosol" "Intermediate filaments, Microtubules" "Nucleoli, Cytosol" "HPA036160: AB_10670711" "unprognostic (6.78e-2)" "unprognostic (3.08e-1)" "unprognostic (3.49e-2)" "unprognostic (2.03e-3)" "unprognostic (3.25e-2)" "unprognostic (3.43e-1)" "prognostic unfavourable (3.32e-6)" "unprognostic (1.75e-2)" "unprognostic (2.74e-1)" "unprognostic (1.45e-1)" "unprognostic (7.35e-2)" "unprognostic (1.82e-2)" "unprognostic (2.55e-2)" "unprognostic (1.47e-1)" "unprognostic (3.88e-2)" "unprognostic (7.03e-3)" "unprognostic (1.77e-1)" 9.6 11.2 9.7 8.5 16.7 7.0 10.4 11.9 16.4 14.1 9.4 9.9 9.8 4.2 13.9 17.1 8.4 11.2 9.5 9.3 9.6 11.0 11.2 7.2 7.9 9.2 8.9 9.5 13.2 9.5 18.9 17.9 11.2 13.1 10.5 9.2 11.6 7.8 14.2 11.5 11.1 6.9 11.8 7.7 9.9 7.9 27.7 8.3 13.9 11.8 8.1 11.1 10.5 8.3 7.1 5.2 1.7 10.1 3.3 6.0 4.2 16.9 13.6 15.2 11.4 10.0 12.4 12.5 11.8 11.6 11.2 11.0 10.9 5.2 4.9 11.9 12.0 8.8 17.2 13.0 18.4 20.4 12.7 9.6 9.1 14.8 9.1 10.1 5.6 11.8 7.9 14.5 9.1 14.9 12.3 7.0 12.1 12.3 10.1 9.3 19.0 8.1 5.0 20.2 9.7 10.3 6.5 12.6 18.5 11.8 12.2 13.8 8.5 5.6 11.4 11.1 12.9 8.5 12.6 7.4 8.2 2.1 8.7 7.1 7.4 1.7 10.1 1.7 4.5 6.9 6.0 5.7 4.0 3.5 5.2 7.1 4.8 3.0 0.5 3.3 8.0 1.7 3.3 4.2 9.7 16.7 11.9 16.4 9.6 11.0 8.9 9.5 13.1 8.3 DISC1 ENSG00000162946 "Disrupted in schizophrenia 1" Q9NRI5 1 231626815-232041272 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Neurogenesis, Wnt signaling pathway" "Developmental protein" Schizophrenia "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "THP-1: 12.2;TIME: 9.5;WM-115: 9.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA048911 Approved "Intermediate filaments" "Intermediate filaments" "HPA048911: " "unprognostic (1.08e-1)" "unprognostic (1.40e-1)" "unprognostic (1.58e-1)" "unprognostic (2.98e-1)" "unprognostic (2.57e-2)" "unprognostic (3.36e-2)" "unprognostic (6.69e-3)" "unprognostic (1.41e-1)" "unprognostic (9.49e-2)" "unprognostic (1.71e-1)" "unprognostic (8.89e-2)" "unprognostic (9.53e-2)" "unprognostic (1.31e-4)" "unprognostic (1.74e-2)" "unprognostic (2.02e-1)" "unprognostic (5.94e-2)" "unprognostic (1.94e-1)" 5.3 3.3 9.1 6.4 10.6 5.3 7.6 2.5 7.6 4.9 3.1 11.6 0.0 2.6 4.2 1.6 3.1 2.9 5.6 19.2 9.2 5.9 2.7 3.1 3.9 11.3 10.5 4.8 9.6 2.1 2.7 2.8 14.3 9.2 3.9 2.9 13.1 4.0 2.4 3.2 2.9 3.1 3.4 10.2 6.1 2.4 2.2 9.3 4.2 4.1 2.5 3.9 4.5 7.2 0.5 3.3 2.6 2.9 0.7 1.6 0.7 0.0 0.5 4.4 0.1 0.1 0.4 3.2 1.7 4.0 4.7 3.9 1.5 0.9 0.1 5.3 1.5 0.0 0.4 0.1 4.1 2.8 1.8 2.4 0.4 4.4 0.6 3.9 5.8 2.5 0.8 1.5 1.3 4.1 0.0 1.8 5.1 0.4 1.1 5.9 2.2 1.6 2.9 1.2 0.5 0.2 0.0 0.8 2.5 1.5 0.0 2.7 0.0 12.2 9.5 2.4 2.6 1.1 1.0 1.1 0.8 0.0 1.9 6.1 9.7 0.3 2.7 0.1 0.9 2.9 0.5 0.1 1.4 0.3 3.3 0.5 1.6 0.5 2.6 0.7 1.2 1.9 0.5 0.7 9.1 10.6 2.5 6.3 9.2 5.9 10.5 4.8 9.2 9.3 DNAH3 "DKFZp434N074, DLP3, Dnahc3b, Hsadhc3" ENSG00000158486 "Dynein axonemal heavy chain 3" Q8TD57 16 20933111-21159441 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "fallopian tube: 10.4;testis: 6.2" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 1.1;CACO-2: 1.0;CAPAN-2: 1.1;hTEC/SVTERT24-B: 1.3;U-698: 1.2" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA062493 Approved "Nuclear membrane,Intermediate filaments" "Nuclear membrane" "Intermediate filaments" "HPA062493: " "unprognostic (1.68e-1)" "unprognostic (9.84e-2)" "unprognostic (1.32e-1)" "unprognostic (2.11e-3)" "unprognostic (1.25e-2)" "unprognostic (5.23e-2)" "unprognostic (1.40e-3)" "unprognostic (1.79e-1)" "unprognostic (7.50e-2)" "unprognostic (1.75e-1)" "unprognostic (2.66e-2)" "unprognostic (1.86e-1)" "unprognostic (1.57e-5)" "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (1.92e-1)" "unprognostic (1.15e-1)" 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.2 0.0 0.0 10.4 0.0 0.0 0.5 0.7 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 1.0 1.1 0.1 0.4 0.0 0.4 0.1 0.1 0.1 0.1 0.5 0.0 0.0 0.1 0.0 0.2 0.8 0.0 0.3 1.3 0.0 0.0 0.4 0.3 0.1 0.0 0.1 0.0 0.6 0.1 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.4 0.3 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.7 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DNAJA2 "CPR3, DNAJ, DNJ3, HIRIP4" ENSG00000069345 "DnaJ heat shock protein family (Hsp40) member A2" O60884 16 46955362-46973788 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049789, HPA060538" Approved Approved "Nucleoli,Intermediate filaments,Cytosol" 31000 "Nucleoli, Cytosol" "Intermediate filaments" "HPA049789: , HPA060538: " "unprognostic (7.68e-3)" "unprognostic (1.05e-2)" "unprognostic (4.77e-2)" "unprognostic (3.67e-2)" "unprognostic (4.46e-2)" "prognostic unfavourable (2.81e-4)" "unprognostic (1.03e-1)" "unprognostic (4.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.53e-2)" "unprognostic (5.41e-2)" "unprognostic (2.12e-1)" "prognostic favourable (1.19e-9)" "unprognostic (9.22e-2)" "unprognostic (2.28e-1)" "unprognostic (9.22e-2)" "unprognostic (4.69e-2)" 25.0 29.2 32.3 18.0 36.5 23.6 22.8 29.8 44.2 21.7 21.1 17.1 20.3 22.3 25.6 33.6 23.4 20.3 18.9 37.9 30.5 27.1 31.2 39.0 17.7 21.4 25.5 27.6 26.1 18.9 29.0 18.9 22.1 31.5 25.6 21.9 18.4 19.1 24.9 43.7 22.3 23.8 26.9 21.2 24.1 20.3 33.0 18.7 20.8 25.4 31.8 23.2 24.5 23.5 13.6 10.5 14.5 14.0 14.3 18.9 10.2 10.9 13.1 13.2 11.2 18.1 17.5 20.1 14.3 17.3 21.6 10.3 11.4 11.5 17.7 11.6 15.4 17.1 21.0 14.8 25.1 4.2 17.6 13.0 6.4 24.0 21.7 19.7 18.2 18.6 17.2 12.5 11.9 14.9 14.9 6.0 18.2 12.0 14.1 27.5 20.1 19.5 16.4 24.2 21.0 26.0 11.7 18.1 11.6 17.0 25.8 15.6 10.0 15.4 15.3 12.8 8.1 9.2 12.0 14.8 10.1 23.7 13.5 17.0 10.7 13.0 11.5 14.5 11.9 14.0 15.4 13.6 16.1 13.3 10.5 10.4 16.0 15.7 12.1 14.3 12.0 7.4 18.9 10.2 32.3 36.5 29.8 44.2 30.5 27.1 25.5 27.6 31.5 18.7 DOLPP1 LSFR2 ENSG00000167130 "Dolichyldiphosphatase 1" Q86YN1 9 129081100-129090438 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019179 Approved Approved "Vesicles,Intermediate filaments" Vesicles "Intermediate filaments" "HPA019179: AB_1847827" "unprognostic (1.32e-2)" "unprognostic (1.23e-1)" "unprognostic (3.89e-1)" "unprognostic (6.12e-3)" "unprognostic (3.11e-1)" "unprognostic (2.63e-2)" "unprognostic (3.18e-1)" "unprognostic (3.10e-2)" "unprognostic (6.96e-2)" "unprognostic (7.12e-2)" "unprognostic (1.65e-1)" "unprognostic (4.37e-3)" "unprognostic (7.59e-3)" "unprognostic (2.38e-2)" "unprognostic (1.35e-1)" "unprognostic (4.69e-2)" "unprognostic (5.34e-2)" 6.4 12.8 10.0 6.8 10.6 7.7 6.8 11.7 19.3 8.3 17.1 17.7 8.6 28.6 6.0 7.4 18.8 6.6 9.2 4.1 10.1 10.7 9.4 21.8 6.7 6.6 13.2 10.6 7.7 10.5 10.4 6.9 11.6 12.5 10.0 14.2 6.1 10.3 5.8 5.2 10.3 27.7 6.3 15.2 8.5 11.8 12.2 11.0 9.4 6.3 8.5 9.1 7.8 8.0 8.8 12.5 9.8 8.3 7.9 21.7 7.2 4.3 16.6 16.3 14.9 5.5 4.7 18.9 10.7 6.2 20.3 11.3 21.3 14.4 8.3 9.4 6.6 31.3 16.7 8.9 8.6 9.8 10.3 11.0 11.2 16.3 9.7 11.3 13.7 5.0 12.5 13.3 10.6 9.0 18.1 8.4 5.7 21.8 13.0 11.8 14.0 13.5 15.3 13.2 15.0 7.4 7.0 18.6 12.2 13.4 12.3 4.5 22.5 7.5 7.4 17.5 8.4 16.4 14.4 10.5 20.0 12.7 7.7 2.3 11.5 4.4 6.8 9.8 8.9 8.1 21.7 8.8 10.9 10.8 8.5 6.0 11.1 10.5 1.4 7.9 8.3 12.5 10.1 7.2 10.0 10.6 11.7 19.3 10.1 10.7 13.2 10.6 12.5 11.0 DSTYK "DustyPK, KIAA0472, RIP5, RIPK5" ENSG00000133059 "Dual serine/threonine and tyrosine protein kinase" Q6XUX3 1 205142505-205211566 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044140 Uncertain Uncertain "Nuclear speckles,Intermediate filaments" "Nuclear speckles, Intermediate filaments" "HPA044140: AB_10965031" "unprognostic (1.42e-2)" "unprognostic (1.07e-2)" "unprognostic (7.92e-2)" "unprognostic (1.02e-3)" "unprognostic (1.39e-1)" "unprognostic (2.66e-1)" "unprognostic (1.43e-2)" "unprognostic (9.01e-2)" "unprognostic (1.81e-1)" "unprognostic (1.06e-1)" "unprognostic (2.25e-3)" "unprognostic (1.20e-1)" "unprognostic (3.26e-2)" "unprognostic (7.80e-2)" "unprognostic (1.93e-1)" "unprognostic (1.55e-1)" "prognostic unfavourable (8.73e-5)" 6.4 9.2 13.8 4.4 13.3 19.6 8.2 20.4 16.4 8.4 6.5 6.8 4.2 3.3 10.5 7.4 6.7 9.2 5.4 5.7 10.7 9.0 9.3 2.5 7.3 5.4 8.1 11.8 14.0 5.9 22.0 11.0 7.1 12.2 7.2 4.6 9.2 6.2 8.8 14.6 14.0 4.8 8.8 11.0 7.0 5.3 11.5 9.2 7.1 8.4 3.6 5.3 7.6 6.4 3.5 3.1 9.8 3.5 4.8 5.1 1.6 6.8 4.5 4.8 5.8 7.0 11.9 3.4 8.6 8.6 9.0 6.2 2.0 3.8 5.1 2.6 14.5 4.9 5.2 5.5 9.2 2.4 5.7 9.2 5.9 2.1 6.3 2.6 4.9 7.0 8.4 9.2 8.8 6.6 11.9 3.4 7.1 4.7 2.0 2.3 5.2 5.4 1.8 8.7 4.4 6.0 4.3 2.7 5.2 7.3 7.6 24.1 5.6 3.4 6.5 5.6 5.7 8.5 5.7 3.5 2.5 3.0 6.6 3.6 20.1 9.8 3.5 6.0 4.6 2.5 4.3 2.7 3.4 3.8 3.1 3.5 5.1 3.7 5.1 4.8 1.8 2.3 2.0 1.6 13.8 13.3 20.4 16.4 10.7 9.0 8.1 11.8 12.2 9.2 DTNA "D18S892E, DRP3, DTN, DTN-1, DTN-2, DTN-3" ENSG00000134769 "Dystrobrevin alpha" Q9Y4J8 18 34493290-34891844 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 106.3;heart muscle: 82.8;skeletal muscle: 90.2" "Cell line enhanced" "Detected in many" "MCF7: 17.5;NTERA-2: 19.5;SCLC-21H: 27.5;U-87 MG: 28.1" "Cancer enriched" "Detected in many" 9 "glioma: 28.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 7.0;T-cells: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015196, HPA071177" Enhanced Approved "Nucleoplasm,Cell Junctions,Intermediate filaments" "Nucleoplasm, Cell Junctions, Intermediate filaments" "CAB015196: AB_2261797, HPA071177: " "unprognostic (1.57e-1)" "unprognostic (4.57e-2)" "unprognostic (3.13e-3)" "unprognostic (7.82e-6)" "unprognostic (5.03e-1)" "unprognostic (2.43e-3)" "unprognostic (2.73e-1)" "unprognostic (7.42e-2)" "unprognostic (1.23e-1)" "unprognostic (6.27e-2)" "unprognostic (1.35e-4)" "unprognostic (6.89e-2)" "prognostic favourable (2.64e-7)" "unprognostic (6.08e-3)" "unprognostic (3.93e-2)" "unprognostic (1.12e-1)" "unprognostic (7.27e-5)" 9.3 5.3 51.5 4.0 47.6 1.6 7.3 37.7 69.1 4.5 5.4 38.7 0.9 3.4 4.3 13.9 13.9 7.6 7.1 82.8 42.3 46.5 2.7 2.5 4.8 2.3 44.7 21.0 5.4 12.3 1.4 6.1 3.6 51.0 14.6 5.6 3.4 5.7 15.9 90.2 1.8 3.9 15.2 106.3 3.9 3.6 4.7 39.5 0.0 9.3 6.5 2.4 12.8 1.7 1.4 7.0 0.4 1.3 1.0 6.7 1.7 0.2 0.1 7.5 0.0 4.8 13.4 1.2 2.0 7.3 0.3 0.9 1.7 0.0 0.0 4.4 0.8 0.6 0.9 3.9 0.7 0.0 5.2 0.0 0.4 3.5 3.9 0.1 0.1 10.2 0.8 6.3 2.2 3.2 1.1 0.9 2.1 17.5 0.1 0.0 19.5 4.0 0.0 3.7 11.9 0.3 0.1 27.5 3.2 0.0 0.7 2.0 10.7 2.6 0.1 8.7 4.7 0.1 2.7 0.6 0.9 0.4 28.1 0.0 3.7 0.4 1.3 0.0 1.4 0.0 1.9 1.4 2.7 1.9 7.0 1.1 2.8 2.0 0.1 1.0 0.0 0.2 6.7 1.7 51.5 47.6 37.7 35.7 42.3 46.5 44.7 21.0 51.0 39.5 DVL3 KIAA0208 ENSG00000161202 "Dishevelled segment polarity protein 3" Q92997 3 184155388-184173610 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046486, HPA058265" Approved Approved "Intermediate filaments,Midbody ring,Centrosome" "Midbody ring, Centrosome" "Intermediate filaments" "CAB046486: AB_10610845, HPA058265: " "unprognostic (2.20e-1)" "unprognostic (1.52e-1)" "prognostic unfavourable (1.90e-4)" "unprognostic (1.88e-2)" "unprognostic (1.64e-2)" "unprognostic (2.23e-1)" "prognostic unfavourable (8.41e-4)" "unprognostic (8.61e-2)" "unprognostic (5.34e-2)" "unprognostic (2.49e-1)" "unprognostic (3.14e-1)" "prognostic unfavourable (4.77e-5)" "prognostic unfavourable (1.53e-8)" "unprognostic (1.87e-1)" "unprognostic (4.10e-1)" "unprognostic (8.41e-2)" "unprognostic (3.95e-1)" 22.8 18.5 18.0 16.8 19.4 15.3 25.1 18.3 23.2 22.6 27.6 24.7 23.9 16.2 32.1 16.4 20.0 22.2 22.2 27.9 19.9 12.3 16.8 13.1 20.6 12.1 21.4 16.0 30.0 22.7 17.2 17.8 56.0 17.4 19.7 15.8 31.1 18.7 26.2 26.3 27.6 19.1 30.3 16.4 17.8 19.4 15.6 20.1 7.3 20.9 13.3 14.6 24.5 26.3 2.5 2.7 4.1 4.0 1.5 3.1 1.2 19.8 6.5 15.8 17.9 16.4 16.4 40.7 11.8 12.1 14.3 11.9 19.1 8.0 13.9 31.7 15.4 17.0 12.9 9.4 10.0 21.9 13.5 15.5 9.8 11.5 24.6 8.6 12.1 16.5 16.9 10.4 11.9 10.4 15.5 19.3 15.0 19.0 12.7 10.2 13.9 9.4 20.3 18.3 12.1 13.3 16.4 17.1 21.7 14.7 17.0 28.8 42.5 11.0 10.2 13.0 12.7 13.6 18.3 20.7 15.3 15.5 12.9 9.2 10.0 0.2 2.4 4.1 2.3 4.0 3.1 2.5 1.5 2.4 2.3 2.0 2.0 1.3 3.6 1.5 2.8 2.7 1.1 1.2 18.0 19.4 18.3 23.2 19.9 12.3 21.4 16.0 17.4 20.1 EIPR1 "EIPR-1, TSSC1" ENSG00000032389 "EARP complex and GARP complex interacting protein 1" Q53HC9 2 3188925-3377882 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031231, HPA031232, HPA031233, HPA031234" Approved Supported "Nucleoplasm,Nucleoli,Intermediate filaments" "Nucleoplasm, Nucleoli" "Intermediate filaments" "HPA031231: AB_10669881, HPA031232: AB_10603222, HPA031233: AB_10670026, HPA031234: " "unprognostic (2.16e-1)" "unprognostic (2.22e-1)" "unprognostic (2.71e-1)" "unprognostic (1.66e-1)" "unprognostic (4.27e-2)" "unprognostic (1.22e-1)" "prognostic unfavourable (3.67e-7)" "unprognostic (1.94e-1)" "unprognostic (1.57e-1)" "unprognostic (7.83e-2)" "unprognostic (2.10e-1)" "unprognostic (2.50e-1)" "unprognostic (1.78e-1)" "unprognostic (1.02e-2)" "unprognostic (3.43e-1)" "unprognostic (2.24e-2)" "unprognostic (3.83e-2)" 7.3 12.3 20.1 17.3 24.4 14.2 9.0 26.0 22.9 8.3 11.9 12.1 10.0 10.7 7.7 18.4 14.5 12.0 7.9 10.3 17.7 19.3 12.4 11.4 7.9 15.2 15.1 14.5 5.8 11.6 14.2 20.8 8.0 13.6 7.7 10.9 10.5 9.9 7.4 10.9 9.2 9.3 9.4 12.4 12.0 9.3 9.9 11.5 14.5 20.4 15.5 15.3 11.1 7.7 15.7 23.4 13.9 13.3 16.3 16.9 14.0 11.1 20.9 11.2 12.6 7.1 9.6 25.3 11.7 12.1 14.1 10.8 13.9 14.1 19.4 20.7 11.8 11.4 8.7 16.8 7.8 15.1 16.5 17.2 13.0 32.2 13.5 16.8 21.5 8.7 15.3 14.2 18.5 17.8 19.1 13.5 12.9 20.7 15.5 24.5 12.9 16.7 18.2 11.8 26.1 17.4 15.4 24.4 28.3 8.2 13.8 12.7 12.8 15.7 12.4 11.3 5.9 9.3 15.6 15.5 37.5 16.1 13.4 17.5 10.4 13.9 11.8 9.4 16.1 13.3 16.3 13.9 13.4 16.8 21.3 15.7 14.7 15.8 5.0 16.3 11.9 23.4 16.9 14.0 20.1 24.4 26.0 22.9 17.7 19.3 15.1 14.5 13.6 11.5 EML4 "C2orf2, ELP120, ROPP120" ENSG00000143924 "Echinoderm microtubule associated protein like 4" Q9HC35 2 42169350-42332548 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 60.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036687, HPA036688, HPA065337" Enhanced Supported "Intermediate filaments,Microtubules,Cytosol" 41000 Microtubules "Intermediate filaments, Cytosol" "HPA036687: AB_2675251, HPA036688: AB_10671968, HPA065337: AB_2685474" "unprognostic (1.70e-1)" "unprognostic (1.38e-1)" "unprognostic (8.17e-2)" "unprognostic (3.53e-3)" "unprognostic (1.79e-2)" "unprognostic (9.19e-2)" "unprognostic (8.61e-3)" "unprognostic (1.61e-2)" "unprognostic (2.96e-3)" "unprognostic (6.80e-2)" "unprognostic (7.44e-2)" "unprognostic (1.60e-2)" "unprognostic (1.86e-2)" "unprognostic (1.27e-1)" "unprognostic (1.05e-1)" "unprognostic (1.39e-1)" "unprognostic (2.13e-2)" 11.3 17.3 5.8 29.3 6.8 19.2 10.5 4.6 5.2 9.4 21.6 6.7 6.8 20.3 13.6 11.6 10.7 8.7 20.3 6.5 5.1 3.9 11.7 26.4 19.3 27.7 4.6 4.0 12.5 37.8 10.8 11.6 26.9 6.5 8.5 12.8 12.1 17.7 8.9 4.3 17.9 33.5 9.2 5.0 30.9 11.7 14.2 5.3 17.4 13.2 6.9 30.0 14.0 9.0 11.5 4.2 10.0 11.0 9.4 17.5 5.9 14.4 25.1 14.6 11.6 5.3 8.8 16.0 9.0 7.1 10.0 9.7 26.2 18.2 13.2 6.2 8.8 7.5 12.6 8.6 17.5 25.8 10.5 12.1 7.8 60.0 6.8 9.1 12.5 9.6 3.3 13.2 9.0 6.9 12.0 13.4 10.7 8.5 8.6 2.4 14.9 7.2 8.9 23.2 7.8 8.2 21.0 14.5 29.2 8.8 9.2 6.8 4.8 3.7 8.0 10.2 13.7 8.1 8.1 15.1 10.5 11.4 8.9 8.8 7.1 4.4 3.9 7.7 7.8 10.9 16.3 11.5 13.0 12.7 3.3 7.9 11.4 8.3 10.0 9.4 11.0 4.2 17.5 5.9 5.8 6.8 4.6 5.2 5.1 3.9 4.6 4.0 6.5 5.3 EPPK1 EPIPL1 ENSG00000261150 "Epiplakin 1" 8 143857324-143878464 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 14.8;skin 1: 14.1;smooth muscle: 15.7" "Cell line enhanced" "Detected in some" "BEWO: 10.9;EFO-21: 10.2;HaCaT: 10.1;HeLa: 16.9;MCF7: 14.6;SK-BR-3: 7.0" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.1" "Lineage enriched" "Detected in single" 22 "T-cells: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA066808, HPA067357, HPA069333" Approved Enhanced "Intermediate filaments" "Intermediate filaments" "HPA066808: , HPA067357: , HPA069333: " "unprognostic (1.42e-1)" "unprognostic (9.30e-2)" "unprognostic (5.89e-2)" "prognostic unfavourable (5.52e-5)" "unprognostic (2.85e-2)" "unprognostic (5.86e-3)" "unprognostic (4.90e-2)" "unprognostic (8.73e-2)" "unprognostic (9.60e-2)" "unprognostic (2.31e-1)" "prognostic unfavourable (3.94e-4)" "unprognostic (1.35e-1)" "unprognostic (1.97e-3)" "unprognostic (5.94e-3)" "unprognostic (4.35e-1)" "unprognostic (3.68e-3)" "unprognostic (5.08e-3)" 0.0 0.0 0.0 3.0 0.0 0.0 1.1 0.7 0.0 0.4 7.8 0.0 7.2 3.1 3.4 2.4 6.0 1.4 2.3 0.0 0.0 0.8 0.0 4.2 0.9 0.0 0.0 1.0 1.9 0.6 0.0 2.8 0.5 2.9 0.8 0.0 14.8 4.9 0.1 14.1 12.1 15.7 0.1 1.5 1.2 2.3 0.0 0.0 0.0 7.2 4.3 4.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 5.7 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 5.4 0.4 0.0 10.2 0.0 10.1 1.0 0.1 0.0 0.0 2.6 0.0 16.9 3.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.0 14.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 3.6 1.7 0.0 1.6 7.0 0.0 5.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 1.0 0.2 0.0 0.0 2.1 0.8 0.0 0.0 0.0 0.0 0.2 0.0 EVPL EVPK ENSG00000167880 Envoplakin Q92817 17 76004502-76027452 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 69.9;lymphoid tissue: 46.1;skin 1: 43.7;tongue: 43.1" "Cell line enhanced" "Detected in some" "HaCaT: 24.1;MCF7: 15.8;RT4: 34.9;SK-BR-3: 17.4;T-47d: 22.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB002220, HPA053969" Enhanced Supported "Intermediate filaments,Cytosol" "Intermediate filaments" Cytosol "CAB002220: AB_563701, HPA053969: " "unprognostic (2.10e-1)" "unprognostic (1.58e-1)" "unprognostic (1.41e-1)" "unprognostic (4.21e-1)" "unprognostic (1.05e-2)" "unprognostic (1.87e-2)" "unprognostic (1.70e-1)" "unprognostic (1.11e-1)" "unprognostic (1.94e-1)" "unprognostic (1.44e-1)" "unprognostic (7.40e-3)" "unprognostic (2.64e-1)" "unprognostic (2.40e-2)" "unprognostic (2.31e-1)" "unprognostic (3.47e-1)" "unprognostic (7.93e-2)" "unprognostic (3.09e-2)" 0.2 0.0 0.0 2.3 0.1 1.1 1.2 0.0 0.3 11.6 5.7 0.1 2.8 4.8 1.9 1.3 69.9 0.9 4.1 0.0 0.0 0.0 4.8 0.0 5.7 0.2 0.0 0.0 0.4 2.4 1.8 1.1 2.3 0.1 3.2 0.7 0.7 10.9 4.5 0.5 43.7 7.8 2.1 0.2 0.1 1.9 0.3 0.1 0.4 6.3 43.1 46.1 5.0 21.6 0.4 1.7 1.9 0.3 1.6 1.4 0.0 11.0 9.3 0.0 0.1 0.1 0.0 3.9 0.1 0.0 0.0 0.0 1.2 6.7 0.0 0.0 0.0 24.1 0.0 3.1 0.0 0.0 0.0 0.2 6.9 7.0 0.0 0.0 1.7 0.0 5.0 0.1 0.0 0.0 0.0 0.4 0.0 15.8 0.4 1.5 0.0 4.2 4.5 0.0 0.1 7.3 34.9 0.4 0.0 4.6 17.4 0.0 22.0 0.4 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.5 0.0 1.0 0.3 0.7 0.6 0.3 0.7 0.2 0.2 0.5 0.1 0.4 1.4 0.6 1.9 1.6 0.2 1.7 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 EXD2 "C14orf114, EXDL2, FLJ10738" ENSG00000081177 "Exonuclease 3'-5' domain containing 2" Q9NVH0 14 69191511-69244020 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002906, HPA005848" Uncertain Approved "Intermediate filaments,Mitochondria" Mitochondria "Intermediate filaments" "HPA002906: AB_1078767, HPA005848: AB_1078768" "unprognostic (3.36e-2)" "unprognostic (1.61e-2)" "unprognostic (1.25e-1)" "unprognostic (1.71e-1)" "unprognostic (2.63e-1)" "unprognostic (2.85e-1)" "prognostic unfavourable (8.47e-4)" "unprognostic (9.91e-2)" "unprognostic (8.03e-2)" "unprognostic (2.46e-1)" "unprognostic (4.64e-2)" "unprognostic (8.97e-2)" "prognostic favourable (2.08e-9)" "unprognostic (1.16e-1)" "unprognostic (3.06e-2)" "unprognostic (8.75e-2)" "unprognostic (2.14e-2)" 8.1 7.7 14.3 5.0 19.0 2.3 10.6 20.4 20.1 15.8 8.8 21.7 10.2 7.2 14.4 13.6 10.7 14.5 8.6 8.9 13.8 12.0 11.5 6.0 9.0 4.0 13.7 13.3 12.4 24.9 21.9 13.2 8.0 13.9 11.4 10.0 9.6 17.0 12.1 10.3 7.0 6.8 11.0 20.7 5.8 8.7 20.0 12.6 5.0 12.4 5.2 5.9 10.5 7.9 4.1 7.4 10.9 3.4 3.6 6.0 3.1 18.8 8.9 6.9 10.1 4.2 5.1 8.7 9.4 8.0 8.8 11.7 7.5 13.3 0.0 7.0 9.8 10.7 7.6 9.5 10.0 4.7 9.1 5.5 3.3 4.4 16.6 4.0 5.3 10.3 15.8 9.0 5.9 12.4 3.4 7.3 8.3 9.5 2.3 6.1 7.4 8.9 0.0 6.6 6.6 13.0 7.0 13.4 12.0 7.0 14.8 6.9 19.7 3.5 9.8 8.2 5.8 6.6 4.8 5.6 7.4 0.0 0.0 4.4 6.1 10.9 3.4 2.9 3.3 1.9 6.0 4.1 3.5 3.3 7.4 2.4 4.2 6.0 0.4 3.6 1.7 5.8 2.4 3.1 14.3 19.0 20.4 20.1 13.8 12.0 13.7 13.3 13.9 12.6 EXOSC4 "FLJ20591, hRrp41p, p12A, RRP41, RRP41A, Rrp41p, SKI6, Ski6p" ENSG00000178896 "Exosome component 4" Q9NPD3 8 144078626-144080647 "Plasma proteins, Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 90.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024792 Approved Supported "Intermediate filaments,Cytosol" "Intermediate filaments, Cytosol" "HPA024792: AB_1848325" "unprognostic (2.32e-1)" "unprognostic (1.55e-2)" "unprognostic (3.06e-1)" "unprognostic (3.53e-2)" "unprognostic (1.33e-1)" "unprognostic (2.29e-2)" "unprognostic (6.58e-3)" "unprognostic (1.26e-1)" "unprognostic (8.36e-2)" "prognostic favourable (2.23e-4)" "unprognostic (4.32e-2)" "unprognostic (1.41e-1)" "unprognostic (2.30e-2)" "unprognostic (5.18e-2)" "unprognostic (1.23e-1)" "unprognostic (2.71e-1)" "unprognostic (5.11e-2)" 12.3 16.7 12.8 11.4 17.6 13.8 8.9 13.9 20.6 8.1 12.0 10.5 13.6 15.8 9.8 10.4 14.5 10.0 9.3 16.5 11.4 11.2 14.9 21.5 8.7 11.4 11.5 13.0 10.3 15.0 8.0 10.2 11.5 12.0 12.1 6.5 11.6 28.0 14.7 12.1 12.7 11.1 6.7 9.3 13.4 13.9 45.0 9.7 14.8 10.8 10.4 11.1 8.7 7.8 24.7 38.2 19.0 31.8 17.1 16.1 18.8 10.2 22.5 4.0 9.6 3.5 2.6 11.0 8.0 3.3 6.3 6.4 15.7 7.2 6.2 11.7 3.3 8.4 7.4 8.8 1.8 8.1 25.0 8.9 16.8 17.4 5.8 6.6 10.6 3.8 9.0 7.3 5.8 3.2 13.9 4.2 5.1 37.2 10.2 13.1 10.4 90.3 4.5 6.6 16.0 6.0 10.4 12.6 16.7 10.0 13.0 18.5 14.7 10.0 3.2 6.5 14.2 15.5 13.6 11.2 13.4 7.7 9.4 10.6 10.1 19.0 31.8 12.5 15.9 29.4 16.1 22.0 12.4 15.4 29.8 24.7 15.9 15.4 9.2 17.1 16.1 38.2 13.7 18.8 12.8 17.6 13.9 20.6 11.4 11.2 11.5 13.0 12.0 9.7 FAIM2 "KIAA0950, LFG, LFG2, LIFEGUARD, NMP35, TMBIM2" ENSG00000135472 "Fas apoptotic inhibitory molecule 2" Q9BWQ8 12 49866896-49904217 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 138.5" "Cell line enhanced" "Detected in some" "HHSteC: 9.2;SH-SY5Y: 4.9;U-87 MG: 28.6" "Cancer enriched" "Detected in many" 8 "glioma: 21.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "gdT-cell: 1.7;T-reg: 6.2" "Lineage enriched" "Detected in single" 9 "T-cells: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018790, HPA048800" Enhanced Approved "Intermediate filaments" "Intermediate filaments" "HPA018790: AB_1852822, HPA048800: AB_2680526" "unprognostic (1.74e-1)" "unprognostic (5.98e-4)" "unprognostic (2.22e-1)" "unprognostic (9.75e-3)" "unprognostic (3.36e-2)" "unprognostic (2.61e-4)" "unprognostic (2.62e-1)" "unprognostic (3.17e-2)" "unprognostic (2.00e-2)" "unprognostic (1.75e-2)" "unprognostic (5.66e-2)" "unprognostic (1.30e-2)" "unprognostic (3.28e-6)" "unprognostic (1.69e-1)" "unprognostic (1.76e-1)" "unprognostic (2.47e-1)" "unprognostic (6.78e-4)" 3.9 27.2 35.6 4.1 57.5 1.4 2.5 42.4 138.5 3.2 4.7 29.1 0.2 2.7 4.2 6.4 3.9 5.8 7.5 7.4 38.8 51.0 2.0 1.5 2.5 3.5 35.9 33.7 2.6 2.8 14.7 7.8 1.5 65.6 8.8 3.5 3.9 3.0 7.1 2.0 1.8 4.0 8.7 36.9 2.5 2.6 12.1 20.5 0.0 1.7 0.0 3.1 4.7 2.0 0.0 0.0 0.0 0.4 0.6 6.2 0.2 0.0 0.3 0.4 0.5 2.0 1.3 0.1 0.5 2.6 0.5 0.3 0.3 0.0 0.0 0.1 3.6 0.2 1.2 0.0 0.3 0.0 0.0 2.0 0.0 0.0 9.2 0.1 0.0 0.8 0.2 2.0 0.0 0.0 1.1 0.3 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 4.9 0.0 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.3 0.0 0.0 28.6 0.0 0.2 0.0 0.1 0.0 1.7 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 6.2 0.2 35.6 57.5 42.4 99.5 38.8 51.0 35.9 33.7 65.6 20.5 FAM118A "bK268H5.C22.4, C22orf8, FLJ20635" ENSG00000100376 "Family with sequence similarity 118 member A" Q9NWS6 22 45308968-45341955 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003902 Uncertain Approved "Intermediate filaments,Cytosol" "Intermediate filaments" Cytosol "HPA003902: AB_1848368" "unprognostic (6.22e-3)" "unprognostic (1.19e-2)" "unprognostic (9.92e-2)" "unprognostic (1.56e-3)" "unprognostic (1.68e-1)" "unprognostic (2.09e-2)" "unprognostic (3.72e-2)" "unprognostic (7.61e-3)" "unprognostic (9.42e-2)" "unprognostic (6.11e-2)" "unprognostic (5.02e-3)" "unprognostic (1.12e-2)" "prognostic unfavourable (1.87e-6)" "unprognostic (9.76e-2)" "unprognostic (1.28e-1)" "unprognostic (4.50e-1)" "unprognostic (1.16e-3)" 8.4 7.9 9.8 14.3 17.3 11.7 14.7 14.6 12.0 10.5 13.9 9.6 10.3 12.2 15.5 41.7 10.8 6.5 15.3 13.9 12.1 7.7 8.4 8.8 10.0 29.0 10.2 5.0 13.8 8.2 32.9 22.7 11.4 11.7 23.7 7.6 12.1 14.6 18.6 20.0 23.9 16.0 14.5 8.1 14.5 12.5 22.1 10.7 14.0 14.4 6.6 17.9 17.3 13.3 8.3 15.7 6.5 8.6 5.9 13.9 4.7 5.5 4.0 4.6 5.9 4.0 4.2 12.9 4.1 6.1 5.9 5.2 11.6 5.2 24.8 3.2 3.7 19.5 6.2 5.4 5.6 5.5 16.3 13.3 5.9 7.8 6.0 12.1 3.5 4.8 5.5 7.9 5.2 3.5 19.9 26.3 2.5 12.3 7.6 23.1 3.9 5.9 9.2 3.4 8.6 2.9 13.9 10.5 13.2 4.7 8.8 11.0 4.3 6.1 4.0 4.4 15.0 5.4 5.2 14.5 2.8 12.8 5.4 8.0 8.1 4.5 8.6 2.5 7.0 7.1 5.6 5.3 8.6 8.6 10.9 8.3 13.9 10.0 6.5 5.9 5.6 15.7 11.4 4.7 9.8 17.3 14.6 12.0 12.1 7.7 10.2 5.0 11.7 10.7 FAM131C "C1orf117, FLJ36766" ENSG00000185519 "Family with sequence similarity 131 member C" Q96AQ9 1 16057769-16073632 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.1" "Cell line enhanced" "Detected in some" "A549: 10.7;HEK 293: 6.9;PC-3: 7.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 41.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031046 Uncertain Approved "Nucleoli,Intermediate filaments,Cytosol" "Nucleoli, Intermediate filaments, Cytosol" "HPA031046: " "unprognostic (4.69e-3)" "unprognostic (4.98e-2)" "unprognostic (7.26e-2)" "unprognostic (2.46e-4)" "unprognostic (1.77e-1)" "unprognostic (1.15e-1)" "unprognostic (1.63e-2)" "unprognostic (4.67e-4)" "unprognostic (2.82e-1)" "unprognostic (1.93e-2)" "unprognostic (1.75e-1)" "unprognostic (1.68e-1)" "prognostic favourable (9.33e-6)" "unprognostic (1.93e-1)" "unprognostic (2.29e-1)" "unprognostic (2.82e-2)" "unprognostic (1.44e-1)" 0.7 7.8 5.6 0.6 4.0 0.5 1.1 41.1 9.1 1.1 1.0 7.7 0.0 0.7 1.0 1.4 1.2 1.1 1.4 5.2 5.0 6.5 10.4 2.2 0.6 0.5 10.7 3.8 1.2 7.1 2.0 5.6 0.7 8.7 0.8 0.6 0.8 6.3 1.6 0.6 3.2 0.8 0.9 17.7 0.6 1.6 1.3 4.9 0.0 1.7 0.0 1.4 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.2 10.7 0.4 0.6 0.0 0.0 0.0 1.0 0.9 1.2 2.7 0.2 2.3 0.0 0.4 0.5 1.2 1.4 0.3 0.3 0.0 6.9 0.0 2.4 0.0 0.1 0.0 0.0 0.0 1.7 0.1 0.9 0.7 0.0 0.0 0.1 2.2 0.0 0.0 0.4 7.9 0.0 0.0 4.5 0.8 0.0 1.5 3.1 0.4 1.3 0.3 0.3 0.0 1.7 0.2 3.8 0.0 0.0 1.7 0.1 0.0 3.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 4.0 41.1 7.1 5.0 6.5 10.7 3.8 8.7 4.9 FAM174B "LOC400451, MGC102891" ENSG00000185442 "Family with sequence similarity 174 member B" Q3ZCQ3 15 92617443-92809884 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 57.6" "Cell line enhanced" "Detected in many" "CACO-2: 21.0;MCF7: 25.3;RPMI-8226: 29.7;RT4: 62.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 10.9" "Group enriched" "Detected in many" 7 "dendritic cells: 4.5;granulocytes: 3.7;T-cells: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015306 Approved Approved "Intermediate filaments" "Intermediate filaments" "HPA015306: " "unprognostic (3.00e-3)" "unprognostic (1.80e-1)" "unprognostic (1.50e-1)" "prognostic favourable (9.03e-5)" "unprognostic (4.68e-2)" "unprognostic (1.63e-1)" "unprognostic (8.35e-2)" "unprognostic (8.23e-3)" "unprognostic (7.67e-3)" "unprognostic (5.05e-3)" "unprognostic (6.60e-2)" "unprognostic (1.33e-1)" "unprognostic (4.67e-2)" "unprognostic (2.01e-1)" "unprognostic (6.64e-2)" "unprognostic (1.61e-2)" "unprognostic (2.35e-2)" 6.1 3.5 5.9 3.3 6.3 0.7 17.9 3.9 8.6 10.9 6.2 2.9 21.5 3.6 5.1 4.9 5.2 14.6 6.4 4.2 7.4 8.3 3.3 4.0 16.3 5.5 6.5 6.2 10.2 57.6 2.5 15.9 4.6 6.7 19.4 9.2 7.7 47.7 10.8 16.3 4.9 5.0 4.6 4.9 3.2 17.3 9.7 3.6 4.2 28.9 3.9 4.8 24.4 15.3 0.4 4.5 3.7 0.9 0.7 10.9 0.7 0.0 3.5 2.3 0.7 0.0 0.0 0.2 1.3 6.2 0.0 0.0 21.0 2.4 0.3 6.0 0.1 0.1 3.9 0.1 0.0 0.1 1.8 0.2 0.3 0.2 0.4 0.3 0.9 0.3 0.1 0.0 0.0 3.0 0.3 15.6 3.5 25.3 0.7 0.0 11.3 0.0 2.4 6.5 29.7 1.5 62.7 1.4 1.1 1.8 12.1 3.8 9.7 2.1 0.0 0.0 0.4 0.1 2.9 0.4 4.6 0.7 0.0 0.2 1.5 1.1 0.8 0.9 0.2 0.9 0.4 0.4 2.5 0.0 0.6 0.3 2.8 3.3 3.7 0.7 0.0 4.5 10.9 0.7 5.9 6.3 3.9 8.6 7.4 8.3 6.5 6.2 6.7 3.6 FAM231C ENSG00000268674 "Family with sequence similarity 231 member C" "P0DMU3, P0DMU4, P0DMU5" Unmapped 35407-35916 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 5 "blood: 1.6;brain: 5.6;parathyroid gland: 3.2;testis: 1.4" "Cell line enhanced" "Detected in single" "U-698: 1.4" "Cell type enhanced" "Detected in single" "naive B-cell: 1.6" "Low lineage specificity" "Detected in single" "HPA043267, HPA043292, HPA077864" Uncertain Approved "Intermediate filaments" "Intermediate filaments" "HPA043267: , HPA043292: , HPA077864: " 0.0 0.3 0.1 0.0 0.1 0.1 0.0 5.6 0.3 0.1 0.3 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.2 0.1 3.2 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 1.6 0.0 0.5 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.5 0.1 0.0 0.0 0.0 0.0 FBXL19 "CXXC11, DKFZp434K0410, Fbl19, JHDM1C" ENSG00000099364 "F-box and leucine rich repeat protein 19" Q6PCT2 16 30923055-30948783 "Predicted intracellular proteins" "Ubl conjugation pathway" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035317 Approved "Intermediate filaments" "Intermediate filaments" "HPA035317: " "unprognostic (1.37e-1)" "prognostic unfavourable (3.27e-4)" "unprognostic (1.03e-1)" "unprognostic (3.80e-2)" "unprognostic (1.40e-1)" "unprognostic (2.20e-1)" "prognostic unfavourable (3.54e-4)" "unprognostic (3.61e-2)" "unprognostic (2.52e-1)" "unprognostic (2.89e-1)" "unprognostic (1.48e-1)" "unprognostic (6.95e-3)" "unprognostic (1.37e-3)" "unprognostic (6.02e-2)" "unprognostic (1.60e-1)" "unprognostic (2.45e-2)" "unprognostic (2.38e-2)" 5.5 6.7 17.4 9.8 15.3 8.3 3.8 13.2 23.5 6.8 9.6 3.4 9.5 11.2 7.5 4.4 10.5 6.0 9.4 4.9 17.6 10.5 6.1 3.1 5.8 9.8 9.6 11.6 6.9 6.6 11.0 8.3 11.2 9.5 6.9 4.1 5.2 8.4 7.1 4.5 12.7 9.8 6.2 4.8 9.9 9.3 19.6 8.4 7.3 5.8 4.7 6.7 9.7 7.0 2.1 2.8 1.9 1.7 3.6 1.5 0.4 6.2 17.4 16.5 13.9 3.0 3.1 15.1 8.8 4.7 7.1 6.7 9.1 9.5 10.0 10.5 5.1 9.2 13.2 9.4 5.2 27.2 41.1 10.7 27.1 13.0 3.7 11.8 27.0 3.1 7.5 8.4 6.0 11.0 29.0 9.7 3.8 17.0 12.9 16.3 17.0 5.7 26.9 5.2 9.8 6.5 8.6 11.7 21.9 3.2 20.1 4.9 12.3 12.6 10.8 8.3 10.1 5.0 6.2 8.6 6.9 5.9 9.6 18.1 11.6 0.0 1.7 1.9 1.5 0.8 1.2 2.1 0.4 0.6 0.9 0.8 0.2 1.2 1.8 3.6 0.2 2.8 0.7 0.4 17.4 15.3 13.2 23.5 17.6 10.5 9.6 11.6 9.5 8.4 GCKR ENSG00000084734 "Glucokinase regulator" 2 27496842-27523684 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "liver: 60.9" "Cell line enhanced" "Detected in some" "HEL: 12.4;Hep G2: 19.0;HUVEC TERT2: 6.1;TIME: 3.7" "Cancer enriched" "Detected in some" 8 "liver cancer: 14.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB034098, HPA064305" Enhanced Approved "Intermediate filaments" "Intermediate filaments" "CAB034098: AB_2247323, HPA064305: " "unprognostic (3.31e-1)" "unprognostic (2.11e-3)" "unprognostic (2.27e-1)" "unprognostic (6.97e-2)" "unprognostic (1.68e-2)" "unprognostic (5.70e-2)" "unprognostic (2.31e-1)" "unprognostic (1.70e-1)" "unprognostic (1.52e-1)" "unprognostic (4.12e-1)" "unprognostic (2.25e-3)" "unprognostic (1.65e-1)" "unprognostic (1.02e-7)" "unprognostic (6.51e-2)" "unprognostic (1.18e-1)" "unprognostic (9.27e-3)" "unprognostic (1.50e-2)" 0.2 2.0 0.1 0.1 0.3 0.2 0.1 0.2 0.2 0.1 0.4 0.1 0.1 0.2 0.1 0.3 0.4 0.0 3.9 0.5 0.1 0.0 0.2 60.9 0.1 0.1 0.1 0.1 2.0 0.9 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.2 1.3 0.1 0.1 0.5 3.1 0.9 0.2 0.1 0.1 0.1 0.2 0.1 0.1 2.4 0.8 2.6 1.2 1.7 0.9 0.7 0.2 0.4 0.4 0.2 0.3 0.2 0.1 0.0 0.1 0.3 0.0 0.4 0.1 0.2 0.5 0.6 0.2 0.2 0.0 0.0 0.1 0.0 12.4 0.5 19.0 0.8 0.1 0.4 0.3 0.9 0.5 0.1 6.1 0.0 0.2 0.2 0.1 0.1 0.7 0.1 0.0 0.3 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.2 0.1 0.5 0.1 3.7 0.1 0.3 0.6 0.2 0.3 0.1 0.2 1.1 0.1 0.2 2.6 1.2 0.3 0.6 1.0 0.6 0.8 0.4 0.4 0.1 2.4 0.9 0.8 2.1 1.7 0.3 0.8 0.1 0.7 0.1 0.3 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.2 GFAP FLJ45472 ENSG00000131095 "Glial fibrillary acidic protein" P14136 17 44903161-44916937 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 61 "brain: 595.5" "Cell line enhanced" "Detected in many" "U-87 MG: 9.5" "Cancer enriched" "Detected in some" 368 "glioma: 2468.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 9.8" "Group enriched" "Detected in many" 5 "granulocytes: 9.8;NK-cells: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000039, HPA056030, HPA063513" Enhanced Supported Supported "Intermediate filaments" 220000000 "Intermediate filaments" "CAB000039: AB_10013382, HPA056030: , HPA063513: " "unprognostic (1.79e-2)" "unprognostic (2.74e-1)" "unprognostic (9.83e-2)" "unprognostic (2.12e-5)" "unprognostic (4.08e-1)" "unprognostic (5.09e-1)" "unprognostic (1.26e-1)" "unprognostic (6.53e-2)" "unprognostic (6.57e-3)" "unprognostic (7.35e-2)" "unprognostic (5.86e-2)" "unprognostic (1.24e-1)" "unprognostic (7.63e-2)" "unprognostic (2.75e-5)" "unprognostic (1.49e-1)" "unprognostic (1.66e-1)" "unprognostic (1.64e-1)" 3.0 2.9 122.2 3.2 105.4 5.8 3.0 33.9 595.5 2.7 3.0 171.0 0.0 2.8 2.9 3.0 3.6 3.2 3.1 4.0 143.0 175.1 3.0 2.8 3.0 3.1 227.0 67.3 3.0 3.0 3.4 1.3 2.8 212.7 3.0 2.9 0.0 3.1 2.9 3.2 3.3 2.8 2.9 482.0 3.0 3.0 2.9 119.0 0.0 3.0 0.0 2.9 3.4 0.0 1.1 0.8 9.8 1.2 2.9 0.8 0.3 1.7 1.1 2.0 3.8 0.0 0.8 0.5 1.7 2.0 2.4 2.0 2.1 2.4 3.5 3.1 0.9 4.3 2.2 0.7 3.0 4.3 1.9 2.8 2.9 1.4 0.1 0.8 4.2 0.2 1.3 1.7 0.0 0.0 1.3 8.3 0.6 2.2 2.9 4.1 2.7 5.2 1.2 1.2 2.8 1.1 1.5 2.7 2.9 0.5 3.4 0.3 2.2 2.2 1.2 2.1 1.6 1.9 2.5 1.2 2.3 2.7 9.5 3.4 3.3 1.9 1.2 0.5 0.5 1.1 0.4 0.4 0.5 0.7 0.3 1.1 0.6 0.8 9.8 2.9 0.7 0.8 0.4 0.3 122.2 105.4 33.9 69.4 143.0 175.1 227.0 67.3 212.7 119.0 GRAMD1B "KIAA1201, LINC01059" ENSG00000023171 "GRAM domain containing 1B" Q3KR37 11 123358428-123627774 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 67.7;brain: 55.2;intestine: 21.7" "Group enriched" "Detected in many" 4 "A549: 21.8;HDLM-2: 57.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.5" "Lineage enriched" "Detected in many" 4 "dendritic cells: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008557 Approved Approved "Nucleoplasm,Nucleoli,Intermediate filaments" Nucleoli "Nucleoplasm, Intermediate filaments" "HPA008557: AB_1079197" "unprognostic (1.86e-1)" "unprognostic (7.18e-3)" "unprognostic (2.43e-2)" "unprognostic (2.74e-3)" "unprognostic (8.15e-2)" "unprognostic (4.28e-2)" "unprognostic (2.69e-3)" "unprognostic (4.12e-3)" "unprognostic (1.40e-1)" "unprognostic (2.90e-2)" "unprognostic (9.60e-2)" "unprognostic (8.06e-2)" "prognostic unfavourable (4.30e-7)" "unprognostic (1.39e-2)" "unprognostic (6.00e-2)" "unprognostic (1.57e-1)" "unprognostic (1.69e-1)" 1.4 67.7 15.5 3.1 16.0 11.8 1.1 55.2 25.0 1.2 3.1 5.1 5.9 21.7 1.2 6.6 0.9 2.9 8.1 4.3 13.6 7.5 10.4 1.3 1.9 3.6 6.8 15.1 7.6 2.0 0.6 6.7 5.0 14.4 1.1 1.2 11.9 1.3 2.5 1.8 0.8 15.6 1.3 4.1 2.7 7.8 10.6 5.1 3.4 3.7 0.0 2.7 1.5 0.8 0.1 11.5 0.6 2.0 2.6 2.7 0.7 0.0 21.8 1.2 0.0 0.1 0.2 3.6 7.2 5.2 1.6 0.6 0.9 0.1 1.3 3.8 3.6 0.0 2.3 0.0 1.7 57.6 2.0 0.0 9.8 0.2 0.0 7.5 0.0 0.4 0.0 2.8 0.0 0.6 0.0 0.0 1.3 0.1 1.2 2.5 2.8 8.2 3.9 3.5 2.3 0.1 0.0 7.2 5.9 1.7 0.1 0.0 0.2 4.2 4.3 8.7 1.4 1.5 0.3 0.0 0.0 0.0 1.8 7.9 0.4 0.0 2.0 0.6 0.7 1.0 0.4 0.0 2.7 2.1 3.0 0.1 0.3 0.3 0.2 2.6 1.0 11.5 1.1 0.7 15.5 16.0 55.2 25.0 13.6 7.5 6.8 15.1 14.4 5.1 HOXA13 "HOX1, HOX1J" ENSG00000106031 "Homeobox A13" P31271 7 27193503-27200106 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 48.5;prostate: 25.1" "Cell line enhanced" "Detected in many" "HAP1: 15.2;HEK 293: 21.1;PC-3: 10.5;RT4: 23.5;THP-1: 10.0;U-937: 11.2" "Cancer enhanced" "Detected in many" "prostate cancer: 10.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA069061 Supported "Nucleoplasm,Intermediate filaments" Nucleoplasm "Intermediate filaments" "HPA069061: " "unprognostic (7.20e-2)" "unprognostic (1.89e-1)" "unprognostic (1.02e-1)" "unprognostic (8.04e-4)" "unprognostic (1.06e-3)" "unprognostic (2.24e-2)" "unprognostic (1.79e-1)" "unprognostic (1.40e-2)" "unprognostic (9.22e-3)" "unprognostic (7.30e-3)" "unprognostic (8.39e-3)" "unprognostic (1.54e-1)" "unprognostic (1.42e-11)" "unprognostic (2.58e-3)" "unprognostic (1.38e-1)" "unprognostic (1.72e-1)" "unprognostic (1.36e-2)" 0.6 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.1 48.5 6.9 0.0 7.1 0.0 5.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 16.5 0.0 25.1 8.6 0.0 0.1 17.9 1.2 0.4 0.1 15.7 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 12.1 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.9 0.0 1.4 0.1 0.0 0.0 7.4 8.2 2.9 1.9 1.5 0.1 0.0 0.9 3.5 0.0 15.2 0.0 2.5 0.0 21.1 1.0 4.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.8 0.0 10.5 1.5 0.3 0.0 0.0 23.5 0.4 0.0 1.8 0.0 0.1 0.0 10.0 0.0 0.2 2.7 0.1 0.1 0.0 0.0 0.0 0.0 11.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 HSDL1 SDR12C3 ENSG00000103160 "Hydroxysteroid dehydrogenase like 1" Q3SXM5 16 84122146-84145192 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045745 Approved "Vesicles,Intermediate filaments,Mitochondria" Mitochondria "Vesicles, Intermediate filaments" "HPA045745: " "unprognostic (2.16e-1)" "unprognostic (4.32e-2)" "unprognostic (2.09e-1)" "unprognostic (4.80e-3)" "unprognostic (3.66e-2)" "unprognostic (1.68e-1)" "prognostic unfavourable (3.50e-4)" "unprognostic (1.25e-2)" "unprognostic (7.43e-2)" "unprognostic (3.39e-2)" "unprognostic (6.42e-2)" "unprognostic (3.66e-1)" "prognostic favourable (4.20e-7)" "unprognostic (2.30e-1)" "unprognostic (1.57e-1)" "unprognostic (1.03e-2)" "unprognostic (1.14e-2)" 6.0 13.4 16.9 5.6 22.1 3.1 10.2 16.5 18.7 9.7 5.8 9.0 6.7 5.1 11.3 9.4 6.7 11.1 6.0 13.1 14.5 19.5 9.1 4.1 7.6 6.8 11.5 13.2 19.6 4.3 12.6 16.7 7.6 20.8 8.6 6.1 10.5 6.3 10.0 15.2 6.5 4.9 9.4 7.4 7.0 5.3 13.5 8.7 8.6 23.2 5.0 7.5 6.6 6.2 7.4 3.1 14.5 6.6 4.2 6.5 4.4 5.6 6.5 30.2 10.3 11.0 7.9 7.6 7.3 6.8 9.1 4.8 7.3 9.7 11.6 13.0 6.4 3.9 16.3 6.3 14.5 2.4 10.0 5.6 4.3 16.5 11.5 8.6 10.1 6.1 10.6 12.7 8.3 10.8 11.5 14.6 17.9 13.9 18.7 8.6 15.3 6.8 18.4 10.6 4.3 8.7 6.2 14.2 10.8 18.0 2.9 19.7 18.0 5.1 9.2 10.3 12.4 7.4 5.7 23.3 18.4 18.9 12.0 6.3 9.3 14.5 5.2 11.7 4.4 3.8 5.6 5.4 4.7 5.2 3.1 7.4 6.1 6.5 6.2 4.2 6.6 0.0 5.6 4.4 16.9 22.1 16.5 18.7 14.5 19.5 11.5 13.2 20.8 8.7 IGSF10 "CMF608, FLJ25972" ENSG00000152580 "Immunoglobulin superfamily member 10" Q6WRI0 3 151425384-151458709 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Osteogenesis" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 17.8" "Group enriched" "Detected in some" 5 "HeLa: 25.0;HL-60: 12.1;REH: 9.0;RPMI-8226: 29.0" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 4 "dendritic cells: 1.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA012921 Uncertain Approved "Nucleoplasm,Intermediate filaments" "Secreted - unknown location" 280000 "Intermediate filaments" Nucleoplasm "HPA012921: AB_1851526" "unprognostic (1.78e-3)" "unprognostic (2.48e-2)" "unprognostic (1.71e-1)" "unprognostic (3.47e-7)" "unprognostic (1.68e-1)" "unprognostic (2.12e-1)" "unprognostic (9.82e-2)" "unprognostic (8.84e-4)" "unprognostic (9.38e-3)" "unprognostic (1.96e-1)" "unprognostic (5.70e-2)" "unprognostic (2.04e-1)" "unprognostic (7.52e-4)" "unprognostic (6.01e-2)" "unprognostic (8.93e-2)" "unprognostic (4.59e-3)" "unprognostic (7.57e-4)" 2.5 2.9 0.6 0.1 0.4 0.0 4.5 0.0 0.2 0.3 0.5 0.0 0.7 0.8 2.0 3.4 7.3 4.1 0.7 0.8 0.0 0.0 6.7 0.5 0.3 17.8 0.1 0.7 1.5 0.0 0.0 0.6 3.7 0.0 0.0 1.2 0.7 0.7 0.3 0.2 0.4 0.3 1.3 1.6 1.5 0.1 0.2 1.5 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.1 0.2 3.9 25.0 0.0 0.9 12.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 29.0 0.0 0.0 0.5 0.0 3.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 1.3 0.0 0.0 0.1 3.7 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 INA "NEF5, NF-66" ENSG00000148798 "Internexin neuronal intermediate filament protein alpha" Q16352 10 103277163-103290351 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 65.4" "Cell line enhanced" "Detected in some" "NTERA-2: 20.6;SCLC-21H: 40.5;SH-SY5Y: 23.0;SiHa: 27.4" "Cancer enhanced" "Detected in many" "testis cancer: 18.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002059, HPA007572, HPA008057" Enhanced Supported Approved "Intermediate filaments" "Intermediate filaments" "CAB002059: AB_442031, HPA007572: , HPA008057: AB_1851833" "unprognostic (1.77e-1)" "unprognostic (2.50e-2)" "unprognostic (9.54e-2)" "unprognostic (5.49e-3)" "unprognostic (3.91e-1)" "unprognostic (1.45e-3)" "unprognostic (1.31e-1)" "unprognostic (2.29e-2)" "unprognostic (2.08e-2)" "unprognostic (1.98e-1)" "unprognostic (8.09e-3)" "unprognostic (3.07e-2)" "unprognostic (1.78e-3)" "unprognostic (1.66e-1)" "unprognostic (1.90e-1)" "unprognostic (1.50e-1)" "unprognostic (1.07e-1)" 1.5 15.7 16.6 2.6 21.3 1.3 1.3 26.9 65.2 1.3 2.7 2.3 0.0 2.0 1.3 1.4 1.9 1.3 1.5 1.3 13.2 34.0 1.3 1.4 1.5 1.4 27.2 17.7 1.3 3.6 1.3 12.8 1.5 65.4 1.5 2.8 5.5 1.3 1.4 1.3 2.2 2.5 2.2 7.9 1.3 2.6 4.1 3.3 0.0 1.5 0.0 1.5 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 4.6 0.0 0.0 0.0 7.5 5.1 1.2 1.2 0.1 0.0 0.0 0.0 2.1 0.3 0.7 4.2 0.0 0.3 9.2 1.9 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 5.0 0.0 20.6 0.0 0.0 0.0 0.0 3.2 0.0 40.5 23.0 27.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 1.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 21.3 26.9 42.0 13.2 34.0 27.2 17.7 65.4 3.3 IQUB FLJ35834 ENSG00000164675 "IQ motif and ubiquitin domain containing" Q8NA54 7 123452400-123535077 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 20.8;testis: 35.5" "Cell line enhanced" "Detected in some" "K-562: 1.8;RPTEC TERT1: 7.1;T-47d: 2.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049626 Approved "Nuclear speckles,Intermediate filaments,Cytosol" "Nuclear speckles, Intermediate filaments" Cytosol "HPA049626: " "unprognostic (8.71e-2)" "unprognostic (1.25e-2)" "unprognostic (1.98e-1)" "unprognostic (6.42e-4)" "unprognostic (1.91e-1)" "unprognostic (1.44e-2)" "unprognostic (6.23e-2)" "unprognostic (7.97e-2)" "unprognostic (1.46e-1)" "unprognostic (1.73e-1)" "unprognostic (2.40e-2)" "unprognostic (3.76e-1)" "unprognostic (5.44e-6)" "unprognostic (2.79e-1)" "unprognostic (9.78e-3)" "unprognostic (2.14e-1)" "unprognostic (7.30e-2)" 0.6 1.0 1.3 0.3 2.9 0.3 0.9 3.0 3.5 1.2 0.5 1.8 3.2 0.4 1.4 6.9 1.8 5.7 1.6 0.6 2.6 1.2 8.5 0.4 3.2 0.3 0.7 1.2 2.7 0.7 2.7 20.8 0.5 6.4 0.9 0.4 0.3 0.7 4.3 0.6 0.5 0.5 0.6 1.0 0.4 0.6 35.5 2.8 0.0 5.6 0.0 0.3 0.7 0.6 0.8 0.0 0.0 0.3 0.5 0.7 0.0 0.3 0.0 1.3 0.6 0.6 0.6 0.1 0.0 0.1 0.0 0.3 0.0 0.8 0.8 0.0 0.4 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.7 0.3 0.2 0.3 0.0 1.8 0.2 0.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 7.1 1.6 1.1 0.4 0.0 0.0 0.1 2.5 0.0 0.0 0.5 0.3 0.4 0.2 0.4 0.1 0.1 0.2 0.2 0.1 0.0 0.2 0.0 0.7 0.3 0.4 0.2 0.2 0.2 0.0 0.8 0.7 0.2 0.0 0.5 0.1 0.0 0.3 0.0 1.3 2.9 3.0 3.5 2.6 1.2 0.7 1.2 6.4 2.8 ITFG1 "CDA08, LNKN-1, TIP" ENSG00000129636 "Integrin alpha FG-GAP repeat containing 1" Q8TB96 16 47154387-47464149 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015590, HPA019728" Approved Approved "Intermediate filaments,Aggresome" "Intracellular and membrane" 21000 "Intermediate filaments" Aggresome "HPA015590: AB_1846347, HPA019728: AB_1846348" "unprognostic (6.53e-3)" "unprognostic (9.26e-3)" "unprognostic (3.13e-2)" "unprognostic (1.35e-1)" "unprognostic (1.27e-1)" "unprognostic (1.39e-3)" "unprognostic (3.70e-2)" "unprognostic (9.32e-2)" "unprognostic (2.47e-1)" "unprognostic (2.11e-1)" "unprognostic (1.62e-1)" "unprognostic (9.54e-2)" "prognostic favourable (1.95e-8)" "unprognostic (1.56e-2)" "unprognostic (1.61e-1)" "unprognostic (3.28e-2)" "unprognostic (4.62e-3)" 14.0 26.6 19.9 8.8 52.4 6.4 15.0 31.2 34.6 18.3 20.0 14.8 9.8 17.3 17.5 19.0 11.5 15.8 17.1 26.0 20.7 26.6 28.7 26.5 15.8 11.0 17.0 19.0 17.4 20.2 43.0 22.9 30.7 28.7 17.9 19.9 13.8 15.1 18.1 14.6 10.8 19.4 17.4 17.6 12.4 16.0 20.7 15.7 13.4 25.8 7.6 11.5 15.3 11.6 12.8 18.7 23.4 24.4 16.6 18.3 17.7 8.1 9.6 17.5 12.1 34.3 26.5 20.9 20.0 28.5 18.2 9.7 5.5 20.1 10.0 27.2 24.6 12.3 8.5 12.7 18.1 4.3 5.9 5.3 9.2 12.7 16.0 12.4 23.3 19.4 22.2 9.2 12.1 17.4 14.9 13.2 22.7 8.0 7.7 5.8 5.6 9.4 11.7 17.3 24.8 24.1 6.1 8.6 12.1 18.1 21.0 8.8 9.2 11.4 16.8 19.4 9.5 10.3 7.6 18.6 24.4 18.6 19.3 7.9 15.1 13.5 24.4 23.4 12.4 23.8 12.0 12.8 15.4 13.7 18.7 11.4 16.9 14.1 15.4 16.6 21.9 13.0 18.3 17.7 19.9 52.4 31.2 34.6 20.7 26.6 17.0 19.0 28.7 15.7 KATNAL2 "DKFZP667C165, MGC33211" ENSG00000167216 "Katanin catalytic subunit A1 like 2" Q8IYT4 18 46917492-47102243 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 30.3;testis: 33.2" "Cell line enhanced" "Detected in many" "AN3-CA: 14.8;Daudi: 19.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA040712, HPA042029" Approved Approved "Nucleoplasm,Intermediate filaments" "Nucleoplasm, Intermediate filaments" "HPA040712: , HPA042029: " "unprognostic (3.40e-1)" "unprognostic (7.75e-2)" "unprognostic (9.00e-3)" "unprognostic (9.28e-2)" "unprognostic (1.74e-2)" "unprognostic (6.55e-3)" "unprognostic (6.97e-2)" "unprognostic (1.28e-2)" "unprognostic (3.90e-2)" "unprognostic (5.36e-2)" "unprognostic (9.52e-6)" "unprognostic (1.28e-1)" "prognostic favourable (1.24e-7)" "unprognostic (1.64e-1)" "unprognostic (7.14e-4)" "unprognostic (1.06e-3)" "unprognostic (1.61e-1)" 5.5 2.9 8.2 4.1 9.7 2.8 7.1 4.0 7.5 2.5 2.4 11.3 2.5 1.8 2.8 7.1 2.7 8.6 5.1 4.3 8.1 7.6 9.5 5.2 4.6 3.4 9.6 6.2 3.1 3.3 30.3 7.0 2.2 9.0 3.4 3.1 6.4 3.4 3.7 6.0 8.0 1.5 2.3 8.7 3.3 2.0 33.2 6.3 2.4 15.5 1.1 3.0 2.3 2.5 3.1 0.6 2.7 1.3 0.8 1.5 0.3 1.9 4.3 2.3 14.8 4.8 5.9 1.1 1.8 1.6 1.5 1.9 0.2 5.0 19.6 1.5 2.8 0.6 4.7 0.5 1.1 2.0 2.5 0.8 1.3 0.3 2.0 1.2 1.9 12.1 1.8 2.5 0.6 0.5 0.7 1.5 8.4 1.9 1.1 2.6 5.3 2.6 5.4 1.1 0.0 4.7 0.4 5.4 5.9 1.9 0.4 0.6 11.2 10.9 1.0 5.0 0.5 1.9 1.2 1.3 1.0 13.2 2.7 12.4 9.5 1.7 0.7 0.5 1.1 1.3 0.9 2.2 0.9 0.5 0.3 3.1 1.5 1.4 2.7 0.8 0.9 0.6 0.2 0.3 8.2 9.7 4.0 7.5 8.1 7.6 9.6 6.2 9.0 6.3 KBTBD11 "KIAA0711, KLHDC7C" ENSG00000176595 "Kelch repeat and BTB domain containing 11" O94819 8 1973878-2006936 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.4" "Cell line enhanced" "Detected in some" "HDLM-2: 10.2;NB-4: 7.4;SCLC-21H: 8.9;THP-1: 14.4;U-937: 20.4" "Cancer enhanced" "Detected in many" "renal cancer: 14.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 4.6" "Group enriched" "Detected in many" 4 "granulocytes: 4.6;monocytes: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051159 Uncertain Approved "Intermediate filaments" "Intermediate filaments" "HPA051159: " "unprognostic (1.19e-1)" "unprognostic (2.27e-1)" "unprognostic (1.20e-3)" "unprognostic (2.70e-2)" "unprognostic (2.03e-1)" "unprognostic (6.84e-2)" "unprognostic (2.76e-4)" "unprognostic (2.50e-2)" "unprognostic (1.06e-1)" "unprognostic (5.68e-2)" "unprognostic (2.64e-2)" "unprognostic (1.30e-1)" "unprognostic (4.75e-2)" "unprognostic (9.53e-2)" "unprognostic (3.52e-2)" "unprognostic (1.75e-1)" "unprognostic (1.04e-2)" 3.2 6.8 17.6 2.6 17.7 8.7 1.8 16.3 22.4 4.5 8.2 10.9 0.0 10.9 1.6 1.7 1.7 3.8 3.8 2.1 16.1 10.8 13.9 6.7 2.3 3.1 13.2 16.7 1.9 3.2 5.1 2.0 0.8 11.4 5.0 6.6 3.1 2.1 2.9 1.8 1.0 12.7 1.7 12.4 6.4 1.9 1.6 9.3 4.7 2.4 0.0 2.0 1.4 0.7 0.0 0.4 4.6 1.4 0.0 0.6 0.4 1.5 1.0 4.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.9 0.4 0.1 0.3 0.0 2.1 0.0 0.0 10.2 1.2 0.0 0.0 0.0 1.0 4.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.7 4.5 7.4 1.0 0.0 1.3 0.0 0.0 2.2 0.3 8.9 4.5 0.0 0.0 0.1 0.1 14.4 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.8 0.1 20.4 0.7 0.7 1.4 4.6 0.0 0.6 0.2 0.0 0.2 0.1 0.4 0.0 0.6 0.3 0.9 0.0 0.3 0.0 0.5 0.4 17.6 17.7 16.3 21.9 16.1 10.8 13.2 16.7 11.4 9.3 KCTD9 "BTBD27, FLJ20038" ENSG00000104756 "Potassium channel tetramerization domain containing 9" Q7L273 8 25427847-25458476 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042468, HPA047902" Supported "Nucleoplasm,Intermediate filaments,Cytosol" Nucleoplasm "Intermediate filaments, Cytosol" "HPA042468: , HPA047902: " "unprognostic (4.18e-2)" "unprognostic (3.90e-2)" "prognostic favourable (7.88e-4)" "unprognostic (7.04e-2)" "unprognostic (7.41e-2)" "unprognostic (1.05e-2)" "unprognostic (2.20e-2)" "unprognostic (6.01e-2)" "unprognostic (4.33e-1)" "unprognostic (2.43e-2)" "unprognostic (4.49e-3)" "unprognostic (2.30e-1)" "unprognostic (1.48e-1)" "unprognostic (6.62e-2)" "unprognostic (1.35e-1)" "unprognostic (1.31e-2)" "unprognostic (4.97e-3)" 14.4 5.8 7.4 17.3 7.7 11.5 14.6 17.7 10.1 15.7 14.1 5.4 16.8 12.4 15.6 12.2 18.2 11.3 12.8 48.4 5.9 5.2 9.6 6.6 10.3 6.9 7.4 5.3 12.4 8.3 7.3 11.2 7.4 14.6 11.8 14.8 9.4 14.6 18.4 19.0 15.0 10.9 16.7 10.8 8.6 10.6 11.2 6.6 11.8 8.7 11.7 8.7 19.1 14.8 2.2 3.2 3.7 2.9 0.9 3.8 1.5 17.9 12.8 14.0 4.8 18.2 24.2 11.5 27.3 24.6 18.0 18.3 9.1 13.2 11.8 11.7 27.2 12.1 12.2 12.8 21.7 6.0 7.3 13.7 12.5 8.4 22.1 4.8 10.2 18.6 15.6 16.3 13.6 15.1 14.4 9.3 20.3 4.8 18.4 8.3 6.8 6.8 7.2 16.2 4.3 18.3 10.3 3.5 4.6 20.9 9.3 14.1 7.1 5.5 16.7 19.9 11.6 38.1 14.7 2.7 4.9 15.6 13.9 8.5 14.3 2.6 1.7 3.7 3.4 2.5 3.8 2.2 3.6 3.6 1.1 1.2 2.2 3.6 1.8 0.9 2.9 3.2 3.5 1.5 7.4 7.7 17.7 10.1 5.9 5.2 7.4 5.3 14.6 6.6 KIAA1549 ENSG00000122778 KIAA1549 Q9HCM3 7 138831381-138981318 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 27.5;seminal vesicle: 39.0" "Cell line enhanced" "Detected in many" "PC-3: 20.0;SH-SY5Y: 19.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 1.2;neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019560 Uncertain Approved "Nuclear membrane,Intermediate filaments" "Nuclear membrane" "Intermediate filaments" "HPA019560: AB_1852418" "unprognostic (7.88e-2)" "unprognostic (2.37e-2)" "unprognostic (2.63e-1)" "unprognostic (6.85e-2)" "unprognostic (2.29e-1)" "unprognostic (8.86e-2)" "unprognostic (2.55e-2)" "unprognostic (6.40e-2)" "unprognostic (1.02e-1)" "unprognostic (2.19e-2)" "unprognostic (2.33e-2)" "unprognostic (8.30e-2)" "prognostic favourable (3.93e-7)" "unprognostic (1.40e-1)" "unprognostic (2.17e-1)" "unprognostic (2.38e-1)" "unprognostic (1.28e-2)" 2.1 3.2 3.3 0.6 4.4 0.6 2.9 1.2 8.3 2.7 1.8 1.6 27.5 1.5 3.7 4.1 1.4 4.9 2.5 1.9 3.1 2.0 8.0 1.5 4.7 0.3 1.6 3.8 2.6 12.9 6.5 3.6 4.6 3.7 3.1 1.5 2.0 4.4 39.0 1.4 2.6 1.8 2.9 3.3 1.2 3.0 2.9 1.2 3.1 2.2 0.1 0.4 3.8 4.4 0.3 0.1 1.5 0.1 0.3 0.2 0.0 5.0 9.5 8.4 14.8 0.1 0.0 4.9 5.1 4.6 3.0 3.8 8.9 3.1 0.0 3.2 7.8 1.0 5.3 1.5 3.6 2.4 3.2 2.4 10.3 2.2 1.3 3.6 3.4 1.2 2.3 1.1 1.6 4.9 1.9 0.1 3.3 4.7 2.6 3.5 8.0 20.0 7.1 4.3 0.0 1.5 3.1 11.2 19.2 2.7 5.1 2.2 4.2 2.2 3.1 3.0 3.1 0.0 4.8 0.7 0.0 0.2 4.0 1.4 7.1 1.2 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 1.5 0.3 0.1 0.1 0.0 0.0 3.3 4.4 1.2 8.3 3.1 2.0 1.6 3.8 3.7 1.2 KIAA1551 "C12orf35, FLJ10652, FLJ20696, GET, UTA2-1" ENSG00000174718 KIAA1551 Q9HCM1 12 31959370-31993107 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 58.8;lymphoid tissue: 56.3" "Low cell line specificity" "Detected in all" "Cancer enhanced" "Detected in all" "testis cancer: 65.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "neutrophil: 58.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 58.8" "Low region specificity" "Detected in all" "HPA013816, HPA015622" Approved Supported "Nucleoli,Intermediate filaments,Cytosol" Nucleoli "Intermediate filaments, Cytosol" "HPA013816: AB_1848661, HPA015622: AB_1848663" "unprognostic (7.97e-3)" "unprognostic (1.69e-1)" "unprognostic (1.76e-1)" "unprognostic (8.49e-2)" "unprognostic (3.21e-1)" "unprognostic (3.09e-3)" "unprognostic (2.24e-1)" "unprognostic (2.19e-1)" "unprognostic (8.87e-2)" "unprognostic (1.09e-1)" "unprognostic (1.13e-1)" "unprognostic (2.90e-2)" "prognostic unfavourable (5.04e-9)" "unprognostic (3.83e-1)" "unprognostic (1.09e-1)" "unprognostic (2.61e-1)" "unprognostic (7.26e-3)" 12.4 5.8 4.7 28.8 6.1 9.0 10.3 8.7 7.0 15.7 17.5 2.7 7.1 10.7 11.2 10.3 12.3 19.0 8.9 6.2 4.8 3.5 8.1 14.2 17.0 56.3 7.5 4.1 38.3 7.0 3.6 8.0 17.5 5.4 11.6 6.5 3.5 8.6 5.5 5.4 6.7 30.0 8.5 8.1 39.1 8.8 8.7 5.9 48.5 10.0 7.6 27.6 17.3 13.9 9.6 3.3 58.8 4.5 8.0 13.2 5.0 2.9 5.3 9.2 3.5 4.2 5.0 13.7 3.6 3.6 2.6 2.8 20.0 19.6 14.3 9.0 3.0 4.0 12.6 2.4 3.7 10.5 1.7 20.0 2.6 2.6 8.2 14.4 32.4 2.7 3.7 2.9 4.8 20.2 11.4 22.8 2.7 1.4 20.2 6.0 19.6 2.2 9.4 8.8 6.2 2.6 5.5 3.7 3.3 4.7 2.4 2.5 8.4 16.0 12.7 2.7 4.4 4.7 3.8 13.9 14.7 17.6 1.5 8.1 3.0 12.5 3.9 3.9 12.5 4.4 11.8 9.6 11.2 11.6 3.3 7.5 13.2 12.6 58.8 8.0 4.5 2.0 10.2 5.0 4.7 6.1 8.7 7.0 4.8 3.5 7.5 4.1 5.4 5.9 KIF3A "FLA10, KLP-20" ENSG00000131437 "Kinesin family member 3A" Q9Y496 5 132692628-132737638 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 54.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 27.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 27.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB037085 Approved Approved "Nucleoplasm,Intermediate filaments,Cytosol" "Nucleoplasm, Intermediate filaments, Cytosol" "CAB037085: AB_477147" "unprognostic (8.22e-3)" "unprognostic (2.58e-1)" "unprognostic (2.29e-3)" "unprognostic (3.59e-2)" "unprognostic (2.51e-1)" "unprognostic (3.80e-1)" "unprognostic (8.21e-4)" "unprognostic (1.30e-1)" "unprognostic (4.71e-2)" "unprognostic (1.46e-1)" "unprognostic (1.44e-2)" "unprognostic (7.64e-2)" "unprognostic (6.08e-3)" "unprognostic (8.62e-2)" "unprognostic (1.92e-1)" "unprognostic (1.17e-1)" "unprognostic (1.23e-1)" 3.4 9.9 19.6 5.0 21.0 2.5 6.6 23.8 54.5 6.2 3.6 8.1 3.2 3.5 6.5 7.1 4.5 8.7 5.3 7.0 28.0 22.9 7.6 2.5 5.7 4.8 18.7 25.5 6.9 4.0 15.8 18.5 4.3 37.7 6.6 3.8 3.8 3.8 6.6 3.5 5.1 3.0 5.7 15.0 3.8 4.9 23.9 11.1 3.5 6.9 0.1 4.7 5.3 3.5 3.4 0.7 27.1 1.1 2.4 4.3 1.1 7.1 8.8 7.9 14.2 5.3 5.3 6.3 6.0 4.7 5.7 8.0 8.6 5.8 19.5 8.3 6.9 4.6 6.1 11.8 11.8 5.8 7.2 2.8 4.4 3.2 5.2 3.6 7.7 4.0 6.1 8.2 9.1 7.0 2.9 11.3 6.9 5.1 22.9 2.7 3.9 3.3 6.4 6.3 2.3 5.6 6.1 24.5 7.7 8.9 2.9 9.0 9.0 1.1 7.4 7.1 12.4 5.2 7.2 8.2 11.9 11.2 8.7 2.9 7.8 27.1 0.4 1.1 3.9 0.8 4.1 3.4 4.0 3.6 0.7 2.1 3.9 4.3 0.3 2.4 1.1 0.7 3.0 1.1 19.6 21.0 23.8 32.3 28.0 22.9 18.7 25.5 37.7 11.1 KIF3C ENSG00000084731 "Kinesin family member 3C" O14782 2 25926596-25982749 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 72.9" "Cell line enhanced" "Detected in many" "SH-SY5Y: 29.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035755 Approved "Nuclear membrane,Nuclear bodies,Intermediate filaments" "Nuclear bodies, Intermediate filaments" "Nuclear membrane" "HPA035755: AB_10602242" "unprognostic (3.95e-1)" "unprognostic (1.40e-2)" "unprognostic (7.85e-2)" "prognostic unfavourable (1.32e-5)" "unprognostic (2.75e-1)" "unprognostic (4.69e-2)" "unprognostic (3.96e-4)" "unprognostic (1.53e-2)" "prognostic favourable (1.22e-4)" "unprognostic (2.03e-1)" "unprognostic (2.20e-2)" "unprognostic (1.55e-1)" "prognostic unfavourable (7.57e-4)" "unprognostic (3.90e-2)" "unprognostic (3.54e-1)" "unprognostic (1.76e-1)" "unprognostic (1.22e-1)" 3.0 7.3 22.8 2.9 21.2 2.2 2.6 22.7 72.9 3.6 2.4 3.8 0.0 2.1 3.9 2.6 3.0 3.3 4.1 3.0 21.6 18.9 2.0 1.6 2.6 2.0 17.5 20.3 7.3 2.3 4.5 4.8 2.8 22.8 3.3 2.6 1.9 1.9 4.6 2.4 2.3 2.7 4.8 6.2 2.2 2.0 3.0 5.2 0.5 2.5 0.0 2.0 3.5 1.5 0.1 0.3 2.4 0.2 0.7 2.0 1.3 13.0 19.8 10.6 8.1 6.2 7.2 8.5 6.8 3.4 4.1 4.7 3.5 2.0 0.0 5.7 6.2 1.4 8.0 4.1 2.8 2.2 3.8 4.7 1.5 7.1 3.7 1.2 4.1 5.2 1.2 12.9 2.6 13.6 1.7 1.7 4.3 0.9 3.3 1.6 10.8 5.8 5.3 5.2 0.8 9.4 3.2 12.9 29.1 2.7 1.2 14.3 0.4 1.6 10.7 7.2 7.4 3.2 6.6 0.4 2.3 1.5 16.3 6.4 6.1 0.0 0.2 0.0 0.4 0.0 1.1 0.0 1.6 1.5 0.3 0.1 0.5 0.6 2.4 0.7 0.0 0.2 2.0 1.3 22.8 21.2 22.7 40.0 21.6 18.9 17.5 20.3 22.8 5.2 KRT13 "CK13, K13, MGC161462, MGC3781" ENSG00000171401 "Keratin 13" P13646 17 41500981-41505705 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 1075.6;lymphoid tissue: 404.8;tongue: 499.8" "Group enriched" "Detected in some" 100 "A-431: 211.8;HaCaT: 141.5" "Group enriched" "Detected in many" 5 "cervical cancer: 899.2;head and neck cancer: 758.7;urothelial cancer: 504.9" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000133, HPA030877, HPA069771" Enhanced Enhanced "Intermediate filaments" 1100000000 "Intermediate filaments" "CAB000133: , HPA030877: , HPA069771: AB_2732141" "unprognostic (1.45e-1)" "unprognostic (6.23e-2)" "unprognostic (1.37e-1)" "unprognostic (2.19e-2)" "unprognostic (9.30e-5)" "unprognostic (7.30e-3)" "unprognostic (1.95e-1)" "unprognostic (1.77e-1)" "unprognostic (5.81e-3)" "prognostic unfavourable (1.02e-4)" "unprognostic (3.16e-1)" "prognostic unfavourable (1.45e-6)" "unprognostic (1.80e-1)" "unprognostic (2.76e-1)" "unprognostic (3.04e-2)" "unprognostic (4.33e-1)" 0.3 0.3 0.0 0.3 0.0 0.5 0.3 0.0 0.3 250.9 0.3 0.0 0.0 0.3 13.7 0.3 1075.6 0.3 0.6 0.5 0.0 0.0 0.3 0.3 0.3 0.3 0.0 0.0 0.3 0.3 0.3 0.0 0.3 0.0 2.4 0.3 0.1 134.9 0.4 0.4 0.3 0.3 1.7 0.0 0.3 0.3 0.4 0.0 0.6 0.3 499.8 404.8 14.9 222.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 211.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 141.5 0.0 0.0 0.0 0.1 0.0 0.3 1.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.1 0.1 0.7 0.2 0.5 0.4 0.0 0.0 0.0 0.6 0.0 0.5 0.4 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRT14 "EBS3, EBS4" ENSG00000186847 "Keratin 14" P02533 17 41582279-41586921 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease mutation, Ectodermal dysplasia, Epidermolysis bullosa, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "skin 1: 439.2;tongue: 363.5" "Cell line enhanced" "Detected in some" "HaCaT: 259.8;HBEC3-KT: 128.1;hTCEpi: 160.3;hTERT-HME1: 52.4;U-2197: 45.2" "Group enriched" "Detected in many" 6 "cervical cancer: 1263.1;head and neck cancer: 5910.5;melanoma: 1277.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "CAB000134, HPA000452, HPA000539, HPA023040" Enhanced Enhanced "Intermediate filaments" 2200000000 "Intermediate filaments" "CAB000134: , HPA000452: AB_1079177, HPA000539: , HPA023040: AB_1852201" "prognostic favourable (2.66e-4)" "unprognostic (1.64e-1)" "unprognostic (1.01e-2)" "unprognostic (1.42e-2)" "unprognostic (1.66e-1)" "unprognostic (1.02e-2)" "unprognostic (2.03e-2)" "unprognostic (2.74e-1)" "unprognostic (1.35e-1)" "unprognostic (1.00e-2)" "unprognostic (5.74e-3)" "unprognostic (1.49e-8)" "unprognostic (8.91e-2)" "unprognostic (2.00e-1)" "unprognostic (8.80e-3)" "unprognostic (1.22e-2)" 0.2 0.1 0.2 0.2 0.2 0.2 23.1 0.2 0.2 27.0 0.2 0.2 0.2 0.1 0.3 0.2 69.3 0.1 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 7.6 0.2 2.1 0.1 0.2 30.8 0.3 1.0 439.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 4.6 0.2 363.5 47.6 0.2 37.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 259.8 0.0 128.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 160.3 0.1 52.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 45.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 KRT15 "CK15, K15, K1CO" ENSG00000171346 "Keratin 15" P19012 17 41513743-41522529 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "breast: 37.4;esophagus: 115.3;skin 1: 119.3;vagina: 38.6" "Group enriched" "Detected in some" 10 "HaCaT: 120.2;hTCEpi: 92.9" "Cancer enhanced" "Detected in many" "cervical cancer: 178.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023910, HPA024554" Enhanced Supported "Nucleoplasm,Intermediate filaments" 580000000 "Intermediate filaments" Nucleoplasm "HPA023910: AB_1852205, HPA024554: AB_1852207" "prognostic favourable (4.50e-4)" "unprognostic (9.14e-2)" "unprognostic (3.28e-2)" "unprognostic (1.19e-3)" "unprognostic (3.57e-2)" "unprognostic (8.84e-2)" "unprognostic (6.12e-3)" "unprognostic (1.70e-1)" "unprognostic (2.13e-1)" "unprognostic (8.65e-3)" "unprognostic (9.91e-3)" "unprognostic (2.09e-1)" "unprognostic (2.24e-11)" "unprognostic (6.91e-3)" "unprognostic (2.62e-1)" "unprognostic (1.33e-5)" "unprognostic (5.35e-2)" 0.6 0.0 1.4 0.6 1.5 0.0 37.4 0.6 1.1 14.6 1.1 0.6 0.6 0.0 0.6 0.6 115.3 2.7 10.6 0.6 1.3 0.0 1.1 0.6 2.1 0.6 0.6 0.6 0.6 0.6 0.0 0.6 3.0 1.1 16.4 0.0 1.4 15.1 0.6 0.6 119.3 3.5 0.6 0.6 0.6 0.0 0.6 0.6 0.6 0.6 1.9 6.2 0.8 38.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 5.9 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.6 2.1 0.0 0.2 0.0 120.2 0.0 4.1 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.4 0.0 92.9 0.2 0.7 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 10.2 0.3 0.7 0.2 0.0 0.1 1.7 0.1 2.3 0.0 2.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.4 1.5 0.6 1.1 1.3 0.0 0.6 0.6 1.1 0.6 KRT16 NEPPK ENSG00000186832 "Keratin 16" P08779 17 41609778-41615899 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Ectodermal dysplasia, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "tongue: 503.5" "Cell line enriched" "Detected in some" 9 "hTCEpi: 134.9" "Group enriched" "Detected in many" 7 "cervical cancer: 713.1;head and neck cancer: 2720.5;melanoma: 712.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000136, HPA000539" Approved Approved "Intermediate filaments" 2200000000 "Intermediate filaments" "CAB000136: , HPA000539: " "unprognostic (3.95e-3)" "unprognostic (6.90e-2)" "unprognostic (1.38e-1)" "unprognostic (1.23e-1)" "unprognostic (1.41e-2)" "unprognostic (1.00e-2)" "unprognostic (7.14e-3)" "unprognostic (1.03e-3)" "unprognostic (2.05e-1)" "unprognostic (3.07e-2)" "prognostic unfavourable (1.09e-5)" "unprognostic (8.23e-2)" "unprognostic (6.53e-8)" "unprognostic (3.81e-1)" "unprognostic (1.83e-1)" "unprognostic (7.40e-2)" "unprognostic (3.61e-2)" 1.6 0.2 0.2 0.2 0.2 0.0 2.1 0.2 0.2 32.4 0.2 0.2 0.2 0.0 1.1 0.2 112.4 0.1 0.6 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.6 0.2 0.7 0.0 0.3 15.5 9.9 0.4 41.4 0.2 0.2 0.2 0.2 0.1 0.6 0.2 3.0 0.2 503.5 26.4 0.6 50.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 3.9 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 134.9 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 15.3 0.1 0.9 0.0 0.0 9.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 KRT17 PCHC1 ENSG00000128422 "Keratin 17" Q04695 17 41619437-41624842 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease mutation, Ectodermal dysplasia, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 109.0;tongue: 144.0" "Group enriched" "Detected in some" 7 "hTCEpi: 638.7;SiHa: 265.9" "Cancer enhanced" "Detected in all" "head and neck cancer: 3317.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000029, HPA000452, HPA000453, HPA000539, HPA045062" Enhanced Enhanced "Intermediate filaments" 750000000 "Intermediate filaments" "CAB000029: AB_2133155, HPA000452: AB_1079177, HPA000453: AB_1079176, HPA000539: , HPA045062: " "prognostic favourable (4.44e-4)" "unprognostic (1.43e-1)" "unprognostic (1.15e-1)" "unprognostic (3.65e-3)" "unprognostic (4.46e-2)" "unprognostic (4.34e-1)" "unprognostic (4.36e-3)" "unprognostic (1.32e-2)" "unprognostic (2.27e-1)" "unprognostic (1.29e-1)" "unprognostic (7.86e-3)" "unprognostic (1.53e-1)" "prognostic unfavourable (5.74e-4)" "unprognostic (1.82e-1)" "unprognostic (1.77e-1)" "unprognostic (2.20e-1)" "unprognostic (3.89e-1)" 0.7 0.0 0.7 0.7 0.7 0.1 52.3 0.7 0.8 12.6 0.8 0.7 1.2 0.0 1.0 3.1 38.6 0.9 0.9 0.7 0.7 0.0 0.8 0.7 3.7 0.7 0.7 1.0 0.8 0.7 0.0 0.9 4.1 0.8 15.0 0.0 0.7 26.8 33.4 0.7 109.0 0.7 1.2 0.7 0.7 0.0 0.8 0.7 5.1 0.8 144.0 19.7 55.6 25.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 6.4 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 64.6 0.0 66.0 0.0 0.0 0.0 0.0 28.9 0.0 0.0 0.0 0.0 0.0 638.7 0.0 49.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 24.2 0.0 0.0 265.9 0.1 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.7 0.7 0.8 0.7 0.0 0.7 1.0 0.8 0.7 KRT19 "CK19, K19, K1CS, MGC15366" ENSG00000171345 "Keratin 19" P08727 17 41523617-41528308 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 205.3;intestine: 184.9;placenta: 179.4" "Cell line enhanced" "Detected in many" "CAPAN-2: 100.7;HBEC3-KT: 151.7;MCF7: 111.9;RT4: 161.1;SK-BR-3: 284.6;T-47d: 191.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 4 "NK-cell: 2.7" "Lineage enriched" "Detected in single" 4 "NK-cells: 2.7" "Not detected" "Not detected" "CAB000031, HPA002465" Enhanced Supported "Intermediate filaments" 330000000 "Intermediate filaments" "CAB000031: AB_2234418, HPA002465: AB_1079179" "unprognostic (1.09e-1)" "unprognostic (1.83e-1)" "unprognostic (3.86e-2)" "unprognostic (1.59e-2)" "unprognostic (2.24e-2)" "unprognostic (1.13e-1)" "unprognostic (2.29e-1)" "unprognostic (2.80e-2)" "unprognostic (3.14e-1)" "unprognostic (4.86e-2)" "prognostic unfavourable (6.82e-5)" "unprognostic (1.90e-2)" "prognostic unfavourable (2.98e-5)" "unprognostic (3.52e-2)" "unprognostic (2.14e-1)" "unprognostic (3.08e-2)" "unprognostic (2.35e-2)" 9.8 1.6 0.7 22.8 0.9 0.0 50.1 2.9 0.8 37.4 126.7 1.0 38.0 37.8 9.9 53.0 102.1 19.5 205.3 2.3 0.8 0.2 35.0 2.1 50.6 0.7 0.8 0.8 16.7 7.5 1.2 2.6 179.4 1.3 39.2 40.1 1.8 103.0 46.3 0.7 15.8 184.9 11.7 0.6 0.6 69.1 6.4 0.7 33.3 4.9 21.2 89.2 77.0 35.4 0.0 0.0 0.0 0.0 2.7 0.6 0.2 0.1 17.6 0.0 0.3 0.0 0.0 61.6 21.2 0.0 0.6 0.1 50.6 100.7 0.0 20.8 10.1 53.9 0.0 151.7 0.1 0.0 0.5 0.0 11.4 34.6 1.6 0.0 4.3 0.0 27.6 0.4 0.0 1.3 7.3 0.1 0.0 111.9 0.2 0.1 0.9 25.6 0.1 0.0 0.3 69.5 161.1 2.1 0.0 0.1 284.6 0.0 191.7 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.2 0.7 0.9 2.9 0.8 0.8 0.2 0.8 0.8 1.3 0.7 KRT2 "KRT2A, KRTE" ENSG00000172867 "Keratin 2" P35908 12 52644558-52652164 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Disease mutation, FDA approved drug targets, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skin 1: 289.9" "Group enriched" "Detected in some" 6 "HEL: 6.5;HMC-1: 2.8" "Group enriched" "Detected in some" 35 "head and neck cancer: 4.7;melanoma: 23.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "naive CD4 T-cell: 4.4;naive CD8 T-cell: 2.1" "Lineage enriched" "Detected in single" 45 "T-cells: 4.4" "Group enriched" "Detected in some" 6 "amygdala: 1.8;hippocampal formation: 2.9" "Low region specificity" "Detected in single" "HPA006299, CAB037321" Enhanced Approved "Golgi apparatus,Intermediate filaments,Cytosol" 14000000000 "Intermediate filaments, Cytosol" "Golgi apparatus" "CAB037321: , HPA006299: AB_1079180" "unprognostic (1.22e-1)" "unprognostic (1.60e-1)" "unprognostic (1.34e-1)" "unprognostic (2.56e-1)" "unprognostic (8.47e-3)" "unprognostic (1.69e-2)" "unprognostic (1.84e-1)" "unprognostic (3.59e-1)" "unprognostic (2.12e-1)" "unprognostic (4.76e-2)" "unprognostic (3.56e-7)" "unprognostic (6.43e-2)" "unprognostic (5.98e-3)" "unprognostic (6.69e-2)" "unprognostic (3.46e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 9.5 0.1 0.1 18.3 0.1 0.1 0.1 0.0 2.0 0.1 0.4 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 4.4 289.9 0.1 0.1 0.1 0.1 0.0 0.1 0.1 6.8 0.1 19.2 1.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 4.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 4.4 2.1 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 KRT23 "CK23, DKFZP434G032, HAIK1, K23, MGC26158" ENSG00000108244 "Keratin 23" Q9C075 17 40922696-40937634 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 128.3;salivary gland: 99.8;skin 1: 48.2" "Group enriched" "Detected in some" 9 "HBEC3-KT: 20.7;Hep G2: 12.8;T-47d: 35.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 12 "neutrophil: 30.1" "Lineage enriched" "Detected in single" 70 "granulocytes: 30.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA012050, HPA016959, CAB017091" Approved Approved "Intermediate filaments,Cytosol" 170000 "Intermediate filaments" Cytosol "CAB017091: , HPA012050: AB_1852226, HPA016959: AB_1852228" "unprognostic (1.62e-1)" "unprognostic (5.29e-2)" "unprognostic (4.35e-2)" "unprognostic (6.18e-3)" "unprognostic (1.45e-2)" "unprognostic (2.83e-1)" "unprognostic (5.22e-2)" "unprognostic (6.84e-3)" "unprognostic (2.74e-1)" "unprognostic (2.15e-2)" "unprognostic (8.96e-2)" "unprognostic (1.56e-1)" "unprognostic (8.22e-2)" "unprognostic (6.78e-2)" "unprognostic (1.40e-1)" "unprognostic (2.99e-1)" "prognostic unfavourable (8.26e-4)" 0.3 0.0 0.2 0.5 0.2 0.5 10.0 0.3 0.3 9.8 0.2 0.2 2.1 0.0 1.1 1.2 2.5 1.5 4.5 0.2 0.2 0.0 0.3 0.6 1.1 0.6 0.2 0.2 0.6 1.2 0.0 0.9 128.3 0.2 6.9 0.0 0.3 99.8 2.8 0.3 48.2 0.2 0.3 0.2 1.0 0.0 9.1 0.2 2.0 0.3 11.7 9.5 2.3 3.2 0.0 0.0 30.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.0 0.3 2.0 0.0 0.3 0.0 0.6 0.0 20.7 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 35.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.3 0.2 0.0 0.2 0.2 0.2 0.2 KRT24 "FLJ20261, MGC138169, MGC138173" ENSG00000167916 "Keratin 24" Q2M2I5 17 40697991-40703750 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 62.1;lymphoid tissue: 68.9;placenta: 48.6" "Cell line enriched" "Detected in single" 14 "SK-BR-3: 12.5" "Cancer enhanced" "Detected in some" "head and neck cancer: 15.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 24 "T-reg: 2.4" "Lineage enriched" "Detected in single" 24 "T-cells: 2.4" "Region enriched" "Detected in single" 18 "cerebellum: 1.1" "Low region specificity" "Detected in all" HPA022978 Uncertain Approved "Intermediate filaments,Cytosol" "Intermediate filaments, Cytosol" "HPA022978: AB_1852230" "unprognostic (2.74e-2)" "unprognostic (1.05e-2)" "unprognostic (1.45e-1)" "unprognostic (3.16e-2)" "unprognostic (2.47e-1)" "unprognostic (3.75e-1)" "unprognostic (2.74e-1)" "unprognostic (2.95e-1)" "unprognostic (3.37e-2)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 9.2 4.1 0.0 0.0 0.0 0.7 9.3 62.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 48.6 0.0 0.1 3.1 0.0 1.2 0.8 0.1 0.1 0.2 3.4 0.1 0.1 1.1 0.1 0.0 0.0 0.1 1.4 68.9 0.6 3.4 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.5 0.0 0.3 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 KRT4 "CK4, CYK4, K4" ENSG00000170477 "Keratin 4" P19013 12 52806549-52814551 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "esophagus: 637.8;lymphoid tissue: 403.6;tongue: 174.6" "Group enriched" "Detected in some" 30 "HaCaT: 94.2;SK-BR-3: 38.2" "Group enriched" "Detected in many" 5 "cervical cancer: 94.3;head and neck cancer: 151.8;stomach cancer: 73.1;urothelial cancer: 38.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB002154, HPA034881" Enhanced Supported "Intermediate filaments" 540000000 "Intermediate filaments" "CAB002154: AB_563803, HPA034881: " "unprognostic (4.04e-1)" "unprognostic (3.22e-3)" "unprognostic (5.16e-3)" "unprognostic (8.52e-3)" "unprognostic (1.20e-1)" "unprognostic (2.64e-1)" "unprognostic (1.84e-1)" "prognostic unfavourable (3.26e-4)" "unprognostic (2.85e-3)" "unprognostic (2.84e-2)" "unprognostic (2.58e-11)" "unprognostic (1.64e-1)" "unprognostic (6.97e-2)" "unprognostic (1.16e-1)" "prognostic unfavourable (6.26e-4)" 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 25.5 0.1 0.0 0.0 0.1 2.5 0.1 637.8 0.3 0.1 0.2 0.0 0.0 0.1 0.1 0.6 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 48.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 174.6 403.6 0.2 20.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 94.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRT5 "EBS2, KRT5A" ENSG00000186081 "Keratin 5" P13647 12 52514575-52520687 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 463.1;skin 1: 338.1;tongue: 522.3" "Cell line enhanced" "Detected in some" "HaCaT: 118.0;HBEC3-KT: 211.3;hTCEpi: 483.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 3340.4" "Region enriched" "Detected in single" 7 "pons and medulla: 1.7" "Cell type enriched" "Detected in single" 197 "plasmacytoid DC: 19.6" "Lineage enriched" "Detected in single" 197 "dendritic cells: 19.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB000027, CAB000129, HPA059479" Enhanced Approved "Intermediate filaments" 6500000000 "Intermediate filaments" "CAB000027: AB_2281083, CAB000129: , HPA059479: " "prognostic favourable (1.27e-4)" "unprognostic (9.81e-2)" "unprognostic (1.14e-1)" "unprognostic (1.29e-2)" "unprognostic (1.84e-1)" "unprognostic (1.14e-1)" "unprognostic (1.33e-1)" "unprognostic (7.20e-2)" "unprognostic (2.82e-1)" "unprognostic (1.90e-1)" "unprognostic (1.41e-2)" "unprognostic (1.73e-1)" "unprognostic (6.01e-7)" "unprognostic (3.46e-2)" "unprognostic (5.56e-2)" "unprognostic (7.96e-2)" "unprognostic (2.81e-3)" 0.3 0.0 0.1 0.3 0.2 0.2 15.9 0.1 0.2 74.2 0.2 0.3 6.2 0.0 4.9 6.4 463.1 0.7 0.1 0.1 0.1 0.0 0.1 0.1 1.1 0.1 0.1 0.2 0.1 0.2 0.0 0.2 4.4 1.7 5.8 0.0 0.4 46.9 7.8 0.5 338.1 0.1 0.3 0.1 0.1 0.1 0.7 0.1 31.7 0.1 522.3 128.9 4.0 96.8 0.0 19.6 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 118.0 0.0 211.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 483.0 0.0 42.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.6 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.2 1.7 0.1 KRT6A "CK6C, CK6D, K6C, K6D, KRT6C, KRT6D" ENSG00000205420 "Keratin 6A" P02538 12 52487174-52493257 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Allergen, Disease mutation, Ectodermal dysplasia, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "cervix, uterine: 209.2;esophagus: 422.1;tongue: 620.2;vagina: 179.1" "Cell line enriched" "Detected in some" 4 "hTCEpi: 459.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 3892.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045697, HPA061168" Supported Enhanced "Intermediate filaments" 7200000000 "Intermediate filaments" "HPA045697: , HPA061168: " "unprognostic (8.10e-3)" "unprognostic (2.11e-1)" "unprognostic (2.78e-2)" "unprognostic (1.06e-1)" "unprognostic (2.45e-1)" "prognostic unfavourable (1.45e-4)" "unprognostic (2.43e-1)" "unprognostic (3.73e-2)" "unprognostic (1.31e-3)" "unprognostic (1.29e-1)" "unprognostic (2.89e-9)" "unprognostic (8.80e-2)" "unprognostic (7.20e-2)" "unprognostic (1.72e-1)" "unprognostic (2.13e-2)" 0.2 0.2 0.0 0.4 0.0 0.2 0.8 0.0 0.3 209.2 0.2 0.0 0.0 0.2 6.8 0.2 422.1 0.3 0.3 0.3 0.0 0.0 0.2 0.2 0.2 0.2 0.0 0.1 0.2 0.2 0.2 0.0 19.8 0.0 0.3 0.2 0.0 37.6 0.2 0.2 19.0 0.2 0.3 0.0 0.2 0.2 0.2 0.0 2.7 0.2 620.2 86.8 0.5 179.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 52.7 0.0 111.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 459.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 KRT6B KRTL1 ENSG00000185479 "Keratin 6B" P04259 12 52446651-52452126 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Ectodermal dysplasia, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "esophagus: 135.3;tongue: 232.4" "Group enriched" "Detected in some" 6 "HBEC3-KT: 19.7;hTCEpi: 22.0;RPMI-8226: 9.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 1424.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000130, HPA045697, HPA061168" Supported Approved "Intermediate filaments" "Intermediate filaments" "CAB000130: , HPA045697: , HPA061168: " "prognostic favourable (9.44e-4)" "unprognostic (3.27e-2)" "unprognostic (1.93e-1)" "unprognostic (1.28e-1)" "unprognostic (1.21e-1)" "unprognostic (1.75e-2)" "unprognostic (2.07e-3)" "unprognostic (2.27e-1)" "unprognostic (1.98e-1)" "unprognostic (1.03e-1)" "unprognostic (5.77e-2)" "unprognostic (9.63e-2)" "unprognostic (3.29e-1)" "prognostic unfavourable (9.52e-4)" 0.2 0.1 0.1 0.5 0.1 0.1 3.9 0.1 0.1 33.3 0.1 0.1 0.1 0.1 0.7 0.1 135.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.1 17.8 0.1 0.1 34.9 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.5 0.1 232.4 15.4 0.1 26.3 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 19.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 KRT6C KRT6E ENSG00000170465 "Keratin 6C" P48668 12 52468516-52473785 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 109.4;esophagus: 125.8;tongue: 244.2" "Cell line enriched" "Detected in some" 6 "RPMI-8226: 44.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 564.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045697, HPA061168" Supported Approved "Intermediate filaments" "Intermediate filaments" "HPA045697: , HPA061168: " "unprognostic (3.18e-2)" "unprognostic (6.26e-3)" "unprognostic (6.63e-2)" "unprognostic (1.54e-3)" "unprognostic (6.97e-2)" "prognostic unfavourable (1.23e-5)" "unprognostic (1.83e-1)" "unprognostic (1.87e-2)" "unprognostic (3.25e-2)" "unprognostic (2.24e-1)" "unprognostic (2.84e-1)" "unprognostic (4.50e-2)" 0.2 0.2 0.0 0.2 0.0 0.2 0.2 0.0 0.2 109.4 0.2 0.0 0.0 0.2 1.1 0.2 125.8 0.2 0.2 0.2 0.0 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.2 0.2 0.2 0.0 0.2 0.0 0.2 0.2 0.0 16.3 0.2 0.2 2.7 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.1 0.2 244.2 6.7 0.2 40.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRT7 "CK7, K2C7, K7, SCL" ENSG00000135480 "Keratin 7" P08729 12 52232520-52252186 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 156.6;salivary gland: 142.6;thyroid gland: 199.7" "Cell line enhanced" "Detected in some" "BEWO: 117.7;HBEC3-KT: 262.1;RT4: 312.5;SiHa: 246.4;SK-BR-3: 143.9" "Cancer enhanced" "Detected in many" "urothelial cancer: 560.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "intermediate monocyte: 3.8" "Lineage enriched" "Detected in single" 5 "monocytes: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000028, HPA007272, HPA007315" Enhanced Supported "Intermediate filaments" 350000000 "Intermediate filaments" "CAB000028: AB_2134589, HPA007272: AB_1079181, HPA007315: " "unprognostic (2.71e-3)" "unprognostic (3.09e-1)" "unprognostic (2.20e-1)" "prognostic unfavourable (1.99e-4)" "unprognostic (2.22e-2)" "unprognostic (8.59e-2)" "unprognostic (1.27e-1)" "unprognostic (5.44e-3)" "unprognostic (2.74e-1)" "prognostic unfavourable (9.42e-5)" "prognostic unfavourable (7.78e-5)" "unprognostic (4.54e-2)" "prognostic favourable (2.77e-9)" "unprognostic (2.82e-1)" "unprognostic (1.43e-2)" "unprognostic (3.28e-1)" "unprognostic (3.98e-3)" 3.5 0.2 0.2 0.6 0.2 0.0 43.1 0.2 0.2 7.8 0.5 0.1 18.0 0.0 1.7 9.6 14.4 11.7 27.1 1.2 0.2 0.2 35.0 4.3 63.2 0.0 0.2 0.2 3.3 15.1 1.7 2.1 156.6 0.6 23.1 0.0 0.1 142.6 67.3 0.4 10.7 0.3 4.3 0.3 0.2 2.3 4.3 0.0 0.4 199.7 6.1 16.3 58.2 22.3 0.0 0.8 0.0 3.8 0.0 0.0 0.2 0.1 99.7 0.0 0.0 0.1 0.0 117.7 21.4 0.0 11.2 1.0 0.3 71.2 0.0 0.0 7.3 78.5 0.0 262.1 0.5 0.1 0.0 0.0 53.5 0.3 2.5 0.0 0.0 0.0 16.3 0.0 105.7 11.3 0.0 0.0 0.0 0.5 0.0 0.1 0.3 0.1 0.0 0.2 1.5 64.7 312.5 0.1 0.1 246.4 143.9 0.0 5.5 0.0 85.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.6 0.0 KRT8 "CARD2, CK8, CYK8, K2C8, K8, KO" ENSG00000170421 "Keratin 8" P05787 12 52897187-52949954 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 102.9" "Cell line enhanced" "Detected in many" "A549: 224.1;BEWO: 150.2;CACO-2: 278.9;CAPAN-2: 176.2;MCF7: 376.4;SK-BR-3: 191.3;T-47d: 160.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "pons and medulla: 13.7" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.9" "Group enriched" "Detected in many" 4 "dendritic cells: 4.9;granulocytes: 3.2;NK-cells: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB000131, CAB001696, HPA049866" Enhanced Supported "Intermediate filaments" 920000000 "Intermediate filaments" "CAB000131: AB_2281144, CAB001696: , HPA049866: " "unprognostic (5.72e-2)" "unprognostic (2.29e-1)" "unprognostic (2.49e-2)" "unprognostic (1.52e-1)" "unprognostic (2.76e-2)" "unprognostic (4.86e-3)" "unprognostic (3.10e-2)" "unprognostic (2.52e-2)" "unprognostic (1.92e-1)" "unprognostic (4.58e-1)" "prognostic unfavourable (1.51e-4)" "unprognostic (8.99e-2)" "unprognostic (2.08e-2)" "unprognostic (2.83e-2)" "unprognostic (3.18e-1)" "unprognostic (3.68e-1)" "unprognostic (1.19e-2)" 13.4 4.8 2.0 11.0 1.5 0.0 13.9 2.7 1.3 15.1 90.2 2.1 29.8 87.2 11.1 18.3 19.3 10.4 20.3 17.6 1.1 0.2 28.8 55.8 20.1 18.4 1.4 1.2 10.6 75.9 4.0 31.8 28.9 13.7 25.2 45.0 12.1 36.9 46.0 3.7 5.0 102.9 5.2 3.3 14.3 61.8 5.1 1.2 2.9 27.6 9.2 11.6 27.1 10.5 0.7 4.9 3.2 0.7 1.6 0.6 0.5 99.5 224.1 0.0 0.2 0.0 0.1 150.2 0.4 1.7 0.2 0.2 278.9 176.2 0.0 42.6 0.5 34.8 0.6 27.6 0.2 0.1 4.8 0.1 46.7 79.7 8.1 0.0 0.0 0.3 0.4 0.5 1.9 0.6 17.1 0.0 0.0 376.4 0.2 0.3 15.6 4.9 0.1 0.0 0.5 44.4 49.4 4.8 0.1 39.0 191.3 0.3 160.9 0.3 0.6 0.2 16.9 0.3 0.3 0.0 0.2 0.2 0.1 0.0 0.4 3.2 0.5 0.6 0.6 0.7 0.4 0.3 0.4 0.3 2.1 0.7 0.4 0.5 1.4 1.6 0.3 4.9 0.5 0.5 2.0 1.5 2.7 1.3 1.1 0.2 1.4 1.2 13.7 1.2 KRT80 KB20 ENSG00000167767 "Keratin 80" Q6KB66 12 52168996-52192000 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 43.9;skin 1: 64.0;tongue: 41.8" "Cell line enhanced" "Detected in many" "A-431: 44.0;MCF7: 62.9;SK-BR-3: 29.1;U-2 OS: 40.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 5.7" "Low region specificity" "Detected in all" "HPA077836, HPA077918" Enhanced "Intermediate filaments" 290000000 "Intermediate filaments" "HPA077836: , HPA077918: AB_2686871" "prognostic unfavourable (1.05e-4)" "unprognostic (5.45e-3)" "unprognostic (5.35e-2)" "unprognostic (9.19e-3)" "unprognostic (2.85e-4)" "unprognostic (6.68e-2)" "unprognostic (2.06e-3)" "unprognostic (1.26e-3)" "unprognostic (5.60e-2)" "unprognostic (4.06e-2)" "unprognostic (7.06e-3)" "unprognostic (1.02e-1)" "unprognostic (8.79e-3)" "unprognostic (8.85e-2)" "unprognostic (2.03e-1)" "unprognostic (1.51e-1)" "unprognostic (2.98e-2)" 0.2 1.9 0.1 0.0 0.2 0.0 3.9 0.0 0.1 5.7 0.5 0.0 1.5 0.0 0.5 4.2 20.4 1.4 1.8 0.2 0.0 0.1 2.7 0.2 1.5 0.0 0.0 0.0 0.6 9.0 7.3 0.2 17.5 0.0 1.8 0.0 0.1 22.1 1.6 0.9 64.0 0.5 0.0 0.1 0.1 0.2 0.5 0.0 0.8 0.4 41.8 43.9 3.2 10.7 0.1 0.9 0.3 0.9 0.0 0.1 0.0 44.0 14.8 0.0 0.0 0.0 0.0 12.4 0.6 0.4 3.5 1.0 1.0 19.3 0.0 21.7 0.5 22.0 0.0 0.2 1.2 0.0 0.0 0.0 23.1 0.5 2.3 0.0 0.0 0.2 2.7 0.7 5.3 5.2 0.0 0.0 1.2 62.9 0.0 0.0 0.0 2.2 0.0 18.1 0.6 19.8 7.9 5.6 0.3 11.2 29.1 0.2 5.4 0.2 3.0 0.0 40.8 0.0 15.8 0.0 0.0 0.1 4.1 1.6 0.2 0.0 0.9 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.1 0.1 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 MAFIP "FLJ00219, FLJ35473, FLJ39633, MIP, pp5644, TEKT4P4" ENSG00000274847 "MAFF interacting protein (pseudogene)" Unmapped 53594-115055 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 10.5" "Cell line enhanced" "Detected in many" "K-562: 15.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA053929 Uncertain "Intermediate filaments" "Intermediate filaments" "HPA053929: " 2.9 5.1 0.5 0.0 0.2 0.9 0.4 0.3 0.7 1.1 0.1 2.0 1.0 1.2 1.4 1.6 1.2 1.0 2.3 2.4 1.6 0.0 0.5 1.7 0.0 2.5 0.3 1.1 0.0 1.5 1.4 2.0 0.0 0.2 1.3 0.3 1.9 5.4 10.5 2.5 5.6 4.5 4.8 3.5 0.2 3.5 0.0 1.4 0.0 0.0 3.9 3.6 1.8 1.1 1.4 6.4 8.1 0.1 7.2 4.7 0.9 2.7 3.8 0.7 0.3 3.4 5.7 3.7 6.5 0.3 0.1 9.1 0.6 5.4 3.3 0.0 3.4 15.4 8.2 2.4 7.0 5.0 1.0 0.2 2.9 0.0 4.7 3.6 3.8 1.0 3.0 5.7 0.0 5.2 6.3 11.5 0.4 8.8 2.2 6.4 3.0 2.8 7.8 6.0 0.0 9.8 0.0 2.2 2.4 4.8 2.5 3.7 5.6 3.1 5.3 3.7 3.5 6.0 5.4 4.6 4.6 0.3 4.5 2.9 10.5 4.8 3.5 MARVELD3 MRVLDC3 ENSG00000140832 "MARVEL domain containing 3" Q96A59 16 71626161-71642114 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 52.9;pancreas: 34.5" "Cell line enhanced" "Detected in some" "A-431: 11.5;BEWO: 17.3;CACO-2: 12.8;CAPAN-2: 12.4;HaCaT: 11.7;MCF7: 21.8;RT4: 10.2;SK-BR-3: 10.3;T-47d: 14.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043514, HPA045471" Approved "Vesicles,Intermediate filaments" Vesicles "Intermediate filaments" "HPA043514: AB_10959475, HPA045471: " "unprognostic (1.18e-1)" "unprognostic (3.92e-1)" "unprognostic (9.92e-2)" "unprognostic (5.56e-2)" "unprognostic (1.03e-1)" "unprognostic (6.16e-3)" "unprognostic (2.04e-1)" "unprognostic (3.22e-2)" "unprognostic (2.54e-1)" "unprognostic (8.75e-3)" "unprognostic (3.29e-1)" "unprognostic (5.16e-2)" "prognostic favourable (6.80e-10)" "unprognostic (2.63e-3)" "unprognostic (4.76e-1)" "unprognostic (3.59e-2)" "unprognostic (2.43e-1)" 0.4 0.3 0.4 12.5 0.3 0.0 5.0 0.7 1.2 2.0 35.7 0.3 5.2 17.3 1.3 8.6 4.1 2.1 15.4 0.5 0.5 0.4 14.2 4.3 3.3 0.5 0.3 0.1 1.0 34.5 5.4 1.2 5.3 2.4 6.5 10.5 2.4 10.4 4.3 0.3 3.0 52.9 0.7 0.4 0.4 2.1 1.2 0.1 1.3 8.3 2.3 4.6 3.0 3.4 1.5 1.4 4.1 0.8 1.5 0.8 0.2 11.5 0.4 0.2 0.5 0.0 0.1 17.3 0.0 0.0 0.0 0.0 12.8 12.4 0.1 1.3 0.0 11.7 1.0 5.6 0.0 0.0 6.7 0.0 0.1 3.3 0.0 0.1 0.1 0.5 7.0 0.0 0.1 0.0 0.2 0.1 0.0 21.8 0.1 0.2 1.9 0.1 0.0 0.0 4.6 0.2 10.2 2.1 0.1 0.2 10.3 0.0 14.6 0.2 0.0 0.0 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 4.1 0.8 0.8 0.7 0.5 0.4 0.8 0.8 0.6 0.3 1.5 0.7 0.7 4.0 1.5 0.5 1.4 0.7 0.2 0.4 0.3 0.7 0.5 0.5 0.4 0.3 0.1 2.4 0.1 MCOLN2 "FLJ36691, TRP-ML2, TRPML2" ENSG00000153898 "Mucolipin 2" Q8IZK6 1 84925583-84997113 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Adaptive immunity, Calcium transport, Immunity, Innate immunity, Ion transport, Protein transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 18.9;epididymis: 18.4;lymphoid tissue: 31.9" "Cell line enhanced" "Detected in many" "Daudi: 13.8;HAP1: 9.9;HDLM-2: 16.4;THP-1: 19.7;U-698: 12.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 18.9" "Group enriched" "Detected in many" 12 "B-cells: 6.6;dendritic cells: 18.9;T-cells: 5.9" "Region enriched" "Detected in single" 5 "amygdala: 0.4" "Low region specificity" "Detected in all" "HPA019114, HPA048999" Uncertain Supported "Intermediate filaments" "Intermediate filaments" "HPA019114: AB_1853645, HPA048999: " "unprognostic (3.02e-2)" "unprognostic (5.67e-2)" "unprognostic (3.07e-1)" "unprognostic (1.44e-1)" "unprognostic (2.47e-1)" "unprognostic (5.66e-3)" "unprognostic (2.38e-1)" "prognostic favourable (2.56e-4)" "unprognostic (8.92e-2)" "unprognostic (1.48e-2)" "unprognostic (6.84e-2)" "unprognostic (2.21e-2)" "unprognostic (3.12e-4)" "unprognostic (3.68e-2)" "unprognostic (4.69e-2)" "unprognostic (1.24e-1)" "unprognostic (4.23e-2)" 1.3 12.5 0.4 31.9 0.4 2.2 1.1 0.2 0.4 1.7 8.5 0.5 1.6 1.2 1.4 18.4 1.3 2.9 3.8 2.0 0.6 0.4 1.4 0.6 7.5 18.4 0.6 0.0 1.0 1.8 0.0 1.2 2.1 1.5 1.5 14.0 1.6 3.2 0.9 0.6 1.8 7.5 0.5 1.7 9.7 1.7 2.7 0.4 4.1 1.0 2.8 27.5 2.3 1.3 6.6 18.9 0.2 0.8 0.4 5.9 1.4 1.0 1.1 0.1 2.9 0.6 0.2 0.4 0.7 3.8 0.9 1.2 0.0 0.1 13.8 0.4 0.0 0.1 9.9 1.2 1.1 16.4 7.3 1.4 0.4 0.0 0.8 0.3 1.3 0.2 0.0 0.9 0.8 0.1 0.0 0.3 0.2 0.4 0.2 0.1 1.1 1.9 0.1 2.3 0.0 0.1 0.3 0.7 0.0 0.1 0.2 6.1 1.7 19.7 0.1 0.9 1.5 0.1 2.6 0.1 0.0 12.3 0.8 0.1 2.4 0.1 0.2 0.0 4.1 0.8 1.3 6.6 3.3 5.9 4.5 1.9 0.5 3.4 0.2 0.4 0.1 18.9 0.2 1.4 0.4 0.4 0.2 0.4 0.6 0.4 0.6 0.0 1.5 0.4 MDN1 "KIAA0301, Rea1" ENSG00000112159 "Midasin AAA ATPase 1" Q9NU22 6 89642499-89819723 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 26.6;NTERA-2: 25.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029666, HPA029667, HPA029668, HPA029669" Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol" "Nucleoli, Cytosol" "Nucleoplasm, Intermediate filaments" "HPA029666: AB_10600888, HPA029667: AB_10696207, HPA029668: AB_10669868, HPA029669: AB_10670429" "unprognostic (2.00e-1)" "unprognostic (4.46e-2)" "unprognostic (7.62e-2)" "unprognostic (2.26e-2)" "unprognostic (6.14e-3)" "unprognostic (3.46e-1)" "unprognostic (6.68e-2)" "unprognostic (1.40e-1)" "unprognostic (3.51e-1)" "unprognostic (1.75e-1)" "unprognostic (1.77e-2)" "unprognostic (9.07e-2)" "unprognostic (2.54e-3)" "unprognostic (6.28e-3)" "unprognostic (9.22e-2)" "unprognostic (2.02e-1)" "unprognostic (6.09e-2)" 10.0 8.8 8.6 10.1 18.2 16.1 14.9 19.2 18.7 9.1 7.5 14.8 8.6 5.9 14.1 10.0 9.2 10.2 6.4 8.6 9.4 9.6 9.4 15.1 7.3 10.9 13.1 12.4 22.3 10.7 19.0 10.9 5.9 15.9 8.1 8.6 9.4 9.3 8.3 16.2 19.6 8.8 9.2 12.7 9.0 8.2 14.0 13.7 8.4 12.8 8.2 12.7 7.5 7.8 3.8 8.9 6.7 1.0 3.3 4.2 0.3 4.5 4.5 4.7 4.4 7.7 7.4 4.7 3.1 2.3 3.6 4.4 10.3 1.7 13.7 3.6 3.2 4.0 12.1 4.2 6.4 5.3 8.1 14.9 5.8 6.7 3.0 19.2 3.7 4.5 3.6 9.5 8.8 6.3 26.6 3.3 3.5 5.5 3.0 7.3 25.9 4.0 6.0 8.9 3.4 3.1 6.5 8.6 3.8 4.4 2.7 2.8 1.9 8.5 8.0 2.4 4.4 3.2 7.2 3.8 4.2 6.7 3.3 11.0 4.1 6.7 1.0 1.9 2.4 0.8 2.1 3.0 3.3 2.6 0.6 3.8 4.2 3.3 0.2 3.3 1.0 8.9 1.3 0.3 8.6 18.2 19.2 18.7 9.4 9.6 13.1 12.4 15.9 13.7 MIEF1 "FLJ20232, MiD51, SMCR7L" ENSG00000100335 "Mitochondrial elongation factor 1" Q9NQG6 22 39499432-39518132 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061059 Approved "Intermediate filaments,Mitochondria" "Intermediate filaments, Mitochondria" "HPA061059: " "unprognostic (5.35e-2)" "unprognostic (2.66e-2)" "unprognostic (2.86e-3)" "unprognostic (1.11e-2)" "unprognostic (3.74e-2)" "unprognostic (1.49e-1)" "unprognostic (1.95e-3)" "unprognostic (1.85e-2)" "unprognostic (5.72e-2)" "unprognostic (1.76e-1)" "unprognostic (3.24e-1)" "unprognostic (6.65e-2)" "prognostic favourable (3.96e-5)" "unprognostic (1.53e-3)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" "unprognostic (2.30e-1)" 14.9 12.6 14.5 15.1 14.9 16.2 12.3 17.3 21.3 10.0 15.1 12.3 12.9 17.5 12.1 12.9 13.9 10.9 14.2 11.6 13.0 12.9 19.6 26.2 10.8 15.5 13.6 15.9 12.1 14.3 16.6 8.3 12.6 12.1 10.6 14.2 12.5 15.6 14.1 16.7 11.5 16.6 10.3 10.8 18.0 11.7 43.1 10.7 15.9 12.6 11.1 16.6 11.5 13.8 7.1 8.1 5.9 8.3 8.7 9.2 7.6 7.9 8.0 8.8 14.0 8.4 9.2 10.2 7.6 9.1 8.8 8.1 13.1 4.2 22.1 6.4 8.2 10.1 19.9 10.6 11.0 9.4 18.4 9.1 11.3 13.3 16.3 32.1 12.1 12.0 12.9 7.8 16.7 9.3 16.0 12.2 8.7 5.4 10.1 8.9 8.2 8.8 13.9 12.5 22.6 10.1 9.7 8.1 6.7 8.5 14.7 21.8 6.5 11.7 9.0 8.3 11.8 7.4 9.3 22.4 23.3 22.6 9.6 14.1 12.7 0.6 7.4 5.9 7.6 8.3 9.2 7.0 7.3 7.2 8.1 7.1 8.1 7.5 0.7 8.7 7.8 4.5 6.3 7.6 14.5 14.9 17.3 21.3 13.0 12.9 13.6 15.9 12.1 10.7 MMP14 MT1-MMP ENSG00000157227 "Matrix metallopeptidase 14" P50281 14 22836557-22849027 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 98.0;HHSteC: 92.7;HSkMC: 94.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009918, HPA051432" Approved Approved "Intermediate filaments,Cytosol" 570000 Cytosol "Intermediate filaments" "CAB009918: AB_2250767, HPA051432: " "unprognostic (1.34e-1)" "unprognostic (1.37e-1)" "unprognostic (1.11e-2)" "unprognostic (2.81e-1)" "unprognostic (4.28e-2)" "unprognostic (1.12e-2)" "unprognostic (3.05e-3)" "unprognostic (5.91e-3)" "unprognostic (1.95e-1)" "prognostic unfavourable (9.48e-4)" "unprognostic (3.82e-3)" "unprognostic (7.31e-2)" "prognostic unfavourable (1.34e-4)" "unprognostic (5.02e-2)" "unprognostic (6.69e-2)" "unprognostic (1.00e-2)" "unprognostic (3.41e-3)" 60.9 10.5 2.4 16.6 4.7 0.2 64.2 2.2 3.2 56.3 35.0 8.2 12.7 12.0 53.1 24.1 47.0 21.9 39.6 17.5 3.4 1.8 16.8 9.0 29.8 16.9 5.8 2.9 39.3 11.2 34.4 4.7 73.5 16.4 39.1 11.3 27.1 24.4 16.7 20.4 37.0 22.9 28.5 20.7 22.5 18.2 26.3 4.6 5.4 22.3 14.6 16.7 52.5 53.9 0.1 0.7 0.0 0.7 0.0 0.0 0.1 7.9 0.1 2.4 0.1 98.0 62.3 45.0 25.1 50.6 7.6 13.6 2.3 29.9 0.1 14.0 26.4 20.3 0.0 26.1 9.8 0.1 0.1 3.7 0.1 0.5 92.7 0.0 0.1 94.2 15.8 31.7 27.2 46.0 0.1 0.2 17.9 0.1 0.0 9.0 1.5 4.3 0.3 8.6 0.0 6.9 13.7 0.0 0.0 16.4 0.0 54.4 0.1 8.1 40.7 61.9 5.3 18.0 28.6 0.1 0.1 0.1 37.7 0.0 35.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.4 4.7 2.2 3.2 3.4 1.8 5.8 2.9 16.4 4.6 MOB3A "MOB-LAK, MOB1C, MOBKL2A, moblak" ENSG00000172081 "MOB kinase activator 3A" Q96BX8 19 2071038-2096673 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 69.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057744 Uncertain "Intermediate filaments,Cytosol" "Intermediate filaments, Cytosol" "HPA057744: " "unprognostic (2.05e-2)" "unprognostic (3.58e-2)" "unprognostic (1.39e-1)" "prognostic favourable (1.33e-6)" "unprognostic (3.40e-2)" "unprognostic (3.53e-3)" "unprognostic (3.12e-3)" "unprognostic (1.17e-2)" "unprognostic (2.48e-2)" "unprognostic (2.16e-2)" "unprognostic (7.74e-3)" "unprognostic (3.83e-1)" "prognostic unfavourable (1.93e-4)" "unprognostic (5.90e-2)" "unprognostic (3.27e-1)" "unprognostic (1.27e-1)" "unprognostic (1.18e-1)" 19.6 9.5 9.8 31.9 10.0 27.4 11.9 11.1 9.2 15.5 19.2 12.7 7.7 7.7 19.9 9.2 14.3 16.7 14.1 10.6 10.0 6.9 10.7 5.7 14.9 39.6 9.4 6.4 15.6 8.2 6.7 7.0 15.9 8.8 15.3 9.2 13.4 11.6 13.1 7.9 12.0 18.2 17.0 7.6 37.3 12.5 8.3 10.0 39.3 11.7 6.7 42.2 17.1 13.1 11.6 14.5 69.3 22.0 13.0 16.5 17.1 13.8 5.7 6.8 6.5 16.2 17.9 5.3 8.7 5.6 6.0 4.8 2.2 5.0 35.7 3.2 15.1 5.9 3.7 19.4 4.8 12.5 1.9 7.7 4.0 3.0 16.0 12.1 40.2 10.5 12.8 16.4 6.9 11.2 4.0 35.9 8.6 5.5 6.2 12.3 2.1 4.1 3.8 2.0 27.7 7.4 3.5 4.3 5.8 4.4 4.7 4.8 5.0 19.7 18.9 7.3 4.0 13.5 5.1 7.1 25.2 28.2 19.6 8.2 8.7 18.0 20.6 23.9 16.5 20.8 14.2 11.6 12.3 13.6 14.5 10.7 9.4 11.8 69.3 13.0 22.0 8.3 14.7 17.1 9.8 10.0 11.1 9.2 10.0 6.9 9.4 6.4 8.8 10.0 MOB3B "C9orf35, FLJ13204, MOB1D, MOBKL2B" ENSG00000120162 "MOB kinase activator 3B" Q86TA1 9 27325209-27529781 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.2;ovary: 29.9" "Cell line enhanced" "Detected in many" "BEWO: 10.0;HAP1: 10.2;K-562: 29.2;SK-BR-3: 12.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 4.8;myeloid DC: 4.6;naive B-cell: 5.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" HPA057744 Uncertain "Intermediate filaments,Cytosol" "Intermediate filaments, Cytosol" "HPA057744: " "unprognostic (6.96e-3)" "unprognostic (9.60e-2)" "unprognostic (5.10e-3)" "unprognostic (1.41e-1)" "unprognostic (1.38e-1)" "unprognostic (1.02e-1)" "unprognostic (1.87e-1)" "unprognostic (7.05e-2)" "unprognostic (2.42e-1)" "unprognostic (7.57e-3)" "unprognostic (1.28e-1)" "unprognostic (9.45e-2)" "prognostic favourable (2.33e-10)" "unprognostic (1.55e-1)" "unprognostic (1.16e-1)" "prognostic unfavourable (1.02e-4)" "unprognostic (7.99e-2)" 6.0 2.3 6.2 4.2 18.0 1.0 7.0 5.0 13.9 7.8 13.2 32.6 2.8 19.0 10.9 6.1 4.3 9.4 5.8 2.0 9.8 6.4 8.6 1.9 7.5 4.2 19.7 6.2 29.9 4.5 0.9 1.8 5.3 17.2 2.8 14.9 5.7 3.9 3.8 8.5 7.1 16.6 7.5 33.2 8.6 6.2 3.7 17.5 0.6 7.0 2.9 6.2 4.0 5.2 5.9 4.6 0.0 1.4 0.0 0.1 0.5 2.0 1.5 4.7 0.0 1.2 0.1 10.0 0.0 0.1 0.1 0.0 1.1 0.0 0.0 2.0 0.0 6.6 10.2 8.0 0.0 4.6 1.6 2.9 6.2 0.0 0.0 0.0 0.6 2.1 8.5 0.0 1.5 0.0 29.2 0.1 0.0 0.0 0.0 0.0 6.0 0.5 1.9 0.4 0.0 2.8 3.9 0.0 1.5 1.6 12.3 2.8 0.8 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.3 0.0 0.9 0.0 0.0 1.4 0.0 4.8 0.0 0.0 4.6 5.9 0.1 0.0 0.0 0.0 0.9 0.2 0.0 0.5 6.2 18.0 5.0 12.0 9.8 6.4 19.7 6.2 17.2 17.5 MOB3C "MOB1E, MOBKL2C" ENSG00000142961 "MOB kinase activator 3C" Q70IA8 1 46607715-46616891 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA057744 Uncertain "Intermediate filaments,Cytosol" "Intermediate filaments, Cytosol" "HPA057744: " "unprognostic (1.76e-3)" "prognostic favourable (3.16e-5)" "unprognostic (1.32e-2)" "unprognostic (1.45e-2)" "unprognostic (3.36e-2)" "unprognostic (7.22e-2)" "unprognostic (6.26e-3)" "unprognostic (1.56e-1)" "unprognostic (1.76e-1)" "unprognostic (9.97e-2)" "unprognostic (3.85e-2)" "unprognostic (1.20e-1)" "unprognostic (4.81e-2)" "unprognostic (1.00e-1)" "unprognostic (2.92e-2)" "unprognostic (2.35e-2)" "unprognostic (4.61e-3)" 16.9 9.0 8.8 8.0 14.7 4.1 12.1 19.7 7.5 10.7 11.2 9.3 11.8 8.8 8.4 12.9 12.6 9.6 10.8 12.3 10.1 5.6 9.1 8.8 13.3 7.8 13.2 6.8 12.6 29.8 10.4 10.9 12.8 12.5 12.2 9.3 9.5 16.8 12.5 20.2 6.0 12.5 9.8 5.5 14.7 10.9 4.2 9.4 3.1 11.1 19.1 11.4 10.8 16.0 9.3 7.1 15.1 9.0 16.1 21.5 11.4 7.4 3.0 1.5 4.5 14.9 11.6 0.6 4.2 10.7 7.7 7.5 0.9 5.3 0.6 4.6 7.1 10.7 1.6 5.4 4.0 11.1 0.2 17.5 4.0 1.1 7.8 1.5 6.6 9.5 8.4 7.3 2.0 5.0 2.6 4.4 3.2 3.1 0.7 2.3 0.5 9.0 1.9 4.9 3.2 4.3 13.5 0.6 1.8 6.5 4.6 5.2 2.8 5.9 3.7 3.9 2.7 6.4 3.7 4.1 0.9 0.5 5.8 2.6 3.2 2.1 8.4 15.1 12.2 9.0 21.5 6.9 12.0 12.3 5.8 9.3 10.7 10.8 6.0 16.1 5.7 7.1 8.1 11.4 8.8 14.7 19.7 7.5 10.1 5.6 13.2 6.8 12.5 9.4 MTRR cblE ENSG00000124275 "5-methyltetrahydrofolate-homocysteine methyltransferase reductase" Q9UBK8 5 7851186-7906025 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038113 Supported Approved "Nucleoplasm,Intermediate filaments,Cytosol" Nucleoplasm "Intermediate filaments, Cytosol" "HPA038113: AB_10671520" "unprognostic (1.06e-1)" "unprognostic (1.08e-1)" "unprognostic (5.32e-2)" "unprognostic (1.17e-2)" "unprognostic (1.63e-1)" "unprognostic (2.43e-1)" "prognostic unfavourable (6.60e-4)" "unprognostic (2.56e-2)" "unprognostic (5.82e-2)" "unprognostic (7.43e-2)" "unprognostic (1.29e-1)" "unprognostic (9.11e-3)" "unprognostic (3.44e-2)" "unprognostic (1.30e-1)" "unprognostic (2.60e-1)" "unprognostic (1.56e-1)" "unprognostic (1.12e-1)" 12.2 12.3 11.2 10.5 13.8 5.4 9.7 15.6 14.3 10.8 10.4 24.1 11.5 10.3 17.3 15.9 10.5 11.3 13.3 15.8 14.2 12.9 22.0 23.9 14.9 11.4 18.1 9.6 13.6 13.6 9.4 13.1 11.6 16.6 10.8 11.9 13.6 11.3 7.4 34.6 10.5 11.5 14.2 22.1 9.3 9.2 8.4 12.5 8.1 14.7 9.9 13.5 13.6 8.8 4.6 4.8 4.6 6.8 3.4 11.4 4.2 9.3 8.8 4.7 10.4 17.9 5.8 13.3 14.5 8.6 7.2 8.2 13.2 7.5 15.7 13.9 11.6 6.0 7.2 7.1 13.6 9.9 8.1 7.5 30.5 7.0 10.9 11.4 3.2 9.4 6.5 12.2 9.0 4.7 9.7 11.9 4.2 1.8 7.3 5.8 3.5 9.8 6.0 5.0 6.6 7.8 7.3 7.3 0.9 25.4 18.5 15.9 5.7 8.9 7.2 16.8 10.6 12.9 11.3 17.7 5.8 12.9 12.2 25.2 8.9 4.6 5.1 4.1 5.5 6.8 9.5 4.6 9.2 7.9 4.8 4.1 5.4 5.1 0.1 3.4 5.4 2.7 11.4 4.2 11.2 13.8 15.6 14.3 14.2 12.9 18.1 9.6 16.6 12.5 NDOR1 "bA350O14.9, NR1" ENSG00000188566 "NADPH dependent diflavin oxidoreductase 1" Q9UHB4 9 137205685-137217009 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024504 Approved Approved "Nucleoplasm,Intermediate filaments,Cytosol" Cytosol "Nucleoplasm, Intermediate filaments" "HPA024504: AB_1854338" "unprognostic (1.67e-1)" "unprognostic (1.44e-2)" "unprognostic (3.55e-2)" "unprognostic (1.53e-1)" "unprognostic (1.55e-1)" "unprognostic (1.41e-2)" "unprognostic (5.89e-3)" "unprognostic (5.99e-2)" "unprognostic (9.30e-2)" "unprognostic (3.00e-1)" "unprognostic (2.61e-3)" "unprognostic (1.14e-1)" "unprognostic (1.07e-1)" "unprognostic (4.69e-3)" "unprognostic (2.05e-1)" "unprognostic (4.30e-2)" "unprognostic (6.74e-3)" 9.6 11.4 10.6 18.4 17.4 29.2 10.0 15.0 16.2 9.4 10.4 18.7 7.4 19.1 11.4 10.5 11.2 11.0 10.4 7.4 11.6 7.7 12.1 9.4 11.6 20.5 18.6 8.6 10.2 14.7 9.7 12.2 9.2 13.5 13.0 6.8 12.5 17.3 16.1 6.5 18.5 16.5 8.7 14.2 19.9 13.9 22.2 14.2 20.6 14.4 4.9 15.8 9.7 9.4 2.7 3.7 6.6 4.8 1.6 4.0 3.0 7.1 10.8 7.4 11.3 3.1 3.2 22.4 10.5 4.9 10.3 7.1 10.8 8.5 10.0 8.3 4.1 26.8 5.3 7.4 2.1 12.9 8.3 8.9 26.0 5.8 5.3 10.0 19.1 4.3 5.3 11.5 4.3 4.7 14.4 10.7 3.7 12.9 10.3 17.7 11.8 13.5 19.1 8.7 14.3 3.2 6.3 9.3 9.2 8.7 8.9 5.4 14.2 11.6 6.2 19.0 12.4 21.8 11.7 6.6 13.1 10.5 8.2 9.1 10.7 1.7 4.4 6.3 3.2 4.8 2.7 1.3 2.8 2.7 3.7 2.7 1.6 1.4 6.6 1.6 3.8 2.4 4.0 3.0 10.6 17.4 15.0 16.2 11.6 7.7 18.6 8.6 13.5 14.2 NEFL "CMT1F, CMT2E, NF68, NFL, PPP1R110" ENSG00000277586 "Neurofilament light" P07196 8 24950955-24957110 "Disease related genes, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 95.1" "Group enriched" "Detected in some" 5 "HEK 293: 112.2;PC-3: 30.1" "Cancer enhanced" "Detected in many" "renal cancer: 24.0" "Cell type enriched" "Detected in some" 5 "memory CD4 T-cell: 13.7" "Lineage enriched" "Detected in single" 138 "T-cells: 13.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014850, HPA015021" Enhanced Supported Approved "Nuclear speckles,Intermediate filaments" "Nuclear speckles" "Intermediate filaments" "HPA014850: AB_1854397, HPA015021: " "unprognostic (7.63e-2)" "unprognostic (1.36e-2)" "unprognostic (9.53e-2)" "unprognostic (6.81e-2)" "unprognostic (2.82e-2)" "unprognostic (6.69e-2)" "unprognostic (3.69e-2)" "unprognostic (3.78e-3)" "unprognostic (3.06e-1)" "unprognostic (1.60e-1)" "unprognostic (1.46e-2)" "unprognostic (1.94e-1)" "prognostic unfavourable (4.91e-4)" "unprognostic (5.76e-3)" "unprognostic (7.88e-2)" "unprognostic (3.97e-3)" "unprognostic (3.17e-3)" 0.7 12.0 10.3 1.4 20.1 0.6 0.6 2.3 92.1 1.8 1.8 3.0 0.0 1.0 0.7 0.8 3.8 0.7 0.6 0.6 14.1 3.5 0.6 0.6 0.7 0.0 23.8 0.7 0.7 0.6 0.0 0.6 95.1 1.6 1.5 5.0 0.6 9.5 0.6 0.7 1.7 1.2 18.0 0.7 1.1 1.6 2.1 0.0 1.0 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 13.7 2.1 0.0 0.1 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.1 0.0 0.0 112.2 0.0 0.0 0.0 4.9 0.0 0.1 1.8 0.4 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.8 30.1 0.0 0.0 0.0 6.9 1.0 6.2 6.4 2.6 0.0 0.4 0.0 0.0 0.0 0.6 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.7 1.5 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.2 2.1 NEFM "NEF3, NF-M, NFM" ENSG00000104722 "Neurofilament medium" P07197 8 24913012-24919098 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 144.7" "Cell line enriched" "Detected in some" 23 "HEK 293: 286.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "MAIT T-cell: 1.0;memory CD4 T-cell: 1.0;naive CD4 T-cell: 1.2" "Lineage enriched" "Detected in single" 12 "T-cells: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010900, CAB012976, HPA022845, HPA023138" Enhanced Enhanced "Intermediate filaments" "Intermediate filaments" "CAB010900: AB_477261, CAB012976: AB_2533154, HPA022845: AB_1854399, HPA023138: AB_1854398" "unprognostic (1.41e-2)" "unprognostic (1.83e-1)" "unprognostic (2.59e-2)" "unprognostic (9.38e-2)" "unprognostic (5.17e-2)" "unprognostic (6.32e-3)" "unprognostic (6.10e-3)" "unprognostic (2.57e-1)" "unprognostic (8.55e-3)" "unprognostic (2.95e-2)" "unprognostic (1.84e-1)" "unprognostic (1.69e-2)" "unprognostic (1.38e-2)" "unprognostic (1.92e-1)" "unprognostic (4.76e-2)" "unprognostic (2.61e-2)" 1.5 18.9 20.3 2.0 24.2 1.3 1.3 10.9 87.6 9.7 2.0 5.6 0.0 1.3 3.8 1.3 4.7 1.3 1.4 1.3 36.1 25.0 2.2 1.2 1.3 1.3 52.2 22.4 2.0 2.5 1.2 3.3 1.4 144.7 2.5 1.9 3.4 1.3 26.9 1.9 1.3 1.5 3.3 26.7 1.3 1.5 12.4 4.9 0.0 1.3 0.0 1.6 1.3 1.2 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 286.0 0.0 0.0 0.0 6.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 1.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 20.3 24.2 10.9 71.9 36.1 25.0 52.2 22.4 144.7 4.9 NES FLJ21841 ENSG00000132688 Nestin P48681 1 156668763-156677397 "Plasma proteins, Predicted intracellular proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 77.9" "Cell line enhanced" "Detected in many" "AF22: 92.4;HUVEC TERT2: 46.7;LHCN-M2: 74.6;RH-30: 76.4;WM-115: 36.0" "Group enriched" "Detected in all" 6 "glioma: 147.0;melanoma: 101.4;testis cancer: 34.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB005889, HPA006286, HPA007007, HPA026111, CAB058692" Enhanced Enhanced "Intermediate filaments" "Intermediate filaments" "CAB005889: AB_2251301, CAB058692: , HPA006286: , HPA007007: AB_1854381, HPA026111: AB_1854382" "unprognostic (7.73e-2)" "unprognostic (2.05e-1)" "unprognostic (2.80e-2)" "unprognostic (1.36e-1)" "unprognostic (6.37e-2)" "unprognostic (1.54e-1)" "unprognostic (1.08e-1)" "unprognostic (4.40e-2)" "unprognostic (7.56e-2)" "unprognostic (9.84e-2)" "unprognostic (4.49e-2)" "unprognostic (1.24e-1)" "prognostic unfavourable (8.02e-7)" "unprognostic (2.87e-1)" "unprognostic (2.48e-1)" "unprognostic (6.67e-2)" "unprognostic (8.11e-3)" 22.1 4.2 6.2 7.1 7.6 0.4 13.8 6.0 13.3 16.9 5.9 13.0 7.5 3.1 23.4 12.3 10.0 12.5 8.9 77.9 6.5 5.1 15.7 4.5 16.0 4.2 8.2 5.1 13.2 2.2 7.5 5.6 8.9 12.8 14.6 4.0 12.2 3.8 20.0 25.3 3.2 4.9 16.1 12.0 26.8 4.2 5.3 6.2 0.4 8.0 16.8 3.5 12.7 17.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 92.4 19.7 0.2 5.0 0.0 22.3 17.6 0.3 0.5 14.6 0.2 0.0 5.3 2.1 0.4 9.3 0.0 0.2 0.0 0.1 0.1 1.3 6.6 0.8 0.0 5.4 4.3 0.0 0.8 0.0 46.7 0.6 0.0 74.6 0.6 0.0 0.0 15.0 12.8 0.1 76.4 0.0 0.0 0.0 0.2 14.9 0.5 0.6 17.1 0.2 0.1 33.8 0.1 5.2 0.6 1.2 0.0 3.3 0.0 2.0 0.0 36.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 7.6 6.0 6.3 6.5 5.1 8.2 5.1 12.8 6.2 NOL9 "FLJ23323, Grc3, NET6" ENSG00000162408 "Nucleolar protein 9" Q5SY16 1 6521347-6554535 "Predicted intracellular proteins" "rRNA processing" "Kinase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036347 Supported "Nucleoli,Intermediate filaments" Nucleoli "Intermediate filaments" "HPA036347: " "unprognostic (3.03e-1)" "unprognostic (4.93e-2)" "unprognostic (4.99e-2)" "unprognostic (3.14e-3)" "unprognostic (2.12e-1)" "unprognostic (1.30e-1)" "prognostic unfavourable (3.69e-5)" "unprognostic (2.48e-1)" "unprognostic (1.31e-1)" "unprognostic (8.90e-2)" "unprognostic (1.44e-3)" "unprognostic (2.32e-1)" "unprognostic (3.80e-2)" "unprognostic (3.32e-2)" "unprognostic (3.40e-1)" "unprognostic (3.54e-2)" "unprognostic (4.65e-2)" 12.7 11.3 10.4 10.3 15.1 19.3 11.0 16.4 19.3 14.7 11.2 14.1 6.8 7.7 13.3 11.6 12.1 11.4 8.8 8.3 10.8 9.7 9.6 15.2 9.4 14.4 8.6 9.6 16.8 14.7 15.5 10.5 9.8 12.0 13.0 10.0 9.4 9.1 10.3 17.9 18.0 11.4 12.4 7.2 22.0 11.0 9.4 9.2 20.9 9.4 8.9 14.9 11.0 9.3 6.9 5.8 5.0 4.8 2.8 8.4 1.9 5.1 7.3 4.1 12.4 5.5 3.3 4.5 5.0 3.3 5.3 5.6 10.0 7.0 14.2 6.1 5.6 6.8 8.3 6.9 9.1 5.7 4.5 9.6 11.3 7.8 5.6 8.1 5.3 4.9 2.1 11.2 9.8 6.2 11.2 6.0 5.4 8.8 7.9 7.3 5.6 7.1 10.1 9.7 6.6 4.1 4.7 8.0 3.7 7.8 9.9 6.2 6.4 3.7 8.0 8.4 6.9 5.9 8.4 5.0 4.7 25.9 7.8 9.1 3.9 5.0 3.5 2.6 5.7 3.2 5.7 5.1 8.1 5.2 2.3 6.9 8.4 7.0 2.2 2.8 4.8 5.8 5.1 1.9 10.4 15.1 16.4 19.3 10.8 9.7 8.6 9.6 12.0 9.2 NYAP2 KIAA1486 ENSG00000144460 "Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2" Q9P242 2 225399710-225654018 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 17.9;pituitary gland: 13.5" "Cell line enhanced" "Detected in some" "HeLa: 1.9;SH-SY5Y: 2.0;SiHa: 6.1;U-2 OS: 2.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045531 Uncertain Approved "Nucleoplasm,Intermediate filaments" Nucleoplasm "Intermediate filaments" "HPA045531: AB_10960749" "unprognostic (2.49e-1)" "unprognostic (3.34e-1)" "unprognostic (1.24e-1)" "unprognostic (2.63e-1)" "unprognostic (2.35e-1)" "unprognostic (6.13e-3)" "unprognostic (3.33e-1)" "unprognostic (2.08e-1)" "unprognostic (1.32e-8)" "unprognostic (9.83e-2)" "unprognostic (2.92e-1)" "unprognostic (6.46e-2)" "unprognostic (1.27e-1)" 0.8 1.1 10.8 1.0 16.4 1.4 0.7 17.9 11.9 0.6 0.7 0.8 0.0 1.0 0.7 0.7 1.2 0.6 0.8 0.7 8.5 2.5 0.7 0.7 1.9 1.1 2.6 8.5 0.6 0.8 0.6 13.5 0.7 2.5 0.7 0.8 0.0 0.7 0.6 2.6 1.2 0.9 0.6 2.7 0.9 0.8 1.0 2.9 0.0 0.6 0.0 0.8 1.2 0.6 0.5 0.5 2.1 0.3 0.2 0.4 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.0 2.0 6.1 0.0 0.0 0.0 0.0 0.0 0.1 2.4 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 2.1 0.3 0.2 0.3 0.2 0.4 0.3 0.2 0.1 0.0 0.5 0.3 0.4 1.2 0.2 0.2 0.5 0.1 0.1 10.8 16.4 17.9 11.9 8.5 2.5 2.6 8.5 2.5 2.9 OTUD3 "DUBA4, KIAA0459" ENSG00000169914 "OTU deubiquitinase 3" Q5T2D3 1 19882513-19912945 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028543, HPA028544" Approved Approved "Nucleoplasm,Intermediate filaments,Cytosol" Cytosol "Nucleoplasm, Intermediate filaments" "HPA028543: AB_10599302, HPA028544: AB_10602277" "unprognostic (6.45e-3)" "unprognostic (9.26e-2)" "unprognostic (3.77e-1)" "unprognostic (1.95e-1)" "unprognostic (1.41e-1)" "unprognostic (3.16e-3)" "unprognostic (1.70e-3)" "unprognostic (3.15e-3)" "unprognostic (4.99e-2)" "unprognostic (1.09e-1)" "unprognostic (8.81e-2)" "unprognostic (4.68e-2)" "unprognostic (1.08e-1)" "unprognostic (9.83e-2)" "unprognostic (1.94e-1)" "unprognostic (7.28e-2)" "unprognostic (2.21e-2)" 6.5 11.0 15.0 6.9 19.2 11.4 10.0 19.3 23.2 10.6 8.9 6.6 6.4 10.2 14.2 13.0 6.1 8.2 7.2 5.2 12.6 7.3 7.1 4.8 8.5 7.0 9.9 12.5 11.2 7.2 9.3 20.2 5.4 9.0 9.8 8.3 6.9 6.2 9.2 9.2 13.0 9.6 11.9 8.1 7.7 7.3 28.4 9.7 6.0 6.9 2.9 6.3 7.0 7.6 1.7 0.6 0.8 0.4 0.6 2.2 0.3 5.0 1.9 8.6 10.3 3.7 3.3 8.5 5.4 3.1 2.8 2.7 9.0 4.8 8.0 4.4 11.9 5.0 8.0 3.1 5.5 5.2 10.7 7.7 10.2 6.2 2.0 5.6 7.1 2.7 3.1 4.4 5.7 3.7 5.4 3.4 4.8 2.7 4.3 5.6 4.1 5.1 10.0 22.0 3.0 4.7 5.5 7.6 5.4 3.9 3.1 4.2 4.7 4.2 4.4 6.7 8.6 7.4 4.6 4.0 3.4 5.0 4.7 7.6 3.1 0.8 0.4 0.1 1.5 0.3 1.4 1.7 1.7 1.4 0.3 1.3 2.2 1.8 0.7 0.6 0.1 0.6 0.9 0.3 15.0 19.2 19.3 23.2 12.6 7.3 9.9 12.5 9.0 9.7 PAFAH1B3 ENSG00000079462 "Platelet activating factor acetylhydrolase 1b catalytic subunit 3" Q15102 19 42297033-42303546 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035639 Uncertain Approved "Intermediate filaments" 370000 "Intermediate filaments" "HPA035639: AB_10670163" "unprognostic (3.19e-1)" "unprognostic (5.38e-3)" "unprognostic (1.13e-1)" "unprognostic (5.99e-2)" "unprognostic (1.83e-1)" "unprognostic (2.09e-2)" "prognostic unfavourable (8.74e-4)" "unprognostic (1.73e-1)" "unprognostic (2.67e-1)" "unprognostic (6.36e-2)" "unprognostic (2.37e-1)" "unprognostic (7.67e-2)" "prognostic unfavourable (2.07e-4)" "unprognostic (2.68e-1)" "unprognostic (3.21e-2)" "unprognostic (4.56e-2)" "unprognostic (6.80e-3)" 4.5 12.8 23.8 10.4 23.2 20.7 12.2 36.4 24.9 17.2 14.6 7.8 8.0 10.9 10.1 11.9 15.5 13.5 9.6 4.6 15.4 25.7 11.7 5.6 5.8 13.6 13.9 13.1 15.4 11.9 8.3 11.8 5.8 12.4 10.3 10.7 11.2 9.8 6.1 10.8 10.6 11.2 6.6 11.7 9.5 11.3 16.3 11.3 37.4 7.8 13.8 15.4 14.6 10.9 19.6 24.6 8.7 13.6 7.8 27.4 10.5 29.4 54.0 33.7 36.0 0.7 1.8 10.4 7.4 10.3 24.4 25.3 17.9 24.8 18.2 9.7 9.0 10.0 15.3 19.5 10.2 27.5 20.9 22.0 14.5 24.0 5.2 13.9 24.5 5.3 9.0 14.9 7.0 10.8 15.5 21.7 17.7 43.0 31.1 10.9 18.7 0.0 23.1 12.9 16.2 19.8 31.1 38.8 30.4 11.8 23.5 12.4 29.3 16.0 5.8 20.3 27.4 1.8 20.0 10.4 21.4 15.5 11.3 22.6 17.8 8.7 13.6 7.2 12.1 10.7 16.1 19.6 17.3 13.9 24.6 18.4 23.0 16.0 1.8 7.8 5.4 13.6 27.4 10.5 23.8 23.2 36.4 24.9 15.4 25.7 13.9 13.1 12.4 11.3 PCDHB4 PCDH-BETA4 ENSG00000081818 "Protocadherin beta 4" Q9Y5E5 5 141121799-141125623 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 5 "SCLC-21H: 12.7;SH-SY5Y: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 17 "T-reg: 1.6" "Lineage enriched" "Detected in single" 17 "T-cells: 1.6" HPA014466 Approved Uncertain "Plasma membrane,Intermediate filaments,Cytosol" "Plasma membrane, Cytosol" "Intermediate filaments" "HPA014466: AB_1855058" "unprognostic (2.60e-1)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (2.22e-1)" "unprognostic (8.60e-3)" "unprognostic (4.03e-1)" "unprognostic (6.44e-2)" "unprognostic (2.44e-1)" "unprognostic (8.66e-2)" "unprognostic (1.52e-1)" "unprognostic (6.70e-3)" "unprognostic (1.44e-1)" "unprognostic (2.82e-3)" "unprognostic (1.11e-3)" "unprognostic (2.17e-1)" "unprognostic (3.32e-4)" "unprognostic (5.18e-3)" 7.1 5.3 13.0 2.0 12.0 0.6 5.9 11.3 11.4 8.0 3.4 12.9 0.1 1.9 12.3 9.1 4.0 5.8 5.7 4.3 10.9 6.3 4.1 1.3 5.1 1.4 13.1 11.3 9.9 18.2 7.3 5.1 0.9 11.0 6.1 2.7 3.7 5.0 5.1 3.8 3.1 2.6 7.9 21.1 2.0 2.6 1.6 12.3 0.0 2.8 1.5 1.1 5.6 5.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.5 2.1 0.4 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 12.7 8.5 0.0 0.0 0.0 0.4 0.1 0.0 0.6 0.2 0.3 0.0 0.0 0.0 0.0 0.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 13.0 12.0 11.3 11.4 10.9 6.3 13.1 11.3 11.0 12.3 PCYT2 ET ENSG00000185813 "Phosphate cytidylyltransferase 2, ethanolamine" Q99447 17 81900965-81911464 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 70.8" "Cell line enhanced" "Detected in all" "Hep G2: 62.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023033, HPA023034" Enhanced Supported "Intermediate filaments,Centrosome" 7000 Centrosome "Intermediate filaments" "HPA023033: AB_1855094, HPA023034: AB_1855095" "unprognostic (4.05e-3)" "unprognostic (4.39e-3)" "unprognostic (3.81e-1)" "unprognostic (9.72e-2)" "unprognostic (1.92e-1)" "unprognostic (9.86e-2)" "unprognostic (1.24e-2)" "unprognostic (1.06e-1)" "unprognostic (4.24e-1)" "unprognostic (8.97e-3)" "unprognostic (1.84e-1)" "unprognostic (2.34e-1)" "prognostic favourable (4.29e-6)" "unprognostic (1.19e-1)" "unprognostic (8.59e-2)" "unprognostic (1.63e-1)" "unprognostic (4.47e-2)" 13.6 5.5 13.3 5.7 12.7 5.3 10.4 12.2 17.0 6.5 16.2 13.4 6.4 30.7 5.8 8.6 7.6 12.2 8.0 17.7 14.0 11.8 21.7 46.5 7.2 6.3 13.4 16.0 7.8 11.5 8.2 4.6 6.0 15.9 10.1 8.5 5.8 10.8 6.6 13.5 4.5 26.5 5.0 14.3 4.1 11.5 70.8 11.0 5.6 6.7 6.8 5.8 7.5 4.4 7.3 6.6 2.1 3.5 4.7 8.4 4.0 12.1 7.0 5.6 15.8 28.2 14.9 8.3 8.7 18.8 12.3 14.6 27.4 12.7 4.2 4.8 9.1 10.0 8.5 16.2 7.1 1.2 6.9 9.2 9.6 62.6 30.2 9.2 7.7 12.2 9.4 11.1 8.6 11.3 17.0 8.8 9.1 10.3 10.9 11.4 4.5 7.5 7.2 6.0 15.0 14.7 23.0 7.2 6.6 6.6 36.4 8.5 10.1 21.9 7.6 9.1 6.0 6.8 7.2 5.7 2.4 4.1 9.4 12.4 8.9 2.1 3.5 1.2 7.1 3.4 4.6 6.0 8.4 7.2 6.6 7.3 7.0 7.2 1.0 4.7 3.0 6.5 5.0 4.0 13.3 12.7 12.2 17.0 14.0 11.8 13.4 16.0 15.9 11.0 PELI1 ENSG00000197329 "Pellino E3 ubiquitin protein ligase 1" Q96FA3 2 64092652-64144454 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 105.7" "Cell line enhanced" "Detected in many" "CACO-2: 21.3;U-698: 53.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 33.9" "Group enriched" "Detected in all" 4 "granulocytes: 33.9;monocytes: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053182 Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments" "Nucleoplasm, Nucleoli, Intermediate filaments" "HPA053182: " "unprognostic (3.33e-2)" "unprognostic (3.43e-2)" "unprognostic (1.79e-2)" "prognostic unfavourable (5.33e-4)" "unprognostic (1.91e-2)" "unprognostic (3.12e-3)" "unprognostic (6.73e-3)" "unprognostic (8.01e-3)" "unprognostic (4.16e-2)" "unprognostic (3.52e-3)" "unprognostic (5.99e-3)" "unprognostic (3.33e-1)" "prognostic unfavourable (5.67e-6)" "unprognostic (6.72e-2)" "unprognostic (6.22e-2)" "unprognostic (8.88e-2)" "unprognostic (1.03e-1)" 15.7 5.1 10.0 15.1 20.5 105.7 22.3 15.1 8.9 9.9 14.5 11.0 3.3 9.9 14.5 7.1 26.4 8.0 14.9 11.6 11.3 6.8 6.7 8.6 20.1 16.8 15.6 5.2 4.8 6.2 11.0 14.8 13.7 10.8 7.6 11.8 6.0 12.3 8.5 4.5 17.5 17.3 8.4 15.0 17.8 10.2 7.8 12.8 19.9 6.3 10.2 19.3 14.1 14.8 3.9 2.3 33.9 9.2 1.3 5.0 2.5 1.2 1.0 13.7 9.1 1.6 1.2 3.1 1.7 2.0 1.6 2.6 21.3 1.5 17.5 4.3 0.6 2.1 4.1 3.8 3.2 4.3 3.3 1.6 0.6 3.4 4.8 1.7 3.1 1.6 3.0 2.4 8.2 9.0 0.9 4.4 1.3 0.1 3.7 2.5 8.9 0.6 4.7 4.7 9.9 6.6 3.9 6.3 8.8 1.3 2.0 4.7 1.1 1.2 6.4 1.5 2.2 1.5 2.5 10.1 0.9 53.0 0.8 1.5 4.0 5.1 6.5 6.3 0.4 6.1 0.7 3.9 2.2 0.9 2.3 2.4 2.7 1.1 33.9 1.3 9.2 0.2 5.0 2.5 10.0 20.5 15.1 8.8 11.3 6.8 15.6 5.2 10.8 12.8 PELI2 ENSG00000139946 "Pellino E3 ubiquitin protein ligase family member 2" Q9HAT8 14 56117814-56301526 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 20.7;MOLT-4: 23.2;REH: 11.4;SCLC-21H: 10.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 21.4" "Cell type enhanced" "Detected in many" "neutrophil: 9.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053182 Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments" "Nucleoplasm, Nucleoli, Intermediate filaments" "HPA053182: " "unprognostic (3.26e-1)" "unprognostic (2.25e-1)" "unprognostic (9.21e-2)" "unprognostic (8.94e-3)" "unprognostic (1.57e-1)" "unprognostic (1.68e-1)" "unprognostic (2.53e-2)" "unprognostic (3.36e-3)" "unprognostic (1.81e-1)" "unprognostic (2.68e-2)" "unprognostic (1.18e-1)" "unprognostic (2.14e-1)" "prognostic favourable (1.53e-6)" "unprognostic (3.64e-1)" "unprognostic (2.15e-1)" "unprognostic (5.43e-2)" "unprognostic (2.22e-1)" 12.3 3.3 5.2 5.6 4.6 16.5 8.7 21.4 6.5 7.5 9.4 5.4 9.7 11.1 9.3 7.1 4.7 5.9 11.5 3.4 4.6 4.5 9.7 3.1 7.3 4.8 5.2 3.9 16.0 38.9 1.7 5.5 3.3 4.4 8.2 4.2 9.2 7.6 12.4 3.8 6.5 12.6 17.7 5.8 6.6 14.1 10.0 4.2 38.2 4.9 3.4 2.6 13.3 14.9 0.9 2.0 9.0 3.0 0.5 0.8 1.1 0.0 1.9 5.5 0.0 3.1 4.6 0.1 0.7 2.5 0.5 0.0 0.1 0.4 0.1 2.6 1.5 0.5 4.2 0.0 0.2 1.3 1.5 4.7 8.5 0.0 2.6 0.7 20.7 2.9 0.2 0.0 0.0 1.0 3.5 0.1 0.6 0.0 23.2 0.2 9.0 0.7 11.4 0.3 1.0 2.2 9.3 10.9 0.0 0.5 0.0 6.1 0.0 3.8 0.3 1.6 2.8 0.5 2.6 0.4 0.0 0.6 2.9 3.2 1.6 1.4 3.0 3.5 0.5 1.6 0.8 0.2 0.6 0.3 2.0 0.9 0.4 0.3 9.0 0.5 1.2 0.5 0.0 1.1 5.2 4.6 21.4 4.4 4.6 4.5 5.2 3.9 4.4 4.2 PFDN5 "MM-1, PFD5" ENSG00000123349 "Prefoldin subunit 5" Q99471 12 53295291-53299450 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008587 Approved Supported "Intermediate filaments,Cytosol" 110000 "Intermediate filaments, Cytosol" "HPA008587: AB_1079597" "unprognostic (3.56e-3)" "unprognostic (2.31e-2)" "unprognostic (2.87e-2)" "unprognostic (4.02e-3)" "unprognostic (1.59e-1)" "unprognostic (3.44e-1)" "unprognostic (3.44e-2)" "unprognostic (1.99e-2)" "unprognostic (2.65e-2)" "unprognostic (2.12e-1)" "prognostic favourable (5.45e-4)" "unprognostic (1.27e-1)" "prognostic unfavourable (1.54e-6)" "unprognostic (5.34e-2)" "unprognostic (9.48e-2)" "unprognostic (2.30e-2)" "unprognostic (2.01e-3)" 75.9 73.7 105.0 82.3 85.4 119.3 142.4 53.8 66.7 97.0 77.1 56.3 102.5 39.7 94.3 156.8 80.3 94.6 91.0 77.0 82.7 76.7 81.8 83.5 64.9 117.2 94.3 69.2 134.5 155.8 49.6 81.2 67.3 63.3 96.1 65.4 60.1 116.4 99.9 87.0 71.6 54.1 108.1 91.0 83.8 64.7 60.5 64.9 60.5 128.1 108.9 101.1 91.8 144.9 163.9 98.0 63.7 127.8 69.4 158.4 329.0 35.4 54.7 53.0 47.7 102.9 143.2 38.7 88.9 121.1 82.9 56.1 50.0 54.7 48.0 53.7 95.5 32.6 46.1 63.7 80.3 45.4 64.5 43.7 67.7 68.6 66.2 71.0 47.8 136.5 93.6 58.5 45.8 73.6 51.0 64.8 82.2 125.4 49.7 106.0 50.0 84.6 40.6 57.5 56.8 94.5 52.5 44.9 51.2 57.1 50.5 64.5 65.6 90.8 64.4 46.9 35.8 22.1 39.7 48.6 51.8 70.6 51.4 56.9 42.8 63.7 127.8 46.5 80.9 97.0 110.9 163.9 123.2 97.6 98.0 156.8 158.4 125.9 38.3 69.4 100.2 91.0 95.8 329.0 105.0 85.4 53.8 66.7 82.7 76.7 94.3 69.2 63.3 64.9 PGD ENSG00000142657 "Phosphogluconate dehydrogenase" P52209 1 10398592-10420144 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Gluconate utilization, Pentose shunt" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 115.1;esophagus: 123.8" "Cell line enhanced" "Detected in all" "A549: 177.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 98.6;classical monocyte: 32.0;eosinophil: 115.1;neutrophil: 38.4" "Group enriched" "Detected in all" 5 "granulocytes: 115.1;monocytes: 32.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031314, HPA031315" Enhanced Supported Approved "Intermediate filaments,Cytosol" 59000000 "Intermediate filaments, Cytosol" "HPA031314: AB_10610278, HPA031315: AB_2673825" "unprognostic (4.65e-2)" "unprognostic (2.58e-1)" "unprognostic (8.65e-2)" "unprognostic (9.80e-2)" "unprognostic (1.31e-2)" "unprognostic (2.28e-1)" "prognostic unfavourable (3.98e-4)" "unprognostic (1.90e-2)" "unprognostic (2.83e-1)" "unprognostic (1.40e-2)" "unprognostic (4.92e-1)" "unprognostic (1.36e-1)" "unprognostic (1.37e-3)" "unprognostic (1.43e-1)" "unprognostic (1.49e-1)" "unprognostic (2.43e-3)" "unprognostic (1.14e-1)" 29.8 12.7 10.9 14.2 11.8 85.5 23.7 8.0 19.1 16.0 14.1 13.8 8.1 22.9 6.3 12.5 123.8 8.4 24.9 14.3 10.3 12.1 15.4 23.2 25.6 34.9 12.4 11.4 14.3 8.3 16.2 10.8 17.0 19.3 7.9 12.9 19.7 31.8 6.8 8.5 10.6 25.3 9.5 12.6 27.6 13.4 27.0 7.4 16.8 21.2 68.8 49.9 14.8 26.1 3.9 15.9 115.1 32.0 2.0 3.0 19.0 22.6 177.4 44.2 47.5 67.3 41.7 9.6 15.3 27.2 21.2 29.1 26.0 26.1 22.2 18.9 15.7 19.2 32.3 27.5 14.3 15.3 28.2 30.0 31.9 54.6 20.5 49.6 33.4 29.7 13.8 33.5 8.3 50.1 40.1 19.7 27.2 25.7 40.9 24.8 26.6 15.6 31.8 40.6 40.9 29.7 12.2 23.8 20.8 13.1 20.8 18.1 22.9 42.6 46.9 11.2 20.0 13.3 16.9 14.9 27.3 39.9 24.5 53.9 10.1 98.6 32.0 115.1 2.6 15.3 3.0 3.9 2.5 2.4 15.9 2.3 2.4 2.6 38.4 2.0 10.9 11.4 2.4 19.0 10.9 11.8 8.0 19.1 10.3 12.1 12.4 11.4 19.3 7.4 PGM2 FLJ10983 ENSG00000169299 "Phosphoglucomutase 2" Q96G03 4 37826633-37862937 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040676 Uncertain Approved "Intermediate filaments" 1900000 "Intermediate filaments" "HPA040676: AB_2677076" "unprognostic (3.11e-2)" "unprognostic (1.01e-2)" "prognostic favourable (2.14e-5)" "unprognostic (2.29e-1)" "unprognostic (3.94e-1)" "unprognostic (5.44e-2)" "unprognostic (1.70e-2)" "unprognostic (2.09e-3)" "unprognostic (5.32e-2)" "unprognostic (7.02e-2)" "unprognostic (5.37e-2)" "unprognostic (2.22e-2)" "unprognostic (6.72e-3)" "unprognostic (3.21e-2)" "unprognostic (1.88e-1)" "unprognostic (9.97e-2)" "unprognostic (1.02e-1)" 11.2 10.8 7.7 11.6 5.9 7.5 13.5 9.8 5.7 14.7 10.3 4.2 6.5 6.1 15.0 7.6 41.3 7.0 11.0 8.3 7.1 4.0 11.1 13.3 7.5 13.2 4.4 5.7 10.0 9.0 9.5 6.4 27.9 10.4 11.1 8.4 6.8 11.0 5.0 2.4 17.7 8.6 12.2 6.9 13.4 9.0 9.0 3.9 17.3 8.8 31.7 22.9 13.6 18.9 4.5 15.3 30.8 13.1 13.2 7.0 7.2 11.5 4.0 6.2 6.6 4.7 5.2 8.1 13.9 8.2 11.4 11.8 7.1 8.4 15.2 6.9 7.6 6.0 15.0 13.0 29.2 9.7 8.7 16.7 6.7 5.0 10.1 17.5 11.7 7.5 15.8 9.4 8.4 18.3 21.7 2.7 10.0 6.1 19.9 20.7 7.1 6.3 15.2 9.8 6.3 7.1 22.3 13.0 4.4 7.0 10.3 4.9 8.9 18.8 15.9 8.6 10.6 11.6 28.2 6.2 16.1 17.3 4.5 23.0 14.4 8.0 13.1 30.8 4.9 10.5 5.8 4.5 4.1 5.6 15.3 2.8 4.0 5.0 16.3 13.2 8.0 3.4 7.0 7.2 7.7 5.9 9.8 5.7 7.1 4.0 4.4 5.7 10.4 3.9 PGS1 DKFZP762M186 ENSG00000087157 "Phosphatidylglycerophosphate synthase 1" Q32NB8 17 78378640-78425114 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022526 Approved Approved "Vesicles,Cell Junctions,Intermediate filaments" "Vesicles, Cell Junctions, Intermediate filaments" "HPA022526: AB_1855271" "unprognostic (1.19e-2)" "unprognostic (1.12e-1)" "unprognostic (3.48e-1)" "unprognostic (1.86e-3)" "unprognostic (1.35e-2)" "unprognostic (1.71e-2)" "prognostic unfavourable (1.37e-4)" "unprognostic (5.76e-3)" "unprognostic (3.17e-2)" "unprognostic (8.46e-3)" "prognostic favourable (7.33e-5)" "prognostic unfavourable (9.94e-4)" "prognostic unfavourable (1.16e-5)" "unprognostic (9.94e-2)" "unprognostic (5.60e-2)" "unprognostic (1.33e-1)" "unprognostic (2.72e-2)" 16.4 11.6 14.5 20.8 20.3 41.4 28.2 17.6 17.4 14.4 13.1 18.4 13.2 13.7 17.3 13.2 14.5 16.9 17.2 14.0 15.7 16.1 14.3 8.0 25.5 19.1 21.6 17.0 18.3 14.0 16.0 13.3 24.0 15.3 13.9 10.2 12.9 13.1 16.8 13.8 11.9 15.1 13.4 18.0 22.6 12.6 13.9 18.8 17.7 18.6 7.8 14.3 16.9 32.3 8.0 14.0 26.0 12.6 6.7 11.3 8.4 13.1 11.6 11.3 8.5 10.0 16.0 13.4 12.4 11.9 13.3 14.7 10.8 10.4 13.6 7.5 7.0 10.2 13.4 8.4 10.5 20.4 15.2 14.9 13.8 10.8 9.8 11.2 12.1 16.3 11.1 9.6 8.7 25.4 17.3 9.5 9.0 7.2 25.3 10.1 11.8 11.2 13.3 20.3 11.6 13.0 12.1 15.0 22.8 10.6 11.7 11.3 12.3 13.6 15.9 17.3 12.0 9.2 10.4 10.5 6.2 10.3 13.1 12.6 12.8 1.5 12.6 13.2 8.4 10.4 9.8 7.8 8.8 8.8 14.0 8.0 11.3 8.1 26.0 6.7 4.6 6.6 10.4 8.4 14.5 20.3 17.6 17.4 15.7 16.1 21.6 17.0 15.3 18.8 PHACTR4 "FLJ13171, PPP1R124" ENSG00000204138 "Phosphatase and actin regulator 4" Q8IZ21 1 28369582-28500369 "Predicted intracellular proteins" Neurogenesis "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028985 Approved Approved "Plasma membrane,Intermediate filaments,Cytosol" "Plasma membrane, Cytosol" "Intermediate filaments" "HPA028985: AB_10602142" "unprognostic (1.55e-1)" "unprognostic (2.61e-2)" "unprognostic (4.50e-3)" "unprognostic (1.73e-1)" "unprognostic (5.27e-1)" "prognostic favourable (1.05e-4)" "unprognostic (9.65e-3)" "unprognostic (8.77e-2)" "unprognostic (2.03e-2)" "unprognostic (1.61e-1)" "unprognostic (1.05e-1)" "unprognostic (1.04e-1)" "unprognostic (2.94e-2)" "unprognostic (3.08e-1)" "unprognostic (4.81e-2)" "unprognostic (3.03e-2)" "unprognostic (2.26e-2)" 11.0 12.3 10.0 17.2 17.4 11.5 11.6 18.7 15.2 17.2 14.2 16.5 11.7 9.9 22.7 12.1 37.0 15.1 12.6 10.7 11.4 7.9 16.4 18.7 13.8 10.4 15.3 8.9 15.3 15.4 22.3 18.1 11.6 12.1 13.7 15.8 15.4 18.1 10.3 14.9 19.1 15.4 15.7 13.6 14.4 12.1 15.7 18.5 17.8 15.2 18.1 30.0 12.1 20.6 5.3 5.6 4.0 6.3 4.8 7.7 3.4 12.2 8.4 19.0 13.6 4.8 5.4 2.8 8.8 9.0 19.4 20.2 8.1 13.9 11.8 8.1 10.5 8.7 13.1 8.8 17.4 8.8 7.3 24.6 14.5 12.5 7.3 14.6 28.4 4.8 8.2 12.4 21.9 25.5 12.4 8.2 12.3 3.8 10.3 3.7 14.4 5.8 10.9 18.1 8.8 10.0 11.1 10.1 12.6 19.8 8.2 10.3 11.1 5.4 16.5 9.5 17.7 6.6 17.0 6.3 9.0 10.0 9.1 12.4 9.9 3.4 4.6 4.0 7.7 4.1 6.8 3.3 5.9 7.2 4.5 5.3 4.0 5.4 3.5 4.8 6.3 5.6 2.7 3.4 10.0 17.4 18.7 15.2 11.4 7.9 15.3 8.9 12.1 18.5 PJA2 "KIAA0438, Neurodap1, RNF131" ENSG00000198961 "Praja ring finger ubiquitin ligase 2" O43164 5 109334709-109409994 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040347, HPA057636" Supported Enhanced "Intermediate filaments" "Intermediate filaments" "HPA040347: AB_10795631, HPA057636: " "unprognostic (5.78e-2)" "unprognostic (1.25e-1)" "unprognostic (5.48e-3)" "unprognostic (1.17e-1)" "unprognostic (2.99e-1)" "unprognostic (7.83e-2)" "unprognostic (2.83e-1)" "unprognostic (4.33e-2)" "unprognostic (4.84e-2)" "prognostic unfavourable (8.02e-4)" "unprognostic (4.46e-2)" "unprognostic (6.03e-2)" "unprognostic (5.64e-3)" "unprognostic (1.47e-3)" "unprognostic (5.94e-2)" "unprognostic (7.59e-2)" "unprognostic (1.00e-2)" 21.6 27.0 40.1 15.9 49.9 29.0 22.1 41.6 63.0 29.0 23.8 19.7 16.8 12.5 29.2 25.0 20.7 20.3 18.6 24.4 44.3 46.2 24.1 29.2 19.4 14.3 36.8 44.0 35.4 14.8 42.8 30.3 21.8 53.2 31.7 20.6 12.5 17.3 37.7 17.1 13.6 15.9 39.2 37.6 19.5 15.8 17.0 27.4 16.7 35.9 9.7 16.3 35.5 21.4 10.3 11.7 29.9 15.5 10.7 12.2 10.6 11.8 8.2 33.1 25.4 32.9 36.1 18.0 19.4 29.4 15.4 25.3 7.6 16.1 15.2 27.0 37.3 6.9 19.3 24.0 28.3 12.9 7.3 17.5 16.8 10.2 23.3 13.1 26.2 24.8 20.1 20.6 29.6 24.5 12.0 28.7 24.8 7.2 15.7 12.1 6.6 5.5 10.2 29.1 25.3 24.0 10.6 6.3 16.3 20.0 7.3 23.4 16.5 19.4 28.2 21.9 10.7 20.2 9.1 19.4 16.5 18.0 23.2 18.3 14.4 17.3 11.6 17.3 9.5 12.2 9.4 10.3 9.4 8.7 11.7 7.4 12.1 8.9 29.9 10.7 15.5 4.9 12.2 10.6 40.1 49.9 41.6 63.0 44.3 46.2 36.8 44.0 53.2 27.4 PKN2 "Pak-2, PRK2, PRKCL2, STK7" ENSG00000065243 "Protein kinase N2" Q16513 1 88684222-88836255 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 35.7" "Lineage enriched" "Detected in all" 8 "granulocytes: 35.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034861, HPA057913" Approved Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol" "Nucleoplasm, Intermediate filaments" "Nuclear bodies, Plasma membrane, Centrosome, Cytosol" "HPA034861: , HPA057913: " "unprognostic (7.52e-2)" "unprognostic (1.46e-1)" "prognostic favourable (5.67e-4)" "unprognostic (5.95e-2)" "unprognostic (3.39e-2)" "unprognostic (2.51e-2)" "unprognostic (4.64e-3)" "unprognostic (1.38e-1)" "unprognostic (4.43e-2)" "unprognostic (1.27e-2)" "unprognostic (2.90e-3)" "unprognostic (1.23e-1)" "unprognostic (1.51e-2)" "unprognostic (5.98e-2)" "unprognostic (2.38e-1)" "unprognostic (1.01e-2)" "unprognostic (1.99e-1)" 21.9 20.7 12.2 21.2 13.7 33.5 27.6 25.6 16.6 28.6 39.3 12.6 15.1 22.9 20.0 20.2 28.2 17.1 13.3 16.2 10.3 8.9 15.9 15.9 26.0 16.4 13.7 8.7 27.2 18.9 24.6 29.7 20.8 13.3 19.6 23.6 14.1 19.5 25.1 15.9 17.5 49.0 17.5 12.5 18.0 15.9 12.4 16.2 29.1 20.3 14.4 13.1 21.9 22.0 4.0 3.7 35.7 4.5 1.4 3.0 1.0 23.3 9.2 18.2 10.9 12.2 13.9 11.8 13.8 12.8 15.6 16.2 9.7 16.8 9.2 16.5 13.1 18.4 17.7 10.5 21.3 3.3 12.9 6.8 19.0 8.3 10.7 6.7 2.0 11.4 11.0 12.2 14.8 17.7 11.3 6.7 16.7 4.7 7.7 5.8 9.1 10.7 7.4 27.7 3.8 13.8 46.0 8.8 5.8 20.7 12.0 17.8 8.9 6.1 16.5 13.2 11.9 16.9 14.4 3.7 3.2 6.3 5.5 6.6 5.0 4.9 4.5 6.8 2.6 2.5 2.3 3.3 2.3 2.4 2.1 4.0 3.0 2.6 35.7 1.4 3.2 3.7 1.8 1.0 12.2 13.7 25.6 16.6 10.3 8.9 13.7 8.7 13.3 16.2 PLEC "EBS1, PCN, PLEC1, PLTN" ENSG00000178209 Plectin Q15149 8 143915147-143976734 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Cancer-related genes, Disease mutation, Epidermolysis bullosa, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 144.9" "Cell line enhanced" "Detected in many" "PC-3: 72.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003847, HPA025967, HPA029906" Enhanced Enhanced "Intermediate filaments,Focal adhesion sites,Cytosol" 7100000 "Intermediate filaments, Cytosol" "Focal adhesion sites" "CAB003847: AB_562198, HPA025967: AB_10601671, HPA029906: AB_10602279" "unprognostic (1.02e-1)" "unprognostic (1.37e-3)" "prognostic unfavourable (4.29e-4)" "unprognostic (2.09e-2)" "unprognostic (1.04e-1)" "unprognostic (1.05e-2)" "unprognostic (1.76e-3)" "prognostic unfavourable (5.33e-4)" "unprognostic (1.72e-3)" "unprognostic (1.13e-2)" "unprognostic (2.85e-3)" "unprognostic (5.48e-2)" "prognostic unfavourable (7.98e-6)" "unprognostic (2.30e-1)" "unprognostic (4.04e-2)" "unprognostic (6.58e-2)" "unprognostic (5.58e-3)" 20.9 11.0 15.9 16.5 13.3 27.9 13.1 15.0 20.7 20.7 17.7 14.6 16.7 13.1 20.2 16.8 25.1 18.2 29.0 23.4 18.9 10.7 11.2 10.9 16.6 15.0 9.9 13.0 18.0 14.0 8.8 12.0 24.2 13.2 17.5 9.8 13.0 17.8 14.8 144.9 36.4 24.1 24.7 11.0 16.9 21.4 6.7 12.7 16.3 9.2 44.2 24.5 20.2 19.2 1.5 3.4 0.8 4.1 0.7 2.9 3.2 16.3 51.2 3.3 4.1 6.0 13.4 11.7 24.0 10.7 6.4 3.6 7.1 17.1 1.6 18.7 35.1 19.4 2.2 33.6 2.5 12.2 1.8 6.2 52.0 5.8 9.5 2.0 5.2 15.4 6.6 17.2 33.6 7.4 3.0 5.3 7.4 28.7 1.2 3.4 2.2 72.1 0.3 9.4 4.4 10.7 30.3 3.4 3.4 40.9 8.7 3.9 10.7 2.4 23.8 24.8 44.9 21.8 28.4 0.8 0.6 1.2 23.6 2.6 35.2 0.0 4.1 0.2 1.4 3.8 2.8 1.4 2.7 2.0 3.4 1.5 2.0 1.1 0.8 0.7 2.7 2.8 2.9 3.2 15.9 13.3 15.0 17.3 18.9 10.7 9.9 13.0 13.2 12.7 PNPLA1 "dJ50J22.1, FLJ38755" ENSG00000180316 "Patatin like phospholipase domain containing 1" Q8N8W4 6 36243203-36312229 "Disease related genes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 28.5;skin 1: 25.1" "Cell line enriched" "Detected in some" 5 "U-937: 20.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "basophil: 28.5;eosinophil: 9.5" "Lineage enriched" "Detected in many" 14 "granulocytes: 28.5" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 10 "cerebellum: 0.4" HPA037853 Uncertain "Intermediate filaments" "Intermediate filaments" "HPA037853: AB_10671723" "unprognostic (3.57e-2)" "unprognostic (2.04e-2)" "unprognostic (1.06e-1)" "unprognostic (3.95e-4)" "unprognostic (1.69e-1)" "unprognostic (1.47e-1)" "unprognostic (7.37e-2)" "unprognostic (2.49e-1)" "unprognostic (8.89e-2)" "unprognostic (1.13e-2)" "unprognostic (2.95e-1)" "unprognostic (2.76e-2)" "unprognostic (2.70e-2)" "unprognostic (9.85e-2)" "unprognostic (2.06e-1)" "unprognostic (2.04e-2)" "unprognostic (1.65e-2)" 0.8 0.2 0.1 0.5 0.1 3.6 0.5 0.1 0.5 0.3 1.5 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 4.5 1.0 1.0 5.5 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.8 0.1 0.1 0.2 25.1 7.4 0.1 0.8 3.7 1.4 0.8 0.1 0.9 0.1 0.1 0.1 0.1 0.5 0.0 0.9 28.5 1.9 0.0 0.1 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.7 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 1.1 0.1 0.1 0.2 0.2 0.0 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.1 4.4 0.2 0.1 0.1 0.1 0.1 0.3 0.2 0.0 0.0 20.5 0.0 28.5 1.9 9.5 0.0 1.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 3.1 0.0 0.5 0.0 0.0 0.4 0.1 0.1 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 POLR1A "DKFZP586M0122, FLJ21915, RPA1, RPO1-4" ENSG00000068654 "RNA polymerase I subunit A" O95602 2 86020216-86106155 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Nucleotidyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010145, HPA031513, HPA049700" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments" "Nucleoli fibrillar center" "Nucleoplasm, Intermediate filaments" "CAB010145: AB_675814, HPA031513: , HPA049700: " "unprognostic (1.22e-1)" "unprognostic (1.82e-2)" "unprognostic (1.55e-1)" "unprognostic (2.46e-2)" "unprognostic (1.32e-1)" "unprognostic (1.93e-1)" "prognostic unfavourable (3.70e-9)" "unprognostic (1.06e-2)" "unprognostic (1.35e-1)" "prognostic unfavourable (3.37e-4)" "unprognostic (4.31e-2)" "unprognostic (4.56e-2)" "unprognostic (3.27e-1)" "unprognostic (2.20e-3)" "unprognostic (1.94e-1)" "prognostic unfavourable (8.41e-4)" "unprognostic (7.20e-2)" 14.3 12.9 10.1 12.4 16.5 9.7 10.3 12.2 20.3 11.1 11.0 17.4 8.3 9.4 19.5 7.4 13.5 12.3 11.7 12.7 9.0 9.2 11.5 15.1 9.4 9.6 9.0 9.4 12.6 14.3 18.2 15.9 11.4 13.8 10.7 11.8 13.9 11.2 12.5 22.5 12.3 8.6 16.0 8.0 11.2 10.4 14.9 10.9 14.0 10.3 11.4 14.2 10.9 9.6 2.6 2.6 1.8 2.5 2.0 3.8 1.2 9.3 21.3 9.5 18.3 9.3 7.5 13.8 8.6 5.7 12.4 7.7 26.7 7.4 21.5 9.2 8.8 10.9 24.5 12.7 11.1 8.9 12.6 18.5 9.1 17.9 6.6 17.5 10.0 5.7 8.0 18.4 14.4 9.6 24.5 5.4 8.5 8.3 12.9 7.5 17.3 14.1 15.6 20.9 10.0 5.5 15.4 14.8 7.7 9.5 12.6 6.8 7.4 6.1 15.2 15.1 11.9 12.8 17.3 7.7 7.4 18.8 7.8 15.1 13.3 1.8 1.5 0.2 3.0 2.5 3.8 2.0 1.5 2.5 1.8 2.6 1.4 1.8 0.7 2.0 1.9 2.6 0.7 1.2 10.1 16.5 12.2 20.3 9.0 9.2 9.0 9.4 13.8 10.9 POLR2K RPB10alpha ENSG00000147669 "RNA polymerase II subunit K" P53803 8 100150584-100154002 "Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047477 Approved "Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments" "Nucleoplasm, Nucleoli fibrillar center" "Intermediate filaments" "HPA047477: " "unprognostic (3.13e-2)" "unprognostic (1.52e-1)" "unprognostic (1.34e-1)" "unprognostic (1.15e-3)" "unprognostic (2.75e-2)" "unprognostic (4.68e-2)" "unprognostic (1.58e-2)" "unprognostic (1.62e-1)" "unprognostic (2.45e-1)" "unprognostic (1.57e-2)" "unprognostic (9.75e-3)" "unprognostic (5.73e-2)" "unprognostic (5.65e-2)" "unprognostic (3.46e-2)" "unprognostic (3.07e-2)" "unprognostic (9.16e-2)" "unprognostic (3.43e-2)" 31.4 43.7 51.1 22.0 38.7 32.9 41.5 34.7 53.0 33.8 28.5 24.7 20.8 21.2 29.3 42.7 33.1 23.8 23.9 35.3 46.2 51.0 47.5 46.6 27.3 29.7 49.0 35.0 26.2 20.2 28.2 36.8 27.1 46.0 37.8 31.8 21.5 32.7 33.3 23.3 21.8 28.4 34.8 40.4 31.9 26.6 22.6 23.7 24.9 36.6 22.3 31.5 39.3 23.1 29.0 30.0 24.2 19.2 25.0 30.9 24.2 39.3 19.9 25.7 18.1 27.7 25.3 17.4 29.2 24.1 29.8 36.3 12.3 27.1 26.4 58.0 23.1 18.1 27.6 24.1 39.5 42.0 30.6 35.8 25.1 25.9 22.0 23.1 26.1 20.5 32.2 23.7 24.3 27.0 28.0 25.9 29.1 25.0 58.4 34.3 26.8 39.6 23.0 14.9 38.1 37.1 22.2 54.3 35.7 19.8 17.8 42.3 36.3 35.3 20.4 17.6 25.3 27.2 31.0 26.7 42.2 41.5 33.4 40.7 27.4 24.2 15.2 22.1 23.7 19.2 28.2 29.0 30.9 29.4 19.0 19.7 27.1 29.3 5.8 25.0 18.2 30.0 30.9 24.2 51.1 38.7 34.7 53.0 46.2 51.0 49.0 35.0 46.0 23.7 PP2D1 "C3orf48, FLJ25449" ENSG00000183977 "Protein phosphatase 2C like domain containing 1" A8MPX8 3 19979961-20012330 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "testis: 28.8" "Cell line enhanced" "Detected in some" "U-266/84: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036870, HPA066083" Enhanced Uncertain "Nucleoplasm,Intermediate filaments" Nucleoplasm "Intermediate filaments" "HPA036870: AB_10671246, HPA066083: " "unprognostic (1.14e-1)" "unprognostic (1.14e-1)" "unprognostic (1.29e-2)" "unprognostic (2.04e-1)" "unprognostic (3.76e-1)" "unprognostic (6.27e-4)" "unprognostic (3.29e-2)" "unprognostic (1.50e-1)" "unprognostic (2.49e-1)" "unprognostic (3.40e-1)" "unprognostic (4.35e-2)" "unprognostic (6.00e-2)" "unprognostic (3.50e-1)" "unprognostic (8.77e-2)" "unprognostic (1.87e-1)" "unprognostic (4.93e-3)" "unprognostic (1.04e-1)" 0.2 0.1 0.1 0.2 0.1 3.0 0.1 0.7 0.4 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.3 0.3 0.2 0.1 0.1 0.3 0.2 28.8 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.7 0.5 1.2 0.6 0.0 0.9 0.0 0.3 0.5 0.7 0.9 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.5 0.8 1.5 0.1 0.0 0.6 0.0 0.0 0.0 0.2 0.6 0.6 0.9 0.2 0.0 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.2 1.0 0.8 1.0 0.3 0.8 0.9 1.6 0.0 0.3 0.4 1.9 0.1 2.2 1.3 0.7 0.8 0.2 0.0 0.3 0.3 0.5 0.6 4.0 1.6 1.8 0.8 0.3 0.0 0.5 0.9 0.8 0.6 0.3 0.2 0.5 0.4 0.1 0.7 0.9 0.8 1.2 0.0 0.4 0.5 0.0 0.0 0.1 0.1 0.7 0.3 0.1 0.1 0.1 0.1 0.1 0.1 PSMD10 p28 ENSG00000101843 "Proteasome 26S subunit, non-ATPase 10" O75832 X 108084207-108091618 "Predicted intracellular proteins" Apoptosis Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002920, CAB010434" Approved Supported "Intermediate filaments,Cytosol" 82000 Cytosol "Intermediate filaments" "CAB010434: AB_640866, HPA002920: AB_1079708" "unprognostic (1.59e-3)" "unprognostic (4.12e-3)" "unprognostic (3.83e-1)" "unprognostic (3.00e-1)" "unprognostic (4.65e-2)" "unprognostic (1.50e-2)" "unprognostic (3.85e-3)" "unprognostic (2.35e-1)" "unprognostic (1.44e-1)" "unprognostic (2.06e-2)" "unprognostic (4.95e-2)" "unprognostic (7.37e-3)" "unprognostic (1.64e-2)" "unprognostic (1.42e-2)" "unprognostic (2.09e-1)" "unprognostic (5.07e-2)" "unprognostic (1.09e-1)" 15.8 23.6 35.5 14.3 32.1 14.2 20.9 27.4 31.1 21.7 19.0 30.3 13.4 14.8 22.4 29.8 21.6 27.1 15.1 14.7 32.0 50.2 20.5 19.0 16.5 18.0 38.9 29.6 19.9 11.1 20.3 20.9 26.1 39.0 19.4 19.8 17.1 14.6 19.0 13.3 15.3 17.4 21.6 38.9 14.8 15.7 15.6 23.8 21.2 24.3 12.2 21.8 22.0 16.1 28.1 30.7 40.2 38.8 32.2 32.4 35.1 31.0 31.6 21.7 19.5 33.0 24.9 19.7 25.6 21.3 23.2 20.3 18.8 20.0 26.5 39.3 24.4 16.9 34.1 24.7 35.8 28.7 29.4 15.5 30.7 23.6 16.8 24.0 17.4 18.9 27.0 21.5 26.1 57.2 29.9 36.0 28.9 40.7 22.6 21.0 39.4 43.1 22.9 31.1 28.0 24.9 20.2 14.0 13.4 39.2 16.3 25.7 17.6 20.8 41.0 18.5 10.7 31.1 18.9 28.8 39.5 28.1 25.6 33.5 21.7 38.3 26.9 40.2 28.2 33.0 30.2 28.1 28.6 30.1 30.4 27.2 28.8 32.2 13.2 32.2 38.8 30.7 32.4 35.1 35.5 32.1 27.4 31.1 32.0 50.2 38.9 29.6 39.0 23.8 PTPN18 BDP1 ENSG00000072135 "Protein tyrosine phosphatase, non-receptor type 18" Q99952 2 130356007-130375409 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB012174, HPA053367" Uncertain Approved "Intermediate filaments" 550000 "Intermediate filaments" "CAB012174: AB_2173224, HPA053367: " "unprognostic (3.11e-3)" "unprognostic (2.89e-3)" "unprognostic (1.67e-3)" "unprognostic (1.73e-3)" "unprognostic (5.81e-3)" "unprognostic (3.08e-3)" "unprognostic (2.49e-2)" "unprognostic (1.28e-2)" "unprognostic (4.65e-1)" "unprognostic (2.10e-2)" "unprognostic (7.33e-2)" "unprognostic (5.65e-2)" "unprognostic (4.52e-2)" "unprognostic (1.00e-2)" "unprognostic (3.60e-1)" "unprognostic (1.05e-1)" "unprognostic (5.85e-3)" 12.8 7.1 11.0 16.7 13.5 18.9 22.3 26.8 13.7 15.3 22.8 6.6 25.7 16.6 9.3 11.0 11.3 13.3 21.3 7.5 9.8 8.5 13.9 19.2 16.9 29.2 8.4 9.5 7.8 28.9 6.4 11.0 9.4 6.9 17.8 19.3 7.9 18.5 24.0 11.0 6.9 28.8 10.5 9.1 37.7 16.0 3.3 9.1 1.6 13.0 7.1 35.5 11.0 10.7 7.6 7.4 6.2 17.1 2.8 6.6 10.2 5.8 3.9 1.5 7.9 9.8 6.8 16.3 3.0 2.7 3.9 4.3 7.8 8.9 21.8 3.0 7.2 6.7 6.9 6.7 3.8 9.9 3.8 7.9 4.7 9.1 5.1 7.7 21.4 8.0 5.5 4.2 5.9 7.3 7.3 16.6 7.4 11.3 1.4 13.3 1.6 4.2 13.3 4.5 29.5 7.7 3.6 10.1 2.6 5.3 18.9 8.6 6.5 11.3 6.8 5.5 6.3 3.0 2.7 2.6 0.7 20.9 8.5 7.0 6.0 6.2 7.8 6.1 6.6 10.8 4.1 7.6 4.4 6.3 6.7 4.5 2.7 5.4 4.9 2.8 17.1 7.4 5.6 10.2 11.0 13.5 26.8 13.7 9.8 8.5 8.4 9.5 6.9 9.1 PTPRE PTPE ENSG00000132334 "Protein tyrosine phosphatase, receptor type E" P23469 10 127907061-128085855 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 91.0" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 19.9;NB-4: 15.0;TIME: 37.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 91.0;plasmacytoid DC: 65.7" "Group enriched" "Detected in all" 11 "dendritic cells: 65.7;granulocytes: 91.0;monocytes: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015870, HPA021872" Supported Approved "Intermediate filaments" "Intermediate filaments" "HPA015870: AB_1855759, HPA021872: AB_1855760" "unprognostic (5.23e-2)" "unprognostic (1.37e-1)" "unprognostic (1.99e-1)" "unprognostic (7.11e-2)" "unprognostic (3.19e-1)" "unprognostic (9.67e-2)" "unprognostic (6.50e-2)" "unprognostic (4.49e-2)" "unprognostic (2.11e-1)" "unprognostic (2.56e-2)" "unprognostic (8.71e-3)" "unprognostic (2.00e-1)" "prognostic unfavourable (4.08e-5)" "unprognostic (1.52e-1)" "unprognostic (6.71e-3)" "unprognostic (2.49e-2)" "unprognostic (5.59e-2)" 16.8 18.5 12.5 24.0 12.5 39.5 11.0 7.4 15.3 4.8 9.2 14.5 1.6 9.6 5.1 8.1 8.8 6.2 10.7 12.3 15.0 12.2 4.4 4.8 22.5 20.0 12.5 6.5 4.3 3.1 3.4 6.5 8.0 9.8 4.5 9.8 4.8 7.0 3.1 1.9 4.9 12.7 7.7 14.3 26.4 7.7 4.3 10.9 11.4 6.6 6.1 12.2 10.0 5.0 1.2 65.7 91.0 25.5 4.0 5.4 4.9 2.0 0.4 0.2 0.0 1.2 0.2 3.6 0.0 0.0 0.8 1.7 0.8 12.0 1.5 1.3 1.0 1.1 1.0 5.8 0.3 1.8 0.9 0.1 0.7 0.0 2.0 7.4 5.6 0.4 3.3 2.9 5.9 19.9 0.0 0.9 1.2 1.8 2.2 15.0 0.1 0.7 8.8 1.2 2.9 3.3 8.6 0.0 1.2 3.4 0.6 0.1 0.3 9.4 37.5 0.8 0.8 3.7 4.1 0.4 0.6 2.1 5.5 5.8 0.0 17.4 25.5 19.3 5.4 9.0 3.2 0.9 2.4 3.6 13.3 1.2 1.7 2.9 91.0 4.0 6.8 65.7 3.5 4.9 12.5 12.5 7.4 12.7 15.0 12.2 12.5 6.5 9.8 10.9 QTRT2 "FLJ12960, QTRTD1" ENSG00000151576 "Queuine tRNA-ribosyltransferase accessory subunit 2" Q9H974 3 114005833-114088422 "Predicted intracellular proteins" "tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036827, HPA036828" Uncertain Approved "Nucleoplasm,Intermediate filaments" Nucleoplasm "Intermediate filaments" "HPA036827: , HPA036828: AB_10696788" "unprognostic (2.22e-1)" "unprognostic (1.11e-1)" "unprognostic (6.71e-3)" "unprognostic (1.01e-3)" "unprognostic (8.57e-2)" "unprognostic (4.41e-1)" "unprognostic (5.82e-3)" "unprognostic (3.58e-1)" "unprognostic (1.35e-1)" "unprognostic (6.94e-2)" "unprognostic (6.48e-3)" "prognostic unfavourable (6.95e-4)" "unprognostic (1.44e-1)" "unprognostic (8.74e-2)" "unprognostic (2.65e-2)" "unprognostic (1.98e-1)" "unprognostic (1.18e-3)" 17.1 13.9 8.7 12.4 10.4 13.3 14.1 6.4 10.3 11.0 11.2 14.9 7.9 10.4 16.1 9.2 13.7 13.1 13.6 7.5 6.7 6.7 15.8 15.7 12.2 14.9 11.0 7.6 12.6 15.3 10.7 16.9 11.6 9.4 11.2 12.5 17.7 11.8 9.8 7.5 12.4 12.9 10.8 11.3 19.9 10.7 14.1 10.0 17.3 13.2 10.9 21.6 11.6 10.9 13.9 15.8 5.3 12.9 6.4 6.6 5.0 13.3 13.9 11.6 12.8 5.1 6.3 11.0 7.0 4.4 12.0 11.1 13.2 9.7 24.9 10.3 6.4 13.4 22.5 10.6 15.8 4.7 10.2 11.2 8.3 9.4 7.3 20.3 10.5 4.9 9.6 10.9 15.6 12.4 11.7 8.9 6.8 10.6 16.9 7.9 22.2 15.2 15.4 8.2 13.3 9.4 9.3 15.8 7.5 10.2 10.1 12.9 11.2 10.3 8.1 10.5 11.5 4.1 13.6 6.3 9.1 34.8 9.2 15.0 21.1 0.3 12.4 2.9 5.6 12.9 5.3 13.9 4.8 5.5 15.8 9.5 6.6 5.3 5.3 6.4 9.1 6.6 5.9 5.0 8.7 10.4 6.4 10.3 6.7 6.7 11.0 7.6 9.4 10.0 RAB3IP "FLJ22548, RABIN3, RABIN8" ENSG00000127328 "RAB3A interacting protein" Q96QF0 12 69738681-69823204 "Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 52.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039794 Uncertain Approved "Intermediate filaments" "Intermediate filaments" "HPA039794: AB_10960557" "unprognostic (4.38e-3)" "unprognostic (1.48e-1)" "unprognostic (6.66e-2)" "unprognostic (8.57e-2)" "unprognostic (3.30e-3)" "unprognostic (1.95e-1)" "unprognostic (1.75e-2)" "unprognostic (7.10e-2)" "unprognostic (2.12e-1)" "unprognostic (1.31e-1)" "unprognostic (1.16e-2)" "unprognostic (1.24e-1)" "prognostic favourable (5.68e-13)" "unprognostic (6.17e-2)" "unprognostic (1.20e-1)" "unprognostic (1.15e-1)" "unprognostic (3.37e-1)" 3.4 10.2 15.9 6.2 17.2 13.7 12.3 49.7 17.9 5.2 12.9 14.0 8.2 11.9 3.5 28.5 6.0 9.3 9.6 11.2 15.8 11.3 29.9 10.2 9.1 7.7 15.0 11.2 3.2 15.0 15.9 24.4 7.3 25.9 13.2 14.1 22.4 9.9 12.0 7.7 8.6 13.4 3.1 14.9 5.6 11.1 42.6 12.1 8.7 9.6 2.6 9.1 5.5 7.6 10.2 5.9 7.4 5.7 7.6 12.4 5.0 14.8 8.0 4.6 8.0 2.4 1.1 14.6 1.5 3.4 5.8 8.1 23.5 6.8 11.7 4.8 0.8 11.4 4.6 7.9 10.3 17.1 8.6 8.3 3.1 11.1 2.3 9.4 5.4 2.5 8.3 5.3 18.6 8.6 4.0 10.6 3.3 16.1 9.2 4.4 12.6 8.9 11.2 7.4 12.3 19.4 18.5 18.8 3.4 5.5 9.5 2.1 16.9 3.9 2.4 2.4 6.6 1.0 6.6 4.9 19.3 52.3 5.8 6.2 3.9 1.9 5.7 7.3 4.8 2.0 9.5 10.2 8.5 7.7 5.9 9.1 10.8 10.3 7.4 7.6 2.3 5.5 12.4 5.0 15.9 17.2 49.7 15.5 15.8 11.3 15.0 11.2 25.9 12.1 RBM23 "CAPERbeta, FLJ10482, RNPC4" ENSG00000100461 "RNA binding motif protein 23" Q86U06 14 22893206-22919184 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004144 Uncertain Approved "Nucleoplasm,Intermediate filaments" "Intermediate filaments" Nucleoplasm "HPA004144: AB_1079747" "unprognostic (5.93e-2)" "unprognostic (1.47e-1)" "unprognostic (1.48e-1)" "unprognostic (7.11e-2)" "unprognostic (1.11e-1)" "unprognostic (1.41e-2)" "unprognostic (2.14e-2)" "unprognostic (1.06e-1)" "unprognostic (4.27e-2)" "unprognostic (4.70e-2)" "unprognostic (3.73e-3)" "unprognostic (2.29e-1)" "prognostic favourable (8.06e-9)" "unprognostic (4.41e-2)" "unprognostic (3.06e-1)" "unprognostic (5.05e-2)" "unprognostic (1.81e-1)" 18.7 26.9 22.0 22.1 29.3 28.1 24.8 33.7 35.7 28.6 22.5 26.9 25.9 18.3 35.0 24.7 25.9 36.9 24.2 20.3 19.9 24.2 27.8 27.0 25.2 25.0 19.7 23.7 40.8 23.2 56.6 37.5 43.9 23.9 27.2 25.7 35.4 25.3 25.8 18.0 22.3 24.8 28.2 22.6 32.7 25.3 23.5 26.7 44.0 42.4 19.7 31.2 24.8 34.9 14.0 17.8 49.9 17.2 20.5 14.3 9.8 19.7 31.4 32.0 16.7 17.6 15.1 13.4 21.7 29.8 42.4 33.3 14.1 24.4 33.2 17.2 20.1 28.2 35.9 18.2 34.6 26.0 29.6 15.6 24.5 1.0 27.7 30.0 25.7 19.3 25.3 24.4 16.2 23.6 19.7 21.6 20.8 25.3 32.8 13.5 14.2 29.5 28.3 26.6 20.2 16.5 28.1 22.1 24.7 32.6 25.3 13.7 18.7 17.8 21.8 7.4 12.6 17.6 20.1 20.5 26.2 31.4 12.3 17.3 26.3 11.3 17.2 17.6 14.3 13.3 9.8 10.8 10.2 12.3 17.8 14.0 12.5 10.9 49.9 20.5 16.4 9.3 10.4 9.8 22.0 29.3 33.7 35.7 19.9 24.2 19.7 23.7 23.9 26.7 RGS14 ENSG00000169220 "Regulator of G protein signaling 14" O43566 5 177357837-177372601 "Predicted intracellular proteins" "Cell cycle, Cell division" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 43.9;brain: 76.1" "Cell line enhanced" "Detected in many" "HDLM-2: 39.8;HMC-1: 35.6;NB-4: 15.7;RPMI-8226: 20.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 4 "basal ganglia: 76.1" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 11 "amygdala: 68.3;basal ganglia: 58.1;cerebral cortex: 46.1;hippocampal formation: 102.5" "Group enriched" "Detected in all" 5 "amygdala: 38.0;basal ganglia: 118.5;cerebral cortex: 32.0;hippocampal formation: 90.8" "HPA046847, HPA061819" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Intermediate filaments" Nucleoplasm "Vesicles, Plasma membrane, Intermediate filaments" "HPA046847: , HPA061819: " "unprognostic (6.05e-3)" "unprognostic (1.65e-2)" "unprognostic (8.57e-2)" "unprognostic (2.61e-1)" "prognostic unfavourable (6.97e-4)" "unprognostic (7.27e-2)" "prognostic unfavourable (1.84e-6)" "unprognostic (1.95e-2)" "unprognostic (4.34e-2)" "unprognostic (2.04e-3)" "unprognostic (2.71e-1)" "unprognostic (1.28e-1)" "unprognostic (9.95e-2)" "unprognostic (3.17e-2)" "unprognostic (1.66e-1)" "unprognostic (1.17e-2)" "unprognostic (2.78e-2)" 1.9 1.5 7.7 12.5 76.1 17.5 1.3 0.4 8.8 1.7 2.6 1.9 0.6 5.1 1.3 1.4 3.2 6.6 3.4 0.7 17.1 1.9 2.1 6.9 4.3 15.5 2.5 3.6 0.8 1.5 0.1 0.9 1.0 0.8 1.2 0.5 0.7 5.2 1.8 1.6 3.5 5.7 1.2 0.7 12.8 3.7 0.7 4.4 24.2 4.3 1.7 12.9 4.9 1.6 9.2 12.2 43.9 12.3 6.5 20.7 12.4 1.8 0.4 0.7 0.4 0.0 0.0 1.2 0.0 0.0 0.1 0.2 1.1 3.7 4.7 2.6 0.0 3.8 0.0 1.2 0.0 39.8 0.1 7.4 0.1 1.5 0.2 5.7 35.6 0.6 0.3 0.2 0.2 0.2 1.2 9.6 0.0 0.1 7.6 15.7 0.6 1.0 3.5 0.0 20.5 0.4 0.1 0.1 0.7 0.0 0.1 3.0 1.3 9.0 0.3 0.0 0.7 0.0 3.4 5.1 2.4 2.0 0.6 10.8 0.8 18.6 12.3 43.9 20.5 11.4 20.7 9.2 19.1 18.7 12.2 8.0 16.0 14.3 43.0 6.5 11.6 5.4 18.2 12.4 7.7 76.1 0.4 8.8 17.1 1.9 2.5 3.6 0.8 4.4 RGS4 SCZD9 ENSG00000117152 "Regulator of G protein signaling 4" P49798 1 163068775-163076802 "Disease related genes, Predicted intracellular proteins" "Signal transduction inhibitor" Schizophrenia "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 88.0" "Cell line enhanced" "Detected in many" "LHCN-M2: 37.4;SH-SY5Y: 74.4;TIME: 151.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA030802 Approved "Intermediate filaments" "Intermediate filaments" "HPA030802: AB_10602295" "unprognostic (1.03e-1)" "unprognostic (1.84e-1)" "unprognostic (3.02e-2)" "unprognostic (6.84e-2)" "prognostic unfavourable (2.62e-4)" "unprognostic (8.26e-2)" "unprognostic (1.27e-1)" "unprognostic (5.34e-3)" "unprognostic (1.82e-1)" "unprognostic (6.45e-2)" "unprognostic (2.12e-2)" "unprognostic (8.47e-2)" "prognostic unfavourable (3.97e-4)" "prognostic unfavourable (1.92e-4)" "unprognostic (1.00e-1)" "unprognostic (8.33e-2)" "unprognostic (2.30e-2)" 2.9 20.9 9.1 2.1 45.3 0.5 1.4 1.1 88.0 4.0 1.7 1.0 0.0 2.9 4.8 1.4 6.3 4.9 11.2 4.7 13.9 10.1 1.5 2.6 2.1 2.3 12.1 36.2 1.1 2.7 1.2 6.2 1.3 16.0 3.3 1.8 1.0 0.9 3.9 0.7 0.6 1.6 3.0 1.9 1.5 3.7 2.1 2.1 0.0 1.5 0.2 0.7 2.8 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 3.7 19.2 0.0 12.9 14.1 1.9 5.0 0.0 0.0 0.0 5.7 8.3 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 3.1 0.0 20.4 2.5 19.7 0.0 0.0 37.4 0.0 0.0 0.0 1.0 1.4 0.0 0.0 0.0 0.0 0.0 0.4 74.4 0.0 0.0 0.0 0.0 0.0 151.8 15.4 0.7 3.0 21.5 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 9.1 45.3 1.1 78.8 13.9 10.1 12.1 36.2 16.0 2.1 RWDD4 "FAM28A, MGC10198, RWDD4A" ENSG00000182552 "RWD domain containing 4" Q6NW29 4 183639635-183659225 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036501, HPA036502" Approved Approved "Intermediate filaments" "Intermediate filaments" "HPA036501: , HPA036502: AB_10670800" "unprognostic (1.30e-1)" "unprognostic (4.15e-1)" "unprognostic (7.50e-2)" "unprognostic (2.30e-1)" "unprognostic (7.80e-2)" "unprognostic (1.72e-1)" "unprognostic (1.13e-1)" "unprognostic (1.97e-2)" "unprognostic (6.27e-2)" "unprognostic (2.21e-2)" "unprognostic (4.68e-2)" "unprognostic (2.98e-1)" "prognostic favourable (1.01e-6)" "unprognostic (6.77e-2)" "unprognostic (1.14e-1)" "unprognostic (3.51e-2)" "unprognostic (4.65e-2)" 11.0 37.4 8.3 9.3 8.2 8.5 14.8 10.0 7.5 10.0 11.6 8.1 10.6 7.6 9.7 12.1 16.0 9.7 11.6 15.7 7.8 9.1 17.6 13.3 10.3 9.9 8.4 6.1 28.6 17.9 7.1 28.4 10.3 8.1 12.2 8.5 8.9 25.6 13.6 30.7 8.2 11.2 10.4 8.4 11.4 9.5 12.3 7.7 10.6 17.1 17.7 10.5 13.2 13.7 7.4 8.5 11.8 9.7 11.4 9.9 6.4 13.2 7.7 11.9 14.6 19.2 20.3 9.0 16.8 13.4 21.2 13.4 5.0 17.5 20.0 3.9 13.7 6.2 16.5 15.7 22.5 13.3 7.3 14.5 9.1 12.7 13.6 22.2 11.0 13.2 16.3 11.6 13.0 15.9 13.8 26.2 22.2 5.5 22.7 18.7 7.9 10.1 15.8 9.2 12.6 20.7 6.4 11.4 16.1 15.8 18.6 14.5 9.3 13.5 11.5 8.9 4.3 9.5 12.9 8.8 6.6 6.8 16.8 16.5 12.6 6.0 6.1 11.8 8.6 8.2 8.4 7.4 7.8 8.1 8.0 5.2 7.4 7.7 5.3 11.4 9.7 8.5 9.9 6.4 8.3 8.2 10.0 7.5 7.8 9.1 8.4 6.1 8.1 7.7 S100A8 "60B8AG, CAGA, CFAG, CGLA, MRP8, P8" ENSG00000143546 "S100 calcium binding protein A8" P05109 1 153390032-153391188 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity" Antimicrobial "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 720.9;bone marrow: 718.8;esophagus: 532.3;tongue: 597.1" "Group enriched" "Detected in some" 28 "hTCEpi: 27.5;SK-BR-3: 100.9;THP-1: 53.6" "Cancer enhanced" "Detected in all" "cervical cancer: 2290.9;head and neck cancer: 2382.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "classical monocyte: 320.7;neutrophil: 720.9" "Group enriched" "Detected in many" 8 "granulocytes: 720.9;monocytes: 320.7" "Low region specificity" "Detected in some" "Not detected" "Not detected" "CAB002791, HPA024372" Enhanced Supported "Intermediate filaments,Cytosol" "Secreted to blood" 10876880 530000000 "Intermediate filaments" Cytosol "CAB002791: , HPA024372: AB_1856536" "unprognostic (1.98e-1)" "unprognostic (1.13e-1)" "unprognostic (3.79e-2)" "unprognostic (1.58e-2)" "unprognostic (8.60e-3)" "unprognostic (9.26e-3)" "unprognostic (4.92e-2)" "unprognostic (1.32e-1)" "unprognostic (1.83e-1)" "unprognostic (6.13e-2)" "unprognostic (3.77e-2)" "unprognostic (2.24e-2)" "prognostic unfavourable (8.94e-7)" "unprognostic (1.17e-1)" "unprognostic (8.90e-2)" "unprognostic (8.27e-2)" "unprognostic (8.94e-3)" 14.0 0.8 0.8 30.5 2.6 718.8 1.1 0.5 1.6 123.0 2.8 0.7 0.4 0.4 12.0 1.2 532.3 5.5 2.1 36.7 1.5 0.5 1.4 4.3 26.2 37.3 3.3 0.4 2.1 2.7 0.1 0.9 4.7 3.3 1.4 0.4 1.3 92.4 0.3 2.5 6.2 1.0 9.0 1.8 72.4 2.0 1.9 0.9 2.6 4.6 597.1 257.6 5.0 224.1 0.6 63.7 720.9 320.7 0.3 0.6 244.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 1.6 0.0 2.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 27.5 0.0 0.9 0.0 1.2 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.4 100.9 0.0 0.6 53.6 1.4 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 1.6 0.0 8.2 320.7 38.9 0.4 26.5 0.6 0.6 0.3 0.2 63.7 0.3 0.3 0.3 720.9 0.3 6.4 2.5 0.4 244.7 0.8 2.6 0.5 1.6 1.5 0.5 3.3 0.4 3.3 0.9 SBF2 "CMT4B2, DENND7B, KIAA1766, MTMR13" ENSG00000133812 "SET binding factor 2" Q86WG5 11 9778667-10294207 "Disease related genes, Predicted intracellular proteins" Autophagy "Guanine-nucleotide releasing factor" "Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 48.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050933 Uncertain Approved "Nucleoplasm,Intermediate filaments,Cytosol" Nucleoplasm "Intermediate filaments, Cytosol" "HPA050933: " "unprognostic (2.26e-1)" "unprognostic (1.45e-2)" "unprognostic (1.91e-2)" "unprognostic (1.00e-1)" "unprognostic (2.28e-1)" "unprognostic (5.36e-2)" "unprognostic (5.55e-2)" "unprognostic (6.44e-3)" "unprognostic (2.84e-2)" "unprognostic (1.87e-1)" "unprognostic (3.62e-3)" "unprognostic (2.43e-1)" "prognostic favourable (3.66e-5)" "unprognostic (3.72e-2)" "unprognostic (8.77e-2)" "unprognostic (3.43e-1)" "unprognostic (4.11e-2)" 26.2 12.7 19.8 8.9 22.5 6.1 17.9 26.7 17.4 23.6 15.6 18.4 13.2 9.8 19.1 14.2 16.9 15.3 14.9 13.7 16.3 12.3 20.8 13.8 13.8 8.7 14.6 12.0 26.8 8.0 33.9 23.2 20.5 13.7 16.8 15.3 15.6 14.7 17.7 8.8 13.2 11.1 22.0 16.1 12.4 13.3 15.3 19.1 7.8 24.0 9.1 9.2 20.2 25.5 0.6 1.0 3.9 3.9 0.9 0.6 0.5 6.6 5.9 9.4 6.6 12.6 16.8 48.2 5.1 9.4 6.2 8.7 3.9 8.1 2.5 2.8 9.1 4.4 5.6 4.2 10.8 2.6 4.0 1.0 4.3 5.3 5.1 2.3 3.5 8.6 5.6 3.2 12.0 10.0 2.1 2.4 7.2 1.9 3.4 0.7 4.0 6.0 3.2 6.6 3.3 5.5 6.0 3.1 6.9 7.1 10.0 4.4 3.0 1.7 10.9 11.1 5.5 10.9 4.2 0.8 1.9 3.6 8.2 1.1 7.7 0.0 1.9 0.1 0.2 1.8 0.6 0.3 0.2 0.4 1.0 0.6 0.3 0.1 3.9 0.9 3.9 0.4 0.2 0.5 19.8 22.5 26.7 17.4 16.3 12.3 14.6 12.0 13.7 19.1 SCN3B HSA243396 ENSG00000166257 "Sodium voltage-gated channel beta subunit 3" Q9NY72 11 123629187-123655244 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 70.3" "Group enriched" "Detected in some" 4 "CACO-2: 2.9;hTCEpi: 9.4;RH-30: 4.2;SCLC-21H: 9.4;SH-SY5Y: 7.0" "Cancer enhanced" "Detected in some" "glioma: 2.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041707 Approved "Intermediate filaments,Cytosol" "Intermediate filaments" Cytosol "HPA041707: " "unprognostic (1.41e-1)" "unprognostic (8.72e-2)" "unprognostic (8.13e-4)" "unprognostic (3.93e-3)" "unprognostic (7.05e-2)" "unprognostic (3.29e-3)" "unprognostic (5.64e-2)" "unprognostic (3.34e-4)" "unprognostic (1.72e-1)" "unprognostic (1.13e-2)" "unprognostic (9.16e-4)" "unprognostic (4.01e-1)" "unprognostic (1.89e-4)" "unprognostic (2.01e-2)" "unprognostic (9.01e-2)" "unprognostic (8.23e-2)" "unprognostic (1.43e-2)" 2.2 8.5 17.7 1.5 23.5 1.3 2.0 2.8 70.3 1.6 1.5 1.2 0.0 1.6 1.5 1.5 1.5 1.8 1.4 1.9 26.2 13.2 1.6 1.0 1.4 1.2 5.2 18.8 1.7 1.9 3.9 12.6 1.1 3.8 1.8 1.6 3.7 1.2 1.4 5.8 1.7 1.5 2.1 1.5 1.3 1.4 2.2 1.2 0.0 3.7 0.0 1.2 1.1 0.4 1.2 1.3 2.7 0.6 1.1 0.8 0.1 0.0 0.2 0.3 0.2 0.1 0.1 0.3 0.2 0.3 0.0 0.0 2.9 0.1 0.3 1.4 0.4 0.2 1.0 0.1 0.1 0.1 0.6 0.0 0.5 0.3 0.1 0.0 0.5 0.4 9.4 0.1 0.1 0.3 0.4 0.5 0.0 0.1 0.1 0.2 0.8 0.1 0.2 4.2 0.0 0.0 0.2 9.4 7.0 0.6 0.1 0.0 0.0 0.0 0.2 0.1 0.4 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.1 0.6 0.6 0.5 0.6 0.4 0.4 0.7 0.7 0.7 0.3 1.2 0.5 0.8 2.7 1.1 0.5 1.3 0.4 0.1 17.7 23.5 2.8 39.5 26.2 13.2 5.2 18.8 3.8 1.2 SEC62 "Dtrp1, HTP1, TLOC1" ENSG00000008952 "SEC62 homolog, preprotein translocation factor" Q99442 3 169966635-169998373 "Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014059, HPA061450" Approved Approved "Endoplasmic reticulum,Intermediate filaments" "Endoplasmic reticulum" "Intermediate filaments" "HPA014059: AB_1858029, HPA061450: " "unprognostic (8.15e-2)" "unprognostic (6.84e-2)" "unprognostic (2.72e-1)" "unprognostic (4.93e-3)" "unprognostic (5.13e-1)" "unprognostic (1.10e-3)" "unprognostic (1.24e-1)" "unprognostic (4.04e-1)" "unprognostic (6.78e-2)" "unprognostic (5.97e-2)" "unprognostic (6.36e-2)" "unprognostic (3.15e-1)" "unprognostic (2.83e-2)" "unprognostic (4.81e-2)" "unprognostic (2.76e-1)" "unprognostic (1.20e-1)" "unprognostic (2.02e-1)" 33.2 30.8 43.1 18.8 46.0 27.3 22.5 30.3 51.7 28.7 26.6 19.7 33.1 19.6 26.1 47.7 25.5 18.7 20.2 21.0 41.7 40.7 41.7 65.7 25.7 19.5 53.2 25.9 31.9 39.5 37.3 34.7 37.8 53.9 34.0 19.9 10.5 39.7 30.8 22.1 11.2 24.4 32.5 55.1 35.3 30.1 16.3 40.2 17.6 42.3 12.2 21.8 43.7 28.3 38.5 14.9 25.0 15.5 12.7 23.6 11.0 33.9 23.9 18.9 16.6 56.5 30.0 11.8 43.6 32.2 20.4 21.2 25.5 35.9 38.3 48.8 31.1 32.5 23.1 21.1 32.1 29.9 22.4 26.5 14.9 25.6 41.2 26.8 17.4 29.9 20.3 22.3 21.9 20.0 16.2 37.1 24.1 28.4 14.0 14.2 19.3 15.7 18.8 27.3 51.5 29.1 21.8 19.3 18.3 35.7 39.2 29.7 58.7 24.7 26.7 29.0 13.1 24.1 35.0 42.9 32.2 59.8 30.3 21.0 27.0 6.4 14.1 25.0 19.4 15.5 22.2 33.2 18.4 19.4 13.0 38.5 23.6 20.9 22.2 12.7 11.6 14.9 16.0 11.0 43.1 46.0 30.3 51.7 41.7 40.7 53.2 25.9 53.9 40.2 SEMA6A "HT018, KIAA1368, SEMA, SEMA6A1, SEMAQ" ENSG00000092421 "Semaphorin 6A" Q9H2E6 5 116443616-116574934 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.2" "Cell line enhanced" "Detected in some" "AF22: 14.5;AN3-CA: 17.3;BEWO: 15.1;HAP1: 20.3;NTERA-2: 45.2;RT4: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031264, HPA031265, HPA031267" Approved Approved "Nucleoplasm,Nuclear bodies,Intermediate filaments" 180000 Nucleoplasm "Nuclear bodies, Intermediate filaments" "HPA031264: , HPA031265: AB_10610423, HPA031267: " "unprognostic (3.79e-2)" "unprognostic (3.91e-1)" "unprognostic (1.82e-2)" "unprognostic (6.81e-2)" "unprognostic (2.69e-2)" "unprognostic (3.77e-1)" "prognostic unfavourable (4.39e-4)" "unprognostic (1.64e-1)" "unprognostic (4.71e-2)" "unprognostic (5.82e-2)" "unprognostic (1.92e-2)" "unprognostic (1.13e-1)" "unprognostic (2.24e-1)" "unprognostic (3.62e-3)" "unprognostic (1.92e-1)" "unprognostic (6.21e-3)" "unprognostic (7.32e-3)" 12.7 37.4 12.6 4.9 34.7 3.6 10.6 18.7 26.5 6.9 19.6 31.2 0.8 19.2 6.1 3.4 3.9 6.2 12.8 5.0 17.2 12.9 6.1 6.0 17.8 4.5 35.9 13.9 13.1 10.3 2.2 4.4 30.2 32.2 6.6 17.5 2.6 15.1 3.2 7.6 5.6 24.0 6.3 48.2 8.2 5.4 6.6 31.4 0.5 6.7 1.6 2.7 4.6 5.9 1.6 0.7 0.1 0.4 0.0 1.3 0.0 0.1 0.0 14.5 17.3 0.1 0.0 15.1 0.2 0.1 0.0 0.1 0.8 0.6 0.6 0.6 0.2 0.1 20.3 0.0 0.0 0.6 3.0 0.2 0.2 4.9 0.2 0.2 1.0 0.3 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.2 1.4 45.2 0.1 2.6 9.5 0.6 7.5 12.9 4.1 1.5 0.1 0.2 7.7 5.6 1.0 0.3 1.4 1.2 0.1 0.5 0.2 0.2 0.3 0.2 0.7 5.3 0.0 0.4 0.0 1.2 0.0 0.1 1.6 1.3 0.0 0.3 1.2 0.4 0.5 0.1 0.0 0.2 0.7 0.1 0.0 12.6 34.7 18.7 24.0 17.2 12.9 35.9 13.9 32.2 31.4 SESTD1 "DKFZp434O0515, Solo" ENSG00000187231 "SEC14 and spectrin domain containing 1" Q86VW0 2 179101692-179264790 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 27.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 4.3" "Group enriched" "Detected in many" 4 "B-cells: 4.3;dendritic cells: 1.1;monocytes: 3.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058236, HPA077408" Approved Enhanced "Intermediate filaments" "Intermediate filaments" "HPA058236: , HPA077408: " "unprognostic (2.76e-1)" "unprognostic (3.55e-2)" "unprognostic (2.77e-1)" "unprognostic (2.12e-1)" "unprognostic (1.78e-2)" "unprognostic (2.10e-1)" "prognostic unfavourable (1.88e-4)" "unprognostic (9.47e-2)" "unprognostic (1.64e-1)" "unprognostic (2.59e-1)" "unprognostic (7.91e-3)" "unprognostic (9.21e-2)" "prognostic favourable (2.78e-11)" "prognostic unfavourable (2.67e-4)" "unprognostic (3.25e-2)" "unprognostic (1.25e-1)" "unprognostic (2.57e-2)" 23.6 5.0 11.2 6.5 11.3 8.1 32.1 10.3 17.0 12.7 10.0 15.8 9.1 4.3 11.1 7.9 8.8 6.4 12.0 9.6 13.5 9.9 12.7 6.5 16.9 6.2 14.4 9.4 9.0 6.2 8.9 7.2 12.5 12.7 9.4 7.6 7.6 16.6 9.2 5.7 7.0 8.7 22.5 21.0 6.5 9.1 15.9 11.5 3.7 6.1 6.2 9.1 19.9 23.7 4.3 1.1 0.2 3.7 0.6 0.1 0.6 0.0 1.2 15.3 2.7 27.8 12.2 8.1 5.3 2.1 2.2 3.8 2.7 3.5 2.6 7.1 5.1 2.5 6.5 3.0 4.1 1.9 1.7 3.2 6.9 7.1 2.2 1.7 1.4 9.0 1.3 3.4 8.6 9.0 0.5 1.3 3.8 1.8 4.1 0.2 3.9 1.5 5.9 10.1 1.7 6.1 13.6 3.4 5.8 4.7 2.0 1.5 0.3 2.0 15.6 7.5 3.8 3.7 2.7 0.8 0.0 6.3 3.7 0.7 2.2 0.0 2.1 0.0 0.0 1.8 0.0 2.7 0.1 0.0 1.1 4.3 0.1 0.0 0.2 0.6 3.7 0.0 0.1 0.6 11.2 11.3 10.3 16.1 13.5 9.9 14.4 9.4 12.7 11.5 SFRP2 "FRP-2, SARP1, SDF-5" ENSG00000145423 "Secreted frizzled related protein 2" Q96HF1 4 153780592-153789120 "Predicted secreted proteins" "Differentiation, Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "urinary bladder: 102.5" "Group enriched" "Detected in some" 12 "AF22: 52.3;ASC diff: 19.9;HSkMC: 32.8;NTERA-2: 72.5" "Cancer enhanced" "Detected in all" "pancreatic cancer: 370.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA002652 Approved "Intermediate filaments" "Secreted in other tissues" "Intermediate filaments" "HPA002652: AB_1079937" "unprognostic (2.63e-1)" "unprognostic (2.47e-1)" "unprognostic (7.21e-3)" "unprognostic (1.80e-2)" "unprognostic (2.73e-1)" "unprognostic (8.80e-3)" "unprognostic (5.71e-3)" "unprognostic (2.62e-2)" "unprognostic (2.79e-1)" "unprognostic (7.47e-3)" "unprognostic (1.44e-2)" "unprognostic (5.29e-2)" "prognostic unfavourable (8.56e-6)" "unprognostic (9.29e-3)" "unprognostic (4.72e-2)" "unprognostic (1.05e-2)" "prognostic unfavourable (4.39e-4)" 42.9 4.0 3.4 17.6 1.7 0.2 70.0 1.3 8.0 10.9 20.6 11.3 18.2 4.4 6.4 64.4 51.5 18.5 74.9 42.2 8.5 1.2 1.9 0.2 21.3 2.6 2.8 5.6 7.9 22.5 1.6 23.2 0.3 4.6 33.4 10.8 8.4 23.9 19.5 2.5 26.1 13.7 72.3 5.4 0.3 11.4 13.2 5.0 0.3 29.1 29.4 6.8 102.5 37.4 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.0 0.0 52.3 0.0 19.9 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.4 1.7 1.3 5.7 8.5 1.2 2.8 5.6 4.6 5.0 SH3RF1 "KIAA1494, POSH, RNF142, SH3MD2" ENSG00000154447 "SH3 domain containing ring finger 1" Q7Z6J0 4 169094256-169271105 "Enzymes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "intermediate monocyte: 5.9;myeloid DC: 3.4;non-classical monocyte: 8.5" "Group enriched" "Detected in many" 13 "dendritic cells: 3.4;monocytes: 8.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA074783 Approved Supported "Vesicles,Intermediate filaments" Vesicles "Intermediate filaments" "HPA074783: " "unprognostic (4.14e-1)" "unprognostic (4.67e-2)" "unprognostic (1.23e-1)" "unprognostic (7.83e-2)" "unprognostic (1.02e-1)" "unprognostic (1.30e-2)" "unprognostic (1.29e-1)" "unprognostic (2.65e-1)" "unprognostic (8.44e-2)" "unprognostic (9.58e-2)" "unprognostic (4.77e-3)" "unprognostic (7.88e-2)" "prognostic favourable (5.51e-8)" "unprognostic (4.43e-2)" "unprognostic (1.63e-1)" "unprognostic (5.99e-2)" "unprognostic (1.77e-1)" 15.2 4.8 13.8 7.2 11.8 3.7 11.1 2.5 12.7 7.5 17.2 15.9 10.8 15.7 6.8 7.2 7.1 6.9 19.7 7.8 17.8 9.3 14.6 9.6 11.3 3.7 13.0 10.9 11.9 12.0 5.2 7.8 8.6 10.3 17.2 16.0 10.7 20.9 10.7 16.2 6.8 17.2 8.8 11.7 4.5 27.6 7.0 11.3 0.9 23.1 7.6 5.5 9.4 6.3 0.4 3.4 0.0 8.5 0.3 0.0 0.7 7.3 6.2 5.6 16.2 6.1 7.6 7.3 20.6 10.0 15.4 7.1 6.1 8.9 0.0 1.0 21.4 4.9 4.5 8.1 17.0 0.0 2.6 4.3 14.1 3.2 13.8 1.5 0.1 4.5 4.5 13.1 10.4 9.4 0.0 0.0 14.2 3.0 1.5 1.4 2.8 5.3 2.3 1.8 0.3 7.0 5.8 4.2 5.1 5.2 8.0 2.0 2.6 0.6 8.5 7.3 5.7 12.1 7.2 0.5 0.0 0.0 8.2 1.5 8.7 0.0 1.4 0.0 0.0 5.9 0.0 0.4 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.3 8.5 0.2 0.0 0.7 13.8 11.8 2.5 12.7 17.8 9.3 13.0 10.9 10.3 11.3 SLC10A3 "DXS253E, P3" ENSG00000126903 "Solute carrier family 10 member 3" P09131 X 154487306-154490690 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 9 "basophil: 51.2" "Lineage enriched" "Detected in all" 13 "granulocytes: 51.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021656 Approved Approved "Intermediate filaments" "Intermediate filaments" "HPA021656: AB_1856955" "unprognostic (1.60e-1)" "prognostic favourable (4.53e-4)" "prognostic unfavourable (4.15e-5)" "unprognostic (8.00e-3)" "prognostic unfavourable (9.97e-4)" "unprognostic (5.47e-2)" "unprognostic (2.28e-3)" "unprognostic (9.76e-2)" "unprognostic (1.63e-1)" "unprognostic (1.05e-1)" "prognostic unfavourable (7.22e-4)" "unprognostic (3.42e-1)" "unprognostic (2.52e-3)" "unprognostic (6.23e-2)" "unprognostic (2.99e-1)" "unprognostic (7.29e-2)" "unprognostic (2.99e-2)" 14.5 14.6 3.6 11.6 5.1 22.5 13.4 5.0 8.1 21.5 15.3 8.1 16.3 10.6 25.0 36.1 22.8 15.4 21.1 19.5 6.0 4.6 17.7 6.7 16.3 14.0 5.8 6.2 32.3 25.7 6.1 12.7 40.1 7.6 23.7 6.4 12.4 11.7 13.3 13.7 26.2 13.6 20.1 5.3 13.1 12.6 11.6 4.7 12.6 15.7 23.3 18.6 23.3 18.3 1.6 2.7 51.2 1.7 2.2 3.8 1.8 24.6 10.6 2.8 14.5 10.0 10.9 18.8 18.4 11.2 12.4 12.6 9.4 12.0 18.8 35.0 17.6 21.3 9.3 9.4 3.3 12.2 4.4 5.8 14.0 7.4 18.4 6.9 9.5 13.6 10.7 11.6 6.3 8.5 6.5 18.5 8.1 32.8 3.7 6.2 2.2 20.5 6.1 7.6 14.2 9.4 9.2 2.6 4.7 11.6 21.0 4.8 6.8 5.5 11.1 14.9 9.3 34.4 23.2 13.2 12.7 19.4 15.8 14.5 7.6 51.2 1.3 5.6 3.8 1.7 2.9 1.6 2.6 2.8 1.1 1.6 1.9 1.8 1.7 2.2 1.5 2.7 1.8 1.8 3.6 5.1 5.0 8.1 6.0 4.6 5.8 6.2 7.6 4.7 SLC16A8 "MCT3, REMP" ENSG00000100156 "Solute carrier family 16 member 8" O95907 22 38078134-38084093 "Plasma proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "retina: 70.9" "Cell line enhanced" "Detected in some" "BEWO: 5.9;SiHa: 6.4;T-47d: 7.7;U-266/70: 11.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA075017 Enhanced Approved "Intermediate filaments,Focal adhesion sites" "Focal adhesion sites" "Intermediate filaments" "HPA075017: " "unprognostic (1.22e-2)" "unprognostic (2.25e-2)" "unprognostic (5.07e-6)" "unprognostic (2.99e-2)" "unprognostic (1.37e-1)" "unprognostic (1.84e-2)" "unprognostic (2.99e-2)" "unprognostic (1.74e-1)" "unprognostic (1.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.63e-2)" "unprognostic (1.32e-2)" "unprognostic (2.34e-4)" "unprognostic (7.69e-2)" "unprognostic (1.15e-1)" "unprognostic (4.06e-1)" "unprognostic (9.71e-5)" 1.6 2.6 1.9 0.8 5.1 1.2 0.8 0.8 3.3 0.8 0.8 0.8 0.8 0.5 1.3 0.8 1.1 1.2 2.7 2.9 2.7 2.9 0.8 0.8 0.8 0.9 2.8 0.8 0.8 2.1 0.0 2.6 0.8 1.3 4.0 0.0 70.9 10.0 0.8 1.9 4.2 0.8 0.8 3.7 1.8 2.3 2.0 0.8 0.8 0.9 0.8 0.8 1.6 0.8 0.0 0.0 0.0 0.0 0.5 0.6 0.0 1.3 0.7 1.1 0.2 0.0 0.0 5.9 0.5 0.0 0.0 0.0 1.2 3.5 0.4 1.7 0.0 0.8 0.0 0.0 0.0 0.0 1.8 0.3 1.0 0.1 0.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 3.9 0.0 0.0 1.4 0.1 2.0 0.0 0.0 0.0 4.4 1.9 0.3 6.4 0.3 0.9 7.7 0.2 0.0 0.0 3.5 0.3 0.0 11.3 1.6 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.9 5.1 0.8 1.2 2.7 2.9 2.8 0.8 1.3 0.8 SLC1A6 EAAT4 ENSG00000105143 "Solute carrier family 1 member 6" P48664 19 14950034-15022990 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 52.1;testis: 23.3" "Cell line enhanced" "Detected in some" "HAP1: 6.4;NTERA-2: 5.3;U-698: 24.1" "Cancer enriched" "Detected in some" 7 "urothelial cancer: 5.2" "Region enriched" "Detected in many" 5 "cerebellum: 52.1" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in many" 6 "cerebellum: 152.9" "Low region specificity" "Detected in all" "HPA041505, HPA044066" Enhanced Supported "Plasma membrane,Intermediate filaments" "Plasma membrane" "Intermediate filaments" "HPA041505: , HPA044066: " "unprognostic (3.62e-2)" "unprognostic (1.35e-1)" "unprognostic (4.41e-2)" "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "unprognostic (5.94e-3)" "unprognostic (8.90e-2)" "unprognostic (6.52e-4)" "unprognostic (1.55e-1)" "unprognostic (5.40e-3)" "unprognostic (1.11e-2)" "unprognostic (9.92e-2)" "unprognostic (1.35e-1)" "unprognostic (5.57e-2)" "prognostic unfavourable (6.88e-6)" 0.4 0.5 3.2 0.5 9.6 1.2 0.8 52.1 12.8 0.4 0.5 0.6 0.0 0.6 0.8 4.2 0.4 0.5 0.5 0.4 4.8 4.0 0.4 0.5 0.5 0.5 1.6 3.4 0.6 0.9 0.6 0.0 4.3 3.0 0.9 0.6 0.1 0.7 0.9 0.5 9.2 0.5 0.5 1.4 0.7 0.5 23.3 0.9 0.0 0.6 0.0 0.6 0.4 0.0 2.0 0.7 2.2 0.7 0.5 0.6 0.1 0.1 0.0 0.3 0.3 0.2 0.2 0.8 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.2 1.2 6.4 0.1 0.1 0.2 0.1 0.2 0.3 0.2 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.6 0.1 0.5 0.0 0.3 5.3 0.1 0.1 0.0 0.1 0.0 0.2 0.4 0.2 0.2 2.5 0.0 0.3 0.1 0.0 0.3 1.0 0.2 0.1 0.4 0.1 24.1 0.1 0.3 0.1 1.6 0.7 0.5 0.6 0.4 0.4 1.0 0.5 0.3 0.3 2.0 0.6 0.6 2.2 0.5 0.4 0.7 0.3 0.1 3.2 9.6 52.1 6.5 4.8 4.0 1.6 3.4 3.0 0.9 SLC25A48 "FLJ44862, HDMCP" ENSG00000145832 "Solute carrier family 25 member 48" Q6ZT89 5 135579202-135889770 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.4;kidney: 11.7;skeletal muscle: 12.8" "Cell line enhanced" "Detected in some" "HAP1: 4.9;HEK 293: 4.1;HEL: 4.0;RPMI-8226: 3.6;SCLC-21H: 3.8;U-2 OS: 5.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA014674 Uncertain Approved "Intermediate filaments,Actin filaments" "Intermediate filaments" "Actin filaments" "HPA014674: AB_1859512" "unprognostic (2.09e-1)" "unprognostic (2.24e-1)" "unprognostic (6.34e-2)" "unprognostic (1.21e-1)" "unprognostic (1.37e-2)" "unprognostic (4.71e-2)" "unprognostic (1.96e-2)" "unprognostic (1.36e-1)" "unprognostic (4.62e-2)" "unprognostic (5.41e-2)" "unprognostic (3.57e-2)" "unprognostic (1.32e-1)" "unprognostic (8.02e-7)" "unprognostic (9.13e-2)" "unprognostic (1.10e-1)" "unprognostic (1.21e-1)" "unprognostic (1.20e-1)" 1.0 0.8 10.8 1.0 13.0 0.9 1.6 1.3 18.8 0.9 2.0 10.3 0.0 2.0 1.0 0.7 1.3 0.7 0.9 0.9 11.9 8.1 11.7 1.3 0.7 1.0 22.4 4.1 0.7 3.3 0.8 0.4 1.1 5.6 1.3 1.8 0.0 3.5 0.6 12.8 3.2 4.1 0.7 5.4 0.9 0.8 1.2 15.2 0.0 1.0 0.5 0.7 0.8 0.3 0.6 1.0 2.1 1.0 0.8 0.7 0.2 0.3 0.3 0.1 0.3 0.0 0.0 0.5 0.0 0.1 0.1 0.1 0.4 0.7 0.1 0.4 0.0 0.5 4.9 0.0 0.0 0.7 4.1 4.0 0.6 0.8 0.0 0.3 0.6 0.0 0.1 0.0 0.0 0.0 0.2 0.5 0.1 0.0 0.0 1.7 0.8 0.1 0.1 0.0 3.6 0.3 0.6 3.8 0.4 0.6 0.5 1.0 1.8 0.6 0.5 0.4 5.0 0.3 0.2 1.7 0.5 0.2 0.4 0.4 0.3 2.1 0.3 0.7 0.5 0.5 0.6 0.5 0.5 0.4 0.3 0.6 0.6 0.7 1.5 0.8 1.0 1.0 0.5 0.2 10.8 13.0 1.3 9.9 11.9 8.1 22.4 4.1 5.6 15.2 SLC31A2 "COPT2, CTR2, hCTR2" ENSG00000136867 "Solute carrier family 31 member 2" O15432 9 113150942-113164137 "Predicted membrane proteins, Transporters" "Copper transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 60.2;salivary gland: 125.5" "Cell line enhanced" "Detected in many" "hTCEpi: 33.0;hTERT-HME1: 22.6;LHCN-M2: 26.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 12 "classical monocyte: 36.6;intermediate monocyte: 50.5;myeloid DC: 21.2;neutrophil: 54.5;non-classical monocyte: 60.2" "Group enriched" "Detected in many" 36 "dendritic cells: 21.2;granulocytes: 54.5;monocytes: 60.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014861 Approved Approved "Nuclear speckles,Plasma membrane,Intermediate filaments" "Nuclear speckles" "Plasma membrane, Intermediate filaments" "HPA014861: AB_1857098" "unprognostic (2.26e-1)" "unprognostic (7.20e-2)" "unprognostic (3.79e-3)" "unprognostic (1.09e-1)" "unprognostic (1.10e-1)" "unprognostic (4.81e-3)" "unprognostic (5.63e-2)" "unprognostic (3.31e-2)" "unprognostic (2.24e-1)" "unprognostic (3.44e-2)" "unprognostic (1.47e-1)" "unprognostic (1.86e-1)" "unprognostic (6.05e-3)" "unprognostic (1.76e-1)" "unprognostic (3.56e-2)" "unprognostic (1.25e-1)" "unprognostic (8.89e-2)" 15.7 8.0 10.0 8.1 20.5 7.0 8.5 3.2 15.0 3.0 8.4 45.1 27.1 5.2 2.0 6.0 4.6 3.0 4.5 3.4 18.2 9.4 9.8 11.2 10.0 6.2 34.3 10.5 2.8 7.8 17.9 1.2 10.2 22.3 2.1 4.4 1.0 125.5 21.8 6.7 18.5 9.9 3.8 48.5 14.1 4.5 5.4 26.2 1.2 2.8 2.9 5.8 3.9 4.1 0.3 21.2 54.5 60.2 0.2 1.2 13.4 5.4 2.4 1.3 2.0 21.7 8.9 4.7 4.1 5.3 5.0 4.8 1.8 1.6 0.3 0.8 3.4 20.2 1.9 11.7 4.7 2.7 0.8 0.3 1.2 2.8 8.3 2.1 1.2 10.0 33.0 11.7 22.6 2.6 1.5 3.0 26.1 5.2 2.1 1.2 0.7 2.3 0.4 19.7 0.3 1.7 3.3 1.2 2.1 5.6 17.5 1.6 6.2 1.9 2.4 2.7 1.9 9.0 3.5 1.8 3.8 0.2 8.7 2.9 2.7 0.8 36.6 3.6 0.9 50.5 1.2 0.2 1.0 1.0 21.2 0.3 0.8 0.8 54.5 0.2 60.2 0.5 0.6 13.4 10.0 20.5 3.2 15.0 18.2 9.4 34.3 10.5 22.3 26.2 SLC5A7 "CHT1, hCHT" ENSG00000115665 "Solute carrier family 5 member 7" Q9GZV3 2 107986523-108013994 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Neurotransmitter biosynthesis, Sodium transport, Symport, Transport" "Congenital myasthenic syndrome, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 45.1" "Group enriched" "Detected in some" 22 "RT4: 8.7;SCLC-21H: 2.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.8" "Group enriched" "Detected in some" 13 "basal ganglia: 13.8;pons and medulla: 45.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "basal ganglia: 21.3;hypothalamus: 10.1;midbrain: 12.2;pons and medulla: 16.6;thalamus: 7.1" "Group enriched" "Detected in some" 15 "basal ganglia: 20.7;hippocampal formation: 7.2;pons and medulla: 26.3" HPA046105 Approved "Nuclear bodies,Cell Junctions,Intermediate filaments" "Cell Junctions, Intermediate filaments" "Nuclear bodies" "HPA046105: " "unprognostic (2.98e-1)" "unprognostic (1.01e-1)" "unprognostic (1.29e-3)" "unprognostic (7.10e-2)" "unprognostic (1.66e-1)" "unprognostic (3.39e-4)" "unprognostic (1.05e-2)" "unprognostic (9.78e-3)" "unprognostic (6.42e-2)" "unprognostic (1.61e-2)" 0.3 2.4 0.1 1.6 13.8 0.0 0.3 0.1 0.4 3.3 5.2 0.1 0.3 2.3 1.6 0.7 1.0 0.2 0.5 1.2 0.2 2.2 0.9 0.2 0.9 0.0 0.3 0.5 0.8 0.5 0.0 0.1 0.0 45.1 0.8 2.5 1.0 0.9 4.2 0.1 0.1 2.5 3.1 10.0 0.1 1.7 0.3 0.8 0.0 4.0 0.3 0.1 4.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 13.8 0.1 0.4 0.2 2.2 0.3 0.5 45.1 0.8 SMARCA2 "BAF190, BRM, hBRM, hSNF2a, SNF2, SNF2L2, SNF2LA, Sth1p, SWI2" ENSG00000080503 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2" P51531 9 1980290-2193624 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Helicase, Hydrolase" "Disease mutation, Hypotrichosis, Mental retardation, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in many" 6 "HDLM-2: 176.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029981, CAB037276" Enhanced Approved "Nucleoplasm,Vesicles,Intermediate filaments" "Nucleoplasm, Vesicles" "Intermediate filaments" "CAB037276: AB_477083, HPA029981: AB_10602406" "unprognostic (5.34e-2)" "unprognostic (1.99e-2)" "unprognostic (6.27e-2)" "unprognostic (6.53e-2)" "unprognostic (1.28e-1)" "unprognostic (1.13e-2)" "unprognostic (4.91e-2)" "unprognostic (2.80e-2)" "unprognostic (2.62e-1)" "unprognostic (3.97e-1)" "unprognostic (3.60e-3)" "unprognostic (9.64e-2)" "prognostic favourable (1.26e-6)" "unprognostic (3.09e-1)" "unprognostic (2.81e-1)" "unprognostic (8.32e-3)" "unprognostic (8.50e-2)" 23.6 29.6 38.8 21.3 43.6 40.7 30.1 41.6 44.0 23.8 17.3 20.0 38.4 10.3 26.4 30.1 20.4 29.4 22.8 21.2 30.2 30.8 23.4 28.9 20.2 29.5 25.9 32.4 85.0 18.5 104.1 35.0 23.2 24.7 23.2 15.9 22.8 26.1 44.8 41.3 27.0 18.3 26.6 19.7 23.9 15.8 26.5 23.4 20.6 28.0 24.8 27.1 23.7 22.0 9.9 11.3 20.4 8.3 8.6 12.5 4.2 5.2 3.9 2.9 4.2 6.0 7.2 8.8 6.7 5.3 3.1 2.3 0.0 2.1 9.1 2.7 6.1 2.3 1.6 5.6 2.2 176.7 2.5 24.6 10.9 1.9 2.3 10.3 14.5 4.7 2.1 3.1 5.8 4.9 0.8 31.3 5.2 2.1 2.5 8.6 2.9 1.5 11.6 3.7 8.2 7.1 4.8 1.9 1.7 4.3 1.0 1.8 1.9 6.7 5.8 5.0 2.4 3.2 3.2 2.9 3.6 4.1 5.4 3.9 1.3 20.4 4.6 13.1 10.3 6.2 9.9 9.9 9.9 10.5 5.6 8.0 12.5 10.0 13.5 8.6 8.3 11.3 10.4 4.2 38.8 43.6 41.6 44.0 30.2 30.8 25.9 32.4 24.7 23.4 SMG7 "C1orf16, EST1C, KIAA0250, SGA56M, SMG-7" ENSG00000116698 "SMG7, nonsense mediated mRNA decay factor" Q92540 1 183472216-183598246 "Plasma proteins, Predicted intracellular proteins" "Nonsense-mediated mRNA decay" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029350 Supported Supported "Intermediate filaments,Cytosol" "Intermediate filaments, Cytosol" "HPA029350: AB_10603031" "unprognostic (6.06e-2)" "unprognostic (1.79e-1)" "unprognostic (3.32e-1)" "unprognostic (2.67e-3)" "unprognostic (1.98e-2)" "unprognostic (1.36e-1)" "unprognostic (5.44e-2)" "unprognostic (6.15e-2)" "unprognostic (1.46e-1)" "unprognostic (9.01e-2)" "unprognostic (6.17e-2)" "unprognostic (2.69e-1)" "unprognostic (6.47e-3)" "unprognostic (7.82e-2)" "unprognostic (3.76e-2)" "unprognostic (2.16e-2)" "unprognostic (4.40e-3)" 14.6 14.3 20.7 17.1 25.3 30.9 17.6 35.8 29.3 17.6 18.1 19.9 6.6 16.8 16.6 13.6 19.1 22.1 12.9 20.0 17.8 14.8 18.2 18.7 15.6 19.7 16.0 23.1 22.7 18.7 25.9 20.2 18.7 15.9 15.1 20.4 15.9 17.2 14.5 19.2 20.5 17.8 15.2 14.4 18.9 18.3 52.1 15.1 31.6 19.9 12.7 23.9 14.5 22.3 9.3 11.7 11.2 9.6 9.5 10.3 8.0 21.5 13.2 19.0 14.9 13.0 12.4 31.8 13.3 24.5 14.9 11.4 19.5 16.9 30.5 15.3 16.4 23.5 25.6 19.7 17.7 13.5 11.2 24.6 14.3 15.8 13.2 32.2 15.8 11.2 18.1 20.3 47.2 16.2 30.5 21.6 15.4 21.9 22.6 14.2 33.0 7.6 14.3 21.3 23.8 11.4 20.2 25.7 20.1 20.5 29.2 15.9 29.1 13.2 15.4 16.9 17.5 16.7 18.8 23.6 27.7 25.3 13.7 18.3 18.0 3.1 9.3 9.5 9.7 9.6 8.9 9.3 8.8 9.5 10.7 8.5 9.9 10.3 11.2 9.5 5.0 11.7 7.8 8.0 20.7 25.3 35.8 29.3 17.8 14.8 16.0 23.1 15.9 15.1 SMYD2 "HSKM-B, KMT3C, ZMYND14" ENSG00000143499 "SET and MYND domain containing 2" Q9NRG4 1 214281102-214337131 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 75.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029023 Uncertain Approved "Intermediate filaments,Mitochondria,Cytosol" Cytosol "Intermediate filaments, Mitochondria" "HPA029023: AB_10601605" "unprognostic (8.53e-2)" "prognostic unfavourable (1.53e-5)" "unprognostic (5.98e-2)" "unprognostic (1.00e-2)" "unprognostic (8.55e-2)" "unprognostic (2.53e-2)" "unprognostic (2.24e-2)" "unprognostic (1.72e-2)" "unprognostic (1.90e-3)" "unprognostic (1.65e-1)" "unprognostic (9.44e-2)" "unprognostic (2.77e-1)" "prognostic favourable (8.68e-4)" "unprognostic (2.65e-1)" "unprognostic (4.92e-2)" "unprognostic (8.10e-2)" "unprognostic (6.37e-2)" 5.9 5.7 8.8 5.6 7.3 2.7 10.0 5.0 23.9 4.9 4.7 2.1 3.1 4.8 3.8 6.7 7.3 10.4 4.5 75.7 7.0 8.4 7.7 9.7 8.1 8.0 5.3 10.0 4.7 7.8 2.9 7.5 10.6 6.9 4.6 5.8 3.1 6.2 3.0 29.5 4.3 4.7 3.8 4.7 6.2 6.2 8.9 2.2 8.0 7.8 5.1 5.6 5.2 4.0 9.3 5.5 8.1 5.9 17.6 14.5 7.3 24.1 7.0 9.5 6.7 9.9 17.2 40.6 13.6 11.3 17.3 19.7 27.5 20.7 12.5 14.1 15.4 11.4 9.0 25.4 16.8 10.4 10.5 4.0 11.8 21.9 8.9 17.6 2.8 18.4 14.3 12.0 9.6 12.5 12.7 3.2 15.5 12.6 12.2 11.1 8.6 9.5 7.6 23.1 10.6 17.1 17.7 9.4 22.0 10.6 38.3 28.2 29.8 11.7 14.4 13.5 19.9 7.4 21.1 12.9 4.8 14.4 17.5 14.0 15.3 6.7 5.9 8.1 9.5 3.2 11.2 9.3 14.5 12.7 5.5 4.8 12.7 11.6 0.6 17.6 1.2 3.8 14.5 7.3 8.8 7.3 5.0 23.9 7.0 8.4 5.3 10.0 6.9 2.2 SPINT2 "HAI-2, Kop" ENSG00000167642 "Serine peptidase inhibitor, Kunitz type 2" O43291 19 38244035-38292614 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 81.3;CAPAN-2: 120.0;hTCEpi: 66.8;RPTEC TERT1: 89.5;RT4: 69.4;SK-BR-3: 78.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA011101, CAB018969" Approved Uncertain "Plasma membrane,Intermediate filaments,Cytosol" "Plasma membrane, Intermediate filaments, Cytosol" "CAB018969: , HPA011101: AB_1079039" "unprognostic (5.13e-2)" "unprognostic (1.06e-3)" "unprognostic (1.40e-1)" "unprognostic (6.25e-2)" "unprognostic (1.13e-1)" "unprognostic (1.91e-2)" "unprognostic (2.23e-1)" "unprognostic (2.03e-2)" "unprognostic (3.51e-1)" "unprognostic (1.67e-2)" "unprognostic (2.89e-2)" "unprognostic (2.04e-1)" "prognostic favourable (3.41e-4)" "unprognostic (3.59e-1)" "unprognostic (1.32e-1)" "unprognostic (6.94e-2)" "unprognostic (2.68e-2)" 1.5 7.2 11.9 15.1 14.0 10.7 29.2 14.3 20.8 24.0 46.3 4.7 63.2 38.3 7.1 44.9 60.6 30.4 51.8 3.3 10.4 22.9 47.5 2.8 25.6 10.3 9.3 14.6 15.3 78.7 30.2 82.7 77.3 11.0 29.6 40.3 15.3 143.1 61.6 0.7 41.7 82.3 13.1 5.6 9.4 34.1 87.0 2.8 15.0 95.6 32.0 37.5 27.1 25.0 23.1 73.9 70.7 17.9 2.6 13.2 17.6 81.3 59.1 0.3 0.3 0.0 0.0 38.7 1.5 0.1 0.1 0.2 41.8 120.0 0.6 6.6 0.4 27.0 4.2 57.9 0.1 0.7 4.9 15.3 1.5 0.0 0.1 0.1 0.0 0.0 66.8 0.0 28.3 0.2 0.3 0.0 0.1 63.0 2.4 0.2 5.9 16.6 8.3 0.0 36.6 89.5 69.4 22.3 0.3 24.2 78.7 0.2 35.1 10.1 0.0 0.1 0.4 0.3 0.3 5.5 7.0 4.5 0.1 1.0 0.1 57.2 17.9 70.7 0.5 12.5 1.1 20.0 6.5 3.2 41.7 23.1 13.2 11.9 7.8 2.6 8.4 73.9 2.5 17.6 11.9 14.0 14.3 20.8 10.4 22.9 9.3 14.6 11.0 2.8 SPIRE2 "KIAA1832, spir-2" ENSG00000204991 "Spire type actin nucleation factor 2" Q8WWL2 16 89818179-89871319 "Predicted intracellular proteins" "Protein transport, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 40.6" "Cell line enhanced" "Detected in many" "BEWO: 14.5;T-47d: 15.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041413, HPA049415" Uncertain Approved "Nucleoplasm,Vesicles,Intermediate filaments" Nucleoplasm "Vesicles, Intermediate filaments" "HPA041413: , HPA049415: " "unprognostic (2.92e-1)" "unprognostic (1.39e-1)" "unprognostic (6.07e-3)" "unprognostic (6.96e-2)" "unprognostic (7.40e-2)" "unprognostic (7.31e-2)" "prognostic unfavourable (9.77e-5)" "unprognostic (2.10e-1)" "unprognostic (7.75e-2)" "unprognostic (5.34e-2)" "unprognostic (1.08e-2)" "unprognostic (6.95e-3)" "unprognostic (7.21e-3)" "unprognostic (6.65e-2)" "unprognostic (1.30e-1)" "unprognostic (3.27e-2)" "unprognostic (1.59e-2)" 1.5 2.1 7.2 3.9 9.3 2.2 1.7 19.5 11.2 2.1 14.8 2.1 5.9 10.9 2.5 3.2 2.5 9.1 7.6 0.8 6.2 7.8 1.9 4.0 3.2 1.0 5.5 6.1 1.6 3.0 8.4 18.4 40.6 7.4 3.5 11.7 2.7 2.2 5.0 1.2 2.0 12.6 1.9 2.5 1.5 20.2 3.8 1.4 0.0 5.0 0.9 1.3 6.4 4.9 2.1 1.6 5.5 1.4 1.7 1.2 0.6 0.3 6.8 4.3 3.6 1.2 0.8 14.5 2.3 1.3 3.2 1.3 2.6 7.2 4.5 1.0 0.6 7.2 1.9 0.2 1.0 1.8 8.3 0.9 5.6 6.9 1.1 0.3 1.5 1.5 1.7 1.0 0.8 0.1 6.9 1.3 0.9 10.1 0.1 1.5 4.7 4.2 3.4 1.5 1.0 1.6 6.9 11.3 5.8 9.4 4.1 4.1 15.5 2.4 0.3 1.9 4.1 2.6 1.9 0.6 2.9 0.4 2.9 1.6 3.9 4.6 1.4 0.9 1.1 0.7 0.8 1.2 0.9 0.7 0.3 2.1 1.2 1.2 5.5 1.7 1.3 1.6 0.5 0.6 7.2 9.3 19.5 11.2 6.2 7.8 5.5 6.1 7.4 1.4 SRMS "C20orf148, dJ697K14.1, PTK70, SRM" ENSG00000125508 "Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites" Q9H3Y6 20 63540810-63547504 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 10.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.7;HaCaT: 2.6;MCF7: 4.9;RT4: 10.1;T-47d: 2.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "naive B-cell: 1.1" "Lineage enriched" "Detected in single" 8 "B-cells: 1.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "CAB044668, CAB044669, HPA073987" Uncertain Approved "Intermediate filaments,Actin filaments,Cytosol" "Intermediate filaments" "Actin filaments, Cytosol" "CAB044668: AB_10609403, CAB044669: AB_10608235, HPA073987: " "unprognostic (2.26e-2)" "unprognostic (1.26e-2)" "unprognostic (2.52e-3)" "unprognostic (8.32e-2)" "unprognostic (2.62e-1)" "unprognostic (5.47e-3)" "unprognostic (1.65e-1)" "unprognostic (2.28e-1)" "unprognostic (9.63e-2)" "unprognostic (6.48e-3)" "unprognostic (7.28e-3)" "unprognostic (1.46e-1)" "unprognostic (1.73e-3)" "unprognostic (2.58e-3)" "unprognostic (4.75e-2)" "unprognostic (4.97e-2)" "unprognostic (2.54e-3)" 0.3 0.0 0.3 0.5 0.3 0.0 1.1 1.1 0.3 0.3 1.8 0.3 0.3 0.4 0.3 10.2 0.4 0.0 0.3 0.3 0.3 0.0 0.9 0.3 0.3 0.3 0.3 0.3 0.3 2.7 0.0 0.3 0.3 0.3 2.2 0.0 0.3 2.5 0.3 0.3 1.7 0.8 0.3 0.3 2.5 4.2 0.9 0.3 0.3 0.3 0.3 0.8 1.5 0.3 1.1 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 5.7 0.2 2.3 0.0 2.6 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.2 0.0 0.8 0.0 0.2 0.0 0.0 10.1 0.8 1.0 0.3 2.1 0.4 2.6 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 1.1 0.3 0.3 0.0 0.3 0.3 0.3 0.3 SRRM3 FLJ37078 ENSG00000177679 "Serine/arginine repetitive matrix 3" 7 76201900-76287288 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "brain: 43.2" "Group enriched" "Detected in some" 11 "SCLC-21H: 14.1;SH-SY5Y: 10.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019337 Approved "Plasma membrane,Intermediate filaments,Microtubules" "Plasma membrane" "Intermediate filaments, Microtubules" "HPA019337: AB_1848909" "unprognostic (1.65e-1)" "unprognostic (1.96e-1)" "unprognostic (8.37e-3)" "unprognostic (4.93e-2)" "unprognostic (1.81e-1)" "unprognostic (1.39e-1)" "unprognostic (8.53e-2)" "unprognostic (6.51e-2)" "unprognostic (1.89e-3)" "unprognostic (1.62e-2)" "unprognostic (5.07e-3)" "unprognostic (6.37e-2)" "unprognostic (3.73e-3)" "unprognostic (5.05e-1)" "unprognostic (2.98e-1)" "unprognostic (1.84e-1)" "unprognostic (5.15e-2)" 0.6 6.2 8.1 0.7 18.1 0.4 0.4 43.2 14.6 0.4 0.6 0.0 0.0 0.9 0.7 1.1 0.5 0.5 0.5 0.5 5.1 0.5 0.4 0.5 0.4 0.0 10.9 0.6 0.5 0.5 4.4 0.4 10.0 0.5 0.7 1.8 0.6 0.5 0.6 0.5 0.6 0.5 0.6 0.4 1.6 2.9 2.9 0.0 0.4 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.3 0.2 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 14.1 10.4 0.0 0.0 0.1 0.4 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 STK3 "KRS1, MST2" ENSG00000104375 "Serine/threonine kinase 3" Q13188 8 98401403-98942827 "Enzymes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 37.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "dendritic cells: 8.3;granulocytes: 9.0;monocytes: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007120, CAB025316" Uncertain Approved "Intermediate filaments,Rods & Rings" "Intermediate filaments, Rods & Rings" "CAB025316: , HPA007120: AB_10601664" "unprognostic (7.88e-3)" "unprognostic (1.96e-1)" "unprognostic (6.57e-2)" "prognostic unfavourable (1.53e-4)" "unprognostic (2.95e-1)" "unprognostic (1.12e-3)" "unprognostic (9.68e-3)" "prognostic unfavourable (4.25e-4)" "unprognostic (6.71e-2)" "unprognostic (9.83e-2)" "prognostic unfavourable (9.21e-5)" "unprognostic (9.16e-2)" "unprognostic (1.03e-1)" "unprognostic (2.27e-1)" "unprognostic (1.29e-1)" "unprognostic (5.86e-2)" "unprognostic (9.72e-2)" 16.5 16.6 6.5 8.1 12.4 2.5 20.5 2.6 10.6 17.2 13.1 10.5 14.2 4.6 22.2 13.1 9.0 16.0 12.6 10.0 7.4 4.1 14.7 12.0 16.2 10.8 12.8 3.6 22.8 10.7 15.1 18.9 53.1 9.9 15.0 6.0 8.2 10.8 16.4 11.6 10.0 10.8 23.5 12.9 8.2 9.5 10.1 11.4 3.4 10.6 7.9 5.9 16.4 24.3 1.9 8.3 9.0 8.7 1.8 1.8 2.9 37.6 7.1 7.5 9.9 24.4 12.2 7.5 13.1 11.8 12.3 10.7 5.2 16.0 0.0 11.4 13.0 15.3 5.2 11.3 19.9 9.0 6.7 10.1 3.5 3.5 8.3 3.3 8.8 8.1 19.5 6.3 17.2 5.2 4.2 5.5 8.9 4.7 8.4 4.0 2.2 2.8 7.4 6.5 3.2 14.0 4.7 1.9 4.4 8.3 9.6 8.1 7.9 5.5 3.9 8.3 5.3 12.5 7.2 4.4 6.5 2.7 7.4 4.2 13.1 2.1 8.6 4.5 1.3 8.7 1.4 1.9 0.8 1.8 8.3 1.3 1.1 0.7 9.0 1.8 5.4 3.4 0.1 2.9 6.5 12.4 2.6 10.6 7.4 4.1 12.8 3.6 9.9 11.4 STX19 MGC21382 ENSG00000178750 "Syntaxin 19" Q8N4C7 3 94014369-94028610 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 20.9" "Cell line enhanced" "Detected in some" "CAPAN-2: 10.4;HaCaT: 2.2;hTCEpi: 7.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebral cortex: 3.5" "Cell type enhanced" "Detected in single" "memory B-cell: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA030604 Uncertain Approved "Intermediate filaments,Cytosol" "Intermediate filaments" Cytosol "HPA030604: AB_10601268" "unprognostic (7.35e-2)" "unprognostic (1.91e-1)" "unprognostic (1.12e-1)" "unprognostic (5.17e-2)" "unprognostic (2.35e-1)" "unprognostic (1.13e-2)" "unprognostic (1.92e-1)" "unprognostic (1.21e-1)" "unprognostic (9.42e-2)" "unprognostic (9.04e-2)" "unprognostic (1.29e-2)" "unprognostic (4.32e-2)" "unprognostic (7.00e-3)" "unprognostic (1.19e-2)" "unprognostic (1.96e-1)" "unprognostic (2.12e-1)" "unprognostic (4.87e-3)" 0.4 0.2 0.3 7.0 0.4 0.0 4.0 1.8 3.5 3.9 11.7 0.1 1.5 5.7 0.5 13.6 12.8 0.8 2.3 0.3 0.5 0.3 1.0 0.4 7.1 0.1 0.3 0.7 0.5 7.7 7.1 0.5 0.7 0.1 4.3 10.6 0.1 9.8 3.2 0.2 6.9 20.9 0.1 0.4 1.0 6.0 0.4 0.1 0.4 0.4 5.0 1.5 0.7 4.1 1.2 0.0 0.0 0.3 0.0 0.7 0.0 0.4 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 10.4 0.1 0.1 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.3 0.0 0.1 7.1 0.0 0.7 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.4 0.1 0.1 0.0 0.2 0.0 0.0 0.2 0.4 1.2 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.3 0.5 1.2 0.7 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.4 1.8 3.5 0.5 0.3 0.3 0.7 0.1 0.1 SUSD6 KIAA0247 ENSG00000100647 "Sushi domain containing 6" Q92537 14 69611596-69715142 "Predicted membrane proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030464 Uncertain Approved "Nucleoplasm,Intermediate filaments" Nucleoplasm "Intermediate filaments" "HPA030464: AB_10601128" "unprognostic (1.04e-1)" "unprognostic (2.29e-1)" "unprognostic (7.34e-2)" "unprognostic (1.58e-2)" "unprognostic (6.94e-2)" "unprognostic (3.46e-2)" "unprognostic (2.17e-1)" "unprognostic (2.73e-2)" "unprognostic (1.57e-1)" "unprognostic (3.66e-3)" "unprognostic (1.10e-2)" "unprognostic (6.70e-2)" "prognostic favourable (2.16e-4)" "unprognostic (1.10e-2)" "unprognostic (5.35e-2)" "unprognostic (1.30e-2)" "unprognostic (2.34e-1)" 25.4 17.4 9.2 26.0 11.9 40.2 19.5 36.4 12.3 12.1 25.0 15.5 14.8 17.2 13.0 31.0 27.0 16.1 19.6 13.2 11.4 8.4 16.7 11.6 30.9 25.3 15.1 8.2 13.4 20.9 13.7 14.6 14.1 13.9 16.0 13.4 14.6 26.6 17.5 10.6 22.5 36.7 14.0 14.1 30.9 17.3 9.1 12.9 12.7 23.4 14.8 27.4 16.4 15.3 4.1 5.3 23.1 9.1 2.9 4.2 5.0 10.6 2.8 4.0 3.7 8.3 6.1 7.4 6.1 12.8 3.5 3.4 3.3 9.5 12.6 6.9 7.6 15.0 2.3 12.5 3.3 21.5 1.7 10.2 2.2 5.4 13.4 1.6 26.5 9.8 12.4 5.8 10.9 7.1 3.1 11.2 4.8 5.2 2.4 4.4 0.8 2.9 4.2 3.5 5.0 6.7 5.5 1.7 2.7 5.0 14.6 2.2 5.9 4.6 10.9 8.1 4.8 5.1 2.4 7.8 1.7 8.9 5.2 5.7 4.2 8.9 7.5 8.3 4.1 7.3 4.2 3.9 3.6 2.5 5.3 4.1 3.5 2.5 23.1 2.9 9.1 3.0 3.2 5.0 9.2 11.9 36.4 12.3 11.4 8.4 15.1 8.2 13.9 12.9 SYCE1L MRP2 ENSG00000205078 "Synaptonemal complex central element protein 1 like" A8MT33 16 77199397-77213215 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 22.4" "Cell line enhanced" "Detected in many" "HEK 293: 12.7;U-698: 9.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA062464, HPA066691" Enhanced "Intermediate filaments" "Intermediate filaments" "HPA062464: , HPA066691: " "unprognostic (5.54e-3)" "unprognostic (2.15e-1)" "unprognostic (1.65e-1)" "prognostic favourable (6.65e-4)" "unprognostic (1.32e-1)" "unprognostic (2.32e-1)" "unprognostic (3.48e-2)" "unprognostic (2.00e-3)" "unprognostic (6.28e-3)" "unprognostic (1.02e-1)" "unprognostic (7.48e-2)" "unprognostic (5.13e-2)" "prognostic unfavourable (2.11e-5)" "unprognostic (9.27e-2)" "unprognostic (4.27e-1)" "unprognostic (2.68e-2)" "unprognostic (1.73e-2)" 3.5 3.4 2.8 4.1 2.7 2.9 3.7 5.2 2.4 8.7 5.0 0.4 11.5 2.1 7.8 7.6 4.4 2.8 1.8 7.0 2.8 3.0 4.3 1.4 1.9 4.5 2.1 1.4 8.5 2.7 2.3 2.3 1.6 1.5 6.6 1.6 5.4 11.1 8.7 1.7 4.3 4.6 2.0 2.5 4.2 2.3 22.4 0.4 6.4 8.0 2.0 2.4 2.3 4.4 3.5 12.2 12.0 2.2 2.7 10.5 3.4 2.8 1.1 2.7 1.3 0.3 0.0 0.5 0.8 0.3 0.5 0.9 0.6 5.6 1.8 3.7 0.6 4.0 0.2 0.0 0.3 1.7 12.7 0.4 1.0 0.0 1.8 0.9 1.2 0.1 0.4 0.1 0.3 1.9 0.7 0.2 0.3 4.1 0.7 1.2 1.8 4.4 6.5 0.7 0.6 2.5 0.7 2.8 3.4 0.4 0.3 0.0 0.1 1.1 6.3 0.4 6.4 0.9 0.2 5.4 2.0 9.9 2.8 0.7 0.1 4.0 1.3 12.0 6.1 2.2 7.3 3.5 7.9 8.4 1.6 2.6 8.7 8.0 1.3 2.7 1.6 12.2 10.5 3.4 2.8 2.7 5.2 2.2 2.8 3.0 2.1 1.4 1.5 0.4 SYNE2 "DKFZP434H2235, KIAA1011, Nesp2, Nesprin-2, NUA, NUANCE, SYNE-2" ENSG00000054654 "Spectrin repeat containing nuclear envelope protein 2" Q8WXH0 14 63852983-64226433 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Actin-binding "Disease mutation, Emery-Dreifuss muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 111.4" "Cell line enhanced" "Detected in many" "Daudi: 43.5" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 6 "cerebellum: 15.8;pons and medulla: 16.3" "Cell type enhanced" "Detected in many" "eosinophil: 30.3" "Group enriched" "Detected in many" 10 "granulocytes: 30.3;T-cells: 16.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003435, HPA050204" Enhanced Supported "Nuclear membrane,Intermediate filaments" "Nuclear membrane, Intermediate filaments" "HPA003435: AB_1080162, HPA050204: AB_2681051" "unprognostic (1.93e-2)" "unprognostic (3.72e-2)" "unprognostic (1.91e-1)" "unprognostic (2.33e-1)" "unprognostic (2.64e-1)" "unprognostic (1.97e-3)" "unprognostic (9.04e-2)" "unprognostic (2.58e-3)" "unprognostic (1.99e-2)" "unprognostic (2.41e-2)" "unprognostic (1.25e-2)" "unprognostic (2.24e-1)" "prognostic favourable (3.56e-9)" "unprognostic (5.05e-3)" "unprognostic (3.14e-1)" "unprognostic (1.51e-2)" "unprognostic (4.80e-2)" 30.8 4.5 2.3 18.0 2.8 5.5 29.7 15.8 3.3 16.1 13.4 1.9 7.7 3.6 18.8 13.6 17.2 7.1 8.6 27.3 2.3 2.4 35.6 13.0 15.2 11.0 2.7 2.1 22.8 22.4 60.1 17.6 14.1 16.3 13.7 4.8 13.0 9.8 9.2 111.4 24.1 10.6 10.2 2.3 16.0 6.9 14.3 1.9 16.9 30.9 29.7 15.8 11.1 26.4 2.3 1.1 30.3 0.1 1.5 16.3 1.3 17.3 5.9 8.7 2.8 8.7 2.6 11.5 1.2 1.2 2.0 3.5 1.9 3.6 43.5 1.8 1.1 8.4 5.7 2.2 2.5 6.6 2.2 0.2 4.3 0.5 1.7 0.7 0.2 3.7 8.2 2.5 2.3 4.5 0.2 3.5 1.4 9.7 4.6 0.2 3.9 1.8 5.4 8.2 1.4 13.2 8.3 8.1 6.0 13.8 3.3 3.7 3.8 0.1 3.9 3.2 5.2 1.0 3.6 4.8 2.1 16.5 0.9 0.0 4.6 0.2 0.0 30.3 16.3 0.1 11.0 2.1 10.0 10.8 0.0 2.3 4.9 7.4 13.3 1.5 0.1 1.1 11.1 1.3 2.3 2.8 15.8 2.6 2.3 2.4 2.7 2.1 16.3 1.9 SYNM "DMN, KIAA0353, SYN" ENSG00000182253 Synemin O15061 15 99098217-99135593 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 111.2;smooth muscle: 147.5;urinary bladder: 85.2" "Cell line enhanced" "Detected in many" "A549: 14.6;HeLa: 21.9;WM-115: 49.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Lineage enriched" "Detected in single" 8 "T-cells: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017192, HPA040066, HPA044200, HPA077856" Enhanced Supported "Intermediate filaments" "Intermediate filaments" "CAB017192: , HPA040066: AB_2676830, HPA044200: AB_2678854, HPA077856: " "unprognostic (1.04e-2)" "unprognostic (1.37e-1)" "unprognostic (3.00e-2)" "unprognostic (6.10e-2)" "unprognostic (1.87e-1)" "unprognostic (1.15e-1)" "unprognostic (3.52e-2)" "unprognostic (1.10e-1)" "unprognostic (2.54e-1)" "unprognostic (1.00e-1)" "unprognostic (1.34e-2)" "unprognostic (6.75e-2)" "unprognostic (3.54e-3)" "unprognostic (2.80e-2)" "unprognostic (7.27e-2)" "unprognostic (5.92e-3)" "unprognostic (3.26e-3)" 6.9 4.2 4.5 5.0 5.4 0.0 11.9 2.5 5.5 2.9 38.4 9.0 27.6 5.4 4.9 7.2 42.1 3.1 9.6 24.8 6.0 5.7 0.8 0.8 2.0 0.7 11.8 4.2 2.9 0.9 1.8 2.0 2.7 8.5 30.1 11.1 10.9 3.2 62.6 111.2 1.5 11.9 147.5 18.2 0.6 16.7 1.5 3.7 0.0 1.4 14.5 1.7 85.2 21.6 0.2 0.1 0.1 0.0 0.2 1.8 0.4 2.5 14.6 3.2 8.7 6.6 0.3 0.2 1.4 2.1 0.8 0.5 2.1 1.9 0.0 2.1 2.1 1.6 2.2 0.0 0.6 0.2 3.6 0.0 21.9 2.1 3.7 0.0 0.4 0.4 0.1 1.4 0.3 1.7 0.0 2.9 2.2 1.4 0.2 0.3 2.9 4.6 0.0 3.0 2.1 0.8 1.4 1.4 1.7 8.6 1.3 5.2 0.0 1.4 1.9 1.6 0.2 1.1 3.4 0.0 0.4 0.0 0.1 0.0 49.6 0.1 0.0 0.0 1.7 0.0 1.4 0.2 1.8 1.1 0.1 0.0 1.6 0.6 0.0 0.2 0.0 0.0 0.0 0.4 4.5 5.4 2.5 4.4 6.0 5.7 11.8 4.2 8.5 3.7 TARS2 "FLJ12528, TARSL1" ENSG00000143374 "Threonyl-tRNA synthetase 2, mitochondrial" Q9BW92 1 150487364-150507609 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028626 Approved Approved "Nucleoplasm,Intermediate filaments,Cytosol" "Nucleoplasm, Cytosol" "Intermediate filaments" "HPA028626: AB_10601719" "unprognostic (2.48e-1)" "unprognostic (7.75e-2)" "unprognostic (6.68e-2)" "unprognostic (3.75e-3)" "unprognostic (2.03e-1)" "unprognostic (1.62e-1)" "unprognostic (4.93e-2)" "unprognostic (2.14e-1)" "unprognostic (9.35e-2)" "unprognostic (4.26e-2)" "unprognostic (2.25e-1)" "unprognostic (3.76e-2)" "unprognostic (9.23e-2)" "unprognostic (9.29e-3)" "unprognostic (4.19e-2)" "unprognostic (1.14e-2)" "unprognostic (5.55e-2)" 10.7 21.1 16.5 10.5 17.8 9.2 11.3 17.5 21.4 10.2 10.9 14.8 12.9 9.4 10.5 14.7 15.7 13.0 11.8 20.9 18.1 12.3 15.6 26.8 9.1 14.0 15.0 19.7 13.3 11.5 20.4 12.2 9.4 16.5 9.8 12.5 13.3 11.3 10.9 36.0 13.3 10.5 10.9 13.8 15.1 12.4 10.7 16.6 10.6 12.3 12.2 15.7 12.5 10.8 21.5 17.4 20.4 18.6 21.5 20.9 12.2 17.0 14.3 9.7 14.5 10.9 10.0 18.4 8.3 9.1 16.5 16.7 11.6 16.0 24.8 18.4 6.2 17.8 23.4 19.3 12.7 14.9 20.3 11.7 13.5 11.7 10.8 16.1 18.0 8.8 16.2 12.5 17.1 10.6 20.3 17.4 11.5 20.7 13.6 13.2 11.9 21.3 14.1 12.3 30.6 11.2 8.1 13.7 16.0 12.6 27.9 19.6 22.5 25.3 6.2 9.7 10.3 7.9 14.0 16.8 19.8 18.7 14.4 18.8 9.3 15.1 11.0 20.4 15.7 18.3 15.6 21.5 15.4 15.5 17.4 18.6 15.1 15.8 1.7 21.5 18.6 11.7 20.9 12.2 16.5 17.8 17.5 21.4 18.1 12.3 15.0 19.7 16.5 16.6 TBC1D16 "FLJ20748, MGC25062" ENSG00000167291 "TBC1 domain family member 16" Q8TBP0 17 79932343-80035848 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 51.3;SK-MEL-30: 54.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "intermediate monocyte: 4.6;naive B-cell: 1.5;non-classical monocyte: 4.7" "Group enriched" "Detected in many" 6 "B-cells: 1.5;monocytes: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024482, HPA065839" Approved Approved "Intermediate filaments" "Intermediate filaments" "HPA024482: AB_1857790, HPA065839: " "unprognostic (4.53e-3)" "unprognostic (1.36e-2)" "unprognostic (1.80e-2)" "unprognostic (2.06e-2)" "unprognostic (4.92e-2)" "unprognostic (7.21e-2)" "unprognostic (1.05e-3)" "unprognostic (1.72e-1)" "unprognostic (5.92e-2)" "unprognostic (1.13e-1)" "unprognostic (2.23e-2)" "unprognostic (9.76e-2)" "unprognostic (1.52e-3)" "unprognostic (3.02e-1)" "unprognostic (1.28e-1)" "unprognostic (3.65e-3)" "unprognostic (3.99e-3)" 32.2 8.1 10.1 7.8 18.2 1.0 32.6 25.5 11.2 10.7 8.6 6.0 28.4 7.5 11.9 20.9 9.8 12.8 9.3 10.0 8.1 7.8 18.1 13.2 8.5 13.7 8.7 5.6 11.8 18.7 9.3 6.6 7.1 8.2 17.3 5.8 15.4 25.5 24.2 4.5 15.8 7.9 10.8 8.1 8.7 7.6 5.2 9.5 2.7 9.7 7.0 3.9 9.2 14.6 1.5 0.3 0.1 4.7 0.1 0.5 0.3 8.0 7.7 12.0 14.1 51.3 27.1 2.3 4.7 4.7 3.0 3.4 14.5 2.8 0.0 3.3 7.9 2.5 12.7 4.4 2.3 0.4 5.9 0.0 3.5 6.7 8.7 0.1 1.1 30.4 7.9 6.5 4.7 12.7 1.9 5.4 5.5 4.9 2.1 0.7 14.4 4.2 6.8 7.6 4.6 3.5 9.9 12.3 16.0 4.2 11.8 54.4 7.7 3.6 8.5 10.5 7.5 8.2 4.1 16.8 2.9 0.8 4.5 3.0 13.2 0.0 0.3 0.0 0.1 4.6 0.5 0.0 0.1 0.2 0.3 1.5 0.2 0.3 0.1 0.1 4.7 0.0 0.0 0.3 10.1 18.2 25.5 11.2 8.1 7.8 8.7 5.6 8.2 9.5 TEKT4 MGC27019 ENSG00000163060 "Tektin 4" Q8WW24 2 94871433-94876829 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 7.6;testis: 21.1" "Cell line enhanced" "Detected in some" "A549: 1.0;fHDF/TERT166: 1.8;HEK 293: 1.0;HEL: 1.3;HMC-1: 1.0;MCF7: 1.5" "Cancer enriched" "Detected in single" 5 "endometrial cancer: 2.7" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA048600, HPA053929, HPA069872" Approved Uncertain "Intermediate filaments" "Intermediate filaments" "HPA048600: AB_2680460, HPA053929: , HPA069872: " "unprognostic (1.49e-2)" "unprognostic (4.00e-1)" "prognostic favourable (1.29e-4)" "unprognostic (9.95e-2)" "unprognostic (1.25e-1)" "unprognostic (2.35e-3)" "unprognostic (2.82e-3)" "unprognostic (2.15e-1)" "unprognostic (5.25e-2)" "unprognostic (5.00e-2)" "unprognostic (9.01e-2)" "unprognostic (5.25e-3)" "unprognostic (5.45e-3)" "unprognostic (2.33e-1)" "unprognostic (3.27e-2)" "unprognostic (7.56e-3)" 0.1 0.1 0.7 0.2 1.5 0.1 0.1 0.2 0.2 0.6 0.1 1.4 0.7 0.1 0.5 5.5 0.1 7.6 0.1 0.1 0.9 0.9 0.1 0.1 3.7 0.1 0.1 0.2 1.7 0.2 0.1 0.0 0.1 2.9 0.1 0.1 0.0 0.7 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 21.1 0.3 0.0 1.0 0.0 0.1 0.1 0.0 1.1 1.8 0.7 0.6 0.1 0.8 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.6 1.8 0.0 0.0 0.0 0.0 0.3 1.0 1.3 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.7 0.6 0.4 0.3 1.1 0.6 0.7 0.8 0.6 0.8 0.5 0.0 0.1 0.6 1.8 0.6 0.3 0.7 1.5 0.2 0.2 0.9 0.9 0.1 0.2 2.9 0.3 TFPI "EPI, LACI, TFI, TFPI1" ENSG00000003436 "Tissue factor pathway inhibitor" P10646 2 187464230-187565760 "Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Protease inhibitor, Serine protease inhibitor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 98.2;placenta: 192.3" "Cell line enhanced" "Detected in many" "HHSteC: 55.2;HUVEC TERT2: 103.8;LHCN-M2: 63.6;TIME: 62.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.5;plasmacytoid DC: 5.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA005575, CAB020842" Supported Approved "Intermediate filaments,Cytosol" "Secreted to blood" 95000000 Cytosol "Intermediate filaments" "CAB020842: , HPA005575: AB_1080290" "unprognostic (8.75e-2)" "prognostic unfavourable (2.02e-4)" "unprognostic (7.95e-2)" "unprognostic (4.99e-2)" "unprognostic (2.32e-2)" "unprognostic (1.48e-1)" "unprognostic (3.05e-1)" "unprognostic (5.63e-2)" "unprognostic (3.86e-3)" "unprognostic (9.22e-2)" "unprognostic (2.43e-2)" "unprognostic (2.72e-2)" "unprognostic (7.05e-2)" "unprognostic (3.39e-3)" "unprognostic (4.05e-2)" "unprognostic (4.49e-2)" "unprognostic (5.81e-2)" 52.8 5.0 1.3 5.2 2.2 1.6 18.5 1.9 2.4 22.8 32.1 0.3 7.2 12.8 13.3 14.8 25.9 12.5 15.0 14.0 1.2 1.1 35.6 98.2 89.7 40.2 2.4 1.0 17.3 7.7 0.9 4.9 192.3 2.3 18.2 6.9 3.8 6.0 3.8 15.8 6.6 37.0 13.6 5.4 16.5 7.7 13.7 1.6 3.4 22.6 10.4 4.0 30.0 14.7 1.5 5.1 5.5 0.6 1.0 0.6 4.9 5.0 3.5 4.1 0.1 32.1 38.5 0.0 9.1 21.7 5.9 9.2 3.2 27.0 0.0 3.6 7.1 0.3 1.2 0.4 15.5 0.2 1.0 1.6 10.9 27.4 55.2 0.1 0.0 17.6 0.7 32.1 8.6 103.8 4.0 0.1 63.6 4.7 0.6 0.1 2.5 8.8 0.0 5.7 0.0 10.1 0.2 0.0 0.0 7.4 0.2 0.4 0.1 0.0 62.1 4.3 4.0 8.5 1.7 0.0 0.1 0.0 34.6 0.0 4.9 5.5 0.6 0.5 0.5 0.3 0.2 0.9 0.4 0.2 0.5 1.5 0.5 0.6 2.6 1.0 0.3 5.1 0.2 4.9 1.3 2.2 1.9 2.4 1.2 1.1 2.4 1.0 2.3 1.6 TMEM131 "CC28, KIAA0257, PRO1048, RW1, YR-23" ENSG00000075568 "Transmembrane protein 131" Q92545 2 97756333-97995891 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017678, HPA017682" Approved Uncertain "Vesicles,Intermediate filaments" "Vesicles, Intermediate filaments" "HPA017678: AB_1858086, HPA017682: AB_1858087" "unprognostic (1.16e-2)" "unprognostic (1.39e-1)" "unprognostic (1.04e-1)" "unprognostic (7.42e-2)" "unprognostic (8.58e-2)" "unprognostic (4.18e-2)" "unprognostic (7.59e-3)" "unprognostic (3.26e-1)" "unprognostic (1.53e-1)" "unprognostic (3.78e-2)" "unprognostic (1.61e-1)" "unprognostic (1.06e-1)" "unprognostic (5.10e-3)" "unprognostic (5.37e-2)" "unprognostic (1.43e-1)" "unprognostic (2.72e-1)" "unprognostic (1.77e-1)" 16.6 19.4 13.7 33.6 19.2 15.8 15.6 18.5 19.4 21.0 25.5 19.1 14.5 18.6 21.8 15.7 19.9 17.3 20.1 17.3 11.7 12.1 14.6 15.8 15.7 24.0 14.1 14.0 21.2 22.0 31.4 27.8 30.9 15.0 17.7 24.1 14.6 18.6 12.7 31.4 24.2 23.6 21.1 13.2 22.5 26.3 14.4 15.3 23.2 14.7 16.8 27.6 20.5 16.7 4.5 5.2 7.3 3.5 5.4 5.4 2.2 13.3 8.2 15.5 11.2 16.3 19.8 16.9 19.9 19.5 10.2 12.3 10.6 19.4 21.4 11.0 20.5 9.7 16.2 26.6 15.2 15.1 10.5 15.5 5.8 15.2 18.4 14.4 20.9 18.9 10.9 18.1 18.9 12.5 9.2 22.9 31.0 8.0 10.4 9.2 8.5 17.8 15.3 9.9 9.4 10.5 16.0 17.5 8.5 12.9 8.9 12.2 7.5 13.4 14.8 26.7 12.3 12.8 7.6 9.8 13.4 10.8 20.9 12.7 18.0 7.3 2.8 7.3 4.0 3.5 4.6 4.5 3.4 4.0 3.7 4.2 4.2 5.4 1.9 5.4 3.2 5.2 2.1 2.2 13.7 19.2 18.5 19.4 11.7 12.1 14.1 14.0 15.0 15.3 TMEM81 "HC3107, KVLA2788, MGC75217, UNQ2788" ENSG00000174529 "Transmembrane protein 81" Q6P7N7 1 205083129-205084460 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA052515 Approved "Intermediate filaments" "Intermediate filaments" "HPA052515: " "unprognostic (9.19e-3)" "unprognostic (3.53e-1)" "unprognostic (1.91e-3)" "unprognostic (6.48e-2)" "unprognostic (2.44e-1)" "unprognostic (2.08e-1)" "prognostic unfavourable (3.25e-6)" "unprognostic (3.66e-2)" "unprognostic (2.68e-2)" "unprognostic (6.18e-2)" "unprognostic (5.86e-2)" "unprognostic (2.48e-2)" "prognostic unfavourable (6.65e-9)" "unprognostic (8.91e-2)" "unprognostic (6.24e-2)" "unprognostic (2.42e-1)" "prognostic favourable (2.67e-4)" 1.5 2.7 2.8 1.6 3.8 2.0 2.1 11.2 5.3 2.1 1.3 1.2 1.5 3.5 1.4 1.2 1.1 2.2 3.3 2.7 4.2 3.3 1.5 2.3 2.8 2.3 1.0 3.4 2.2 2.0 1.8 1.7 1.4 2.1 4.6 4.1 1.2 1.7 2.4 3.0 1.0 6.1 1.4 2.7 0.9 1.6 1.5 1.5 4.3 1.4 0.2 4.6 0.9 2.4 3.7 6.2 8.2 9.1 3.6 3.2 4.5 2.7 2.3 1.4 6.6 1.7 4.5 3.2 2.5 2.1 10.0 3.8 4.1 3.9 3.9 3.7 5.2 3.3 6.3 1.9 2.1 3.7 6.9 3.6 1.8 4.6 8.4 1.9 2.9 4.7 4.4 8.2 4.8 5.4 3.0 7.2 4.7 5.4 2.3 3.9 6.1 2.8 3.4 7.2 2.5 8.1 2.1 4.4 2.3 5.6 4.9 4.3 5.3 3.6 6.3 2.9 7.4 4.3 1.2 0.2 4.6 1.4 0.2 1.5 2.3 1.1 1.5 1.4 2.5 4.0 2.5 0.2 1.4 1.5 2.7 0.9 TNNI2 "AMCD2B, DA2B, FSSV" ENSG00000130598 "Troponin I2, fast skeletal type" P48788 11 1838989-1841680 "Disease related genes, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "skeletal muscle: 635.0;tongue: 527.7" "Group enriched" "Detected in some" 6 "CAPAN-2: 22.7;hTCEpi: 65.2" "Group enriched" "Detected in many" 10 "cervical cancer: 12.7;head and neck cancer: 33.6;pancreatic cancer: 12.9;urothelial cancer: 39.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 46.4" "Group enriched" "Detected in many" 4 "dendritic cells: 46.4;granulocytes: 26.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "CAB018697, HPA055938" Enhanced Approved "Plasma membrane,Intermediate filaments" 29000 "Plasma membrane" "Intermediate filaments" "CAB018697: AB_628400, HPA055938: " "unprognostic (2.03e-2)" "unprognostic (1.13e-1)" "unprognostic (1.29e-2)" "unprognostic (3.70e-1)" "unprognostic (1.85e-1)" "unprognostic (1.02e-2)" "unprognostic (9.99e-3)" "unprognostic (1.01e-1)" "unprognostic (1.73e-1)" "unprognostic (1.51e-1)" "unprognostic (1.10e-1)" "unprognostic (2.70e-1)" "unprognostic (1.23e-3)" "unprognostic (5.92e-3)" "unprognostic (5.62e-2)" "unprognostic (1.77e-1)" "unprognostic (2.79e-2)" 13.9 0.1 0.1 0.1 0.1 0.5 0.6 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 16.5 11.6 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.5 0.2 0.1 0.0 0.1 0.5 0.0 0.1 0.3 0.0 1.2 0.1 0.0 15.7 0.4 635.0 4.8 0.2 0.1 0.2 0.4 0.1 0.1 0.0 0.0 3.0 527.7 11.5 2.1 0.1 2.3 46.4 26.7 8.6 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.5 22.7 0.6 0.1 0.0 1.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 5.4 65.2 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.8 1.4 0.0 0.6 0.0 0.6 0.0 0.4 0.0 7.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 6.1 3.1 26.7 0.0 6.5 0.0 1.9 0.0 0.0 4.3 2.3 0.0 0.0 21.1 0.2 8.6 46.4 0.0 1.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 TOM1L2 ENSG00000175662 "Target of myb1 like 2 membrane trafficking protein" Q6ZVM7 17 17843511-17972422 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 81.5" "Cell line enhanced" "Detected in many" "HaCaT: 46.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022541, HPA023304" Enhanced Supported "Golgi apparatus,Intermediate filaments" 66000 "Intermediate filaments" "Golgi apparatus" "HPA022541: AB_1858182, HPA023304: AB_1858183" "unprognostic (2.32e-1)" "unprognostic (7.54e-2)" "unprognostic (1.12e-1)" "unprognostic (2.57e-2)" "unprognostic (3.25e-2)" "prognostic favourable (1.24e-4)" "unprognostic (2.22e-1)" "unprognostic (1.08e-1)" "unprognostic (6.29e-2)" "prognostic unfavourable (2.58e-4)" "prognostic favourable (1.92e-4)" "unprognostic (3.19e-2)" "prognostic favourable (6.21e-9)" "unprognostic (7.11e-2)" "unprognostic (1.40e-1)" "unprognostic (4.18e-2)" "unprognostic (4.51e-2)" 11.8 14.8 24.7 7.3 27.4 3.5 10.4 23.2 38.2 10.5 12.8 32.3 8.7 8.8 12.8 8.2 35.9 12.7 8.8 81.5 25.9 21.8 13.1 4.4 14.4 4.8 24.4 23.8 15.7 12.2 28.7 14.4 6.3 42.3 21.1 9.7 19.5 9.7 19.3 32.0 29.0 10.5 16.0 16.4 7.7 10.9 14.7 20.9 4.3 24.8 13.7 10.5 12.0 11.0 2.7 2.2 14.6 3.9 1.4 5.3 1.8 11.1 13.4 3.6 2.8 8.9 9.0 5.7 19.3 9.1 10.9 9.1 12.3 8.1 2.0 25.3 18.9 46.8 2.9 11.3 6.5 3.1 5.2 3.4 12.1 2.3 5.5 0.7 2.3 10.6 7.8 9.9 7.4 10.9 1.2 3.0 13.8 11.7 1.4 1.8 0.6 8.2 1.9 8.7 5.0 14.2 21.9 4.1 3.8 8.6 11.2 6.9 5.7 1.5 13.9 10.1 2.7 20.3 7.0 2.6 2.1 0.8 11.7 1.0 24.2 7.1 3.9 5.1 3.5 1.2 2.5 2.0 3.2 2.8 1.8 2.7 5.3 3.9 14.6 1.4 3.4 2.2 1.5 1.8 24.7 27.4 23.2 38.2 25.9 21.8 24.4 23.8 42.3 20.9 TRIM29 "ATDC, FLJ36085" ENSG00000137699 "Tripartite motif containing 29" Q14134 11 120111275-120185529 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 176.3;lymphoid tissue: 93.6;skin 1: 90.1;tongue: 113.6" "Cell line enhanced" "Detected in some" "HaCaT: 53.0;hTCEpi: 70.5;RT4: 27.9;SiHa: 39.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 93.4" "Region enriched" "Detected in single" 8 "pons and medulla: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA020053 Enhanced Supported "Nucleoplasm,Intermediate filaments" "Nucleoplasm, Intermediate filaments" "HPA020053: AB_1858280" "unprognostic (1.10e-1)" "unprognostic (6.22e-2)" "unprognostic (1.53e-1)" "prognostic unfavourable (2.88e-4)" "unprognostic (9.79e-3)" "unprognostic (3.08e-2)" "unprognostic (3.30e-1)" "unprognostic (5.24e-3)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "prognostic unfavourable (4.46e-4)" "unprognostic (9.37e-2)" "unprognostic (4.29e-3)" "prognostic favourable (4.93e-4)" "unprognostic (2.59e-1)" "unprognostic (2.91e-2)" "unprognostic (4.15e-2)" 0.3 0.2 0.1 0.0 0.1 0.1 7.3 0.0 0.1 30.4 0.6 0.2 1.6 0.3 3.1 2.9 176.3 3.7 0.8 0.1 0.1 0.1 0.5 0.4 1.4 0.0 0.0 0.0 0.4 0.2 0.0 2.2 24.4 1.1 11.1 0.5 0.0 25.5 4.8 0.9 90.1 0.2 1.6 0.3 0.0 0.2 0.7 0.0 7.5 0.1 113.6 93.6 9.6 42.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 3.3 0.0 0.8 0.0 53.0 0.0 12.1 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.1 0.0 70.5 0.0 0.5 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.9 0.2 0.9 39.6 5.6 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 1.1 0.0 TRIM32 "BBS11, HT2A, LGMD2H, TATIP" ENSG00000119401 "Tripartite motif containing 32" Q13049 9 116687302-116701300 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Limb-girdle muscular dystrophy, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050060 Approved Approved "Intermediate filaments" "Intermediate filaments" "HPA050060: " "unprognostic (2.47e-2)" "unprognostic (7.06e-3)" "unprognostic (5.50e-2)" "unprognostic (3.63e-1)" "unprognostic (5.08e-2)" "prognostic unfavourable (4.53e-4)" "prognostic unfavourable (4.72e-4)" "unprognostic (2.41e-3)" "unprognostic (2.92e-1)" "unprognostic (5.01e-2)" "unprognostic (1.79e-2)" "unprognostic (5.63e-2)" "unprognostic (6.03e-2)" "unprognostic (7.06e-2)" "unprognostic (2.73e-1)" "unprognostic (6.64e-3)" "unprognostic (9.77e-2)" 9.5 9.1 6.6 5.8 11.5 0.8 8.0 23.2 17.1 12.8 7.9 7.2 6.2 6.7 17.0 8.0 8.8 15.9 8.2 8.9 5.7 7.3 6.2 5.0 6.3 8.4 5.7 9.8 12.6 12.5 12.2 7.7 7.0 9.1 10.3 7.4 10.4 10.9 9.2 23.9 6.6 8.9 12.9 5.3 6.9 6.8 6.5 2.2 9.4 8.4 6.2 8.3 11.1 8.8 6.1 3.5 0.2 2.6 5.6 16.0 4.7 6.4 14.9 8.8 9.7 17.9 12.9 6.7 12.1 13.3 13.8 11.6 9.9 7.1 6.7 5.4 18.5 13.9 10.7 13.6 12.6 5.9 5.2 3.6 9.6 6.0 9.3 2.4 11.9 11.0 12.3 13.0 7.7 8.9 5.0 5.7 16.1 8.3 6.4 0.0 8.0 9.0 7.6 23.7 4.4 5.6 15.2 8.8 4.5 9.5 6.6 6.9 18.4 2.4 11.0 12.8 10.3 9.4 9.1 9.4 2.5 10.5 10.7 1.6 12.5 0.0 1.3 0.0 9.3 2.6 7.2 6.1 8.2 7.4 1.8 4.4 8.3 8.4 0.2 5.6 2.1 3.5 16.0 4.7 6.6 11.5 23.2 17.1 5.7 7.3 5.7 9.8 9.1 2.2 TRIM52 RNF102 ENSG00000183718 "Tripartite motif containing 52" Q96A61 5 181254417-181261139 "Predicted intracellular proteins" "Antiviral defense, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA054565, HPA056819" Approved Approved "Nucleoli,Intermediate filaments" Nucleoli "Intermediate filaments" "HPA054565: , HPA056819: " "unprognostic (1.21e-1)" "unprognostic (1.43e-1)" "unprognostic (2.38e-2)" "unprognostic (5.23e-1)" "unprognostic (2.75e-1)" "unprognostic (1.10e-1)" "unprognostic (5.16e-2)" "unprognostic (3.98e-2)" "unprognostic (7.37e-2)" "unprognostic (2.71e-1)" "unprognostic (2.24e-3)" "unprognostic (7.48e-3)" "prognostic unfavourable (3.46e-4)" "unprognostic (2.96e-1)" "unprognostic (6.41e-2)" "unprognostic (1.33e-2)" "prognostic favourable (4.07e-4)" 9.2 13.0 17.8 15.3 19.7 10.9 11.5 42.3 24.2 10.9 10.9 9.8 15.4 11.8 12.1 14.3 6.6 10.3 8.2 9.1 15.0 10.5 11.2 9.7 11.0 18.8 18.0 12.0 17.7 14.6 15.3 19.4 8.6 16.2 13.8 10.2 8.1 14.0 15.6 9.8 14.5 12.6 8.3 14.0 16.9 11.3 11.7 20.8 15.3 16.8 5.0 13.9 10.3 15.1 5.4 2.7 5.6 2.5 5.5 11.2 3.7 3.5 4.2 6.8 8.7 12.4 7.9 6.1 4.0 3.5 3.9 3.4 6.0 6.7 7.8 4.3 4.3 6.7 3.7 5.3 4.6 13.4 7.7 3.0 15.9 5.0 3.0 9.1 7.0 7.9 4.5 4.2 2.4 4.6 3.2 18.6 4.0 6.8 5.0 8.4 2.4 5.4 6.0 3.7 5.3 3.2 4.8 7.8 6.3 5.7 4.1 3.6 7.7 6.3 5.5 7.8 4.1 3.6 3.7 13.7 6.6 5.4 8.9 8.1 3.0 5.0 2.5 5.6 8.4 2.2 9.3 5.4 9.0 9.2 2.0 4.2 11.2 8.9 2.6 5.5 2.0 2.7 5.9 3.7 17.8 19.7 42.3 24.2 15.0 10.5 18.0 12.0 16.2 20.8 TTBK2 "KIAA0847, SCA11" ENSG00000128881 "Tau tubulin kinase 2" Q6IQ55 15 42738734-42920809 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Kinase, Serine/threonine-protein kinase, Transferase" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 41.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018113, HPA049866" Approved Uncertain "Intermediate filaments" "Intermediate filaments" "HPA018113: AB_1858421, HPA049866: " "unprognostic (2.15e-1)" "unprognostic (1.67e-1)" "unprognostic (1.08e-1)" "unprognostic (6.30e-2)" "unprognostic (7.73e-2)" "unprognostic (4.26e-1)" "unprognostic (6.64e-2)" "unprognostic (5.11e-2)" "unprognostic (1.32e-1)" "unprognostic (2.43e-2)" "unprognostic (2.78e-2)" "unprognostic (8.62e-2)" "unprognostic (3.46e-2)" "unprognostic (7.29e-2)" "unprognostic (3.63e-2)" "unprognostic (2.18e-1)" "unprognostic (1.38e-1)" 6.7 7.3 8.7 5.1 14.0 8.0 6.0 17.8 22.0 7.0 7.2 10.9 3.8 3.3 8.5 6.2 4.2 7.8 6.2 10.7 9.4 11.5 6.1 4.3 6.1 5.5 11.1 14.8 11.5 3.3 9.0 13.9 8.8 24.7 8.2 5.6 7.6 4.8 6.5 11.6 6.3 4.6 8.4 10.9 7.1 4.9 41.8 10.8 3.6 6.7 1.9 5.4 6.8 8.7 2.5 1.4 1.3 3.0 2.1 3.1 0.7 6.1 3.4 9.2 4.9 6.3 6.6 1.9 5.1 7.2 4.4 6.6 4.6 1.4 4.0 6.4 4.8 4.1 8.1 6.0 6.7 12.9 5.7 4.9 7.6 1.9 4.9 7.0 8.6 5.2 6.2 3.9 20.8 5.5 7.4 6.5 4.1 0.8 4.7 5.0 2.6 3.8 7.9 8.7 1.9 5.5 3.8 6.9 7.8 12.4 0.9 2.6 3.2 8.7 6.7 5.7 5.7 7.0 7.0 7.5 10.0 5.9 4.2 5.5 3.6 0.4 3.0 1.2 1.7 1.4 3.1 1.5 1.6 1.3 0.8 2.5 2.1 1.5 1.3 2.1 1.5 1.4 0.5 0.7 8.7 14.0 17.8 22.0 9.4 11.5 11.1 14.8 24.7 10.8 TTC26 "dyf-13, DYF13, FLJ12571, IFT56" ENSG00000105948 "Tetratricopeptide repeat domain 26" A0AVF1 7 139133744-139191986 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036338, HPA036339" Enhanced Approved "Nuclear speckles,Intermediate filaments,Cytosol" "Nuclear speckles, Intermediate filaments, Cytosol" "HPA036338: AB_10673351, HPA036339: AB_10673386" "unprognostic (3.40e-2)" "unprognostic (8.88e-2)" "unprognostic (5.01e-2)" "unprognostic (6.72e-2)" "unprognostic (8.34e-3)" "unprognostic (1.45e-1)" "unprognostic (2.46e-7)" "unprognostic (1.72e-1)" "unprognostic (4.96e-2)" "unprognostic (5.27e-2)" "unprognostic (7.12e-2)" "unprognostic (2.75e-1)" "unprognostic (5.18e-2)" "unprognostic (1.16e-1)" "unprognostic (1.38e-1)" "unprognostic (1.15e-1)" "unprognostic (1.56e-1)" 3.5 6.5 6.9 2.5 8.1 3.3 5.6 6.9 8.3 6.1 3.1 4.4 7.4 1.3 6.6 7.6 3.1 20.9 4.5 3.5 5.7 5.1 8.3 1.9 5.1 2.8 2.7 4.8 8.8 3.2 13.0 20.1 3.8 8.4 5.6 2.8 5.4 3.6 5.5 2.3 3.2 2.2 4.6 2.7 2.6 3.1 17.4 3.9 3.8 7.3 2.8 3.1 3.7 3.9 3.6 2.5 5.3 1.5 1.6 2.3 0.9 11.3 8.6 7.6 9.0 9.5 11.1 3.8 5.5 5.8 9.1 9.3 5.5 8.2 2.5 9.3 4.3 5.7 8.5 6.5 13.3 7.1 7.3 3.1 6.9 4.7 4.7 8.8 2.1 6.3 5.9 13.6 6.2 6.7 6.8 1.6 7.2 10.7 14.9 10.3 7.6 7.6 5.2 9.0 4.0 7.9 3.4 11.2 8.0 13.7 5.8 7.8 7.0 4.7 4.6 8.5 7.4 7.7 10.2 3.7 4.6 1.9 14.9 4.3 9.9 1.2 0.5 1.2 2.1 0.5 1.1 3.6 1.5 1.4 1.1 2.4 2.3 1.7 5.3 1.6 1.5 2.5 1.0 0.9 6.9 8.1 6.9 8.3 5.7 5.1 2.7 4.8 8.4 3.9 TTC4 "CNS1, FLJ41930, MGC5097" ENSG00000243725 "Tetratricopeptide repeat domain 4" O95801 1 54715822-54742657 "Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041608, HPA042459" Approved Enhanced "Intermediate filaments,Cytoplasmic bodies" "Intermediate filaments" "Cytoplasmic bodies" "HPA041608: AB_10794485, HPA042459: AB_10797496" "unprognostic (4.89e-2)" "unprognostic (1.81e-1)" "unprognostic (2.05e-2)" "unprognostic (8.62e-4)" "unprognostic (8.91e-2)" "unprognostic (1.34e-1)" "unprognostic (1.21e-5)" "unprognostic (1.39e-4)" "unprognostic (1.51e-2)" "unprognostic (1.47e-1)" "unprognostic (3.18e-1)" "unprognostic (2.42e-3)" "unprognostic (7.12e-2)" "unprognostic (2.85e-1)" "unprognostic (7.79e-2)" "unprognostic (5.86e-2)" "unprognostic (1.76e-3)" 10.9 10.6 14.5 13.4 17.6 3.5 17.1 13.7 14.0 18.2 10.9 12.8 12.7 9.1 14.9 14.1 11.9 15.7 8.0 13.4 14.6 14.0 13.2 16.4 8.9 13.0 13.5 9.3 18.5 16.6 15.6 14.6 12.5 12.9 13.5 10.8 9.2 13.1 14.7 33.3 14.7 8.5 12.8 20.4 10.3 11.2 13.3 12.0 11.7 11.5 15.1 14.0 11.4 13.6 11.5 11.3 8.6 11.7 15.0 14.9 10.5 9.8 7.5 8.8 4.5 14.3 7.3 7.8 13.6 6.8 17.7 10.7 9.3 2.8 18.3 7.3 9.1 5.7 19.8 13.4 17.9 15.5 15.6 17.6 3.4 5.3 12.6 13.3 4.3 6.5 13.7 25.8 15.8 7.2 18.8 2.3 9.6 4.7 11.8 8.0 18.6 14.3 10.9 18.8 8.3 8.7 2.8 5.8 4.1 11.6 6.1 11.4 5.6 7.3 7.0 8.7 9.6 8.7 18.3 6.6 11.6 14.5 11.1 15.2 8.8 5.9 10.3 8.6 12.5 11.7 13.3 11.5 10.3 11.8 11.3 11.0 14.9 13.2 0.2 15.0 11.3 9.6 9.3 10.5 14.5 17.6 13.7 14.0 14.6 14.0 13.5 9.3 12.9 12.0 UAP1L1 ENSG00000197355 "UDP-N-acetylglucosamine pyrophosphorylase 1 like 1" Q3KQV9 9 137077501-137084539 "Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 29.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044356 Approved Approved "Intermediate filaments,Cytosol" "Intermediate filaments" Cytosol "HPA044356: AB_10959902" "unprognostic (1.93e-1)" "unprognostic (1.11e-2)" "unprognostic (1.30e-1)" "unprognostic (1.25e-3)" "unprognostic (2.49e-2)" "unprognostic (3.80e-1)" "prognostic unfavourable (3.77e-4)" "unprognostic (3.01e-2)" "unprognostic (2.33e-1)" "unprognostic (5.65e-2)" "prognostic favourable (5.23e-4)" "unprognostic (1.22e-1)" "unprognostic (5.06e-2)" "unprognostic (1.67e-2)" "unprognostic (6.42e-2)" "unprognostic (3.28e-2)" "unprognostic (5.64e-3)" 10.5 14.7 13.6 9.8 20.6 5.0 16.3 3.4 17.5 13.0 8.8 22.1 8.6 10.0 7.3 9.7 5.9 5.8 9.4 11.3 14.7 8.1 12.5 3.1 11.6 12.2 24.9 9.3 3.9 10.5 8.5 14.7 10.9 14.2 12.8 6.7 14.1 15.2 10.9 2.5 9.0 9.4 6.6 13.5 20.3 10.8 3.5 29.1 1.4 13.3 4.9 10.3 11.4 13.9 2.1 1.8 0.6 3.7 0.3 3.0 1.2 0.4 2.8 0.0 7.6 13.1 6.1 2.2 3.8 10.1 10.9 7.6 5.5 1.3 1.7 2.3 3.9 5.8 14.2 0.9 2.2 4.6 1.3 3.7 4.2 5.2 29.2 0.0 15.4 4.5 1.0 6.2 5.1 8.5 1.1 8.7 7.3 6.2 0.3 3.8 1.2 4.0 6.0 0.1 5.3 4.3 0.5 4.5 2.8 0.9 21.3 8.6 11.5 10.3 6.7 19.7 4.3 13.7 1.8 9.5 13.6 3.7 17.1 4.0 5.6 0.4 3.7 0.1 0.8 2.0 3.0 2.1 0.4 1.3 1.8 1.0 1.0 1.3 0.6 0.3 0.0 1.1 1.7 1.2 13.6 20.6 3.4 17.5 14.7 8.1 24.9 9.3 14.2 29.1 UBE2K "HIP2, HYPG, UBC1" ENSG00000078140 "Ubiquitin conjugating enzyme E2 K" P61086 4 39698044-39782792 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028869, CAB033212, CAB033515" Supported Supported "Intermediate filaments,Actin filaments,Cytosol" 150000 Cytosol "Intermediate filaments, Actin filaments" "CAB033212: AB_2272506, CAB033515: AB_2304024, HPA028869: AB_10602487" "unprognostic (1.14e-2)" "unprognostic (6.02e-2)" "unprognostic (2.42e-3)" "unprognostic (3.06e-1)" "unprognostic (6.81e-2)" "unprognostic (2.05e-1)" "unprognostic (5.05e-3)" "unprognostic (1.44e-2)" "unprognostic (2.71e-3)" "unprognostic (1.01e-1)" "prognostic unfavourable (8.60e-4)" "unprognostic (1.08e-1)" "unprognostic (3.67e-1)" "unprognostic (4.83e-2)" "unprognostic (6.88e-2)" "unprognostic (1.22e-1)" "unprognostic (4.10e-3)" 27.2 21.8 27.0 21.2 27.6 17.3 21.6 38.6 40.7 17.0 33.2 11.8 14.1 29.1 19.9 18.5 29.9 14.9 18.5 28.1 27.7 26.8 26.6 44.5 17.1 17.9 24.1 26.4 16.9 15.8 18.9 26.9 29.8 25.2 19.7 24.0 13.4 18.4 17.3 31.8 22.0 24.6 18.8 19.2 16.9 29.3 16.0 15.9 21.3 23.6 19.7 18.8 22.8 20.4 17.6 23.7 20.6 19.9 10.9 14.1 8.9 23.8 24.5 13.2 12.5 8.3 7.8 22.5 32.9 7.0 8.8 9.3 37.0 24.6 29.8 29.0 9.2 10.1 25.4 14.3 14.2 20.0 18.2 38.6 24.8 32.0 10.4 41.4 21.9 7.3 16.2 12.4 13.4 11.5 39.2 10.7 9.1 23.1 28.9 23.0 17.6 18.7 17.1 39.7 11.2 12.3 33.3 27.4 12.1 24.6 9.3 14.7 12.0 13.9 31.5 13.8 29.3 16.4 30.2 15.2 44.3 32.8 7.2 26.6 16.1 13.9 16.6 20.6 13.5 14.3 12.7 17.6 14.1 12.6 16.6 12.5 10.7 12.0 13.3 10.9 19.9 23.7 13.7 8.9 27.0 27.6 38.6 37.7 27.7 26.8 24.1 26.4 25.2 15.9 UNC13B "hmunc13, UNC13, Unc13h2" ENSG00000198722 "Unc-13 homolog B" O14795 9 35161992-35405338 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.9" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024493, HPA062300" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles,Intermediate filaments" Vesicles "Nucleoplasm, Golgi apparatus, Intermediate filaments" "HPA024493: AB_1858618, HPA062300: " "unprognostic (9.73e-3)" "unprognostic (2.33e-1)" "prognostic favourable (4.96e-4)" "unprognostic (6.56e-2)" "unprognostic (9.93e-2)" "prognostic favourable (8.51e-5)" "unprognostic (7.64e-2)" "prognostic favourable (6.59e-5)" "unprognostic (3.80e-1)" "unprognostic (1.64e-1)" "prognostic favourable (3.71e-4)" "unprognostic (1.74e-1)" "prognostic favourable (4.34e-11)" "unprognostic (2.40e-1)" "unprognostic (1.89e-1)" "unprognostic (1.48e-1)" "unprognostic (2.80e-2)" 11.9 12.1 9.3 9.0 18.3 1.4 10.4 16.6 18.8 12.2 21.4 10.1 35.0 11.5 10.6 8.4 14.9 11.1 14.6 11.1 9.2 7.1 22.1 21.5 37.6 2.2 9.5 9.5 7.9 28.7 21.7 13.7 6.3 10.1 20.5 25.1 27.2 20.7 33.6 21.1 14.6 13.0 12.2 9.4 5.0 15.8 16.2 9.1 0.8 12.5 11.6 5.8 8.6 10.4 0.9 1.9 0.0 0.4 0.0 0.3 0.4 5.4 7.3 8.1 13.0 15.7 8.8 6.9 8.9 4.1 6.6 9.0 6.0 2.5 0.0 4.1 11.6 2.6 20.4 10.4 8.5 0.0 6.5 3.3 20.7 7.7 7.6 1.2 3.8 6.9 8.2 10.5 10.9 21.4 7.4 4.7 7.8 4.2 1.1 0.1 7.3 7.7 0.0 5.0 1.9 9.1 7.1 8.7 9.2 6.3 3.9 6.5 6.7 4.2 19.6 4.6 4.3 7.1 6.8 7.4 8.8 0.0 5.0 10.4 4.6 0.0 0.4 0.0 0.0 0.3 0.0 0.9 0.3 0.3 1.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 9.3 18.3 16.6 18.8 9.2 7.1 9.5 9.5 10.1 9.1 VDR "NR1I1, PPP1R163" ENSG00000111424 "Vitamin D receptor" P11473 12 47841537-47943048 "Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 57.1;parathyroid gland: 45.8" "Cell line enhanced" "Detected in many" "HBEC3-KT: 22.7;HDLM-2: 32.0;U-937: 31.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "classical monocyte: 3.7;eosinophil: 2.1;intermediate monocyte: 7.0;myeloid DC: 5.7;neutrophil: 7.5;non-classical monocyte: 6.9" "Group enriched" "Detected in many" 8 "dendritic cells: 5.7;granulocytes: 7.5;monocytes: 7.0" "Region enhanced" "Detected in single" "olfactory region: 2.5" "Low region specificity" "Detected in some" "CAB004617, HPA047740, HPA072102" Supported "Nucleoplasm,Intermediate filaments,Cytosol" Nucleoplasm "Intermediate filaments, Cytosol" "CAB004617: AB_628040, HPA047740: , HPA072102: " "unprognostic (1.11e-2)" "unprognostic (5.49e-2)" "unprognostic (1.01e-1)" "unprognostic (7.59e-3)" "unprognostic (3.33e-3)" "unprognostic (2.74e-2)" "unprognostic (4.78e-2)" "unprognostic (1.69e-1)" "unprognostic (1.40e-1)" "unprognostic (1.62e-1)" "unprognostic (5.53e-3)" "unprognostic (6.72e-2)" "prognostic favourable (4.89e-6)" "unprognostic (1.46e-1)" "unprognostic (8.76e-2)" "unprognostic (3.28e-1)" "unprognostic (3.82e-2)" 3.0 9.2 0.2 10.0 0.3 2.5 7.8 0.3 0.6 3.5 40.9 0.4 4.1 21.2 1.2 7.7 10.2 1.1 10.7 1.5 0.5 0.3 13.0 0.6 8.3 3.8 0.5 0.1 1.3 6.5 45.8 11.7 4.4 0.6 2.1 12.6 0.4 4.9 2.8 5.3 15.2 57.1 1.2 1.5 3.1 2.6 1.5 0.2 2.0 1.9 9.4 8.2 4.0 5.2 0.7 5.7 7.5 7.0 0.2 0.8 1.2 5.4 0.9 0.0 0.0 4.7 6.9 0.1 6.7 3.4 5.7 5.0 4.0 4.6 1.4 7.3 4.6 10.2 0.2 22.7 2.7 32.0 1.6 2.4 1.3 0.3 3.5 4.8 7.7 9.3 10.6 6.3 10.4 0.4 0.7 1.5 2.6 3.7 0.1 2.3 0.0 7.4 0.1 0.0 3.5 5.2 5.5 2.6 0.1 5.7 16.5 2.0 18.6 2.7 0.4 11.0 2.9 3.2 3.8 0.9 0.0 1.2 3.4 31.4 2.7 0.2 3.7 2.1 0.0 7.0 0.1 0.7 0.3 0.0 5.7 0.1 0.1 0.0 7.5 0.2 6.9 0.6 0.8 1.2 0.2 0.3 0.3 0.6 0.5 0.3 0.5 0.1 0.6 0.2 VIM ENSG00000026025 Vimentin P08670 10 17228259-17237593 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 558.9;fHDF/TERT166: 290.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000080, HPA001762, CAB058687" Enhanced Supported "Intermediate filaments" 19000000 "Intermediate filaments" "CAB000080: AB_2304493, CAB058687: , HPA001762: AB_1080568" "unprognostic (1.02e-1)" "unprognostic (2.58e-1)" "unprognostic (2.87e-2)" "prognostic favourable (9.75e-6)" "unprognostic (3.81e-2)" "unprognostic (2.52e-1)" "unprognostic (3.21e-1)" "unprognostic (1.61e-1)" "unprognostic (1.17e-1)" "unprognostic (2.05e-1)" "unprognostic (9.29e-2)" "unprognostic (5.61e-2)" "prognostic unfavourable (8.69e-8)" "unprognostic (1.87e-3)" "unprognostic (7.32e-2)" "unprognostic (1.82e-1)" "unprognostic (9.47e-3)" 254.1 29.2 29.3 51.3 36.2 93.6 285.0 7.5 21.1 137.6 58.0 29.9 46.0 15.8 92.6 100.0 78.4 80.7 71.3 94.8 30.5 14.5 38.7 15.5 100.5 171.0 37.6 26.1 302.9 27.1 32.1 46.2 95.0 38.3 90.5 30.6 161.6 42.6 43.4 52.3 76.2 43.1 101.6 50.7 93.0 38.3 69.8 20.1 56.8 142.0 74.6 73.1 99.2 139.1 24.3 112.1 68.9 90.4 12.2 60.8 61.0 0.5 32.3 58.5 93.3 194.1 558.9 0.0 152.0 101.2 114.7 102.5 0.2 2.0 0.0 8.1 290.4 0.2 8.2 4.2 112.0 100.8 11.3 16.0 16.5 0.0 59.8 8.4 6.6 204.4 0.1 169.2 96.2 186.0 24.8 46.3 203.0 0.1 20.5 25.7 18.6 40.8 16.0 81.2 2.6 114.9 0.0 0.2 28.1 0.0 0.2 152.7 0.2 9.7 157.8 114.4 49.5 95.8 180.1 52.1 26.3 3.7 172.8 0.8 108.7 68.9 90.4 26.5 30.0 59.5 38.6 24.3 49.6 39.1 112.1 14.9 30.8 30.0 53.5 12.2 55.9 44.9 60.8 61.0 29.3 36.2 7.5 20.7 30.5 14.5 37.6 26.1 38.3 20.1 VPS4B "SKD1, SKD1B, VPS4-2" ENSG00000119541 "Vacuolar protein sorting 4 homolog B" O75351 18 63389190-63422483 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040393, CAB046445, HPA057649" Approved Approved "Vesicles,Intermediate filaments" 34000 Vesicles "Intermediate filaments" "CAB046445: AB_10603252, HPA040393: , HPA057649: " "unprognostic (8.54e-2)" "unprognostic (1.06e-1)" "unprognostic (1.85e-3)" "unprognostic (5.59e-2)" "unprognostic (1.71e-1)" "unprognostic (9.47e-2)" "unprognostic (1.75e-1)" "unprognostic (1.79e-1)" "unprognostic (4.54e-2)" "unprognostic (9.10e-2)" "unprognostic (1.94e-3)" "unprognostic (1.67e-1)" "prognostic favourable (1.23e-4)" "unprognostic (4.59e-1)" "unprognostic (1.40e-1)" "unprognostic (4.08e-1)" "unprognostic (1.21e-1)" 16.8 13.0 14.3 14.3 17.2 28.0 17.2 15.4 19.1 19.8 24.0 21.8 15.5 20.0 16.7 12.1 55.0 13.1 15.1 9.9 13.7 16.0 15.6 20.5 14.3 21.6 17.0 14.7 11.9 14.0 17.5 17.4 27.4 23.4 14.3 22.2 9.3 21.8 15.0 9.9 22.1 28.7 15.2 20.2 17.3 18.7 9.0 14.6 27.8 17.0 17.6 31.8 18.6 24.7 20.7 13.6 56.4 20.6 19.1 18.9 15.4 18.4 6.8 7.6 8.3 11.8 16.7 13.2 16.2 15.3 12.4 13.6 5.0 13.2 17.8 10.6 11.8 40.1 9.1 17.7 16.5 12.9 7.3 8.9 9.6 7.7 16.9 30.6 19.5 15.1 27.6 10.9 19.5 11.5 4.4 16.7 17.6 6.4 19.1 9.6 7.9 10.7 16.0 16.2 17.1 15.6 21.7 13.0 11.5 12.2 12.0 18.1 11.5 16.7 17.6 19.2 9.4 7.2 10.6 56.1 26.9 22.9 11.0 14.5 14.2 39.4 16.8 36.0 16.5 16.6 15.4 18.9 17.4 17.0 13.6 20.7 15.8 16.6 56.4 19.1 20.6 13.6 18.9 15.4 14.3 17.2 15.4 19.1 13.7 16.0 17.0 14.7 23.4 14.6 WDR37 KIAA0982 ENSG00000047056 "WD repeat domain 37" Q9Y2I8 10 1049538-1132297 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037376, HPA037565" Enhanced Approved "Intermediate filaments" "Intermediate filaments" "HPA037376: AB_10672789, HPA037565: AB_10696937" "unprognostic (1.50e-2)" "unprognostic (2.07e-1)" "unprognostic (9.08e-3)" "unprognostic (8.51e-3)" "unprognostic (1.81e-1)" "prognostic favourable (1.75e-5)" "unprognostic (2.59e-3)" "unprognostic (3.56e-2)" "unprognostic (1.80e-1)" "unprognostic (1.62e-2)" "prognostic favourable (1.46e-6)" "unprognostic (3.16e-1)" "unprognostic (4.10e-2)" "unprognostic (1.30e-1)" "unprognostic (1.26e-1)" "prognostic unfavourable (1.34e-5)" "unprognostic (5.98e-2)" 10.6 17.4 26.3 11.4 24.2 24.5 10.4 19.4 35.4 7.4 9.2 11.8 10.1 9.8 9.4 12.1 9.9 9.3 8.3 22.1 25.7 14.1 9.7 10.7 10.9 14.6 12.0 29.5 12.4 11.4 12.1 16.3 8.8 16.0 9.5 9.0 10.6 8.9 7.6 21.9 14.9 11.9 8.9 11.7 23.3 11.6 23.3 16.8 7.1 12.8 8.1 12.5 7.7 8.5 7.3 6.7 7.5 8.6 14.0 14.1 6.3 9.4 6.8 8.8 7.2 8.5 12.4 6.7 12.1 6.4 7.3 7.3 8.6 8.2 5.0 7.6 15.3 9.3 4.7 13.6 6.3 6.9 8.5 11.3 6.7 5.8 6.1 6.8 13.0 15.7 10.5 10.3 3.7 16.1 7.6 5.6 11.5 8.3 7.1 5.2 5.1 4.4 11.4 5.2 7.9 10.1 10.1 4.2 8.8 5.6 10.3 9.3 9.8 13.4 21.5 5.9 2.3 19.2 9.4 12.5 10.4 6.7 13.6 7.5 4.3 7.5 6.3 4.7 14.1 8.5 12.0 7.3 8.1 10.4 6.7 6.7 9.1 10.3 6.0 14.0 8.6 6.3 6.8 6.3 26.3 24.2 19.4 35.4 25.7 14.1 12.0 29.5 16.0 16.8 WDR89 "C14orf150, MGC9907" ENSG00000140006 "WD repeat domain 89" Q96FK6 14 63597039-63641861 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000813 Uncertain Approved "Intermediate filaments,Cytosol" "Intermediate filaments, Cytosol" "HPA000813: AB_1078324" "prognostic favourable (3.37e-4)" "unprognostic (6.46e-2)" "unprognostic (5.40e-2)" "unprognostic (1.00e-1)" "unprognostic (6.05e-2)" "unprognostic (3.84e-2)" "prognostic unfavourable (3.26e-4)" "unprognostic (1.05e-1)" "unprognostic (3.08e-2)" "unprognostic (8.66e-3)" "unprognostic (3.63e-1)" "unprognostic (3.28e-1)" "unprognostic (1.86e-1)" "unprognostic (1.09e-2)" "unprognostic (3.08e-1)" "unprognostic (8.63e-2)" "unprognostic (3.29e-1)" 13.2 12.6 11.5 11.6 13.4 4.6 13.7 19.3 18.8 12.5 10.3 9.5 7.4 8.0 14.6 11.5 10.5 11.9 8.6 8.1 11.0 10.7 14.8 16.1 9.1 17.8 15.7 11.6 15.0 14.0 16.2 16.3 12.9 12.3 12.0 12.1 8.3 8.7 8.4 13.2 10.8 8.9 10.5 11.8 13.8 8.5 8.6 14.4 21.0 16.9 7.6 17.0 11.6 10.2 7.0 4.3 0.6 3.6 8.4 14.0 4.9 25.2 11.0 13.8 7.3 8.3 9.1 19.6 10.2 5.6 10.3 11.5 7.8 11.9 24.5 8.4 3.0 11.7 16.8 9.9 18.3 15.8 9.6 16.7 6.9 9.7 10.5 21.1 11.5 8.2 12.9 11.8 17.7 10.0 13.5 13.6 7.7 12.6 17.6 12.0 12.3 21.9 13.1 13.9 13.7 11.4 9.8 11.7 9.6 10.9 11.7 7.7 13.5 11.5 6.9 12.5 11.9 8.1 12.1 7.9 5.9 15.0 5.6 15.6 8.8 0.0 2.5 0.3 8.2 2.5 10.5 7.0 8.7 7.5 4.3 6.9 14.0 12.1 0.6 8.4 3.6 2.8 8.7 4.9 11.5 13.4 19.3 18.8 11.0 10.7 15.7 11.6 12.3 14.4 ZDHHC12 "FLJ14524, ZNF400" ENSG00000160446 "Zinc finger DHHC-type containing 12" Q96GR4 9 128720869-128724127 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 77.4" "Cell line enhanced" "Detected in many" "MCF7: 54.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059339 Uncertain Approved "Nucleoplasm,Intermediate filaments" Nucleoplasm "Intermediate filaments" "HPA059339: " "unprognostic (2.05e-1)" "unprognostic (5.81e-2)" "unprognostic (2.54e-1)" "unprognostic (1.53e-3)" "unprognostic (5.34e-3)" "unprognostic (3.11e-2)" "unprognostic (1.50e-3)" "unprognostic (6.56e-3)" "unprognostic (1.02e-1)" "unprognostic (6.42e-2)" "unprognostic (9.97e-2)" "unprognostic (9.41e-2)" "unprognostic (1.09e-2)" "unprognostic (8.82e-3)" "unprognostic (2.18e-1)" "unprognostic (1.95e-2)" "unprognostic (3.23e-1)" 7.3 10.9 3.9 15.3 4.5 21.8 11.2 2.5 6.5 7.5 21.2 6.8 19.3 16.2 5.9 8.3 27.2 6.9 21.5 9.2 3.5 3.1 20.6 23.6 14.2 28.0 3.8 3.8 5.0 40.5 4.3 5.0 24.7 4.8 11.1 8.4 7.7 26.3 13.3 7.5 16.8 33.0 5.4 5.8 14.9 18.7 9.2 2.7 23.6 10.3 16.4 24.4 10.1 11.7 22.2 50.6 77.4 28.7 17.4 26.1 18.8 14.1 38.8 1.6 8.4 5.1 3.5 16.4 9.2 8.2 10.0 6.7 31.8 16.4 9.9 8.6 6.8 37.5 3.5 18.1 1.0 18.2 9.3 5.2 29.5 13.9 10.3 8.7 24.1 5.6 12.6 8.2 3.1 7.4 5.2 25.2 1.9 54.5 11.9 17.4 7.2 32.1 5.4 5.8 28.4 7.6 13.3 11.6 8.4 12.4 17.2 4.8 26.5 9.3 7.4 0.0 10.5 7.1 12.2 16.3 28.8 4.4 16.8 10.0 11.0 39.2 26.5 77.4 23.5 24.7 20.3 20.3 21.8 22.5 21.0 22.2 22.7 20.6 56.8 17.4 28.7 50.6 26.1 18.8 3.9 4.5 2.5 6.5 3.5 3.1 3.8 3.8 4.8 2.7 ZFC3H1 "CCDC131, CSRC2, KIAA0546, MGC23401, PSRC2" ENSG00000133858 "Zinc finger C3H1-type containing" O60293 12 71609472-71667725 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007072, HPA007151" Enhanced Approved "Nucleoplasm,Intermediate filaments" Nucleoplasm "Intermediate filaments" "HPA007072: AB_1846134, HPA007151: AB_1846133" "unprognostic (3.90e-3)" "unprognostic (3.69e-1)" "unprognostic (2.78e-1)" "unprognostic (2.15e-2)" "unprognostic (9.44e-2)" "unprognostic (6.14e-2)" "prognostic unfavourable (3.63e-4)" "unprognostic (1.00e-1)" "unprognostic (1.15e-1)" "unprognostic (6.56e-2)" "unprognostic (3.80e-2)" "unprognostic (2.53e-3)" "prognostic unfavourable (1.48e-5)" "unprognostic (1.46e-1)" "unprognostic (1.31e-1)" "unprognostic (1.85e-1)" "unprognostic (4.07e-3)" 12.1 12.8 17.6 19.1 17.4 22.7 12.9 35.3 23.8 15.4 16.9 6.7 14.6 8.0 13.7 17.3 15.1 12.8 12.7 12.1 14.6 7.7 10.7 8.0 16.4 19.1 14.8 12.3 17.1 11.6 17.6 17.6 14.6 14.9 12.6 13.2 6.7 12.0 14.2 11.6 12.2 15.2 12.4 14.7 15.9 13.5 17.5 17.6 16.8 13.5 8.4 17.1 15.7 20.8 14.8 12.7 29.7 10.3 4.2 7.2 1.1 10.5 10.7 7.7 5.3 10.7 19.1 4.6 8.2 13.2 13.0 12.9 9.8 5.8 13.6 4.7 10.1 11.3 10.9 4.8 17.4 13.7 8.0 13.2 16.5 4.6 6.0 14.4 6.5 10.7 10.4 9.2 3.9 13.0 12.2 6.0 11.9 3.2 10.2 5.0 7.7 6.2 8.8 9.4 10.4 9.8 7.8 5.3 4.8 8.3 5.3 5.4 14.2 9.5 9.9 7.3 5.0 4.2 4.1 10.5 6.3 10.5 8.6 10.1 5.1 20.7 10.3 12.1 7.2 4.8 5.5 9.2 6.2 4.6 3.9 14.8 5.8 4.9 29.7 4.2 8.7 12.7 4.9 1.1 17.6 17.4 35.3 23.8 14.6 7.7 14.8 12.3 14.9 17.6 ZFP36 "G0S24, NUP475, RNF162A, TIS11, TTP" ENSG00000128016 "ZFP36 ring finger protein" 19 39406813-39409412 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 40.9;hTCEpi: 49.7;Karpas-707: 43.0;U-266/84: 42.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 72.5" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006009 Approved Approved "Intermediate filaments" "Intermediate filaments" "HPA006009: AB_1859030" "unprognostic (2.30e-2)" "unprognostic (2.27e-1)" "unprognostic (8.26e-2)" "unprognostic (6.76e-2)" "unprognostic (4.74e-3)" "unprognostic (1.19e-1)" "unprognostic (2.22e-1)" "unprognostic (4.59e-2)" "unprognostic (5.20e-1)" "unprognostic (3.61e-3)" "unprognostic (9.44e-2)" "unprognostic (3.11e-1)" "unprognostic (4.20e-3)" "unprognostic (5.22e-3)" "unprognostic (1.35e-1)" "unprognostic (7.05e-2)" "unprognostic (6.92e-3)" 109.7 49.3 7.7 112.8 40.3 90.1 63.0 7.5 26.2 60.2 52.9 25.4 12.4 22.8 47.3 23.9 121.7 98.2 78.0 32.5 28.8 7.9 23.2 43.8 124.6 24.9 10.9 2.3 53.9 21.5 29.3 31.4 20.8 47.7 55.8 26.4 45.3 34.3 46.6 82.9 61.6 58.0 56.4 50.0 35.1 42.7 27.8 8.4 15.5 35.5 106.5 58.3 114.5 57.7 12.0 15.4 72.5 19.3 3.8 9.5 7.9 6.8 4.2 1.1 0.8 31.5 40.9 2.1 5.4 6.6 3.2 2.4 3.6 7.4 4.5 1.6 9.4 3.5 0.6 10.2 0.9 4.9 0.4 1.9 3.3 2.2 18.1 1.6 12.0 16.9 49.7 2.4 18.1 1.8 2.5 43.0 5.5 6.3 2.9 4.3 0.3 0.7 4.6 0.6 8.3 3.7 12.4 0.4 1.1 2.4 6.2 1.3 4.3 9.7 2.6 4.2 1.5 7.4 1.5 31.7 42.6 4.8 3.8 3.7 1.6 23.9 14.9 15.0 9.5 15.6 7.7 11.2 8.0 9.5 15.4 12.0 9.2 8.7 72.5 3.8 19.3 11.8 9.2 7.9 7.7 40.3 7.5 26.2 28.8 7.9 10.9 2.3 47.7 8.4 ZIK1 ZNF762 ENSG00000171649 "Zinc finger protein interacting with K protein 1" Q3SY52 19 57578456-57593777 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 16.5;NTERA-2: 19.7;REH: 14.2;U-266/84: 18.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059975 Uncertain Approved "Intermediate filaments" "Intermediate filaments" "HPA059975: " "unprognostic (2.14e-2)" "unprognostic (9.03e-3)" "unprognostic (9.42e-2)" "unprognostic (1.83e-1)" "unprognostic (3.77e-2)" "unprognostic (1.34e-4)" "unprognostic (2.22e-1)" "unprognostic (1.28e-1)" "unprognostic (1.90e-2)" "unprognostic (1.13e-1)" "unprognostic (8.16e-3)" "unprognostic (1.02e-1)" "unprognostic (4.18e-6)" "unprognostic (6.21e-2)" "unprognostic (5.15e-1)" "unprognostic (5.21e-2)" "unprognostic (3.50e-1)" 4.0 4.9 5.6 4.1 6.7 6.2 5.2 14.4 8.2 5.2 4.5 4.8 4.7 1.2 5.0 7.5 2.3 8.3 4.0 5.4 4.3 5.0 3.8 1.3 4.1 10.8 3.7 5.3 10.4 2.7 12.9 6.2 5.4 5.5 6.2 2.4 7.5 5.7 7.2 5.0 3.8 5.0 4.5 3.7 8.4 2.8 8.2 3.0 12.7 9.3 1.9 10.1 6.5 2.8 10.8 3.3 8.8 2.2 4.3 8.4 3.0 0.0 0.0 13.0 0.0 0.5 0.5 0.0 4.5 4.2 6.5 5.9 0.0 0.1 0.0 3.2 2.2 0.3 0.0 7.2 9.3 0.0 16.5 2.6 0.0 1.3 1.5 0.0 4.9 2.7 0.0 5.0 0.0 0.5 0.1 0.0 2.1 0.0 9.7 1.3 19.7 1.6 14.2 0.0 3.1 1.9 0.0 9.5 9.6 0.1 0.0 0.4 0.0 0.2 0.0 6.0 3.1 0.0 5.2 0.1 18.5 4.8 0.0 0.0 5.8 2.1 1.8 8.8 2.2 2.2 4.4 8.0 4.3 2.8 2.9 10.8 8.4 3.9 0.5 4.3 1.8 3.3 4.9 3.0 5.6 6.7 14.4 8.2 4.3 5.0 3.7 5.3 5.5 3.0 ZKSCAN5 "ZFP95, ZNF914, ZSCAN37" ENSG00000196652 "Zinc finger with KRAB and SCAN domains 5" Q9Y2L8 7 99504651-99534700 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003201 Uncertain Approved "Intermediate filaments" "Intermediate filaments" "HPA003201: AB_10610701" "unprognostic (2.47e-1)" "unprognostic (2.34e-2)" "unprognostic (2.99e-2)" "unprognostic (2.18e-1)" "unprognostic (4.42e-2)" "unprognostic (1.74e-1)" "prognostic unfavourable (7.59e-6)" "unprognostic (1.12e-1)" "unprognostic (2.15e-2)" "unprognostic (2.62e-1)" "unprognostic (5.35e-2)" "unprognostic (8.07e-2)" "unprognostic (1.18e-2)" "unprognostic (6.82e-2)" "unprognostic (1.66e-2)" "prognostic unfavourable (1.13e-4)" "unprognostic (3.42e-1)" 6.3 7.2 8.4 5.9 11.8 5.4 8.1 16.5 12.6 7.2 6.1 12.9 3.8 3.7 7.7 8.4 5.4 7.6 5.9 7.4 9.8 8.2 7.4 6.6 6.8 6.7 9.9 8.2 8.9 7.6 10.5 9.0 7.7 9.8 7.6 6.4 6.8 4.7 8.8 9.5 5.2 5.3 9.9 7.2 6.9 5.5 17.8 10.2 12.5 8.7 4.6 8.6 7.3 5.8 1.7 4.0 4.7 2.8 3.8 4.7 2.4 5.6 9.5 11.4 15.0 8.5 6.3 4.6 9.8 10.0 12.1 11.9 6.5 5.3 9.6 9.3 7.6 4.1 10.4 6.8 12.3 5.8 5.0 6.1 6.4 6.1 8.6 9.1 10.3 5.6 9.6 10.5 16.2 8.6 12.8 13.6 12.9 7.2 13.0 10.0 9.7 7.6 8.0 10.1 8.2 7.6 5.7 8.0 13.0 9.2 8.0 7.1 5.0 7.0 7.7 15.3 11.1 12.2 8.3 9.1 12.8 15.1 6.8 6.1 13.5 1.3 1.5 4.7 4.7 2.8 4.1 1.7 1.7 2.3 4.0 0.9 3.5 3.7 0.3 3.8 1.7 1.6 2.9 2.4 8.4 11.8 16.5 12.6 9.8 8.2 9.9 8.2 9.8 10.2 ZNF131 "pHZ-10, ZBTB35" ENSG00000172262 "Zinc finger protein 131" P52739 5 43065176-43192021 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007023, HPA027748, HPA074630" Approved Enhanced "Nucleoplasm,Intermediate filaments" Nucleoplasm "Intermediate filaments" "HPA007023: , HPA027748: , HPA074630: " "unprognostic (1.23e-1)" "unprognostic (8.24e-2)" "unprognostic (4.70e-2)" "unprognostic (7.97e-2)" "unprognostic (8.84e-2)" "unprognostic (7.18e-2)" "prognostic unfavourable (1.56e-4)" "unprognostic (2.52e-1)" "unprognostic (2.98e-3)" "unprognostic (1.94e-2)" "unprognostic (5.83e-2)" "unprognostic (8.07e-2)" "unprognostic (2.09e-2)" "unprognostic (1.47e-2)" "unprognostic (2.76e-1)" "unprognostic (3.11e-3)" "unprognostic (1.46e-2)" 16.0 14.3 15.0 18.6 16.7 24.3 20.3 24.8 18.5 18.9 13.0 10.6 10.3 10.0 19.3 10.3 15.3 13.4 13.3 10.8 15.1 13.0 12.3 14.8 12.6 21.6 12.8 14.6 21.6 16.1 13.9 17.3 20.0 14.2 13.9 13.8 8.1 11.9 16.0 16.5 18.2 12.9 16.5 11.9 16.1 12.5 31.0 13.0 27.2 15.5 15.3 17.2 15.5 18.0 13.0 8.9 7.9 7.1 11.7 18.3 7.4 10.4 6.4 13.9 18.5 13.2 9.1 11.8 13.8 11.3 13.8 11.7 10.0 9.4 21.1 11.3 9.2 7.4 16.4 8.7 19.5 10.2 14.5 13.0 36.7 7.4 12.2 22.4 10.6 8.2 16.7 10.1 16.6 10.5 16.5 22.6 15.6 10.1 21.9 28.3 9.2 10.6 14.5 21.3 16.4 11.6 10.2 8.6 12.7 35.2 17.1 17.7 9.5 21.4 7.8 17.3 16.1 8.8 12.9 9.1 12.9 24.0 9.1 29.6 11.5 7.9 6.1 4.1 15.0 7.1 15.3 10.1 14.9 14.5 8.9 13.0 18.3 14.6 3.1 11.7 4.8 8.5 10.8 7.4 15.0 16.7 24.8 18.5 15.1 13.0 12.8 14.6 14.2 13.0 ZNF132 pHZ-12 ENSG00000131849 "Zinc finger protein 132" P52740 19 58432814-58440222 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008726 Uncertain Approved "Vesicles,Intermediate filaments" Vesicles "Intermediate filaments" "HPA008726: AB_1080664" "unprognostic (4.86e-2)" "unprognostic (2.03e-1)" "unprognostic (6.79e-3)" "unprognostic (3.06e-2)" "unprognostic (8.16e-2)" "unprognostic (4.78e-2)" "unprognostic (4.02e-2)" "unprognostic (2.32e-3)" "unprognostic (5.00e-2)" "unprognostic (1.29e-1)" "prognostic favourable (1.92e-4)" "unprognostic (4.51e-1)" "prognostic favourable (7.26e-13)" "unprognostic (2.70e-1)" "unprognostic (7.65e-2)" "unprognostic (6.09e-2)" "unprognostic (3.72e-1)" 2.9 4.7 4.0 2.5 5.9 0.8 5.1 11.8 8.5 5.9 4.1 6.6 4.5 2.5 4.2 7.2 3.5 7.9 4.7 5.9 6.0 4.5 6.2 2.1 3.6 3.3 4.4 5.5 7.6 4.3 15.3 12.1 3.7 5.9 6.1 2.4 5.4 5.8 6.7 3.7 4.7 2.6 5.9 4.2 4.5 3.6 7.2 6.0 3.1 10.8 2.8 4.3 5.7 6.3 3.9 2.9 2.0 2.6 2.6 5.7 2.1 1.7 2.1 4.8 1.7 5.6 4.6 0.2 3.6 4.5 3.0 2.7 0.1 1.4 4.5 0.3 4.4 1.8 0.0 5.4 2.1 0.7 8.2 0.8 1.4 1.0 5.0 1.7 3.0 5.1 1.9 5.1 3.2 2.6 0.7 0.5 5.6 0.6 1.0 0.1 4.9 1.7 0.6 1.1 1.3 1.8 2.0 4.3 4.4 1.4 1.3 1.5 0.3 4.4 3.3 3.1 0.4 0.8 0.7 5.9 1.1 0.0 1.5 0.1 1.9 0.0 1.9 2.0 2.2 2.2 5.7 2.9 2.9 1.2 2.9 3.9 4.6 3.7 0.2 2.6 2.6 2.4 2.5 2.1 4.0 5.9 11.8 8.5 6.0 4.5 4.4 5.5 5.9 6.0 ZNF175 OTK18 ENSG00000105497 "Zinc finger protein 175" Q9Y473 19 51571298-51592508 "Predicted intracellular proteins, Transcription factors" "Antiviral defense, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 25.7;RT4: 23.4;TIME: 23.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA002717 Uncertain Supported "Nucleoplasm,Intermediate filaments,Cytosol" Cytosol "Nucleoplasm, Intermediate filaments" "HPA002717: AB_1080681" "unprognostic (9.41e-2)" "unprognostic (1.43e-1)" "unprognostic (2.44e-1)" "unprognostic (1.59e-1)" "unprognostic (1.46e-1)" "unprognostic (9.50e-3)" "unprognostic (2.44e-1)" "unprognostic (1.84e-1)" "unprognostic (7.33e-3)" "unprognostic (9.94e-2)" "unprognostic (6.33e-3)" "unprognostic (6.20e-2)" "unprognostic (1.35e-3)" "unprognostic (1.50e-2)" "unprognostic (2.01e-1)" "prognostic unfavourable (6.64e-4)" "unprognostic (3.50e-3)" 6.1 6.7 11.2 6.1 12.6 4.7 8.4 26.2 16.0 7.7 6.5 7.1 9.4 8.4 9.2 8.5 5.5 7.6 4.9 6.6 12.7 7.4 7.3 6.4 8.0 8.7 11.1 10.3 14.5 7.3 19.8 10.9 12.1 11.4 7.6 6.1 6.4 9.1 9.5 6.4 5.5 7.9 8.1 8.8 9.7 6.7 15.0 11.7 9.2 10.8 5.0 9.2 8.7 11.9 2.1 4.6 0.6 1.3 0.9 2.2 0.7 1.8 3.3 3.3 3.5 3.5 4.9 0.0 4.2 5.4 3.9 4.8 3.3 2.8 3.4 2.4 4.2 3.1 3.5 2.9 7.1 0.0 5.2 25.7 5.0 1.1 3.1 4.3 16.6 1.9 2.7 8.0 3.9 6.3 8.6 3.5 4.3 0.0 4.6 3.2 1.8 3.3 0.0 4.3 1.6 2.1 23.4 4.2 3.0 3.9 1.3 2.5 1.0 3.5 23.7 6.0 2.7 1.4 4.0 4.6 8.5 3.4 16.8 2.5 3.0 0.1 1.3 0.0 1.7 0.5 1.8 1.9 1.6 1.4 1.4 2.1 2.2 1.7 0.6 0.9 0.3 4.6 0.3 0.7 11.2 12.6 26.2 16.0 12.7 7.4 11.1 10.3 11.4 11.7 ZNF189 ENSG00000136870 "Zinc finger protein 189" O75820 9 101398873-101410660 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 61.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034814 Uncertain Approved "Intermediate filaments" "Intermediate filaments" "HPA034814: AB_10601030" "unprognostic (3.87e-2)" "unprognostic (3.47e-1)" "unprognostic (5.30e-2)" "unprognostic (2.75e-1)" "unprognostic (6.45e-2)" "unprognostic (1.42e-1)" "unprognostic (1.26e-2)" "unprognostic (3.59e-3)" "unprognostic (1.70e-2)" "unprognostic (1.15e-1)" "unprognostic (1.38e-1)" "unprognostic (1.10e-1)" "prognostic favourable (5.32e-4)" "unprognostic (3.31e-1)" "unprognostic (4.58e-1)" "unprognostic (1.86e-2)" "unprognostic (6.57e-2)" 15.6 15.8 15.1 6.3 28.2 2.8 11.6 13.9 15.9 9.5 9.0 16.8 9.0 8.6 10.0 61.6 5.5 7.8 16.3 10.9 18.7 9.3 10.6 12.5 6.8 6.8 15.4 11.4 11.8 23.0 11.2 23.6 6.3 14.1 10.3 7.5 5.0 6.7 9.4 11.6 4.4 9.7 9.7 25.1 9.9 8.7 9.3 16.1 8.5 9.6 3.7 10.2 6.1 8.0 3.6 2.2 4.1 3.0 3.6 4.7 1.9 5.4 4.5 14.8 10.8 13.2 9.3 7.1 7.8 12.1 9.2 8.0 9.5 4.3 7.4 5.4 9.4 10.8 7.3 7.4 8.2 9.7 5.1 8.1 7.1 20.3 9.9 8.4 7.1 11.3 10.3 8.2 12.8 11.5 9.5 10.7 13.5 3.0 10.1 3.6 10.7 5.1 7.2 21.2 5.6 8.8 6.4 15.4 9.7 8.5 5.9 8.5 4.8 10.7 9.6 9.1 6.6 7.5 6.0 10.2 15.7 3.6 7.8 3.3 9.1 1.3 2.5 4.1 2.3 3.0 2.4 2.8 4.0 4.7 2.2 3.6 4.7 4.1 1.4 3.6 2.3 1.7 2.0 1.9 15.1 28.2 13.9 15.9 18.7 9.3 15.4 11.4 14.1 16.1 ZNF404 ENSG00000176222 "Zinc finger protein 404" Q494X3 19 43872363-43901385 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 8.4;U-2 OS: 30.8" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA032014, HPA063607" Uncertain Supported "Nucleoli,Intermediate filaments" Nucleoli "Intermediate filaments" "HPA032014: AB_10602591, HPA063607: " "unprognostic (3.76e-3)" "unprognostic (3.41e-1)" "unprognostic (1.11e-2)" "unprognostic (4.32e-3)" "unprognostic (8.92e-2)" "unprognostic (2.82e-1)" "unprognostic (1.64e-2)" "unprognostic (2.68e-2)" "unprognostic (7.47e-2)" "unprognostic (1.26e-1)" "unprognostic (2.03e-5)" "unprognostic (1.46e-2)" "unprognostic (3.79e-3)" "unprognostic (2.89e-2)" "unprognostic (1.59e-1)" "unprognostic (2.12e-1)" "unprognostic (4.80e-3)" 0.9 2.2 4.6 0.7 4.8 0.1 2.6 5.8 4.8 1.5 2.5 0.2 2.0 10.9 1.2 3.7 2.2 6.0 4.6 4.4 1.5 1.0 1.8 3.1 6.0 7.5 0.8 2.6 8.2 2.6 4.6 1.6 2.6 2.2 1.5 2.9 1.0 1.8 7.0 3.9 1.9 3.4 2.6 1.2 1.5 1.1 1.9 0.9 1.9 0.4 2.1 1.9 0.6 2.2 0.3 2.3 0.3 5.9 8.4 1.4 3.1 1.5 2.0 2.8 0.2 0.8 0.0 3.3 1.5 0.3 0.4 1.6 2.7 0.3 2.3 0.8 0.0 0.9 2.1 0.2 0.6 5.0 3.8 1.5 1.4 1.7 0.1 0.0 1.8 0.2 0.0 0.0 1.9 0.5 0.0 1.3 0.4 1.9 1.5 1.2 1.0 1.3 0.6 1.6 0.1 0.9 0.7 2.9 30.8 2.5 1.8 4.0 5.2 0.0 4.1 0.0 1.6 0.0 0.3 1.9 0.7 0.0 0.8 0.9 1.4 0.0 0.4 1.9 1.9 1.5 0.0 2.1 0.4 0.9 1.3 0.6 ZNF557 MGC4054 ENSG00000130544 "Zinc finger protein 557" Q8N988 19 7069444-7087968 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA003151, HPA029291" Uncertain Approved "Nucleoplasm,Intermediate filaments,Cytosol" "Nucleoplasm, Intermediate filaments" Cytosol "HPA003151: AB_1859344, HPA029291: AB_10602357" "unprognostic (1.05e-1)" "unprognostic (2.96e-3)" "unprognostic (5.29e-2)" "prognostic favourable (5.70e-4)" "unprognostic (2.56e-2)" "prognostic favourable (3.67e-6)" "unprognostic (1.32e-1)" "prognostic favourable (2.62e-4)" "unprognostic (2.51e-2)" "unprognostic (2.51e-2)" "prognostic favourable (1.51e-4)" "unprognostic (2.28e-1)" "unprognostic (2.24e-2)" "unprognostic (1.52e-3)" "unprognostic (4.71e-2)" "unprognostic (6.18e-2)" "unprognostic (2.81e-3)" 6.8 9.2 7.2 8.1 9.4 13.1 8.5 12.4 9.9 7.0 6.5 11.1 7.2 5.1 9.5 7.7 8.7 8.5 6.0 5.5 5.9 5.6 6.9 10.3 6.8 9.7 7.6 8.1 9.8 9.0 7.0 12.9 6.7 9.2 7.5 6.4 7.2 9.2 10.5 5.3 7.2 7.6 7.6 6.7 11.7 8.0 8.4 9.8 21.7 9.0 4.0 11.3 7.0 7.1 10.7 11.1 9.3 6.7 13.7 11.5 4.0 3.6 4.4 4.0 8.2 6.3 4.6 3.3 3.8 4.9 5.1 6.8 5.0 2.5 7.0 6.8 4.7 4.9 7.9 5.1 4.8 9.0 4.8 10.1 7.8 2.6 4.4 10.1 10.8 6.1 5.9 5.5 7.5 4.7 4.1 12.6 7.4 5.3 7.8 3.1 3.9 6.2 5.5 6.0 4.2 3.2 9.4 4.7 5.8 5.7 4.2 4.4 3.5 6.2 6.9 4.4 3.2 8.5 4.1 12.0 9.2 6.7 4.8 5.4 3.4 9.3 6.7 8.6 9.5 5.5 10.6 7.6 10.3 8.6 7.2 10.7 11.5 9.6 7.4 13.7 5.2 11.1 9.3 4.0 7.2 9.4 12.4 9.9 5.9 5.6 7.6 8.1 9.2 9.8 ZNF573 FLJ30921 ENSG00000189144 "Zinc finger protein 573" Q86YE8 19 37735833-37817300 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA042776 Uncertain Approved "Intermediate filaments,Cytosol" "Intermediate filaments" Cytosol "HPA042776: AB_10961399" "unprognostic (3.79e-2)" "unprognostic (2.57e-1)" "unprognostic (1.29e-1)" "unprognostic (2.77e-2)" "unprognostic (3.72e-2)" "unprognostic (3.29e-2)" "unprognostic (8.26e-2)" "unprognostic (1.10e-1)" "unprognostic (3.62e-2)" "unprognostic (3.69e-1)" "unprognostic (1.03e-1)" "unprognostic (9.16e-2)" "unprognostic (9.97e-3)" "unprognostic (1.71e-1)" "unprognostic (2.17e-1)" "unprognostic (3.11e-2)" "unprognostic (2.60e-2)" 6.2 6.4 7.3 4.2 8.6 7.2 7.6 14.1 9.5 6.3 4.6 8.6 5.2 4.3 7.5 10.8 4.8 5.0 6.8 5.3 5.8 4.1 5.3 4.2 6.0 4.1 10.0 5.7 8.4 6.8 6.7 11.7 5.7 6.2 5.5 4.9 5.9 6.4 5.6 5.3 7.8 5.3 6.9 6.8 5.3 7.5 10.0 9.5 4.5 9.8 4.0 6.2 7.4 6.2 6.3 3.3 3.3 2.6 3.6 5.7 1.0 1.0 3.6 2.8 2.4 1.4 3.4 1.2 2.3 2.7 0.9 2.2 3.5 2.8 3.5 2.3 2.1 2.2 2.8 3.8 3.4 1.8 1.9 4.0 5.4 1.8 1.4 3.3 2.6 3.0 1.4 4.8 2.1 2.8 1.8 1.6 0.7 1.4 2.7 2.0 4.5 0.4 2.8 5.7 1.1 0.2 1.6 3.7 3.7 4.6 1.5 0.4 3.5 3.1 1.0 3.2 3.3 2.8 3.8 4.2 5.3 5.7 0.8 0.4 2.6 3.2 1.0 3.3 4.2 1.2 3.4 3.4 3.5 4.5 1.9 6.3 5.7 4.4 0.4 3.6 2.6 3.3 2.0 1.0 7.3 8.6 14.1 9.5 5.8 4.1 10.0 5.7 6.2 9.5 ZNF619 FLJ90764 ENSG00000177873 "Zinc finger protein 619" Q8N2I2 3 40477113-40490236 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045094 Uncertain Approved "Nucleoplasm,Intermediate filaments" Nucleoplasm "Intermediate filaments" "HPA045094: AB_10959900" "unprognostic (7.16e-2)" "unprognostic (5.94e-1)" "unprognostic (8.38e-3)" "unprognostic (5.42e-2)" "unprognostic (8.16e-3)" "unprognostic (1.32e-2)" "unprognostic (5.59e-2)" "unprognostic (1.85e-1)" "unprognostic (5.46e-2)" "unprognostic (2.65e-1)" "unprognostic (7.99e-2)" "unprognostic (6.15e-3)" "unprognostic (8.28e-6)" "unprognostic (1.94e-1)" "unprognostic (1.69e-1)" "unprognostic (6.56e-2)" "unprognostic (1.38e-2)" 8.8 7.6 6.3 9.2 9.5 9.0 9.2 7.9 8.7 7.0 6.7 13.3 8.4 7.3 9.3 6.6 6.4 8.4 8.9 6.9 7.8 5.8 7.1 8.1 9.6 18.0 12.7 9.2 9.4 12.3 14.0 6.6 6.3 7.3 7.0 8.2 9.7 8.6 10.4 8.5 7.3 7.5 7.6 9.6 9.0 7.3 3.8 9.3 6.0 10.2 5.0 9.4 8.0 6.8 4.1 4.5 5.1 4.5 5.2 5.1 2.7 2.7 4.0 4.7 4.1 6.8 7.2 1.7 3.6 4.4 7.0 6.9 1.2 3.9 0.3 2.2 3.4 3.0 4.3 7.4 7.6 4.7 1.6 8.2 3.2 1.9 7.2 5.8 7.4 5.8 5.6 7.1 10.5 6.4 5.4 3.9 4.3 3.4 0.1 2.6 2.5 3.6 1.6 4.8 4.5 2.9 6.3 3.0 3.1 4.0 5.9 3.2 4.8 3.8 4.9 5.1 3.9 2.8 4.1 2.2 2.8 0.3 3.1 3.6 5.3 2.8 3.2 5.1 3.0 4.5 3.3 3.3 3.0 3.8 4.5 4.1 3.1 3.9 3.8 5.2 4.3 2.8 5.1 2.7 6.3 9.5 7.9 8.7 7.8 5.8 12.7 9.2 7.3 9.3 ZNF774 MGC75360 ENSG00000196391 "Zinc finger protein 774" Q6NX45 15 90352245-90369146 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA030839, HPA030840" Uncertain Supported "Intermediate filaments,Cytosol" "Intermediate filaments" Cytosol "HPA030839: , HPA030840: AB_10602691" "unprognostic (1.11e-1)" "unprognostic (2.14e-1)" "unprognostic (1.38e-1)" "unprognostic (5.82e-3)" "unprognostic (3.29e-2)" "unprognostic (1.35e-1)" "unprognostic (6.89e-2)" "unprognostic (9.22e-3)" "unprognostic (7.82e-2)" "unprognostic (1.94e-1)" "unprognostic (3.43e-1)" "unprognostic (2.89e-2)" "unprognostic (2.71e-1)" "unprognostic (5.62e-2)" "unprognostic (1.27e-1)" "unprognostic (4.48e-2)" "unprognostic (4.82e-2)" 1.5 5.1 5.8 3.6 8.6 1.6 5.7 14.0 8.7 5.0 7.5 4.1 0.0 3.9 5.5 7.3 2.8 5.3 5.1 4.2 4.8 5.4 2.6 2.9 2.1 1.2 3.9 5.9 2.3 6.5 7.1 5.7 1.3 9.4 4.3 12.4 3.0 6.8 10.3 11.9 5.3 3.5 3.3 3.1 1.3 4.6 8.2 4.7 3.8 4.9 3.1 1.7 3.9 3.5 2.0 1.9 4.2 1.1 2.7 1.3 0.4 2.3 1.1 3.1 3.4 1.3 0.7 7.1 1.5 2.4 1.8 2.3 3.7 2.8 0.9 2.8 1.7 3.5 3.0 5.0 1.8 1.7 6.0 2.4 11.3 1.7 2.3 1.4 2.0 0.7 6.1 2.7 2.6 3.1 2.7 1.2 3.0 2.3 1.9 1.3 0.9 3.6 1.8 2.6 0.7 3.7 6.3 6.9 2.9 2.8 4.4 1.2 2.9 0.4 1.6 2.1 1.9 1.7 3.0 7.4 5.0 0.6 3.3 3.9 0.9 3.6 1.1 2.2 1.0 0.5 0.7 0.9 0.8 1.3 1.9 2.0 1.0 0.9 4.2 2.7 0.6 1.2 0.5 0.4 5.8 8.6 14.0 8.6 4.8 5.4 3.9 5.9 9.4 4.7 ZYG11B "FLJ13456, ZYG11" ENSG00000162378 "Zyg-11 family member B, cell cycle regulator" Q9C0D3 1 52726467-52827342 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 63.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028156 Uncertain Approved "Golgi apparatus,Intermediate filaments" "Golgi apparatus, Intermediate filaments" "HPA028156: AB_10602360" "unprognostic (2.54e-1)" "unprognostic (2.02e-1)" "prognostic favourable (5.42e-6)" "unprognostic (1.58e-2)" "unprognostic (4.44e-2)" "unprognostic (3.04e-3)" "unprognostic (7.15e-2)" "unprognostic (1.85e-1)" "unprognostic (4.84e-3)" "unprognostic (5.06e-2)" "unprognostic (2.76e-1)" "unprognostic (6.08e-2)" "prognostic favourable (9.80e-7)" "unprognostic (2.22e-1)" "unprognostic (3.37e-1)" "unprognostic (1.13e-1)" "unprognostic (9.57e-2)" 8.9 9.1 10.8 5.6 15.6 7.1 7.7 22.3 21.7 9.9 10.4 9.1 5.6 4.7 11.0 6.5 9.7 7.3 6.8 15.9 10.7 15.4 12.9 17.7 7.7 5.0 10.1 11.6 11.3 6.5 12.7 9.1 7.2 16.4 9.8 7.9 10.1 6.1 9.2 63.9 6.5 5.8 12.3 8.4 5.7 6.3 8.4 7.7 6.9 12.7 11.4 5.7 9.2 7.0 2.2 2.2 5.7 2.4 2.1 3.8 1.0 8.1 7.4 9.4 11.7 17.3 15.1 8.2 9.2 11.8 7.3 6.8 6.3 2.7 7.8 9.3 17.8 4.2 10.7 8.1 11.7 6.5 7.0 10.0 8.5 3.9 9.2 7.5 6.2 10.7 8.8 10.5 7.4 12.7 8.9 1.6 13.2 3.4 2.9 4.7 9.7 7.7 5.1 17.8 7.1 7.5 12.9 4.3 8.8 16.0 10.0 8.5 6.0 5.8 14.6 11.4 6.7 11.2 5.7 6.8 8.2 6.0 7.8 5.1 7.3 1.0 2.4 2.7 2.1 1.3 2.3 2.2 2.6 1.6 2.2 2.1 3.8 2.7 5.7 2.1 2.0 1.7 3.0 1.0 10.8 15.6 22.3 21.7 10.7 15.4 10.1 11.6 16.4 7.7